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Apolipoproteins are major determinants of plasma lipoprotein-lipid distribution. Dyslipidemia 
with elevated level of low-density lipoprotein cholesterol (LDL-C) and decreased level of high-
density lipoprotein cholesterol (HDL-C) is associated with increased risk of cardiovascular 
disease (CVD), which is a major public health problem worldwide. Therefore, unraveling the 
genetic basis of plasma lipoprotein-lipid traits would provide insight into risk prediction and 
contribute to the developing of new therapeutic and intervention measures to reduce the CVD 
burden, which has a public health importance. The objective of this study was to characterize 
genetic variation in the APOE-C1-C4-C2 gene cluster on chromosome 19q13.32 by resequencing 
selected individuals from non-Hispanic White (NHW) and African Black populations with 
extreme lipid profile and then genotyping the identified sequence variants (common tagSNPs and 
rare variants) along with the HapMap tagSNPs covering the intergenic regions in the entire 
datasets (623 NHWs, and 788 Blacks) to evaluate their association with major lipid traits. 
Sequencing of the four apolipoprotein genes along with their hepatic control regions in subjects 
falling in the upper (47 NHWs, 48 Blacks), and lower (48 NHWs, 47 Blacks) 10th percentile 
distribution of HDL-C/triglycerides (TG) revealed 230 variants (215 substitution, 15 indels), of 
which 63 were shared in both populations, 52 were NHW-specific and 115 were Black-specific. 
A total of 70 variants (65 sequencing-identified, 5 HapMap tagSNPs) in NHWs and 108 variants 
(103 sequencing-identified, 5 HapMap tagSNPs) in Blacks were successfully genotyped in the 
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entire datasets and were considered for the association analyses. Twenty variants in NHWs and 
twenty-four variants in Blacks (MAF>1%) showed nominally significant association (P<0.05) 
with at least one lipid trait. Although the major contribution of the APOE-C1-C4-C2 gene cluster 
was on LDL-C and apolipoprotein (apo) B, we observed multiple associations with other lipid 
traits, including TG, HDL-C, and apoA1. In addition to the significant contribution of common 
variants, rare/less common variants showed significant association with lipid traits. Our findings 
confirm the significant contribution of APOE-C1-C4-C2 genetic variation in affecting plasma 
lipid profile in the general population and consequently the CVD risk. 
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1.0  IMPORTANCE AND SIGNIFICANCE 
Cardiovascular disease (CVD) continues to be a leading cause of death worldwide (Ordovas and 
Shen, 2008), which makes CVD a public health burden, and determining individuals with high 
risk of developing CVD is a public health initiative. CVD is a complex disease in which multiple 
genetic and environmental factors modulate its risk (Ordovas and Shen, 2008). Hyperlipidemia 
with increased low-density lipoprotein cholesterol (LDL-C), and decreased high-density 
lipoprotein cholesterol (HDL-C) amplifies the risk of CVD (Kones, 2011). Although lipoprotein-
lipids are complex quantitative traits in which multiple genetic and environmental factors 
influence their distribution pattern in the circulation, about 40-80% of their inter-individual 
variation is under genetic control (Beekman et al., 2003; Lusis et al., 2004).  
Genome-wide association studies (GWAS), which are based on “Common Disease 
Common Variants” (CDCV) hypothesis, had accelerated success in identifying about 100 loci 
for plasma lipid traits (Teslovich et al., 2010). However, the identified variants from GWAS 
explain a small portion of lipid trait heritability (Weisglass-Volkov and Pajukanta, 2010). This 
indicates that CDCV hypothesis is not sufficient to explain the entire genetic basis of complex 
traits and emphasizes on the role of multiple rare variants with moderate to large effect sizes that 
may explain the remaining variance of lipid traits (Manolio, 2009; Schork et al., 2009; Johansen 
et al., 2010; Johansen and Hegele, 2012; Cohen et al., 2004; Cohen et al., 2005; Kotowski et al., 
2006; Romeo et al., 2007; Pollin et al., 2008). Since the existing data support both CDCV and 
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“Common Disease-Rare Variants” (CDRV) hypotheses (Anderson et al., 2011), in this study we 
have integrated both hypotheses to investigate the potential effect of both rare and common 
genetic variation in biological candidate genes on plasma lipoprotein-lipid traits.   
1.1 CARDIOVASCULAR DISEASE 
Cardiovascular disease, the leading cause of morbidity and mortality worldwide, is a complex 
disease in which multiple genetic and environmental factors modulate its risk (Ordovas and 
Shen, 2008). Several CVD risk factors have been defined, including non-modifiable factors such 
as age, sex, and genetic background, and modifiable factors such as dyslipidemia, obesity, 
hypertension, and insulin resistance. Most of the CVD risk factors have genetic determinants and 
there is strong evidence that genes affect lipoproteins levels, blood pressure, diabetes, obesity, 
coagulation, immune system, and the vessel walls integrity and reactivity, all influence the CVD 
risk (Breslow, 2000). 
Cardiovascular disease is a common disease and it is estimated that 1 in 3 subjects are 
affected with this CVD. Moreover, CVD is the leading cause of death in United States and it 
accounts for 36% of the total deaths (Rosamond et al., 2008; CDC, 2010). The annual direct and 
indirect health care cost of CVD is approximately $444 billion (CDC, 2010). Therefore, CVD is 
a major public health problem and lowering the prevalence of CVD is a public health challenge. 
CVD risk could be manageable in individuals with a high genetic risk through modulating their 
life style. Because of the inverse correlation between HDL-C and CVD risk (Kones, 2011), 
increasing HDL-C is the primary therapeutic target. Life style modification including, regular 
exercise, weight control, increased monosaturated fat intake, and smoking cessation, has been 
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recommended to be the primary intervention measures to treat patients with low HDL-C level 
(Gotto, 2001). 
Atherosclerosis is the primary manifestation of CVD as a result of cholesterol 
accumulation on the arterial walls resulting in narrowing down the vascular vessels diameter and 
blockage the blood flow. Atherosclerosis is a complicated mechanism that involves multiple 
cellular types and biological processes. Under normal condition, cholesterol-containing 
lipoproteins such as, chylomicron remnants (CM), very low-density lipoprotein (VLDL), and 
LDL do not accumulate in the vascular endothelium cells. On the other hand, under abnormal 
condition of the lipid metabolism, cholesterol gets accumulated in the peripheral tissues and 
penetrated to the vascular endothelium cells. Once the cholesterol gets retained in the vascular 
sub endothelium cells, it gets oxidatively modified followed by triggering of the immune 
response and initiating of the atherosclerosis process (Williams and Tabas, 1995; 1998; von 
Eckardstein et al., 2001). Atherosclerosis process is depicted in Figure 1. Elevated level of the 
circulatory cholesterol promotes atherosclerosis development, which explains the positive 
established association between cholesterol and atherosclerosis (Tabas, 2002). The modified 
lipoproteins are responsible for foam cells formation and act as extracellular signals triggering 
immune system, and initiating the inflammatory process (Tabas, 2002). More strikingly, high-
density lipoprotein (HDL) poses specialized functions including, reverse cholesterol transport 
(RCT) mechanism, antioxidant, anti-inflammatory, and anticoagulant factors making HDL an 
antiatherogenic agent.  
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 Figure 1. Atherosclerosis initiation process 
(adapted from Barlic and Murphy, 2007) 
1.2 LIPID AND CARDIOVASCULAR DISEASE 
Variation in plasma lipoprotein-lipid levels and their particle size are good indicators of CVD 
risk (Tian and Fu, 2010). It has been known for a while that LDL-C and HDL-C have opposite 
effects on CVD risk, whereas LDL-C has a positive effect and HDL-C has a negative influence 
on the CVD risk (Kones, 2011). It is estimated that 40% of patients with CVD have low HDL-C 
(Genest et al., 1992; Genest et al., 1993), and most of the CVD patients have multiple risk factor 
such as, high triglycerides (TG), obesity, diabetes militius (DM), hypertension along with low 
HDL-C (Dastani et al., 2006; Weber et al., 1997), implying that HDL-C may not be an 
independent risk factor of CVD. However, for each 1mg/dl increase in HDL-C, the CVD risk is 
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decreased by 2-3% (Chapman et al., 2004), indicating the protective effect of HDL-C on CVD. 
Additionally, it is found that increasing total cholesterol (TC) from 200 mg/dl to 240 mg/dl in 
men is associated with a three-fold increase in the mortality rate of CVD (Stamler et al., 2000), 
and the risk ratio of CVD is increased 1.3 in males and 1.8 in females for each 1 mmol/l 
increases in TG level (Austin et al, 1998). Thus, dyslipidemic profile with elevated TG, LDL-C, 
TC, and decreased HDL-C levels increases the risk of CVD (Austin et al., 1998; Castelli et al., 
1992; Brunzell et al., 1984; Lusis, 2000).  
The percentage of individuals with uncontrolled LDL-C level has been declined 9.3% 
between 1999 and 2010 in the United States because of the tremendous improvements in 
understanding the pathology of genetic diseases, access to health care, medical consultation and 
medications, and implementation of intervention measures (Fryar et al., 2012). More strikingly, 
the risk of coronary heart disease (CHD) differs among different ethnic groups in which Blacks 
tend to have more CHD than whites (Schiller et al., 2010), indicating the importance of different 
genetic architecture and environmental exposure on modulating the CHD risk.  
1.3 LIPOPROTEIN AND LIPID METABOLISM 
Lipoprotein particles are water-soluble macromolecules that play a key role in lipid 
transportation and distribution in the circulation (Ordovas, 2009). They are composed mainly of 
lipid and proteins and synthesized primarily in the liver and intestine (Ordovas, 2009). 
Lipoprotein particles composed of two layers with different constituents; inner hydrophobic core 
of cholesterol ester and triglycerides, and outer hydrophilic layer with a phospholipid, free 
cholesterol and apolipoproteins (Breslow, 2000). There are six classes of lipoprotein particles 
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with a different lipid and protein composition that influence their size, density, and function, 
including chylomicrons (CM), chylomicron remnants, very low density lipoprotein (VLDL), low 
density lipoprotein (LDL), intermediate density lipoprotein (IDL), and high density lipoprotein 
(HDL). Variation in the lipoprotein composition, size, shape and functions has different 
contribution to the CVD risk. 
Lipid and lipoprotein metabolism (Figure 2) is a complex biological mechanism with 
multiple pathways that involve large number of nuclear factors, binding proteins, 
apolipoproteins, enzymes, and receptors (Ordovas, 2009).  Broadly, three inter-related pathways; 
endogenous, exogenous and reverse cholesterol transport metabolism pathways are involved in 
lipid metabolism. The exogenous pathway accounts for dietary lipid metabolism. The dietary 
lipids are transferred in a TG-form and carried out in CM that is synthesized in the intestine. In 
the circulation, CM acquires apoE from HDL particle and under the lipoprotein lipase (LPL) 
action, TG is hydrolyzed into free fatty acids and glycerol. After TG hydrolysis, CM becomes 
CM remnants, which can be taken up by the liver through the remnants receptor. The free fatty 
acids transferred to the muscle cells to be used as energy source or to the adipose tissues for 
storage. Because of the effect of hepatic lipozymes, the CM remnants are hydrolyzed and their 
cholesterol is either excreted into bile or incorporated into endogenous lipoprotein synthesis 
(Ahmad et al., 2004).  
Endogenous pathway involves lipoprotein synthesis of VLDL, which contains more fatty 
acids and little cholesterol, with apoB-100, apoCs, and apoE as primary apolipoproteins. In the 
circulation, VLDL acquires apoCs and apoE from HDL. ApoC-II mediates VLDL lipolysis 
under LPL action, and transfers VLDL into remnants (IDL). Then, VLDL remnants can be taken 
up by the liver through apoE-mediated endocytosis. Most VLDL remnants undergo further 
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lipolysis and forms LDL with apoB-100 as a primary apolipoprotein of LDL particle. Hepatic or 
extra-hepatic tissues can take up LDL-C through apoB-100 receptors (Ahmad et al., 2004). As a 
result of exogenous and endogenous lipid metabolism, cholesterol (mainly LDL-C) accumulates 
in the extra-hepatic tissues in which HDL plays important role in transporting cholesterol back to 
the liver. This mechanism is known as reverse cholesterol transport  (RCT). ApoAs and apoE are 
the main apolipoprotein constituents of HDL particles (Ahmad et al., 2004). 
Since lipid metabolism involves participation of multiple factors, genetic variation in 
their encoding genes can affect the efficiency of lipid metabolism and consequently the 
distribution of plasma lipoprotein-lipid levels.  
 
Figure 2. Lipoprotein metabolism 
(adopted from: Lusis and Pajukanta, 2008)        
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1.3.1 High-density lipoprotein 
 High-density lipoprotein is a heterogeneous molecule with different sub-fractions having 
distinct composition, density, shape, size, and function (Rye et al., 2009). In general, HDL 
particles contain a cholesteryl ester and small amount of TG in the hydropobic core surrounded 
by a layer of phospholipid, free cholesterol and apolipoproteins (Rye et al., 2009; Florentin et al., 
2008). ApoA-I and apoA-II are the primary HDL apolipoproteins. HDL molecule contains other 
minor apolipoproteins such as apoA-IV, apoC-I/C-II/C-III, apoD, apoE, apoJ, apoL, and apoM 
(Rye et al., 2009; de Silva et al., 1990; Duchateau et al., 1997; Christoffersen et al., 2006). Also, 
HDL contains enzymes involved in the lipid metabolism, including paraoxonase 1 (PON1), 
lecithin cholesterol acyltransferase (LCAT), cholesteryl ester transfer protein (CETP), and 
phospholipid transfer protein (PLTP) (Link et al, 2007). 
1.3.1.1 High-density Lipoprotein metabolism 
Complex interaction of several enzymes, lipids transfer molecules and apolipoproteins are 
involved in the cholesterol efflux and HDL maturation process. ATP binding cassette transporter 
(ABC) A1 [ABCA1] plays important role in cholesterol efflux mechanism, which is the initial 
step in HDL metabolism. Cholesterol efflux is mediated by interaction of apoA1 with ABCA1 
on the cell membrane. ABCA1 transfers free cholesterol and phospholipids from atherogenic 
tissues to nascent HDL molecules. LCAT is a key component in the HDL maturation process, 
which esterifies free cholesterol into cholesterol ester that promotes discoidal HDL to be 
converted into spherical mature-HDL. HDL remodeling occurs in the plasma under influence of 
several enzymes, including CETP, hepatic lipase (HL), endothelial lipase (EL), and 
phospholipids transfer protein (PLTP) (Daniels et al., 2009; Fisher et al., 2012).  
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1.3.1.2 Antiatherogenic role of HDL-C 
The HDL-C antiatherogenic properties come from its involvement in RCT (Kontush and 
Chapman, 2006; Von Eckardstein et al., 2001), and having antioxidant, anti-inflammatory (Kwan 
et al., 2007), and anti-aggregation (Myers et al., 1996) properties. RCT mechanism is an essential 
process and transports excess cholesterol from extra-hepatic tissues back to the liver for bile 
excretion or to steroidgenic tissues for apolipoprotein, vitamin D, and steroid hormone synthesis 
(Genest et al., 1999; Stein and Stein, 1999; von Eckardstein and Assmann, 2000). RCT 
mechanism is complex and can be accomplished through three ways; 1) the large HDL particle 
with multiple copies of apoE can be taken by the liver through LDL receptor (Bruce et al., 1998); 
2) the accumulated cholesteryl ester can be taken selectively by the liver through SR-B1 (Acton 
et al., 1996; Fisher et al., 2012); 3) or the cholesteryl ester can be transferred from HDL to 
triglyceride-rich lipoproteins (TGRL) through CETP (Bruce et al., 1998; Fisher et al., 2012) to 
remove the excess cholesterol from peripheral tissues back to the liver.  
1.3.2 Apolipoprotein structure and function 
Apolipoproteins are major constituents of lipoprotein particles and play important role in lipid 
metabolism as enzyme cofactors, receptor ligands, and lipid transfer carriers (Cai et al., 2009). 
Apolipoproteins are composed of two functional domains; lipid-binding domain on the carboxyl 
terminal (-COOH) and lipoprotein receptor-binding domain on the amino terminal (-NH3). The 
lipid-binding domain has multiple α-helical structures with amphipathic feature to facilitate 
binding to lipid molecules (Segrest et al., 1974). There are several major classes of 
apolipoproteins and many other subclasses including, A (apoA-I, apoA-II, apoA-IV, and apoA-
V), B (apoB-48, and apoB-100), C (apoC-I, apoC-II, apoC-III, and apoC-IV), apoD, apoE, apoH, 
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apoJ, apoL, and apoM (Cai et al., 2009; Rye et al., 2009, de Silva et al., 1990; Duchateau et al., 
1997; Christoffersen et al., 2006).  
ApoA-I is the primary apolipoprotein constituent of HDL followed by apoA-II and there 
is inverse correlation between plasma HDL-C and apoA-I concentration and CHD risk (Cai et 
al., 2009). ApoC2 is the major constituent of CM, VLDL, and HDL particles and has 
fundamental role in activating LPL enzyme (Cai et al., 2009). ApoB-48 is present on CM, while 
ApoB-100 is the major constituent of LDL. ApoC-III is present on VLDL that inhibits LPL and 
HL activity (Cai et al., 2009).  
Human apoCs are major constituent of CM, VLDL and HDL and represent 40-80% of 
the apolipoprotein percentage on these lipoprotein particles (Jong et al., 1999; Tian et al., 2009). 
A little attention has been paid on the roles of apoCs in lipid metabolism as compared to apoE 
(Jong et al., 1999). Their encoding genes, APOC1, APOC2, APOC4, are located on chromosome 
19 along with the APOE gene as a member of 45 kb gene cluster (Li et al., 1988). Apolipoprotein 
Cs play important role in TG metabolism and their concentrations in plasma are critical for 
optimal lipid metabolism (Jong et al., 1999).   
1.3.3 APOE-C1-C4-C2 gene cluster  
APOE-C1-C4-C2 gene cluster encodes for four distinct amphipathic lipid-binding proteins that 
have significant involvement in lipid metabolism and share structural and sequencing properties 
(Allan et al., 1995; Lauer et al., 1988; Li et al., 1988). All genes in this gene cluster contain 4 
exons and 3 introns, except APOC4 contains 3 exons and 2 introns (Paik et al., 1985; Das et al., 
1985). The protein products of APOE-C1-C4-C2 genes are present predominantly on CM, VLDL 
and HDL (Tian et al., 2009; Jong et al., 1999), and are the major determinants of lipoproteins 
 10 
fate and role in lipid metabolism. Thus, normal concentration of apolipoproteins in plasma is 
critical for optimal lipid metabolism (Jong et al., 1999). Figure 3 represents the structure of 
APOE-C1-C4-C2 gene cluster. 
 
 
Figure 3.  APOE-C1-C4-C2 gene cluster. 
APOE: (apolipoprotein E); APOC1: (apolipoprotein C-I); HCR1: (hepatic control region 1); APOC1P1: 
(apolipoprotein C1 pseudo gene); HCR2: (hepatic control region 2); APOC4: (apolipoprotein C4); APOC2: 
(apolipoprotein C2). 
1.3.3.1 Apolipoprotein E 
ApoE is a glycoprotein present predominantly on TG-rich lipoproteins (CM and VLDL) and 
HDL-C and has a pivotal role in lipid metabolism (Mahley et al., 1984; Mahley, 1988). The two 
key roles of apoE in lipid metabolism are participation in TG clearance and in RCT (Miettinen et 
al., 1992). Moreover, apoE has antioxidant activity and prevents LDL oxidation (Miyata and 
Smith, 1996). Besides its involvement in lipid metabolism, apoE is involved in multiple 
functions in the human body, including nerve growth and regeneration (Pitas et al., 1987; Boyles 
and Zoeliner, 1989; Westlye et al., 2012; Dumanis et al., 2013), cognitive function, 
immunoregulation, and influencing susceptibility to infectious disease (Mahely and Rall, 2000; 
Kuhlmann et al., 2010; Nikodemova et al., 2013). Because of the multiple functional roles of 
apoE in the human body, APOE genetic variation is associated with wide-range of diseases.  
The APOE gene is 3.7 kb in size with 4 exons and 3 introns (Das et al., 1985). APOE is 
expressed in multiple tissues with the liver as a primary site followed by the brain (Pitas et al., 
1987). In addition to the promoter region, multiple tissue-specific enhancers and regulatory 
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elements regulate its expression (Paik et al., 1985). The APOE gene is translated into 317 amino 
acids with the first 18 amino acids as a signal peptide (Tata et al., 1984). ApoE is composed of 
two main functional domains, an amino terminal domain that includes LDL receptor-binding site 
(22 kD fragment), and a carboxy terminal domain that has lipid-binding site (10 kD fragment) 
(Breslow, 1985). The LDL receptor-binding domain mapped to amino acid (1-183) (Wilson, 
1990), while the lipid-binding domain mapped to amino acid (216-299) includes multiple 
amphipathic α-helical structure to facilitate lipid-binding mechanism (Breslow, 1985). Optimal 
plasma level of apoE is critical for normal physiological function, whereas apoE deficiency 
diminishes TG-rich lipoprotein clearance; apoE overexpression stimulates TG-rich lipoproteins 
production and inhibits their lipolysis and both states contribute to hypertriglyceridemia  
(Mahley et al., 2009).  
A common polymorphism due to amino acid substitutions at codons 112 and 158 and 
resulting into three alleles, APOE*2, APOE*3, and APOE*4, exists in the APOE gene.      
ApoE3 is the most common form and has cystein at codon 112 and arginine at codon 158, while 
ApoE2 has cystein and ApoE4 has arginine at both codons. As a consequence of three alleles, six 
genotypes are present in the general population with three homozygous (E2/E2, E3/E3, E4/E4), 
and three heterozygous  (E2/E3, E2/E4, E4/E3) (Beisiegel et al., 1989).  
 Cystein-Arginine interchange is associated with different lipid receptor-binding activity, 
affinity to lipoprotein particles, various serum lipid profile, and CVD risk (Davignon et al., 1988; 
Mahely and Rall, 2000). In comparison with the reference apoE3, apoE2 has a lower lipid 
receptor-binding efficiency. While apoE4 has similar receptor–binding efficiency, as does 
apoE3, apoE4-associated lipoproteins have high turnover. Consequently, apoE2 is associated 
with high TG and low LDL-C levels, while apoE4 is associated with low TG and high LDL-C 
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level. Therefore, APOE*4 allele is a risk factor for CVD, while APOE*2 is protective in absence 
of type III hyperlipoproteinemia (Sing and Davignon, 1985: Davignon et al., 1988; Mahely and 
Rall, 2000; Medina-Urrutia et al., 2004).   
1.3.3.2 Apolipoprotein C-I 
ApoC-I is constituent of various lipoprotein particles (VLDL, IDL, and HDL) and has multiple 
roles in lipid metabolism, including maintaining HDL structure regulating LCAT activity 
(Weisgraber et al., 1990), and displacing apoE from lipoproteins and interfering with their 
hepatic clearance (Windler et al., 1980; Quarfordt et al., 1982). Although the contribution of 
apoC-I in TG metabolism is not clear, it is hypothesized that apoC-I displaces apoE on TG-rich 
lipoproteins (TGRL) and interferes with apoE-mediated binding to LDL receptor (LDL-R) and 
LDL receptor related protein1 (LRP1) (Weisgraber et al., 1990). APOC1 transgenic mice 
developed hyperlipidemia with increased TG and TC levels (Jong et al., 1998; Shachter et al., 
1996; Simonet et al., 1991), confirming the apoC-I inhibition role of TGRL clearance (Jong et 
al., 1999). In addition to the interference with hepatic uptake of TGRL, apoC-I inhibits the 
lipolytic function of LPL (Conde-Knape et al., 2002). In vitro studies have confirmed the apoC-I 
involvement in HDL metabolism through activating LCAT (Soutar et al., 1975; Jonas et al., 
1984; de Haan et al., 2008), and inhibiting CETP activities (Gautier et al., 2000; de Haan et al., 
2008).   
APOC1 is a 4.7 kb long gene, with 4 exons, and 3 introns, expressed mainly in the liver 
and to a lesser extent in other tissues such as lung, testis, skin, and spleen (Lauer et al., 1988). It 
is located either 4.3 kb  (Myklebost and Rogne, 1986) or 5.3 kb (Lauer et al., 1988) downstream 
from APOE. Another copy of APOC1 is located 7.5 kb downstream of APOC1 (Lauer et al., 
1988) with no protein product and is called as APOC1 pseudo gene (APOC1P1). APOC1 gene 
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encodes for 83 amino acids long protein containing 26 residues as a signal peptide (Knott et al., 
1984). ApoC-I has three amphipathic helical structures mapped to residue (7-14), (18-29), and 
(33-53) that facilitate lipid binding process (Segrest et al., 1974) and residues 17-57 contain all 
the functional domains to activate LCAT enzyme (Soutar et al., 1975).  
Several genetic variations in the APOC1 gene have showed significant association with 
plasma lipid variation. A 4-base insertion at -317 bp of the transcription initiation site (known as 
Hpal polymorphism) is the most common polymorphism in APOC1 promoter region (Smit et al., 
1988) and it has been shown to be associated with increased APOC1 gene expression (Xu et al., 
1999). Although several single-nucleotide polymorphisms (SNPs) have identified in genome-
wide association studies (GWAS) are mapped to APOC1 gene, their functional roles have yet to 
be characterized. 
1.3.3.3  Apolipoprotein C-IV 
 The APOC4 gene spans 3.3 kb, composed of three exons and two introns, and encodes for a 127 
amino acid protein with the first 26 residues as a signal peptide (Allan et al., 1995). The first 
exon encodes most of the signal peptides, while the remaining exons encode the C-terminal 
region and each has amphipathic helical structure (lipid-binding domain) (Zhang et al., 1996). 
Exon 1 encodes for amino acid 1-25, exon 2 encodes for amino acid 26-73 and exon 3 encodes 
for the remaining amino acid (Kotite et al., 2003). APOC4 is expressed only in the liver with 
undetectable level in the plasma and its expression level is 100-fold lower than the APOC2 
expression level (Allan et al., 1995). Lacking the typical TATA box in APOC4 promoter region, 
having weak Sp1 Motif (Allan et al., 1995) and only one copy of purine-rich region (Kotite et al., 
2003), explain the lower expression level of APOC4 in humans.  
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In normotriglyceridemic condition, more than 80% of apoC-IV is present on VLDL 
(representing 0.7% of apo VLDL) and most of the remainder is on HDL, while apoC-I and apoC-
II distribute equally to both HDL and VLDL (Kashyap et al., 1977; Schonfeld et al., 1979). 
Overexpression of APOC4 in transgenic mice causes hypertrigylceridemia, which suggests a 
direct association between apoC-IV and TG metabolism (Allan and Taylor, 1996). The similar 
hypertrigylceridemic phenotype of expression all apoCs suggests that all human apoCs have a 
common underlying mechanism in TG metabolism (Allan and Taylor, 1996).  
There are two assumptions behind accumulation of TG-rich lipoprotein (VLDL) in 
APOC4 transgenic mice: 1) impairing hepatic uptake of VLDL through interfering with apoE 
mediated cellular uptake, and 2) impairing the TG lipolysis mechanism through interfering with 
LPL or HL activity (Allan and Taylor, 1996). Additional evidence from in vitro study suggests 
the potential role of apoC-IV in lipid metabolism and atherosclerosis. Expression of APOE-C1-
C4-C2 gene cluster in lipid-loaded macrophages, suggests their potential antiatherogenic role in 
cholesterol efflux in a similar manner to the RCT mechanism (Mak et al., 2002).  
1.3.3.3 Apolipoprotein C-II 
ApoC-II is the major constituent of VLDL, and HDL particles and this is a required cofactor for 
LPL (Cai et al., 2009; Bier and Havel, 1970; LaRosa et al., 1970). ApoC-II is synthesized with 
22-residue signal peptide that is cleaved cotranslationally and resulting a 79 amino acid mature 
protein with a molecular mass of 8.8 kDs (Fojo et al., 1984). Its encoding gene, APOC2 is a 3.4 
kb long and includes 4 exons and 3 introns (Das et al., 1987; Wei et al., 1985; Fojo et al., 1987). 
Several mutations have been found in either APOC2 or LPL that cause indistinguishable 
phenotype of hypertriglycerdemia (Brunzell, 1995). ApoC-II protein is composed of three helical 
regions spanning amino acid 16-36, 50-56, and 63-77. LPL activating region has been localized 
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to the C-terminal region (44-79), while the N-terminal region (1-43) is involved in phospholipid 
binding (Sparrow and Gotto, 1980; Vainio et al., 1983; MacPhee et al., 1999). It is proposed that 
binding of apoC-II to LPL enzyme causes conformational changes in LPL, which makes LPL 
more efficient in lipolytic activity (Bengtsson and Olivecrona, 1982).  
Previous studies have shown quantitative variation in apoC-II either low (Brechinridge et 
al., 1978) or high (Shachter et al., 1994) apoC-II level impairs TG lypolysis activity and results 
in hypertriglycerdemic phenotype. Moreover, quantitative variation of apoC-II affects the 
distribution of HDL subfractions and overexpression of apoC-II disrupts HDL maturation 
process and impairs the RCT mechanism (Tian et al., 2009). Mutations in APOC2 leads to 
familial I hyperlipoprotienemia, which is characterized with extremely severe 
hypertriglycerdemia due to accumulation of CM (Brunzell et al., 1989). Several mutations in 
APOC2 have been identified in different families causing familial chylomicronemia and 
hyperlipidemia (Jong et al., 1999). Therefore, APOC2 genetic variation affects the distribution of 
all lipoprotein lipid levels and affects the RCT efficiency. 
1.3.4 Regulation expression of the APOE-C1-C4-C2 gene cluster 
The expression of all four genes in the APOE-C1-C4-C2 gene cluster is regulated by the action 
of two hepatic control regions (HCR-1 and HCR-2). The first control region (HCR-I) is 774 bp 
long and is located 19 kb downstream of the APOE transcription initiation site and 9 kb 
downstream of the APOC1 promoter region (Simonet et al., 1993). Additional copy of the 
hepatic control region (HCR-2) in the same cluster is located 5.5 kb downstream of the 
APOC1P1 pseudo gene and shares an 85% homology with the functional domain (319 bp) of the 
first hepatic control region (HCR-I) (Allan et al., 1995), which has the full activity of regulating 
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APOE-C1-C4-C2 gene cluster expression (Shachter et al., 1993). The unique functional domain 
in HCR-1 is mapped to the sequence 6-325 bp at the 5’ end and it is associated with prominent 
liver specific Dnase 1 hypersenstivity (Dang et a., 1995).  
It has been shown that the presence of at least one of the hepatic control regions is 
sufficient for expression all the four genes within the cluster. If both are present, HCR-1 
regulates the expression of its nearby genes, APOE and APOCI, while HCR-2 regulates the 
expression of the farther genes, APOC4 and APOC2 (Allan et al., 1997).  
However, regulating the expression of all four genes in the same cluster is complicated, 
and requires an interaction between tissue specific regulatory elements and enhancer sequences 
in the promoter region to direct the hepatic expression of APOE gene cluster (Dang et al., 1995). 
Accordingly, the promoters of APOE, APOC1, APOC4, and APOC2 genes are not sufficient for 
their full hepatic expression (Allan et al., 1997; Simonet et al., 1993) and additional cis-acting 
tissue specific elements could regulate their hepatic and extra-hepatic expression. The first 
hepatic control region has an advantage over the second one of regulating the expression of all 
the four genes in extra hepatic tissues in addition to the hepatic tissues (Allan et al., 1997). The 
proximity of HCR-1 to APOE and APOC1 genes makes their expression level in non-hepatic 
tissue higher than the expression level of the other two genes, APOC2 and APOC4 (Allan et al., 
1997).  
The high degree of homology between the two hepatic control regions suggests that 
HCR-2 has been arisen from a duplication event occurred in primate lineage similar to what 
happened to APOC1P1 pseudo gene (Allan et al., 1995). Since no enhancer elements have been 
found within the upstream 30 kb of APOE gene (Simonet et al., 1993), and similarly no enhancer 
elements have been found within the 3 kb downstream of APOC2 gene (Allan et al., 1997), 
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suggesting that HCR-1 and HCR-2 are the only regulatory regions in 80 kb genomic cluster 
regulating the hepatic expression of all four genes in this cluster (Allan et al., 1995).  
1.4 GENETIC EVIDENCE OF LIPOPROTEIN-LIPID TRAITS 
Lipoprotein-lipid traits have considerable genetic determination and their estimated heritability 
ranges between 40% and 80% (Wang and Paigen, 2005; Goode et al., 2007; Kronenberg al., 
2002; Lusis et al., 2004; Beekman et al., 2003). Family-based linkage studies are more powerful 
in localization disease-causing mutations in monogenic disorders than in complex diseases. 
Mutations in ABCA1, APOA1 and LCAT genes have been identified to be associated with 
hypoalphalipoproteinemia characterized with extremely low HDL-C, while mutations in CETP 
were associated with familial hyperalphalipoproteinemia (FHA) characterized with extremely 
high HDL-C (Miller et al., 2003). Although monogenic disorders causing low or high HDL-C, 
are rare and explain ~1% of the HDL-C variation in the general population (Strong and Rader, 
2010; Miller and Zhan, 2004), they highlight the importance of genetic factors in affecting HDL-
C and other lipid levels. A meta-analysis of genome-wide linkage studies of lipid traits had 
identified a linkage signal on chromosome 19q13.13-13.45 including the APOE-C1-C4-C2 gene 
locus (19q13.32) (Beekman et al., 2003; Malhotra et al., 2007).  
Genome-wide association studies (GWAS) had accelerated success in identifying  ~100 
loci associated with lipid traits, including the APOE-C1-C4-C2 gene cluster (Teslovich et al., 
2010). However, the identified common variation explains 25-30% of the genetic variance of 
each major lipid trait (LDL-C, HDL-C and TG) (Teslovich et al., 2010; Kathiresan et al., 2009; 
Weisglass-Volkov and Pajukanta, 2010).  
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APOE is the most frequently studied candidate gene and the influence of its common 
polymorphisms on lipid traits and CVD risk has been extensively investigated in different 
population groups (Bennet et al., 2007). Although the association of APOE polymorphisms with 
lipid traits is well established (Sing and Davignon, 1985; Davignon et al., 1988; Bennet et al., 
2007), the contribution of other genes genetic variation on lipid traits and CVD risk remains 
uncertain.  
 Since common variants with small effect size explain ~25-30% of the lipid variation, 
additional common and rare variants in candidate genes could explain additional variation in    
plasma lipid levels. It has been shown that multiple rare and common variants interact with each 
other and modulate the risk of complex diseases (Anderson et al., 2011; Visscher et al., 2012). 
Therefore, sequencing candidate genes would provide insight into the role of common and rare 








1.5 HYPOTHESIS AND SPECIFIC AIMS 
1.5.1 Hypothesis 
Genetics plays an important role in influencing plasma lipid levels and more than 50% of lipid 
variation is believed to be genetically determined. Although lipid GWAS have identified ~100 
loci, they explain only 25-30% of the plasma lipid variation. This emphasizes that in addition to 
common variation, multiple rare/uncommon variants with larger effect sizes may be responsible 
for part of the missing heritability of lipid traits. Genetic studies carried out on some lipid genes 
have confirmed the significant contribution of both common and rare variants in modulating 
lipid traits. Therefore, the objective of this study was to test both “common disease-common 
variant” (CDCV) and “common disease-rare variant” (CDRV) hypotheses by resequencing the 
APOE-APOC1-APOC4-APOC2 gene cluster in selected individuals with extreme HDL-C/TG 
levels from two racial groups. Figure 4 illustrates the study design and the objective of this study 
was fulfilled by carrying out the following aims: 
1.5.2 Specific Aims 
Aim 1: 
Resequence the four apolipoprotein genes (APOE, APOC1, APOC4, and APOC2) and their two 
hepatic control regions (HCR-1 and HCR-2) in selected individuals falling in the upper (47 
NHWs and 48 Blacks), and lower (48 NHWs and 47 Blacks) 10th percentile distribution of HDL-
C/TG to identify additional common (MAF≥5%) and potential rare variants (MAF<5%) that may 
affect plasma lipid levels. 
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Aim 2: 
Screen the entire population samples of NHWs (n=623) and Blacks (n=788) for common 
tagSNPs and rare variants identified in Aim 1 plus HapMap tagSNPs covering the intergenic 
regions, that are not covered by the sequencing effort, to examine their association with plasma 
lipid traits. 
Aim 3: 
Evaluate the single and cumulative (haplotypes) effects of common variants on major plasma 
lipoprotein-lipid traits (LDL-C, HDL-C, TC, TG, apoB, and apoA1) to test the “common 
disease-common variant” hypothesis. 
Aim 4: 
Evaluate the cumulative effect of rare variants on major plasma lipoprotein-lipid levels (LDL-C, 
HDL-C, TC, TG, apoB, and apoA1) using Sequencing Kernel Association Test-Optimal (SKAT-
O) approach to test the “common disease-rare variant” hypothesis. 
 
Figure 4.  Flow chart of study design 
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2.0  METHODS AND MATERIALS 
2.1 SUBJECTS 
2.1.1 Study Population 
The study was conducted on two well-characterized epidemiological samples, including 623 
non-Hispanic whites (NHWs) and 788 African Blacks. NHW samples were collected as part of 
San Luis valley Diabetes Study (SLVDS). SLVDS was established as a geographical based case-
control study of non-insulin dependant diabetes mellitus and cardiovascular disease in Alamosa 
and Conejos counties of south Colorado (Hamman et al., 1989). All NHWs used in this study 
were non-diabetics and the basic characteristic of this study are described elsewhere (Rewers et 
al., 1993; Hamman et al., 1989; Demirci et al., 2010). African Blacks were recruited from Benin 
City, Nigeria as part of study on CHD risk factors in Blacks and the study details have been 
described in Bunker et al. (1995, 1996). The demographic characteristics of both populations are 






Table 1.  Demographic characteristic of study populations 
Variable NHWs (n=623) 
African Blacks 
(n=788) 
Males/Females (n) 295/328 495/293 
Age (Yrs) 52.83 ± 0.46 40.95 ± 0.30 
BMI (kg/m2) 25.5 ± 4.1 22.87 ± 0.14 
LDL-C (mg/dl) * 137.8 ± 1.51 109.25 ± 1.23 
HDL-C (mg/dl) * 50.76 ± 0.57 47.88 ± 0.46 
Triglycerides (mg/dl)* 139.45 ± 2.79 72.96 ± 1.40 
Total cholesterol 
(mg/dl)* 216.11 ± 1.67 172.01 ± 1.37 
ApoB (mg/dl) ** 87.72 ± 1.16 66.98 ± 0.79 
ApoA1**(mg/dl) 149.62 ± 1.59 137.03 ± 1.01 
Data are unanadjusted means ± SE after outliers removal. 
(*) the four lipid traits values were measured in the entire datasets. 
(**) ApoB and ApoA1 were measured in subset of the samples (435 NHWs). 
BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density  
lipoprotein cholesterol; ApoB; apolipoprotein B; ApoA1: apolipoprotein A1. 
In NHWs, total cholesterol was measured using esterase-oxidase method (Richmond, 
1973), HDL-C level was determined enzymatically following dextran sulfate magnesium 
precipitation (Wamick et al., 1982), and TG level was determined enzymatically by using 
Stavropoulous and Crouch procedure (Stavropoulous and Crouch, 1974). In Blacks, total 
cholesterol, HDL-C, and TG measurements were done at Heinz Nutrition laboratory, University 
of Pittsburgh, which is standardized for lipid measurement with US-Center for disease control 
and prevention (CDC), Atlanta, GA (Kamboh et al., 1999). LDL-C was estimated using 
Friedewald equation (Friedewald et al., 1972) when TG level was less than 400 mg/dl. ApoB and 
apoA1 were measured in subsets of the samples (435 NHWs, and 766 Blacks) using Boehringer 
Manneheim turbidmetric procedures (Kamboh et al., 1997). The DNA used for sequencing and 
TaqMan genotyping was extracted from clot sample in Blacks and from Buffy coats in NHWs 
using standard DNA extraction procedures. 
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2.1.2 Resequencing Samples 
Ninety-five NHWs (47 individuals having high HDL-C/low TG and 48 having low HDL-C/high 
TG) and 95 African Blacks (48 individuals having high HDL-C/low TG and 47 having low 
HDL-C/high TG) were selected for resequencing the APOE-APOC1-APOC4-APOC2 gene 
cluster and their hepatic control regions (HCR-1, and HCR-2) to detect both rare and common 
variants. The characteristics of subjects selected for resequencing are summarized in Table 2. 
Table 2.  Characteristics of the resequencing samples in NHWS and African Blacks 
 








TG (n=47) p-value 
Sex  (M/F) 24/23 24/24 1 24/24 23/24 1 
Age (years) 55.45 ± 1.0 53.03 ± 1.08 0.25 41.29 ± 0.89 40.87 ± 0.73 0.80 
BMI (kg/m2) 23.17 ± 0.32 27.35 ± 0.40 1.2E-07 22.06 ± 0.48 23.91 ± 0.56 0.08 
TC (mg/dl) 22.734 ± 5.31 208.81± 4.58 0.07 201 ± 4.08 141.68 ± 3.18 2.4E-12 
LDL-C(mg/dl) 126.84 ± 4.82 125.54 ± 5.64 0.90 112.55 ± 4.08 95.04 ± 2.9 0.02 
HDL-C (mg/dl) 77.68 ± 1.36 31.81 ± 0.44 2.2E-16 76.05 ± 0.77 25.51 ± 0.58 2.2E-16 
TG (mg/dl) 114.09 ± 6.25 240.21 ± 15.73 1.7E-06 61.98 ± 2.03 95.79 ± 7.51 0.004 
ApoB(mg/dl)* 87.88 ± 2.61 89.61± 2.58 0.80 66.00 ± 2.07 69.64 ± 2.20 0.40 
ApoA1(mg/dl) 174.08 ± 3.57 130.20 ± 2.78 1.4E-06 166.04 ± 2.89 103.84 ± 2.79 2.2E-16 
Variables are presented in unadjusted mean ± SE. 
*ApoB and apoA1 were measured in part of the NHWs (n=29). 
2.2 PCR AMPLIFICATION AND SEQUENCING 
All four genes (APOE, APOC1, APOC4, APOC2) and their two hepatic control regions (HCR-1, 
and HCR-2), which represents 49% of the entire nucleotide sequence of this gene cluster (~22.2 
kb of the total 45 kb sequence) were sequenced in 190 individuals with extreme HDL-C and TG 
levels from two ethnic groups (NHWs and African Blacks) using Sanger sequencing technique 
on the amplified DNA. DNA amplification of the target genomic regions was conducted in our 
lab using either M13 tagged forward and reverse primers that publicly available in SeattleSNPs 
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database (http://pga.mbt.washington.edu/) or designed primers using Primer3 software version 
0.4 (http://frodo.wi.mit.edu/primer3/) for the complicated regions or expansion the amplified 
genomic regions.  
We used seattleSNPs reference sequences for APOE, APOC1, APOC4, and APOC2 and 
NCBI database (build 137) to locate HCR-1 and HCR-2 reference sequences according to Allan 
et al. (1995) and Dang et al. (1995). For some genes with insufficient coverage in either flanking 
regions, additional sequences were adopted from Chip bioinformatics database to extend the 
sequencing coverage in either 5’ or 3’ flanking region. The sequencing PCR primers are given in 
Table 3.  
PCR primers generated 9, 13, 8 and 12 overlapping fragments for the amplification of the 
APOE, APOC1, APOC4, and APOC2 gene sequences, respectively. We amplified 5.491 bp of 
APOE  (1,180 bp of exons, 2,432 bp of introns, 1,034 bp in 5’ flanking and 845 bp in 3’ flanking 
region), 6,687 bp of APOC1 (1,000 bp in 5’ flanking region, 4,225 bp of introns, 462 bp of 
exons, and 1,000 bp in 3’ flanking region), 5,086 bp of APOC4 (956 bp in 5’flanking region, 614 
bp of exons, 2,644 bp of introns, and 872 bp in 3’flanking region), and 6,438 bp of APOC2  
(1,400 bp in the 5’ flanking region, 2855 bp of introns, 721 bp of exons, and 1,461 bp in the 3’ 
flanking region). We sequenced 820 bp genomic region of HCR-1 (ch19: 45427374 - ch19: 
45428194) and 849 bp genomic region of HCR-2 (ch19: 45438997- ch19: 45439846). 
Both forward and reverse strands were sequenced for all the targeted sequencing genes. 
The PCR conditions are given in Table 4. The PCR conditions were optimized first at small 
scale before amplifying DNA from 190 individuals in 96-well plates. Necessary modifications to 
the standard PCR conditions were made for complicated regions either by changing the 
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annealing temperature, MgCl2 concentration, or adding DMSO for the GC-rich regions. The 
quality of PCR was evaluated on agarose gel electrophoresis. 




















Forward Primer Sequence (5’-3’) Reverse Primer Sequence (3’-5’) SEQ-01 25-655 GAGACGGAGTCTTGCTCTTTCGC TCAGTTTCCTCCTCCATAAAGTG SEQ-02 489-1245 ATTACAGGCACGCATCACTACTT CACACAGATGATCCCAGTTTGTA SEQ-03 1108-1842 GTGAGAAGAAGTGGGTGGAGG GTCAGGATATGGAGACCATCCTG 
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Forward Primer Sequence (5’-3’) Reverse Primer Sequence (3’-5’) SEQ-01-1** 62-585 TTAGCGGTCAGGGGACACAT CCCTCAGGTGGTCGTCATAG SEQ-01-2** 478-997 CTAGGTCTGGGAGGAGTGGA CAAGCCCACAATAGGGTGTT SEQ-02 685-1555 AAGACAGCCTCTTGAAGAAGACC GTCATGGTTCCAACACGGGCTT SEQ-03 1455-2170 TGGGTCTCAACCACTATAAAGCC GCTAGAGTACAGTGGCACGATCT SEQ-04 1840-2734 GAACTGTAGACTATTTGAGCTTCT CTAAGTCAGACCTCATGTCCCTG SEQ-05** 2665-3338 TGCCGTACTTCCTCATCTCC AGCTGGAATCACAAGCACCT SEQ-06 3165-3909 TCACTTGAGGTTAGGAGTTCAAGA TACCAGGAGGACAAGAAACAGAG SEQ-07** 3810-4535 GAGCACACACAGAGCAGGAT GTACAAGTCCCTGGGGAGAA SEQ-08-1** 4390-4960 GCCCGCTGTAGATGAGAAAC GAGAGAAAGCCGGACTTCAA SEQ-08-2** 4860-5430 AGGACTCAAGGTGCCAAGAT CTTGCTTTGTTTGTGCGTTT SEQ-09 5350-6059 GCCAAAATCCAGCCTTCTCATTTGTA CACGGGACCATTATACACTGATT SEQ-10** 5920-6370 GCTCAAGAGATCCTCCCATC CTATCTCCGCCTCCAGGGTA 
(**) marked amplicons represent the PCR designed primers using Primer3 software, while the other 
remaining primers are M13-tag primers based on SeattleSNPs database. 
Table 4.  PCR reaction and cycling conditions 
PCR Reaction Conditions 
(Reaction volume 25 µL) 
PCR Cycle 
Genomic DNA (1ng/dl)                   3.0 µL 1. 95˚C for 5 minutes. 
2. 95˚C for 45 sec. 
3. 58-60˚C for 45 sec 
4. 72˚C for 1 min. 
Repeats 2-4 for 40 cycles 
5. 72˚C for 10 min. 











   
 
d.H2O                                                   11.75-13.25 µL 
10x BufferGold 2.5 µL 
MgCl2 (25 mM) 1.5-3.0 µL 
dNTPs (1.25 mM) 3.8 µL 
Forward Primer (20 mM)  0.4 µL 
Reverse Primer  
(20mM) 
0.4 µL 
Tag Polymerase enzyme 
Enzyme (5U/µL)  
0.15 µL 
 
After PCR, gel electrophoresis was performed to confirm DNA amplification prior to 
DNA sequencing. Invitrogen TM E-Gel® 96 2% with SYBR® Safe precaste gels (Invitrogen 
corporation, Carlsbad, CA) was used for large scale PCR, while regular 2% agarose gel was used 
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for small scale PCR for samples that failed in the initial DNA amplification. The amplified DNA 
was sent to a commercial lab for automated fluorescence-based Sanger sequencing and capillary 
electrophoresis on ABI 3730x1DNA Analyzers (Genomic Services of Beckman Coulter 
Genomics, Denver, MA). Variant Reporter version 1.0 (Applied Biosystem, Foster City, CA) 
and Sequencher version 4.8 (Gene Codes Corporation, Ann Arbor, MI) were used to analyze the 
sequencing data. Variants calling were made by two independent reviewers to maximize the 
sequencing analysis accuracy. 
The sequencing coverage was pretty good for the APOE and APOC2 genes along with 
their hepatic control regions as compared to the other two genes (APOC1, and APOC4). Despite 
our repeated efforts we could not amplify the following sequences: 33 bp (nt: 1842-1875 bp) a 
repetitive region in intron 1 of APOC4, 16 bp  (nt: 2147-2163) a repetitive region in intron 1 of 
APOC4, 75 bp gap (nt: 1950-2025) in intron 2 of APOC1, and 1,475 bp (nt: 3500-4975) in intron 
3 of APOC1. 
2.3 GENOTYPING 
2.3.1 Selection of variants for genotyping 
We genotyped tagSNPs (MAF≥5% and r2=0.9) and all rare variants that were discovered in the 
sequencing subsets, in addition to the HapMap tagSNPs covering the intergenic unsequenced 
region based on HapMap data (CEPH Utah residents with ancestry from northern and western 
Europe [CEU], and Yoruba in Ibadan, Nigeria [YRI]). 
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2.3.2 Genotyping of APOE-C1-C4-C2 gene cluster variation  
Although we did not sequence the entire APOE-C1-C4-C2 gene cluster, we genotyped common 
tagSNPs covering the intergenic regions based on HapMap genotype data of CEU and YRI 
population groups plus tagSNPs and rare variants identified in the sequencing region. Custom 
assays with masking population-specific sequencing variants and the database common variants 
with MAF≥5% in each racial group were ordered for genotyping. Either Sequenom iPLEX 
MassArray (Sequenom, San Diego, CA, USA) or TaqMan (Applied Biosystem, foster City, CA, 
USA) genotyping approach was used to genotype selected variants in the entire datasets (623 
NHWs, and 788 Blacks). Upon genotyping completion, we compared the genotyping and 
sequencing results for those variants that were identified in the sequencing data and passed the 
genotyping process as a quality control measure. This step was done to check the concordance 
between sequencing and genotyping steps and also to increase the call for individuals that failed 
either sequencing or genotyping.  
2.3.2.1 TaqMan Genotyping 
TaqMan genotyping involves DNA amplification and end-point fluorescence reading using the 
ABI Prism 7900HT instrument. The TaqMan genotyping Master Mix and Assay were added to 
dried whole genome amplified DNA in 384-well plate. For TaqMan genotyping, we followed 
ABI manufactures protocol (Applied Biosystem, 2006) with some modifications on the DNA 
concentration and the number of cycle that are given in Table 5. TaqMan SNPs genotyping is 
based on 5’nuclease principle. Each TaqMan SNPs genotyping assay in a single tube consists of 
two primers to amplify the polymorphic sequence site, and two minor groove binder (MGB) 
probes for allele discrimination purpose. Each MGB probes contains three primary elements, 
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reporter dye (VIC or FAM) at the 5’ end of the probe to label alleles at the polymorphic site, 
minor groove binder (MGB) at the 3’ end of the probe to increase the melting temperature, and 
non-fluorescent quencher (NFQ) at the 3’ end of the probe. Several steps are undertaken in the 
PCR process; MGB probes anneal specifically to the complementary sequences between the 
forward and reverse primers, once the probe attached to the complementary sequence, the ampli-
tag gold enzyme cleaves the dye from the quencher resulting in increasing the fluorescence 
signal which indicates the allele change (Applied Biosystem, 2006). SDSv2.4.1 and TaqMan 
Genotyper software were used to analyze the genotype calls. 
Table 5.  TaqMan SNPs Genotyping Condition 
TaqMan Reaction total volume (5μL) PCR condition 
d.H2O 2.43 μL 1. 95˚ for 10 min. 
2. 95˚ for 45 sec. 
3. 60˚ for 1 min. 
    -repeat 2-3 49x 
Master Mix 2.5 μL 
Assay 0.06 μL 
 
2.3.2.2 Sequenom iPlex massarray Genotyping 
Sequenom iPlex massarray genotyping technique is one of the high throughput genotyping 
massarrays and successful iPLEX reaction can take up to 40 multiplexed reactions. Whole 
genome amplification DNA was used for iPLEX Massarray genotyping. Sequenom Massarry 
designer software was used to design PCR and extension primers. Sequenom genotyping 
technique involved multiple steps, including locus-specific PCR reaction, followed by locus-
specific primer extension in which the oligonucleotide primers anneal immediately upstream the 
target polymorphic site. The mass of the extended primer was determined by using MALDI-TOF 
spectrometry and the mass density indicates the sequence, which corresponds to the allele at the 
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target polymorphic site (Gabriel et al., 2009). SpectroTYPER software was used to translate the 
mass of the observed primer into a genotype.  
2.4 STATISTICAL ANALYSES  
2.4.1 Variants detection 
After generating the sequencing data, variants call was made using Variant Reporter version 1.0 
(Applied Biosystem, Foster City, CA) and Sequencher software version 4.8 (Gene Codes 
Corporation, Ann Arbor, MI). 
2.4.2 Sequencing subset analysis 
Haploview software (version 1.0: http://www.broadinstitute.org) was used to analyze the variant 
allele frequencies, their distributions between the two extreme lipid groups, and visualize their 
linkage disequilibrium (LD) patterns. Allele and genotype frequencies were determined by using 
direct counting. Chi squared test (X2) was used to check concordance of genotype distribution to 
Hardy-Weinberg Equilibrium (HWE) and to compare allele frequencies between the two 
extreme lipid groups. 
2.4.3 Phenotype trait and covariates detection 
We used Box-Cox transformation (Box and Cox, 1964) for apoB, HDL-C and TG in NHWs and 
all lipid traits in Blacks such that the transformed lipid traits achieved normality. Significant 
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covariates for each trait were identified using stepwise regression method to select the most 
parsimonious set of covariates for each trait. In NHWs, gender, age, BMI (weight [kg]/height 
[m]2), and smoking were included as covariates in the final analysis model. Among Blacks: 
gender, age, waist, BMI, smoking, Jobmin (minutes walking or bicycling to work each day 
[min]), and Staff (staff level [junior/senior]) covariates were included in the final analysis model. 
2.4.4 Data cleaning 
SNPs with extensive missing data (>15%) and/or deviating highly from HWE (P<0.01) were 
excluded from statistical analyses (call rate cut-off [85%], and HWE-p cut-off [0.01]). A total of 
seventy variants in NHWs and 108 variants in Blacks were included in the statistical association 
analyses. 
2.4.5 Association analysis with major lipid traits 
For SNPs genotyped in the entire datasets, R statistical package (version 2.3.1, http://www.r- 
project.org) was used to run the single-locus, haplotype-based and rare variants association 
analyses and versatile gene-based associations (VEGA) to perform gene-based analysis (Liu et 
al., 2010) with four major lipid traits (LDL-C, HDL-C, TC, and TG), apoB and apoA1.  
2.4.5.1 Single-locus and gene-based association analyses 
In the single-locus association analysis, additive linear regression model was used to test the 
association between SNPs and each lipid traits (HDL-C, LDL-C, TC and TG), apoB, and apoA1, 
and a p-value < 0.05 was considered as suggestive evidence of association. The versatile gene-
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based associations (VEGA) were also performed to assess the relationship between traits and 
APOE gene cluster variation (Liu et al., 2010).  
2.4.5.2 Haplotype-based association analysis 
For haplotype association analysis, the generalized linear model (GLM) (Lake et al., 2003) was 
used. Including too many haplotypes can make above model inefficient and impractical. To 
reduce the number of haplotypes considered in association analysis, we used sliding window 
approach, 4-SNP per window, and assessed evidence for association within each window. 
Specifically, a global p-value for testing overall effects of the haplotypes with frequency greater 
than 0.01 was used to assess the association between the trait and haplotypes in each window. 
Sliding-window haplotype analysis was performed with the haplo.glm function in the 
Haplo.Stats R package (version 1.5.0). Haplotype sliding window approach resulted in 66 
windows in NHWs and 104 windows in African Blacks. 
2.4.5.3 Rare variants association analysis 
We analyzed the cumulative effects of uncommon/rare variants (MAF<5%) by using the SKAT-
O (Lee et al. 2012), which has been proposed to be the optimal test for rare variant analysis and 
exceeded the SKAT and burden tests in several ways. To date various methods have been 
developed and introduced for rare variants analysis but each method has its advantages and 
drawbacks depending on the data structure. In this study we used four methods; two burden-
based approaches; rare variants test-1 (RVT1), rare variants test-2 (RVT2), and two kernel-based 
approaches; sequence kernel association test (SKAT), and sequence kernel association test-
optimal (SKAT-O). Whereas RVT1 and RVT2 are two specific burden tests, SKAT and SKAT-
O are kernel-based tests. Burden tests assume all variants affect the phenotypic traits on the same 
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direction with same effect and its power is affected by coexistence of multiple variants with 
different directions. SKAT has advantage over burden test and it is more powerful if the data has 
multiple variants with different effect directions. Since SKAT-O p-value combines both burden 
test and SKAT p-values, we rely on SKAT-O p-value. The analyses were performed by using 
three different minor allele frequency bin thresholds (<1%, <2% and <5%). The SKAT method 









3.0  RESULTS 
3.1 SEQUENCING APOE-C1-C4-C2 GENE CLUSTER 
Sequencing all the four genes and their two hepatic control regions in selected individuals with 
extreme HDL-C and TG levels from two ethnic groups (NHWs and African Blacks) revealed a 
total of 230 variants (215 substitutions, and 15 indels) of which 160 were reported and the 
remaining 70 were novel. We observed one dinucleotide microsatellite in APOC4/APOC2 that 
mapped to (APOC4: 4929-4954), and (APOC2: 1625-1650). Of the 230 identified variants, 63 
variants were shared in both populations, while 52 variants were NHW-specific and 115 variants 
were Black-specific (Figure 5). 
 
Figure 5. APOE-C1-C4-C2 gene cluster sequencing-identified variants in NHWs and African Blacks 
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3.1.1 Sequencing variation in non-Hispanic Whites (NHWs) 
A total of 115 variants were identified in NHW subset with extreme lipid traits (47 subjects with 
high HDL/low TG levels, and 48 subjects with low HDL-C/high TG levels), of which 105 
variants were substitutions and 10 were indels. Of the 115 variants, 85 variants were reported, 
while the remaining 30 variants were novel. Of the 115 variants, 63 SNPs were present also in 
Blacks and the remaining 52 variants were NHW-specific (Table 6).  
Of the 115 variants, 19 variants were mapped to APOE (17 reported, 2 novel), 29 variants 
were mapped to APOC1 (20 reported, 9 novel), 5 variants were mapped to HCR-1 (3 reported, 2 
novel), 3 variants were mapped to HCR-2 (2 reported, 1 novel), 21 variants were mapped to 
APOC4 (13 reported, 8 novel), 2 variants were overlapped in APOC4/APOC2 (both of them are 
reported), and 36 variants were mapped to APOC2 (28 reported, 8 novel). Figure 6 represents 
the distribution of sequencing variants in the sequenced regions and Figure 7 summarizes the 
percentage of reported and novel variants in each gene in NHWs. 
 
Figure 6. Percentage of the sequencing identified variants among the sequenced regions in NHWs 
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 Figure 7. Gene-based distributions of reported and novel sequencing variants in NHWs 
Gene-based distribution of the sequencing variants showed that 16% of APOE variants 
was located in the promoter region, 33% was in intronic region, 21% was in coding region, 5% 
was in UTR, and 26% was in 3’ flanking region (Figure 8). For APOC1 variation, 21% was in 
the promoter region, 52% was in intronic region, 7% was in coding region, 3% was in UTR, and 
17% was in 3’ flanking region. For APOC4 variation, 29% was in promoter region, 52% was in 
introns, 14% was in coding region, and 5% was in UTR. For APOC2, 64% was in introns, 3% 
was in splice site, 5% was in 3’UTR, and 28% was in 3’flanking region.  
 




Table 6.  APOE-C1-C4-C2 gene cluster sequencing-identified variants in NHWs sequencing subset  






C/high TG HWE-P %Geno 
APOE-560 A>T rs449647 5'flanking   0.126 0.085 0.167 0.379 100 
APOE-624 T>C rs769446 5'flanking   0.075 0.111 0.042 1.000 97.9 
APOE-832 G>T rs405509 5'flanking   0.484 0.479 0.490 1.000 100 
APOE-1163 G>C rs440446 intron1  0.358 0.340 0.375 0.108 100 
APOE-1575 C>T rs769448 intron1  0.021 0.043 0.000 1.000 100 
APOE-1998 G>A rs769449 intron 2  0.126 0.128 0.125 1.000 100 
APOE-2294 C>T  intron 2  0.005 0.011 0.000 1.000 100 
APOE-2440 G>A rs769450 intron 2  0.400 0.404 0.396 0.855 100 
APOE-2907 T>G rs769451 intron 2  0.005 0.000 0.010 1.000 100 
APOE-3038 G>A rs111833428   exon 3 Ala 23 Ala 0.005 0.011 0.000 1.000 100 
APOE-3937 T>C rs429358 exon 4 Cys 130 Arg 0.168 0.160 0.177 1.000 100 
APOE-4075 C>T rs7412 exon 4 Arg 176 Cys 0.063 0.074 0.052 1.000 100 
APOE-4310 T>A rs199768005 exon 4 Val 254 Glu 0.005 0.011 0.000 1.000 100 
APOE-4528 C>T  exon 4 (3' UTR)  0.005 0.011 0.000 1.000 100 
APOE-4737 C>G rs117656888 3'flanking  0.011 0.021 0.000 1.000 100 
APOE-4951 A>C rs1081105 3'flanking  0.042 0.032 0.052 1.000 100 
APOE-5229 G>T rs1065853 3'flanking  0.064 0.076 0.052 1.000 98.9 
APOE-5230 INDEL rs55729972 3'flanking  **** **** **** **** **** 
APOE-5361 T>C rs1081106 3'flanking  0.105 0.117 0.094 1.000 100 
APOC1-607 G>A rs72654447 5'flanking   0.005 0.011 0.000 1.000 100 
APOC1-655 A>T rs66807996 5'flanking   0.016 0.021 0.011 1.000 98.9 
APOC1-659 G>C rs72654448 5'flanking   0.005 0.000 0.010 1.000 100 
APOC1-698 C>A rs72654449 5'flanking   0.011 0.011 0.010 1.000 100 
APOC1-703 C>T rs3207187 5'flanking   0.005 0.011 0.000 1.000 100 
APOC1-
720_721 ins4 Hpal 5'flanking   0.226 0.223 0.229 0.894 100 
APOC1-1170 G>A  intron1  0.005 0.011 0.000 1.000 100 
APOC1-1276 C>G rs72654453 exon2 Ile 3 Met 0.011 0.021 0.000 1.000 100 
APOC1-1294 T>G  intron2  0.005 0.011 0.000 1.000 100 
APOC1-1317 G>A rs12721048 intron2  0.011 0.021 0.000 1.000 100 
APOC1-1422 G>A  intron2  0.005 0.011 0.000 1.000 100 
APOC1-1566 G>A rs12691088 intron2  0.026 0.011 0.042 1.000 100 
APOC1-1669 T>C  intron2  0.005 0.011 0.000 1.000 100 
APOC1-1870 T>C rs5117 intron2  0.229 0.228 0.229 0.8701 98.9 
APOC1-2041 C>T rs3826688 intron2  0.370 0.337 0.402 0.674 96.8 
APOC1-2629 G>A  exon3  0.005 0.011 0.000 1.000 100 
APOC1-2817 C>T  intron3  0.005 0.011 0.000 1.000 100 
APOC1-3423 G>A rs389261 intron3  0.005 0.000 0.010 1.000 100 
APOC1-3494 C>T  intron3  0.005 0.011 0.000 1.000 100 
APOC1-4334 G>A rs12721046 intron 3  0.181 0.202 0.160 0.288 98.9 
APOC1-4957  G>A rs484195 intron3  **** **** **** **** **** 
APOC1-
5053_5054 del1 rs12721052 intron3  0.306 0.326 0.287 1.000 97.9 
APOC1-5240 C>G rs12721051 intron3  0.209 0.226 0.193 0.935 90.5 
APOC1-5641 T>G rs1064725 3'UTR  0.037 0.021 0.052 1.000 100 
APOC1-5773 G>A  3'flanking   0.005 0.011 0.000 1.000 100 
APOC1-5926 G>A rs56131196 3'flanking   0.221 0.234 0.208 0.541 100 
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APOC1-6026 A>G rs4420638 3'flanking   0.221 0.234 0.208 0.541 100 
APOC1-6122 G>C rs142134314 3'flanking   0.005 0.000 0.010 1.000 100 
APOC1-6213 G>A  3'flanking   0.005 0.011 0.000 1.000 100 
HCR1-292 C>G rs4803771 HCR-1  0.042 0.021 0.062 0.285 100 
HCR1-362 C>A  HCR-1  0.011 0.011 0.010 1.000 100 
HCR1-423 C>G  HCR-1  0.026 0.043 0.010 1.000 100 
HCR1-575 A>G rs157599 HCR-1  0.005 0.000 0.010 1.000 100 
HCR1-727 T>G rs149345 HCR-1  0.005 0.000 0.011 1.000 98.9 
HCR2-188 C>G rs35136575 HCR-2  0.242 0.277 0.208 0.263 100 
HCR2-365 C>A  HCR-2  0.011 0.011 0.010 1.000 100 
HCR2-523 C>T  HCR-2  0.026 0.021 0.031 1.000 100 
APOC4-92_94 del3 rs12721101 5’ flanking   0.253 0.256 0.250 0.015 87.4 
APOC4-108 G>A rs112391061 5’flanking   0.253 0.256 0.250 0.015 87.4 
APOC4-116 A>G  5’flanking   0.007 0.000 0.013 1.000 78.9 
APOC4-
150_152 ins114  5’flanking   0.256 0.262 0.250 0.022 88.4 
APOC4-204 G>A rs4803773 5’flanking   0.250 0.212 0.292 0.237 52.6 
APOC4-636 C>T  5’flanking   0.005 0.000 0.010 1.000 100 
APOC4-968 A>G rs76214972 5’ UTR  0.037 0.011 0.062 1.000 100 
APOC4-1150 A>G  rs148247675   Intron1  0.005 0.011 0.000 1.000 100 
APOC4-1229 G>C  Intron1  0.011 0.000 0.021 1.000 100 
APOC4-
1325_1327 del3  Intron1  0.147 0.138 0.156 1.000 89.5 
APOC4-1733 C>T rs12721111 Intron1  0.263 0.276 0.250 0.016 82.1 
APOC4-1823 C>G  Intron1  0.187 0.191 0.183 0.440 78.9 
APOC4-2063 C>G  Intron1  0.005 0.000 0.011 1.000 98.9 
APOC4-2557 C>A  Intron1  0.005 0.000 0.010 1.000 100 
APOC4-2623 C>T rs5157 Intron1  0.479 0.446 0.510 0.654 98.9 
APOC4-2640 C>T rs5158 Intron1  0.147 0.149 0.146 1.000 100 
APOC4-2683 G>A rs12721109 Intron1  0.011 0.011 0.010 1.000 100 
APOC2-242 G>A rs12691089 APOC4-exon2  Gly 52 Asp 0.005 0.000 0.010 1.000 100 
APOC2-194C4-
3498 C>T rs1132899 APOC4-exon2 Pro 36 Leu 0.474 0.436 0.510 0.898 100 
APOC2-543 T>C rs186448850 APOC4-intron2  0.011 0.000 0.021 1.000 100 
APOC2-623C4-
3927 T>G rs5167 APOC4-exon3  Leu 96 Arg 0.358 0.394 0.323 0.515 100 
APOC2-1324 G>A rs12721063 APOC4-3'FR/APOC2-5'FR  0.021 0.021 0.021 1.000 100 
APOC2-
1357C4-4661 G>C rs2288912 
APOC4-
3'FR/APOC2-5'FR  0.484 0.457 0.510 0.885 100 
APOC2-
1442C4-4746 G>T rs2288911 APOC2-splice site  0.495 0.479 0.510 0.878 100 
APOC2-1591 G>A  APOC2-intron1  0.005 0.000 0.010 1.000 100 
APOC2-1851 C>T rs12709886 intron1  0.037 0.011 0.062 1.000 100 
APOC2-2191 C>T rs9304644 intron1  0.457 0.457 0.457 0.691 98.9 
APOC2-2410 T>C rs12721076 intron1  0.154 0.160 0.149 1.000 98.9 
APOC2-2486 G>A rs9304645 intron1  0.188 0.185 0.191 1.000 97.9 
APOC2-2566 T>C rs9304646 intron1  0.457 0.467 0.447 0.541 96.8 
APOC2-2870 G>T  intron1  0.005 0.011 0.000 1.000 100 
APOC2-2935 C>G rs11879392 intron1  0.153 0.160 0.146 1.000 100 
APOC2-2938 A>G  intron1  0.005 0.011 0.000 1.000 100 
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APOC2-3010 A>G rs10419086 intron1  0.063 0.085 0.042 1.000 100 
APOC2-3030 A>G rs4803774 intron1  0.453 0.457 0.448 0.630 100 
APOC2-3086 C>T rs4803775 intron1  0.484 0.543 0.490 0.885 100 
APOC2-3348 G>A rs10420434 intron1  0.063 0.085 0.042 1.000 100 
APOC2-3409 T>C  intron1  0.005 0.000 0.010 1.000 100 
APOC2-3600 A>G rs7256684 intron1  0.453 0.457 0.448 0.630 100 
APOC2-3778 A>T rs5120 intron1  0.484 0.457 0.510 0.885 100 
APOC2-3814 T>G rs10422603 intron1  0.189 0.191 0.188 1.000 100 
APOC2-4429 G>C rs3745152 intron3  0.489 0.489 0.489 0.018 96.8 
APOC2-4430_4431 ins3 rs35625559 intron3  0.489 0.489 0.489 0.018 96.8 
APOC2-4477 G>A  intron3  0.005 0.011 0.000 1.000 95.8 
APOC2-4493 C>T rs4803776 intron3  0.483 0.543 0.489 0.800 94.7 
APOC2-4532 C>T  intron3  0.075 0.098 0.054 1.000 91.6 
APOC2-4534_4535 del1  intron3  0.075 0.098 0.054 1.000 91.6 
APOC2-4853_4854 del1 rs150448996 3'flamking   0.261 0.261 0.260 1.000 98.9 
APOC2-4971 C>T rs1130742 3'flanking   0.295 0.713 0.698 0.100 100 
APOC2-5004 G>A rs10421404 3'flanking   0.189 0.191 0.188 1.000 100 
APOC2-5018_5022 del5 rs78403558 3'flanking   0.153 0.160 0.146 1.000 100 
APOC2-5303 C>T rs7257468 3'flanking   0.458 0.468 0.448 0.480 100 
APOC2-5310 T>G rs7258345 3'flanking   0.457 0.543 0.543 0.614 97.9 
APOC2-5324 C>T rs7257476 3'flanking   0.458 0.468 0.448 0.480 100 
APOC2-5398 G>A rs12709889 3'flanking   0.268 0.277 0.260 1.000 100 
APOC2-5644 G>A  3'flanking   0.011 0.011 0.010 1.000 100 
APOC2-5815 G>A rs10423208 3'flanking   0.453 0.457 0.448 0.630 100 
APOC2-5922 A>G rs10422888 3'flanking   0.149 0.160 0.138 1.000 98.9 
APOC2-6037 G>A rs10402642 3'flanking   0.453 0.457 0.448 0.630 100 
Nucleotide position is according to the reference sequence; Ch. Position: chromosomal position is according to NCBI 
build 138; (***) Unavailable data for population-specific variants or not analyzed indels; HWE-P (hardy Weinberg 
equilibrium p-value); %Geno (call rate); Grey-highlighted variants represent shared variants in both populations. 
3.1.2 Sequencing variation in African Blacks 
A total of 178 variants were identified in 95 individuals from African Blacks with extreme lipid 
traits (48 subjects with high HDL/low TG levels, and 47 subjects with low HDL-C/high TG 
levels), of which 163 variants were substitutions and 15 variants were indels. Out of 178 
variants, 133 variants were reported, while the remaining 45 variants were novel. Sixty-three of 
the 178 variants were found also in NHWs and the remaining 115 variants were Black-specific 
(Table 7). 
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Of the 178 SNPs, 31 variants were mapped to APOE (22 reported, 9 novel), 23 variants 
were mapped to APOC1 (19 reported, 4 novel), 3 variants were mapped to HCR-1 (all of the 3 
variants were reported), 4 variants were mapped to HCR-2 (2 reported, 2 novel), 46 variants were 
mapped to APOC4 (32 reported, 14 novel), 5 variants were overlapped in APOC4/APOC2 (all of 
them are reported), and 66 variants were mapped to APOC2 (50 reported, 16 novel). Figure 9 
represents the distribution of sequencing variants in the sequenced regions and Figure 10 
summarizes the percentage of reported and novel variants in each gene in Blacks. 
 
Figure 9. Percentage of the sequencing identified variants among the sequenced regions in Blacks 
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 Figure 10. Gene-based distribution of the reported and novel sequencing variants in Blacks 
 
Gene-based distribution of the sequencing variants among the genomic region (Figure 
11) showed that 32% of APOE variants was located in promoter region, 36% was in intronic 
region, 10% was in coding region, 3% was in splice site, 3% was in UTR, and 15% was in 3” 
flanking region. For APOC1 variation, 9% was in promoter region, 65% was in intronic region, 
4% was in UTR, and 22% was in 3’ flanking region. For APOC4 variation, 26% was in promoter 
region, 54% was in introns, 15% was in coding regions, and 5% was in UTR. For APOC2 
variation, 60% was in introns, 8% was in exons, and 32% was in 3’flanking region.  
 
 
Figure 11. Gene-based distribution of sequencing variants (percentage) among the genomic regions in Blacks 
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Table 7.  APOE-C1-C4-C2 gene cluster sequencing-identified variants in African Blacks sequencing subset 







APOE-73 C>T rs1081101 5'flanking  0.074 0.062 0.087 1.000 98.9 
APOE-173 A>G  5'flanking  0.005 0.000 0.011 1.000 100 
APOE-308 C>T rs769445 5'flanking  0.005 0.000 0.011 1.000 100 
APOE-471 A>G rs439382 5'flanking  0.132 0.125 0.138 1.000 100 
APOE-494 C>T  5'flanking  0.005 0.010 0.000 1.000 100 
APOE-526 T>C  5'flanking  0.005 0.010 0.000 1.000 100 
APOE-560 A>T rs449647 5'flanking  0.395 0.385 0.404 0.169 100 
APOE-618 G>C  5'flanking  0.005 0.000 0.011 1.000 100 
APOE-624 T>C rs769446 5'flanking  0.005 0.010 0.000 1.000 100 
APOE-832 G>T rs405509 5'flanking  0.261 0.260 0.261 0.337 98.9 
APOE-1109 C>T rs9282609 Splice site  0.053 0.052 0.054 1.000 98.9 
APOE-1163 G>C rs440446 intron1  0.124 0.115 0.133 0.822 97.9 
APOE-1231 G>A  intron1  0.011 0.010 0.011 1.000 98.9 
APOE-1279 C>A rs877973 intron1  0.048 0.062 0.033 1.000 98.9 
APOE-1539 A>G rs184686013 intron1  0.011 0.021 0.000 1.000 100 
APOE-1591 G>T rs147236548 intron1  0.016 0.021 0.011 1.000 100 
APOE-2072 G>A rs189660912 intron 2  0.016 0.021 0.011 1.000 100 
APOE-2269 G>A rs61357706 intron 2  0.016 0.010 0.022 1.000 98.9 
APOE-2440 G>A rs769450 intron 2  0.394 0.383 0.404 0.978 98.9 
APOE-2544 A>G rs115299243 intron 2  0.016 0.010 0.022 1.000 98.9 
APOE-2576 G>A  intron 2  0.005 0.010 0.000 1.000 100 
APOE-3673 C>G rs769453 intron 3  0.005 0.000 0.011 1.000 100 
APOE-3937 T>C rs429358 exon 4 Cys 130 Arg 0.237 0.240 0.234 0.201 100 
APOE-4036 C>T rs769455 exon 4 Arg 163 Cys 0.016 0.011 0.022 1.000 96.8 
APOE-4075 G>A rs7412 exon 4 Arg 176 Cys 0.042 0.062 0.021 1.000 100 
APOE-4569 G>T  3'UTR  0.005 0.010 0.000 1.000 100 
APOE-4951 A>C rs1081105 3'flanking  0.042 0.042 0.043 1.000 100 
APOE-5223 G>C  3'flanking  0.005 0.000 0.011 1.000 100 
APOE-5229 G>T rs1065853 3'flanking  0.059 0.074 0.043 1.000 98.9 
APOE-5230 INDEL rs55729972 3'flanking  **** **** **** **** **** 
APOE-5231 T>G  3'flanking  0.032 0.042 0.021 1.000 100 
APOC1-
720_721 ins4 rs72654451 5'flanking   0.237 0.260 0.213 1.000 100 
APOC1-894 C>T rs190454394 5'flanking   0.005 0.010 0.000 1.000 100 
APOC1-1166 G>A rs72654452 intron1  0.032 0.031 0.032 1.000 100 
APOC1-1331 G>A rs10408994 intron2  0.108 0.098 0.117 0.637 97.9 
APOC1-1526 C>T rs5114 intron2  0.047 0.062 0.032 1.000 100 
APOC1-1642 C>T  intron2  0.011 0.010 0.011 1.000 98.9 
APOC1-1684 G>A rs12709881 intron2  0.075 0.083 0.067 1.000 97.9 
APOC1-1870 T>C rs5117 intron2  0.212 0.239 0.185 0.756 96.8 
APOC1-2041 C>T rs3826688 intron2  0.126 0.115 0.138 0.894 100 
APOC1-2099 T>C  intron2  0.005 0.000 0.011 1.000 100 
APOC1-2296 A>T rs185495905 intron2  0.005 0.010 0.000 1.000 100 
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APOC1-3358 A>G  intron3  0.005 0.010 0.000 1.000 100 
APOC1-3423 G>A rs389261 intron3  0.389 0.406 0.372 0.011 100 
APOC1-3573 G>A rs10424339 intron3  0.181 0.198 0.163 0.761 98.9 
APOC1-5006 G>T rs112528434 intron3  0.081 0.083 0.078 1.000 97.9 
APOC1-5053_5054 del1 rs12721052 intron3  0.215 0.191 0.239 1.000 97.9 
APOC1-5240 C>G rs12721051 intron3  0.035 0.045 0.024 1.000 89.5 
APOC1-5667 A>G rs12721054 3'UTR  0.137 0.135 0.138 0.914 100 
APOC1-5716 G>T rs12721055 3'flanking   0.026 0.031 0.021 1.000 100 
APOC1-5717 G>C rs72654457 3'flanking   0.021 0.021 0.021 1.000 100 
APOC1-5926 G>A rs56131196 3'flanking   0.153 0.156 0.149 0.160 100 
APOC1-6026 A>G rs4420638 3'flanking   0.158 0.156 0.160 0.131 100 
APOC1-6158 G>A  3'flanking   0.005 0.000 0.011 1.000 100 
HCR1-424 G>A rs117664574 HCR-1  0.011 0.021 0.000 1.000 100 
HCR1-575 A>G rs157599 HCR-1  0.424 0.448 0.398 0.034 96.8 
HCR1-727 T>G rs149345 HCR-1  0.392 0.404 0.380 0.012 97.9 
HCR2-188 C>G rs35136575 HCR-2  0.181 0.181 0.181 1.000 98.9 
HCR2-286 G>A  HCR-2  0.059 0.032 0.085 1.000 98.9 
HCR2-523 C>T rs118004808 HCR-2  0.005 0.010 0.000 1.000 100 
HCR2-632 T>C  HCR-2  0.083 0.033 0.136 0.940 94.7 
APOC4-65 C>T  5’ flanking   0.007 0.000 0.015 1.000 77.9 
APOC4-92_94 del3 rs12721101 5’ flanking   0.262 0.209 0.321 0.571 86.3 
APOC4-108 G>A  rs112391061 5’ flanking   0.262 0.209 0.321 0.571 86.3 
APOC4-150_151 ins114  5’ flanking   0.283 0.228 0.341 1.000 94.7 
APOC4-204 G>A rs4803773 5’ flanking   0.233 0.250 0.216 1.000 94.7 
APOC4-233 C>T  5’ flanking   0.006 0.000 0.011 1.000 93.7 
APOC4-245 G>T  rs192072159  5’ flanking   0.006 0.000 0.011 1.000 94.7 
APOC4-368 A>G  5’ flanking   0.011 0.010 0.011 1.000 100 
APOC4-438 G>A  rs146656012 5’ flanking   0.006 0.000 0.011 1.000 94.7 
APOC4-489 C>T  rs140241604 5’ flanking   0.017 0.011 0.023 1.000 93.7 
APOC4-637 G>T rs113814026 5’ flanking   0.042 0.042 0.043 1.000 100 
APOC4-757 C>A rs12721105 5’ flanking   0.058 0.062 0.053 0.052 100 
APOC4-1088 T>G  intron1  0.005 0.000 0.011 1.000 100 
APOC4-1130 T>C  intron1  0.005 0.010 0.000 1.000 100 
APOC4-1192 G>A  rs113745034   intron1  0.011 0.010 0.011 1.000 100 
APOC4-1325_1327 del3  intron1  0.043 0.064 0.022 1.000 97.9 
APOC4-1430_1431 insG  intron1  0.037 0.042 0.032 0.216 100 
APOC4-1702 G>A rs12721102 intron1  0.006 0.011 0.000 1.000 91.6 
APOC4-1719 C>A  intron1  0.006 0.011 0.000 1.000 91.6 
APOC4-1733 C>T rs1271111 intron1  0.244 0.228 0.262 1.000 90.5 
APOC4-1823 C>G  intron1  0.203 0.238 0.156 0.286 77.9 
APOC4-2099 G>T  rs111339708   intron1  0.011 0.010 0.011 1.000 100 
APOC4-2467 C>T  rs115225947 intron1  0.021 0.021 0.021 1.000 100 
APOC4-2559 C>T rs5155 intron1  0.09 0.074 0.106 1.000 98.9 
APOC4-2607 G>A rs5156 intron1  0.011 0.010 0.011 1.000 100 
APOC4-2623 C>T rs5157 intron1  0.163 0.167 0.160 1.000 100 
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APOC4-2640 C>T rs5158 intron1  0.032 0.042 0.021 1.000 100 
APOC4-2641 G>A  intron1  0.005 0.000 0.011 1.000 97.9 
APOC4-2678 G>C  rs148564866   intron1  0.005 0.000 0.011 1.000 100 
APOC4-2767 G>T rs12721107 intron1  0.021 0.031 0.011 1.000 100 
APOC4-2971 A>G rs5159 intron1  0.15 0.152 0.148 0.613 94.7 
APOC4-3213 T>C rs28616151 intron1  0.056 0.064 0.048 0.038 93.7 
APOC4-3348 G>A  intron1  0.005 0.011 0.000 1.000 97.9 
APOC2-59C4-3363 G>A rs60170431 APOC4-intron1  0.043 0.053 0.032 1.000 98.9 
APOC2-75C4-3380 G>A rs12721104 APOC4-intron1  0.147 0.146 0.149 0.638 100 
APOC2-194C4-3498 C>T rs1132899 APOC4-exon2  Leu36Pro 0.232 0.240 0.223 1.000 100 
APOC2-198C4-3502 C>T rs10423683 APOC4-exon2  Ser37Ser 0.058 0.062 0.053 0.052 100 
APOC2-228 G>A rs5164 APOC4-exon2  Trp47Ter 0.005 0.000 0.011 1.000 100 
APOC2-288C4-3592 C>T rs12691090 APOC4-exon2  Asp67Asp 0.026 0.042 0.011 1.000 100 
APOC2-396C4-3700 G>A  APOC4-intron2  0.005 0.010 0.000 1.000 100 
APOC2-488C4-3792 G>A rs5165 APOC4-intron2  0.016 0.021 0.011 1.000 100 
APOC2-623C4-3927 T>G rs5167 APOC4-exon3 Leu96Arg 0.011 0.010 0.011 1.000 100 
APOC2-665C4-3969 A>C rs138548797 APOC4-exon3 Lys110Thr 0.468 0.448 0.489 0.747 100 
APOC2-708C4-4012 G>A  APOC4-exon3 Lys124Lys 0.005 0.000 0.011 1.000 100 
APOC2-850C4-4154 G>A rs12709884 APOC4-3' UTR  0.112 0.104 0.120 0.623 98.9 
APOC2-853C4-4157 G>A rs10425530 APOC4-3' UTR  0.101 0.104 0.098 1.000 98.9 
APOC2-1042C4-4346 A>T rs12709885 APOC4-3'FR/APOC2-5'FR  0.005 0.010 0.000 1.000 98.9 
APOC2-1187C4-4491 G>A rs111782345 APOC4-3'FR/APOC2-5'FR  0.005 0.000 0.011 1.000 97.9 
APOC2-1229C4-4533 C>T rs112698600 APOC4-3'FR/APOC2-5'FR  0.011 0.010 0.011 1.000 98.9 
APOC2-1275C4-4579 G>A rs111356234 APOC4-3'FR/APOC2-5'FR  0.053 0.031 0.076 1.000 98.9 
APOC2-1357C4-4661 G>C rs2288912 APOC4-3'FR/APOC2-5'FR  0.232 0.240 0.223 1.000 100 
APOC2-1442C4-4746 G>T rs2288911 APOC2-exon1/UTR   0.207 0.223 0.189 0.857 96.8 
APOC2-1540C4-4844 G>A rs75463753 APOC2-intron1  0.095 0.094 0.096 0.371 100 
APOC2-1608C4-4912 G>C  APOC2-intron1  0.005 0.000 0.011 1.000 100 
APOC2-2003 G>A rs187834478 intron1  0.016 0.021 0.011 1.000 100 
APOC2-2090 G>A rs12721072 intron1  0.058 0.052 0.064 1.000 100 
APOC2-2191 T>C rs9304644 intron1  0.358 0.365 0.351 1.000 100 
APOC2-2258 A>C rs116489256  intron1  0.058 0.052 0.064 1.000 100 
APOC2-2339 A>G rs115943687 intron1  0.058 0.052 0.064 1.000 100 
APOC2-2371 A>G  intron1  0.005 0.010 0.000 1.000 100 
APOC2-2410 T>C rs12721076 intron1  0.032 0.042 0.021 1.000 100 
APOC2-2486 G>A rs9304645 intron1  0.394 0.415 0.372 0.685 98.9 
APOC2-2566 C>T rs9304646 intron1  0.288 0.293 0.283 1.000 96.8 
APOC2-2935 C>G rs11879392 intron1  0.027 0.042 0.011 1.000 98.9 
APOC2-3010 A>G rs10419086 intron1  0.142 0.146 0.138 0.232 100 
APOC2-3030 G>A rs4803774 intron1  0.289 0.302 0.277 1.000 100 
APOC2-3082_3083 ins3  intron1  0.058 0.052 0.064 1.000 100 
APOC2-3086 C>T rs4803775 intron1  0.158 0.167 0.149 0.343 100 
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APOC2-3154 G>A rs145931717 intron1  0.058 0.052 0.064 1.000 100 
APOC2-3193 A>G rs148616221  intron1  0.005 0.000 0.011 1.000 100 
APOC2-3234 T>C  intron1  0.005 0.010 0.000 1.000 100 
APOC2-3259 C>T rs12721061 intron1  0.058 0.052 0.064 1.000 100 
APOC2-3260 G>A rs151176577  intron1  0.011 0.000 0.021 1.000 100 
APOC2-3348 G>A rs10420434 intron1  0.126 0.135 0.117 0.379 100 
APOC2-3600 G>A rs7256684 intron1  0.287 0.298 0.277 1.000 98.9 
APOC2-3617 C>T  intron1  0.005 0.000 0.011 1.000 98.9 
APOC2-3692 T>G rs12721060 intron1  0.011 0.011 0.011 1.000 98.9 
APOC2-3778 A>T rs5120 intron1  0.158 0.167 0.149 0.343 100 
APOC2-3805 C>G rs7257095 intron1  0.163 0.138 0.189 0.524 96.8 
APOC2-3806 C>G rs12709887 intron1  0.043 0.053 0.032 1.000 98.9 
APOC2-3814 T>G rs10422603 intron1  0.306 0.340 0.272 0.588 97.9 
APOC2-3892 C>T rs5121 exon2/UTR  0.027 0.021 0.033 1.000 96.8 
APOC2-4086 G>A rs114780592 intron2  0.021 0.031 0.011 1.000 100 
APOC2-4112 G>C rs74500990 intron2  0.059 0.052 0.065 1.000 98.9 
APOC2-4118 G>A rs201709243 exon3 Val20 Ile 0.005 0.010 0.000 1.000 100 
APOC2-4319 G>A rs5123 intron3  0.055 0.044 0.065 1.000 95.8 
APOC2-4429 C>G rs3745152 intron3  0.259 0.293 0.226 0.545 87.4 
APOC2-4430_4431 ins3 rs35625559 intron3  0.259 0.293 0.226 0.545 87.4 
APOC2-4458 C>T  intron3  0.024 0.043 0.000 1.000 44.2 
APOC2-4460_4461 del1  intron3  0.157 0.161 0.154 0.449 56.8 
APOC2-4493 C>T rs4803776 intron3  0.179 0.188 0.170 0.002 96.8 
APOC2-4513 A>C rs180809422  intron3  0.011 0.011 0.011 1.000 92.6 
APOC2-4532 C>T  intron3  0.194 0.216 0.167 0.097 70.5 
APOC2-4534_4535 del1  intron3  0.165 0.171 0.158 0.170 83.2 
APOC2-4587 A>C rs5126 exon4 Lys 77 Gln 0.044 0.044 0.043 1.000 95.8 
APOC2-4754 C>T rs7253690 exon4/UTR  0.065 0.062 0.067 1.000 97.9 
APOC2-4853_4854 del1 rs150448996  3'flamking  0.272 0.255 0.289 0.659 96.8 
APOC2-4971 C>T rs1130742 3'flanking   0.279 0.740 0.702 0.529 100 
APOC2-4973_4974 ins1 rs199828513 3'flamking  0.005 0.000 0.011 1.000 100 
APOC2-5004 G>A rs10421404 3'flanking   0.305 0.344 0.266 0.551 100 
APOC2-5018_5022 del5 rs78403558 3'flanking   0.058 0.083 0.032 1.000 100 
APOC2-5303 T>C rs7257468 3'flanking   0.284 0.292 0.277 1.000 100 
APOC2-5310 G>T rs7258345 3'flanking   0.285 0.302 0.267 1.000 97.9 
APOC2-5324 T>C rs7257476 3'flanking   0.295 0.302 0.287 1.000 100 
APOC2-5398 G>A rs12709889 3'flanking   0.25 0.240 0.261 1.000 98.9 
APOC2-5491 C>T  3’flanking  0.005 0.010 0.000 1.000 100 
APOC2-5512 G>A rs12721064 3'flanking   0.005 0.010 0.000 1.000 100 
APOC2-5562 G>C  3'flanking   0.021 0.010 0.032 1.000 100 
APOC2-5586 T>G rs73558127 3'flanking   0.089 0.104 0.074 1.000 100 
APOC2-5612 A>G  3'flanking   0.063 0.062 0.064 1.000 100 
APOC2-5771_5775 del5  3'flanking   0.005 0.011 0.000 1.000 97.9 
APOC2-5815 A>G rs10423208 3'flanking   0.293 0.302 0.283 1.000 98.9 
APOC2-5922 A>G rs10422888 3'flanking   0.121 0.156 0.085 0.258 100 
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APOC2-5965 G>A  3'flanking   0.005 0.010 0.000 1.000 100 
APOC2-6037 A>G rs10402642 3'flanking   0.295 0.302 0.287 1.000 100 
APOC2-6222 G>C  3'flanking   0.011 0.010 0.989 1.000 100 
APOC2-6334 G>A  3'flanking   0.026 0.031 0.021 1.000 100 
Nucleotide position is according to the reference sequence; Ch. Position: chromosomal position is according to NCBI 
build 138; (***) Unavailable data for population-specific variants or not analyzed indels; HWE-P (hardy Weinberg 
equilibrium p-value); %Geno (call rate); Grey-highlighted variants represent shared variants in both populations. 
3.2 ANNOTATED COLORED FASTA  
The colored FASTA adopted from SeattleSNPs database with some modifications have been 
made by adding color-coded sequencing discovered variants in each population. Red-colored 
variants represent NHW-specific variants, while blue-colored variants represent Black-specific 
variants, and black-colored variants represent overlapped variants in both populations. All 
variants that identified previously in database but not in our study are depicted with Dark green 
font.  Yellow highlight is used for deletion and blue highlight is used for bases flank the insertion 
with population-specific colored-font. Variants identified in database (comparing to NCBI build 
138) and in our study include reference SNPs ID in addition to its position according to the 
annotated reference sequence and the corresponding allele change. The color code used in 
SeattleSNPs reference sequence is as follows: light grey for flanking regions and introns, green 
for UTR, dark blue for exons, purple for repeat regions, and light blue for regions not scanned in 
SeattleSNPs database.  
For all these four genes (APOE, APOC1, APOC4, and APOC2), we used SeattleSNPs 
database reference sequence, while we used NCBI (build 137) for their two hepatic control 
regions (HCR-1 and HCR-2). For some genes with no sufficient coverage in either flanking 
regions, additional sequences were adopted from chip bioinformatics or gene bank database to 
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extend the sequencing coverage in the 5’ and 3’ flanking region. For APOC1 gene we adopted 
803 bp in the 5’flanking region and 942 bp in the 3’ flanking region from Chip bioinformatics. 
For APOC4, we adopted 546 bp in the 3’flanking region from Chip bioinformatics.  
We noticed two issues in APOC2 SeattleSNPs reference sequence where all subjects in 
the sequencing subsets had (P.65_66insC) and (P.178_179delG) similar to what we found in 
APOC2 reference sequence from other databases (NCBI build 138, and Chip Bioinformatics). 
Additional issues were found in APOC4 SeattleSNPs reference sequence where all subjects had 
C>G change at position 1722 (rs10409424) and G>C change at position 1723 (rs10409808). 
Since all subjects are homozygote for these two allele changes, we assumed that these two (C4-
1722/rs10409424, and C4-1723/rs10409808) are errors in the reference sequence and thus are 
not polymorphisms. Moreover, we noticed some difference in APOC1 reference sequence from 
SeattleSNPs database and that from genebank database where there is deletion T at position 
1673, and position 4697 in SeattleSNPs reference sequence and insertion A at position 3173. 
Since we used genebank reference sequence in variant reporter software for variant detection, the 
nucleotide position of our data corresponds to the genebank reference sequence.  
We observed that reference allele is the minor allele for couple of variants. For these 
overlapped variants in APOC4/APOC2 genes, C2-1357/C4-4661 (rs22889120), and C2-
1442/C4-4746 (rs2288911), seattleSNPs reference allele is the major allele (APOC2 annotated 
FASTA), while Chip Bioinformatics reference allele is the minor allele (APOC4 annotated 
FASTA). Additionally, reference allele was the minor allele for these two variants; C2-
3600/rs7256684 and C2-4429/rs3745152. Moreover, reference allele is the minor allele for one 
deletion in APOC2 at position C2-4853_4854delT, which is insertion not deletion. Figure 12 
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represents the annotated colored FASTA of all the sequenced four genes along with their two 
hepatic control regions (HCR1 and HCR2).
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APOE annotated colored FASTA (Accession # AF261279.1) 
CTTGATGCTC AGAGAGGACA AGTCATTTGC CCAAGGTCAC ACAGCTGGCA 50  | REPEAT  
ACTGGCAGAG CCAGGATTCA CGCCCTGGCA ATTTGACTCC AGAATCCTAA 100 | P.73/rs1081101[C>T] 
CCTTAACCCA GAAGCACGGC TTCAAGCCCC TGGAAACCAC AATACCTGTG 150  
GCAGCCAGGG GGAGGTGCTG GAATCTCATT TCACATGTGG GGAGGGGGCT 200 | P.173[A>G] 
CCCCTGTGCT CAAGGTCACA ACCAAAGAGG AAGCTGTGAT TAAAACCCAG 250 | REPEAT  
GTCCCATTTG CAAAGCCTCG ACTTTTAGCA GGTGCATCAT ACTGTTCCCA 300  
CCCCTCCCAT CCCACTTCTG TCCAGCCGCC TAGCCCCACT TTCTTTTTTT 350 | P.308/rs769445[C>T] | REPEAT  
TCTTTTTTTG AGACAGTCTC CCTCTTGCTG AGGCTGGAGT GCAGTGGCGA 400  
GATCTCGGCT CACTGTAACC TCCGCCTCCC GGGTTCAAGC GATTCTCCTG 450  
CCTCAGCCTC CCAAGTAGCT AGGATTACAG GCGCCCGCCA CCACGCCTGG 500 | P.471/rs439382[A>G] | P.494[C>T]  
CTAACTTTTG TATTTTTAGT AGAGATGGGG TTTCACCATG TTGGCCAGGC 550 | P.526[T>C]| P.545/rs1081103[C>T] 
TGGTCTCAAA CTCCTGACCT TAAGTGATTC GCCCACTGTG GCCTCCCAAA 600 | P.560/rs449647[A>T]  
GTGCTGGGAT TACAGGCGTG AGCTACCGCC CCCAGCCCCT CCCATCCCAC 650 | P.618[G>C]| P.624/rs769446[T>C]  
TTCTGTCCAG CCCCCTAGCC CTACTTTCTT TCTGGGATCC AGGAGTCCAG 700  
ATCCCCAGCC CCCTCTCCAG ATTACATTCA TCCAGGCACA GGAAAGGACA 750  
GGGTCAGGAA AGGAGGACTC TGGGCGGCAG CCTCCACATT CCCCTTCCAC 800  
GCTTGGCCCC CAGAATGGAG GAGGGTGTCT GGATTACTGG GCGAGGTGTC 850 | P.832/rs405509[G>T]  
CTCCCTTCCT GGGGACTGTG GGGGGTGGTC AAAAGACCTC TATGCCCCAC 900  
CTCCTTCCTC CCTCTGCCCT GCTGTGCCTG GGGCAGGGGG AGAACAGCCC 950  
ACCTCGTGAC TGGGGGCTGG CCCAGCCCGC CCTATCCCTG GGGGAGGGGG 1000  
CGGGACAGGG GGAGCCCTAT AATTGGACAA GTCTGGGATC CTTGAGTCCT 1050 | Exon 1 | UTR 
ACTCAGCCCC AGCGGAGGTG AAGGACGTCC TTCCCCAGGA GCCGGTGAGA 1100  
AGCGCAGTCG GGGGCACGGG GATGAGCTCA GGGGCCTCTA GAAAGAGCTG 1150 | P.1109/rs9282609[C>T] 
GGACCCTGGG AAGCCCTGGC CTCCAGGTAG TCTCAGGAGA GCTACTCGGG 1200 | P.1163/rs440446[G>C]  
GTCGGGCTTG GGGAGAGGAG GAGCGGGGGT GAGGCAAGCA GCAGGGGACT 1250 | P.1231[G>A] 
GGACCTGGGA AGGGCTGGGC AGCAGAGACG ACCCGACCCG CTAGAAGGTG 1300 | P.1279/rs877973[C>A] 
GGGTGGGGAG AGCAGCTGGA CTGGGATGTA AGCCATAGCA GGACTCCACG 1350  
AGTTGTCACT ATCATTTATC GAGCACCTAC TGGGTGTCCC CAGTGTCCTC 1400  
AGATCTCCAT AACTGGGGAG CCAGGGGCAG CGACACGGTA GCTAGCCGTC 1450  
GATTGGAGAA CTTTAAAATG AGGACTGAAT TAGCTCATAA ATGGAACACG 1500  
GCGCTTAACT GTGAGGTTGG AGCTTAGAAT GTGAAGGGAG AATGAGGAAT 1550 | P.1522/rs769447[G>A]| 
P.1539/rs184686013[A>G]  
GCGAGACTGG GACTGAGATG GAACCGGCGG TGGGGAGGGG GTGGGGGGAT 1600 | P.1575/rs769448[C>T]| 
P.1591/rs147236548[G>T]  
GGAATTTGAA CCCCGGGAGA GGAAGATGGA ATTTTCTATG GAGGCCGACC 1650  
TGGGGATGGG GAGATAAGAG AAGACCAGGA GGGAGTTAAA TAGGGAATGG 1700  
GTTGGGGGCG GCTTGGTAAA TGTGCTGGGA TTAGGCTGTT GCAGATAATG 1750  
CAACAAGGCT TGGAAGGCTA ACCTGGGGTG AGGCCGGGTT GGGGCCGGGC 1800  
TGGGGGTGGG AGGAGTCCTC ACTGGCGGTT GATTGACAGT TTCTCCTTCC 1850  
CCAGACTGGC CAATCACAGG CAGGAAGATG AAGGTTCTGT GGGCTGCGTT 1900 | Exon 2 | UTR  
                              M   K  V  L   W  A  A  L 8 
GCTGGTCACA TTCCTGGCAG GTATGGGGGC GGGGCTTGCT CGGTTCCCCC 1950  
  L  V  T   F  L  A                                    14 
CGCTCCTCCC CCTCTCATCC TCACCTCAAC CTCCTGGCCC CATTCAGGCA 2000 | P.1998/rs769449[G>A] 
GACCCTGGGC CCCCTCTTCT GAGGCTTCTG TGCTGCTTCC TGGCTCTGAA 2050  
CAGCGATTTG ACGCTCTCTG GGCCTCGGTT TCCCCCATCC TTGAGATAGG 2100 | P.2072/rs189660912[G>A] 
AGTTAGAAGT TGTTTTGTTG TTGTTGTTTG TTGTTGTTGT TTTGTTTTTT 2150 | REPEAT  
TGAGATGAAG TCTCGCTCTG TCGCCCAGGC TGGAGTGCAG TGGCGGGATC 2200  
TCGGCTCACT GCAAGCTCCG CCTCCCAGGT CCACGCCATT CTCCTGCCTC 2250  
AGCCTCCCAA GTAGCTGGGA CTACAGGCAC ATGCCACCAC ACCCGACTAA 2300 | P.2269/rs6135770[G>A]| P.2294[C>T]  
CTTTTTTGTA TTTTCAGTAG AGACGGGGTT TCACCATGTT GGCCAGGCTG 2350  
GTCTGGAACT CCTGACCTCA GGTGATCTGC CCGTTTCGAT CTCCCAAAGT 2400  
GCTGGGATTA CAGGCGTGAG CCACCGCACC TGGCTGGGAG TTAGAGGTTT 2450 | P.2440/rs769450[G>A]  
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CTAATGCATT GCAGGCAGAT AGTGAATACC AGACACGGGG CAGCTGTGAT 2500  
CTTTATTCTC CATCACCCCC ACACAGCCCT GCCTGGGGCA CACAAGGACA 2550 | P.2544/rs115299243[A>G] 
CTCAATACAT GCTTTTCCGC TGGGCGCGGT GGCTCACCCC TGTAATCCCA 2600 | REPEAT| P.2576[G>A]  
GCACTTTGGG AGGCCAAGGT GGGAGGATCA CTTGAGCCCA GGAGTTCAAC 2650  
ACCAGCCTGG GCAACATAGT GAGACCCTGT CTCTACTAAA AATACAAAAA 2700  
TTAGCCAGGC ATGGTGCCAC ACACCTGTGC TCTCAGCTAC TCAGGAGGCT 2750  
GAGGCAGGAG GATCGCTTGA GCCCAGAAGG TCAAGGTTGC AGTGAACCAT 2800  
GTTCAGGCCG CTGCACTCCA GCCTGGGTGA CAGAGCAAGA CCCTGTTTAT 2850  
AAATACATAA TGCTTTCCAA GTGATTAAAC CGACTCCCCC CTCACCCTGC 2900  
CCACCATGGC TCCAAAGAAG CATTTGTGGA GCACCTTCTG TGTGCCCCTA 2950 | P.2907/rs769451[T>G] 
GGTACTAGAT GCCTGGACGG GGTCAGAAGG ACCCTGACCC ACCTTGAACT 3000  
TGTTCCACAC AGGATGCCAG GCCAAGGTGG AGCAAGCGGT GGAGACAGAG 3050 | Exon 3| P.3038/rs111833428[G>A]  
             G  C  Q   A  K  V   E  Q  A  V   E  T  E  27 
CCGGAGCCCG AGCTGCGCCA GCAGACCGAG TGGCAGAGCG GCCAGCGCTG 3100  
 P  E  P   E  L  R  Q   Q  T  E   W  Q  S   G  Q  R  W 44 
GGAACTGGCA CTGGGTCGCT TTTGGGATTA CCTGCGCTGG GTGCAGACAC 3150 | P.3106/rs769452[T>C] 
  E  L  A   L  G  R   F  W  D  Y   L  R  W   V  Q  T   60 
TGTCTGAGCA GGTGCAGGAG GAGCTGCTCA GCTCCCAGGT CACCCAGGAA 3200  
L  S  E  Q   V  Q  E   E  L  L   S  S  Q  V   T  Q  E  77 
CTGAGGTGAG TGTCCCCATC CTGGCCCTTG ACCCTCCTGG TGGGCGGCTA 3250  
 L  R                                                  79 
TACCTCCCCA GGTCCAGGTT TCATTCTGCC CCTGTCGCTA AGTCTTGGGG 3300  
GGCCTGGGTC TCTGCTGGTT CTAGCTTCCT CTTCCCATTT CTGACTCCTG 3350  
GCTTTAGCTC TCTGGAATTC TCTCTCTCAG CTTTGTCTCT CTCTCTTCCC 3400  
TTCTGACTCA GTCTCTCACA CTCGTCCTGG CTCTGTCTCT GTCCTTCCCT 3450  
AGCTCTTTTA TATAGAGACA GAGAGATGGG GTCTCACTGT GTTGCCCAGG 3500 | REPEAT  
CTGGTCTTGA ACTTCTGGGC TCAAGCGATC CTCCCGCCTC GGCCTCCCAA 3550  
AGTGCTGGGA TTAGAGGCAT GAGCCACCTT GCCCGGCCTC CTAGCTCCTT 3600  
CTTCGTCTCT GCCTCTGCCC TCTGCATCTG CTCTCTGCAT CTGTCTCTGT 3650  
CTCCTTCTCT CGGCCTCTGC CCCGTTCCTT CTCTCCCTCT TGGGTCTCTC 3700 | P.3673/rs769453[C>G]  
TGGCTCATCC CCATCTCGCC CGCCCCATCC CAGCCCTTCT CCCCGCCTCC 3750  
CACTGTGCGA CACCCTCCCG CCCTCTCGGC CGCAGGGCGC TGATGGACGA 3800 | Exon 4  
                                        A   L  M  D  E 84 
GACCATGAAG GAGTTGAAGG CCTACAAATC GGAACTGGAG GAACAACTGA 3850  
  T  M  K   E  L  K   A  Y  K  S   E  L  E   E  Q  L   100 
CCCCGGTGGC GGAGGAGACG CGGGCACGGC TGTCCAAGGA GCTGCAGGCG 3900  
T  P  V  A   E  E  T   R  A  R   L  S  K  E   L  Q  A  117 
GCGCAGGCCC GGCTGGGCGC GGACATGGAG GACGTGTGCG GCCGCCTGGT 3950 | P.3937/rs429358[T>C]  
 A  Q  A   R  L  G  A   D  M  E   D  V  C   G  R  L  V 134 
GCAGTACCGC GGCGAGGTGC AGGCCATGCT CGGCCAGAGC ACCGAGGAGC 4000  
  Q  Y  R   G  E  V   Q  A  M  L   G  Q  S   T  E  E   150 
TGCGGGTGCG CCTCGCCTCC CACCTGCGCA AGCTGCGTAA GCGGCTCCTC 4050 | P.4036/rs769455[C>T]  
L  R  V  R   L  A  S   H  L  R   K  L  R  K   R  L  L  167 
CGCGATGCCG ATGACCTGCA GAAGCGCCTG GCAGTGTACC AGGCCGGGGC 4100 | P.4075/rs7412[C>T]  
 R  D  A   D  D  L  Q   K  R  L   A  V  Y   Q  A  G  A 184 
CCGCGAGGGC GCCGAGCGCG GCCTCAGCGC CATCCGCGAG CGCCTGGGGC 4150  
  R  E  G   A  E  R   G  L  S  A   I  R  E   R  L  G   200 
CCCTGGTGGA ACAGGGCCGC GTGCGGGCCG CCACTGTGGG CTCCCTGGCC 4200  
P  L  V  E   Q  G  R   V  R  A   A  T  V  G   S  L  A  217 
GGCCAGCCGC TACAGGAGCG GGCCCAGGCC TGGGGCGAGC GGCTGCGCGC 4250  
 G  Q  P   L  Q  E  R   A  Q  A   W  G  E   R  L  R  A 234 
GCGGATGGAG GAGATGGGCA GCCGGACCCG CGACCGCCTG GACGAGGTGA 4300  
  R  M  E   E  M  G   S  R  T  R   D  R  L   D  E  V   250 
AGGAGCAGGT GGCGGAGGTG CGCGCCAAGC TGGAGGAGCA GGCCCAGCAG 4350 | P.4310/rs199768005[T>A] 
K  E  Q  V   A  E  V   R  A  K   L  E  E  Q   A  Q  Q  267 
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ATACGCCTGC AGGCCGAGGC CTTCCAGGCC CGCCTCAAGA GCTGGTTCGA 4400  
 I  R  L   Q  A  E  A   F  Q  A   R  L  K   S  W  F  E 284 
GCCCCTGGTG GAAGACATGC AGCGCCAGTG GGCCGGGCTG GTGGAGAAGG 4450  
  P  L  V   E  D  M   Q  R  Q  W   A  G  L   V  E  K   300 
TGCAGGCTGC CGTGGGCACC AGCGCCGCCC CTGTGCCCAG CGACAATCAC 4500  
V  Q  A  A   V  G  T   S  A  A   P  V  P  S   D  N  H  317 
TGAACGCCGA AGCCTGCAGC CATGCGACCC CACGCCACCC CGTGCCTCCT 4550 | UTR| P.4528[C>T]   
GCCTCCGCGC AGCCTGCAGC GGGAGACCCT GTCCCCGCCC CAGCCGTCCT 4600 | P.4569[G>T] 
CCTGGGGTGG ACCCTAGTTT AATAAAGATT CACCAAGTTT CACGCATCTG 4650  
CTGGCCTCCC CCTGTGATTT CCTCTAAGCC CCAGCCTCAG TTTCTCTTTC 4700  
TGCCCACATA CTGGCCACAC AATTCTCAGC CCCCTCCTCT CCATCTGTGT 4750 | P.4737/rs117656888[C>G] 
CTGTGTGTAT CTTTCTCTCT GCCCTTTTTT TTTTTTTTAG ACGGAGTCTG 4800 | REPEAT  
GCTCTGTCAC CCAGGCTAGA GTGCAGTGGC ACGATCTTGG CTCACTGCAA 4850  
CCTCTGCCTC TTGGGTTCAA GCGATTCTGC TGCCTCAGTA GCTGGGATTA 4900  
CAGGCTCACA CCACCACACC CGGCTAATTT TTGTATTTTT AGTAGAGACG 4950  
AGCTTTCACC ATGTTGGCCA GGCAGGTCTC AAACTCCTGA CCAAGTGATC 5000 | P.4951/rs1081105[A>C] 
CACCCGCCGG CCTCCCAAAG TGCTGAGATT ACAGGCCTGA GCCACCATGC 5050  
CCGGCCTCTG CCCCTCTTTC TTTTTTAGGG GGCAGGGAAA GGTCTCACCC 5100 | REPEAT  
TGTCACCCGC CATCACAGCT CACTGCAGCC TCCACCTCCT GGACTCAAGT 5150  
GATAAGTGAT CCTCCCGCCT CAGCCTTTCC AGTAGCTGAG ACTACAGGCG 5200  
CATACCACTA GGATTAATTT GGGGGGGGGG TGGTGTGTGT GGAGATGGGG 5250 | P.5223[G>C] | P.5229/rs80125357 
[G>T]| P.5230/rs55729972[delG/insG]| P.5231[T>G] 
TCTGGCTTTG TTGGCCAGGC TGATGTGGAA TTCCTGGGCT CAAGCGATAC 5300  
TCCCACCTTG GCCTCCTGAG TAGCTGAGAC TACTGGCTAG CACCACCACA 5350  
CCCAGCTTTT TATTATTATT TGTAGAGACA AGGTCTCAAT ATGTTGCCCA 5400 | P.5361/rs1081106[T>C] 
GGCTAGTCTC AAACCCCTGG GCTCAAGAGA TCCTCCGCCA TCGGCCTCCC 5450  
AAAGTGCTGG GATTCCAGGC ATGGGCTCCG AGCGGCCTGC C          5491 
APOC1 ANNOTATED COLORED FASTA  
CAAAAAAGGG AGACTGAGAA CCATGAAGTT AAGAGCCCAG AGAATATCAC 50 
GGTGGTCTGG GGTGCTTCAA GGGCTGGTCT GGAATAAATT GGAGGTGGCA 100 
CGCAGGGTAG GAGCGCCGGG CCAACTGGGA GACCCAGCAA CATAAAGGAA 150 
AAGTTGTTGG GGCTGAGGAG GCTTGCTGAG AGAGGGGAAG TGAGGGAAAG 200 
AGGTGATCTA GGGACACGGT GTGAATGAGG GGGGGATGAG ATCACAGGGT 250  
TATTACTGGG AGACCCCTGA GGGAAGATGG CCACAGGGAC AGGACAAGGC 300   
TGTCTTCTTA AGGGAGGAGA CCACCCCTCA TATTGTCTTA TGCCCAATTT 350 
CTGCCTCCAA AGAAAGAAAA AGTAAAAACT AAAAGGCAGA AATGAAATCC 400 
ACAAGCAGAC AGCCCGCGCC ACACCCTGGG CCTGGTGGTT AAAGATTGAC 450 
CCCTGACCTA ATCCGTTAGG TTATCTATAG ATTACAGACA TTGTATAGAA 500 
AAGCACTGTG AAAATCCCTA TTCTGTTTTG TTCCGATCTA ATTACCGGTG 550 
CATGCAGCCC CCAGTCACGC ATCCCCTGCT TGTTCAATCG ATCACGACCC 600  
TCTCACGTGC ACCCACTTAG AGTTGTGAGC CCTTAAAAGG AACAGGGATT 650 | P.607/rs72654447[G/A] 
GCTCACTCGG GGAGCTCGGC TCTTGAGACA GGAATCTTGC CCATTCCCCG 700 | P.655/rs66807996[A/T] | 
P.659/rs72654448[G/C] | P.698/rs72654449[C/A] 
AACGAATAAA CCCCTTCCTT AACTCAGCGT CTGAGGAATT TTGTCTGCGG 750 | P.703/rs3207187[C/T] | 
P.720_721/rs72654451 [insCGTT] 
CTCCTCCTGC TACATTCTGA GTGGGGAAAG GGACTAAGGT GGTCTGAGGA 800 
CCCCACAGAG TCAGGAAGAT TGAGAGGTGA GAGTGCTGAA CGGGGAGGGG 850 
CTTTGGGGCT AAGGGAAGTG CCCGGGACCC CACCTGACCC CAACGCTCAC 900 | P.894/rs190454394[C/T] 
GGGACAGGGG CAGAGGAGAA AAACGTGGGT GGACAGAGGG AGGCAGGCGG 950 
TCAGGGGAAG GCTCAGGAGG AGGGAGATCA ACATCAACCT GCCCCGCCCC 1000 
CTCCCCAGCC TGATAAAGGT CCTGCGGGCA GGACAGGACC TCCCAACCAA 1050 
GCCCTCCAGC AAGGATTCAG GTTGGTGCTG AGTGCCTGGG AGGGACACCC 1100 | Exon 1 | UTR 
GCCTACACTC TGCAAGAAAC TCAAAAAGGG AGATGAGGGG ATCGTGGGAG 1150 
GGAGGTAGGG AGGGAGGAGG GTGCCACTGA TCCCCTGAAC CCCTGCCTCT 1200 | P.1166/rs72654452[G/A]| P.1170[G/A] 
GCCTCCAGAG TGCCCCTCCG GCCTCGCCAT GAGGCTCTTC CTGTCGCTCC 1250 | Exon 2 | UTR |                                    
                               M   R  L  F   L  S  L   7 
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P.1249/rs12721047[C/T] 
CGGTCCTGGT GGTGGTTCTG TCGATCGTCT TGGAAGGTAA AAGTGGGATG 1300 | P.1276/rs72654453[C/G]| P.1294[T/G] 
P  V  L  V   V  V  L   S  I  V   L  E                  19 
GGAGAATTGC GGAGTTGGAG ATTTGGAAGA GTGAAGGTGG CTACAGGCCT 1350 | P.1317/rs12721048[G/A]| 
P.1331/rs10408994[G/A] 
GGGGTCCCGG CTTAGAGGAC CTCTGAGAGC TCCGGGGCCC CTTCTGGGTC 1400 
GTGGTTGCCT CATCGTGGTC GGGTGGGTCT CCAGGTTCTC CCAGGCTCAG 1450 | P.1422[G/A] 
TCCCGCAGGC GCCAAATCTG CGCAGGAGAG CACTAGCAAC CGATGACGTA 1500 
TTGAGGCCCA CACCTCTGGG ATTGGCTGTC CTGCTTCGAC AGCCTTGAAA 1550 | P.1526/rs5114[C/T] 
GTGGGTAAGC TGGGTGGGGG GCTCTGGGAG AGGTCAGTGC TGAGTAAGGC 1600 | P.1566/rs12691088[G/A] 
AATTCCCAGC AGCTTGAGCC CCACCAGGTC ACTCCAGTAT TCCTCCCCAT 1650 | P.1642[C/T] 
TCTTTTTTTT TTTTTTTTTT TTTCTCTTGA GACGGAGTCT CGCTCTGTCG 1700 | P.1669[T/C]| P.1684/rs12709881[G/A] 
CCGAGGCTGG AGTGCAGTGG CGCGATCTCG GCTCACTGCA AGCTCCGCCT 1750 
CCCTGGTTCA CGCCATTCTC CTGCCTCAGC AGGACTACAG GCGCCCGCCA 1800 
CCGCGCCCGG CTAATTTTTT GTATTTTCAG TAGAGACAGG GTTTCACCGT 1850 
GGTCTCGATC TCCTGACTTT GTGATCCGCC TGCCTCGACC TCCCAAAGTG 1900 | P.1870/rs5117[T/C] 
CTGGGATTAC AGGCGTGAGC CACCGCGTCC GGCCATTCCT CCCCATTCTA 1950 
ACCACATGAT CCCCAAGGAT CTCTATCCAT CCCGGTATCC CAACCTAAGG 2000 
GGGTTCCAAT AACAAATTTT TGGCCGGGCA GGGTGGCTCA CGCCTGTAAT 2050 | REPEAT| P.2041/rs3826688[C/T] 
CCCAGCACTT TGGGAGGCCG AGGCGGGCAG ATCACTTGAG GTCAGGAGTT 2100 | P.2099[T/C] 
CGAAACCAGC CTGGCCAACA TGGTGAAACT TCGTCTCTAC TAAAAATACA 2150 
AAAAAATTAG CCAGGTGTGG AGGCACGCGC CTGTAGGCCC AGCTACTCGG 2200 
GAGGCTGAGG CAGGAGAATC ACTTGAACCC GGGAGGCGGA GGTTGCAGTG 2250 
AGCCGAGATC ATACCACTGC ACTCCAGCCT GGCTGACACA GCAAGACTCC 2300 | P.2296/rs185495905[A/T] 
GTCTCAAAAC AAAACAAAAC AAAAATAGCT GGGTGTGGTG GTGCACACCT 2350 |REPEAT 
GTAATCCCAG CTACTTGGGA GGCTGAGGCA GGAGAACTGC TTGAACCCGG 2400 
GAGGTGGTGG TTGCAGTAGG CCGAGATCAT GCCACTGCAC TCCAGCTTGG 2450 
GCTACAGAGC AAGACTCCAT CTCCAAAAAA AAAAAAAAAA AAACAAATTT 2500 
TGAACCCCTG CCCATCTTCC TGGCAGGCCC AGCCCCAGCC CAGGGGACCC 2550 | Exon 3 
                            G  P   A  P  A   Q  G  T   27 
CAGACGTCTC CAGTGCCTTG GATAAGCTGA AGGAGTTTGG AAACACACTG 2600  
P  D  V  S   S  A  L   D  K  L   K  E  F  G   N  T  L  44 
GAGGACAAGG CTCGGGAACT CATCAGCCGC ATCAAACAGA GTGAACTTTC 2650 | P.2629[G/A] 
 E  D  K   A  R  E  L   I  S  R   I  K  Q   S  E  L  S 61 
TGCCAAGATG CGGTTAGAAC CCTTCCCAGG GCACGGGAGA GCTGGGGTGT 2700 
  A  K  M   R                                          65 
GTTTTTGGGT GGAGCCCTGG CAGATGGTCC AAGATGAACA GATTGAAAAA 2750 
AAAACAAGTC CTGGAGAGGC TGACAACATC CCTCTGGTCA CACAGCTAGA 2800 
TCTCAAGGTG CTCAGACTTC AAGGACAGTT TCCCTGACTC CCATCCAGGC 2850 | P.2817[C/T] 
CATATTTTAA AAGATGGTCT TGGGCTGGGC ACGGTGGCTC ATGCTTGCAA 2900 | REPEAT 
TCCCAGCACT TAGGGAGGCC GAGGTGGGCT GATTGCCTGA GGTCAGGAGT 2950 
TCGAGACCAG TCTGACCAAC ATGGTGAAAC CTTGTCTCTA CTAAAAATAC 3000 
AAAAAAATTA GGCAGGCATG GTGGCGTGCA CCTGTAATCC CAGCTAGTCG 3050 
GGAGGCTGAG GCAGGGGAAT TGCTTGAACC AGGAAGGTGG GAGTTACAGT 3100 
GAGCCAACAT TGTGCCAGCC TGGGTGACAG AAGGAGACTC TGTCTCAAAA 3150  
AAAAAAAAAA AAAAAAAAAA AACAAGATGG TCTTGCCCAG GTATGGTGGC 3200 | REPEAT 
TCACACCTGT AATTCCAGCA CTATGGGAGG CTGAGATGGG AGGATTGCTT 3250 
GAGCCCAGGA GTTCGAGACC AGCCTGACCA ACATGGCGAG ATCCTGTCTC 3300 
CATTTAAAAA AAAAAAAAAA AAGATGGTTT TGTGAGGTAA TGAAAATGAA 3350 
GGCCCCAAGC TTGGCCAGAC CTGGGTCCCC AGGCTGGAGT AGCACCCCTT 3400 | P.3358[A/G] 
CCTGTGTGAT CTTGACAGAG GGGCATTACT GTGAGCCTCA GTTTCCTCTC 3450 | P.3423/rs389261[G/A] 
CTATAAACTG GTGGTTCTAC AGGGAAGTAA AGGAGCAGGC CTACAGGGTG 3500 | P.3494[C/T] 
TCTGGTACAT GTAGATGCTC AGTATATCAT GAAACCCACC CTTGCCCCCT 3550 
TTGGCAAGTT AGAGAGTCAT TCGTTCTTTC AAAAATATTT ACTGAGCATC 3600 | REPEAT| P.3573/rs10424339[G/A] 
TGCTAAGTGC TGGAAACTGT TTCAATGTGG GGAATAAAAC AGTGAAGAAC 3650 | REPEAT 
GTGCCGAGCA CGGTGGCTCA CACCTGTAAC CCCACCACTT TGGAAGGCCG 3700 
AGGTGGGTGG ATCACTTGAG GTCAGGAGTG CGAGAACCCC GTCCCTAATA 3750 
GAAATGCAAA AAAAATTAGC TGGGCATGGT GGCCCATGCC TGTAGTCCCA 3800 
GCTCCTTGGG AGGCTGAGGC GAGAGGATTG CTTGAGCCCA GGAGATCTAG 3850 
GCTGCAGTGC GCCATGTTTG TGCCACTGCA TTCCAGCCTG GGTAACAGAA 3900 
TGAGACCCTG TCTCAACAAA AAAAGAAAAG AAAAGAGAAG AAAAGAGAAA 3950 
AGAAAGACAG GGAGGGAGGG AGGAAGGAAG GGAGGGAGGG AGGGAAAATA 4000 
GAGCCAGGCA TAAACTTAGA AAGATCGTTT GGAGGCCAGG CACAATGGCT 4050 | REPEAT 
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CACACCTGTA ATCCCAGCAC TTTGGGAGGC CAAGGCAAGC AGATCACCTG 4100 
AGGTCAGGAG TTCGAGACCA GCCTAACATG GAGAAACCCT GTCTCTACTA 4150 
AAAATACAAA ATTAGCCGGG CGTGGTGGTG CATTCCTGTA GTCCTAGCTA 4200 | P.4180/rs3925681[G/A] 
CTCGGGAGCC TGAGGCAGGA GAATCACTTG AACCCGGGAG GCGGAGGTTG 4250 
CAGTGAGCCG AGATCATGCC ACTGCACTCC AGCCTGGGCG ACAAGGCGAG 4300 | P.4298/rs12721044[insA] 
ACTCCATGCC AAAAAAGAAA AAAAACTCCT GGCGCGGTGG CTCACGCCAG 4350 | REPEAT| P.4334/rs12721046[G/A] 
TAATCCCAGC ACTGTGGGAG GCTGAGCAGG CGGATCACGA GGTCAGGAGT 4400 
TCGAGACTAG CCTGCTCAAC ATAATGAAAC CCTCTCTGTA CTAAAAATAC 4450 
AAAAATTAGC TGGGTGTGGT GGCAGGCACC TGTAGTCCCA GCTACTCGGG 4500 
AGGCTGAGGC AGGAGAATGG CTTGAACCTG GGAGGCAGAG GTTGCAGTGA 4550 
GCCGAGACAG TGCCATTGCA CTCCAGTCCA GGTGACAGAG CGAAACTCCA 4600 
TCTCAAAAAA AAAAGGAAGG CATTGGTAGC AAGAGATGGC AGGCCTTGAA 4650 
AGCCAGGCCA GGGTGAAGTG TTTCTTTTTT TTTTTTTTTT TTTTTTCTTT 4700 | REPEAT 
TTAAATTTTT TTTTTTGAGA CGGAGTCTCG CTCTGTCACC CAGGCTGGAT 4750 
TGCAGTGGCC TGATCTCGGC TCACTGCAAG TTCCGCCTCC CGGGTTCATG 4800 
CCATTCTCCT GCCTCACCCT CCCGAGTAGC TGGGACTACA GGCACCTGCC 4850 | P.4824/rs12721056[G/T] 
ACCACGCCAG CTAATTTTTT GTATTCTTAG TAGAATGTAG AATTTACTTA 4900 
GTAGAATTTT TTGTATTCTT AGCCAGCATG GTCTCGATCT CCTGACCTGG 4950 
TGATCCGCCC GCCTCGGCCT CCCAAAGTGC TGGGATTACA GGCGTGAGCC 5000 | P.4957/rs484195[G/A] 
ACGGCGCCCG GCCTTATTTT TTCTTTTTGA GATGTACCCA GACTGGAGTA 5050 | P.5006/rs112528434[G/T] 
CAGTGGTGCG ATCTCGGCTT ACTGGAACCT CCACCTCCCG GGTTCAGGCA 5100 | REPEAT| P.5053_5054/rs12721052[del1] 
ATTCTCCTGC CTCAGCCTCA TGAGTACTTG GAACTACAGG TGTGTGACAC 5150 
CACACATGGT ATTTTTTGTA TTTTTAGTGA AGATGACATT TCACCATGTT 5200 
GCCCAGGTTG GTCTCGAACT CCTGACCTCA AGTGATCAGC CTACCTCGGC 5250 | P.5240/rs12721051[C/G] 
CTCCCAAAGT GTTGGGATTA CAGGCGTGAG CCAAATGCCC AGCCAAGGGT 5300 
AAAGTGTTTA GACTTCAACG TGCTTTGGTC CATCTGGGAA ACTGAGGCAC 5350 | P.5338/rs12721050[G>A] 
AGAAGTTGGC CCACCCAGCC CAGCGGTCCT CCTAATCCCA CAGACAGTGG 5400 
GGATGGAGAT TCTGCAAGGG GAAGAGGTGG GAGTCAGGTA GCAGGCAGAA 5450 
TTTGGACAGC CTGGGAGGTA GCTGCACACA GTGACCCCCT TCCTTATTCC 5500 
TCCCCACAGG GAGTGGTTTT CAGAGACATT TCAGAAAGTG AAGGAGAAAC 5550 | Exon 4  
            E  W  F   S  E  T  F   Q  K  V   K  E  K   78 
TCAAGATTGA CTCATGAGGA CCTGAAGGGT GACATCCCAG GAGGGGCCTC 5600 | UTR 
L  K  I  D  S                                          83 
TGAAATTTCC CACACCCCAG CGCCTGTGCT GAGGACTCCC TCCATGTGGC 5650 | P.5641/rs1084725[T/G] 
CCCAGGTGCC ACCAATAAAA ATCCTACAGA AAATTCTCTC CTGAGTGCTT 5700 | P.5667/rs12721054[A/G] 
CTTTACTCTG GGGAAGGGGC TGCGGGAGAG GGTAGGGGCT TCCAGAGAGG 5750 | P.5716/rs12721055[G/T]| 
P.5717/rs72654457[G/C] 
GCAGGGTCTG CAGGAGAGGG CAGGGGCTAA ACCTTAGGTA CTCCTCACAA 5800 | P.5773[G/A] 
GCCCTCCAAT GCCCTATCTA CTTGCCCTGT GCTGAGGATG TTTTAACTCC 5850 
ATGGTCTCAA AAGAGTCTTC CTAAGAACCC TGCAAACTGG GCCTTATTAA 5900 
TCCCATAAGG GCATTGAGGC CCAGAGAGGT GAAGTTACTT GTATAAGGTC 5950 | P.5926/rs56131196[G/A] 
ACACAGCCAG GAAGTAGAGA ACTGGAACTA GATTGAACCC TCAGCCTAGC 6000 
AATGTCACTA TGCTACACTT TTCCTAGTGT GGTCTACCCG AGATGAGGGG 6050 | P.6026/rs4420638[A/G] 
CTGAGGTTTT TTTTTGTTTT TGTTTCTGTT TTGAGGCAGA CTCACTCTCT 6100 
CCCCCAGGAT GGAGTACAGT GGTGCGATCT CAGCTCACTG CAACCTCCAC 6150 | P.6122/rs142134314[G/C] 
CTCCCAGGTT CAAGAGATTA TCCTGCCTCA GCCTCCCAAG TAGCTGGGAT 6200 | P.6158[G/A] 
TTACAGGTGT GCGCCACCAC ACCCAGCTAA TTTTTGTATT TTTAGTAGAG 6250 | P.6213[G/A] 
ACAGGGTTTC ATCATGTTGG CCAGGCTGGT CTCCAACTCC TGGGCTTAAG 6300 
CAATCCTCCT GCCTTGGCCT CCCAAAGTAT TAGAATTACA GGCGTGAGCC 6350 
ACTGTGCCTG GCTCTTATGT AAAATTAAAC CACATACACA TGAGAAACAA 6400 
CCCTATGTAA TTAAGATTTC TTTCTTTTTT TTTTTTTTTT TAAGAGATGG 6450 
AGTCACCCAG GCTGGAGTGC AGTTGCACAA TCTCCATTCA CTGCAGCCTT 6500 
GCAACCTCCA CCACCTGAGT TCAAGGGATT CTCCTGCCTC AGCCTCCTGA 6550 
GTAGCTGGGA TTATAGGCAT GTGCCACCAC GCCCAGCTAA TTTTTTTGTA 6600 
TTTTTAGTAG AGACGGAATT TCCCCATGTT GGCCAGGCTG GTCTCAAACT 6650 




HCR-I ANNOTATED COLORED FASTA 
GTATCCAGCC AGGAGGGGAG GGGCTAGAGA CACCAGAAGT TTAGCAGGGA  50        
GGAGGGCGTA GGGATTCGGG GAATGAAGGG ATGGGATTCA GACTAGGGCC  100          
AGGACCCAGG GATGGAGAGA AAGAGATGAG AGTGGTTTGG GGGCTTGGTG  150           
ACTTAGAGAA CAGAGCTGCA GGCTCAGAGG CACACAGGAG TTTCTGGGCT  200          
CACCCTGCCC CCTTCCAACC CCTCAGTTCC CATCCTCCAG CAGCTGTTTG  250          
TGTGCTGCCT CTGAAGTCCA CACTGAACAA ACTTCAGCCT ACTCATGTCC  300 | P.292/rs4803771[C>G]          
CTAAAATGGG CAAACATTGC AAGCAGCAAA CAGCAAACAC ACAGCCCTCC  350          
CTGCCTGCTG ACCTTGGAGC TGGGGCAGAG GTCAGAGACC TCTCTGGGCC  400 | P.362[C>A]        
CATGCCACCT CCAACATCCA CTCGACCCCT TGGAATTTCG GTGGAGAGGA  450 | P.423[C>G]| P.424/rs117664574[G>A]        
GCAGAGGTTG TCCTGGCGTG GTTTAGGTAG TGTGAGAGGG TCCGGGTTCA  500            
AAACCACTTG CTGGGTGGGG AGTCGTCAGT AAGTGGCTAT GCCCCGACCC  550          
CGAAGCCTGT TTCCCCATCT GTACAATGGA AATGATAAAG ACGCCCATCT  600 | P.575/rs157599[A>G] 
GATAGGGTTT TTGTGGCAAA TAAACATTTG GTTTTTTTGT TTTGTTTTGT  650          
TTTGTTTTTT GAGATGGAGG TTTGCTCTGT CGCCCAGGCT GGAGTGCAGT  700          
GACACAATCT CATCTCACCA CAACCTTCCC CTGCCTCAGC CTCCCAAGTA  750 | P.727/rs149345[T>G] 
GCTGGGATTA CAAGCATGTG CCACCACACC TGGCTAATTT TCTATTTTTA  800          
GTAGAGACGG GTTTCTCCAT GTTGGTCAGC CTCAGCCTCC CAAGTAACTG  850           
GGATTACAGG CCTGTGCCAC CACACCCGGC TAATTTTTTC TATTTTTGAC  900          
AGGGACGGGG TTTCACCATG TTGGTCAGGC TGGTCTAGA              939 
 
**Yellow-highlighted sequences represent the 325bp functional domain 
HCR-II ANNOTATED COLORED FASTA 
GGAGGGGAGT GGCTAGAGAC ACCAGAAGAT TAGCAGGGAG GAGGGTGCAG 50            
GGTTTCGGGG GATGAGGGGA TGGGATTCAG ACCAGGGTAA GGATCCAGGG 100           
GTAGAGAGAA AGATTTGAGA GTGGTTTTGG GGCTTGGTGA CTTAGAGAAC 150          
AGAGTTGCAG GCTCTGTTTT TGGGCCCGCC CTGCCCCCTT CCGACCTCTT 200 | P.188/rs35136575[C>G]          
AGTTCCTATC CTCCAGCAGC TGTTTGTGTG CTGCCTCTGA AGTCCACCCT 250                
GAATGACCTT CAGCCTGTTC CCGTCCCTGA TATGGGCAAA CATTGCAAGC 300 | P.286[G>A]            
AGCAAACAGC AAACACATAG CCCTCCCTGC GTGCTGACCT TGGAGCTGCG 350                
GCAGAGGTCA GAGACCTCTC AGGGCCCATA CCACTTCCAA CATCCCCTTG 400 | P.365[C>A]              
ATCTCTTGGA TTTTGGTGGA GAGGGGCAGA GGTTGTCCTG GCCTGGTTAG 450              
GTAGTGTGAG AGGGTCCCGG TTCAAAACCA CCACTTGCTG GTTGAGGAGT 500          
CGTCAGTAAG TGGCTGCGCC CCCACCCTGA GGCTTGTTTC TCCATCTGTA 550 | P.523/rs118004808[C>T]               
CAATGGAAAT GATGAAGATG CCCACCTGAT AGGGTTTTTG TGGCAAATAA 600                
GTAAGTAGTT TTTTTGTTTT TCTTTTTCTT TTTTTTTTTT TTTTTTTGAG 650 | P.632[T>C]              
ATGGAGTCTC ACTCTGTCAC CAGGCTGGAG CGCAGTGGCG TGATCTCGGC 700                
TCACTGCCAA CTCCACCTCC CGGGTTCAAG CGATTCTCCT GCCTCAGCCT 750                
CTGAGTAGCT AGGACTACAG GCGCCCGCCA CCACACCCAG CTAATTTTTG 800                 
CATTTTTAGT AGAGATGGGG TTTCACCATG TTGGCCAGGA TGGTCTCAAT 850  
CTCTTGACCT TGTGATCCAC CTGCCTCGGC CTCCCAAAGT GCTG       894 
 
**Yellow-highlighted sequences represent the sequences of 85% homology with the 325bp functional domain of HCR-I. 
APOC4 ANNOTATED COLORED FASTA  
GAGACGGAGT CTTGCTCTTT CGCCCAGGCT GGACTGCAGT GGCGCGATCT 50  | REPEAT  
CGGCTCAATG CAAGCTCCAC CTCCCAGGTT CACGCCATTC TCCTGCCTCA 100 | p.65[C>T]| p.92_94/rs12721101[delCCT]  
GCCTCCCGAG TAGCTAGGAC TACAGGCGCC TGCCACCACG CCTGGCTAAT 150 | p.108[G>A]/rs112391061| p.116[A>G] 
TTTTCATATT TTTAGTAGAG ATGGGGTTTC ACCGTGTTAG CCAAGATGGT 200 | P.150_151[ins114] 
CTCAATCTCC TGACCTCGTG ATCCGCCTGC CTCGGCCTCC CAAAGTGTTG 250 | p.204/rs4803773[A>G]| p.233[C>T]| 
p.245/rs192072159[G>T]  
GGGTTACAGG CATGAGCCAC CGCGCCTGGC CAACAGCAAT GATCTTTGAG 300 | REPEAT 
CACCTATATT GCCAGTCTCC ACGGTAAGAG CTTTCTTCAT TTTTTGTTTT 350 | REPEAT  
GTTTTGTTTC AAGACAGAGT CTTGCTCTGT CACCCAGGCT GGAGTGCAGT 400 | p.368[A>G]   
GGTGTGATCG CGGCTCACTG CAGCCTTCAC TTCCCGGGTT CAAGCCATTC 450 | p.438/rs146656012 [G>A] 
 55 
TCCTGCCTCA GCCTCCCAAG TAGCTGGGAT TACAGGCACG CATCACTACT 500 | p.489/rs140241604 [C>T] 
TCTGGCTAAT TTTTGTATTT TTAGTAGGGA CAGGGTTTTT CACCATGTTG 550  
GCCAGGTTGG TCTCAAACTC CTGGCCTCAT ATGATCTGCC CACCTCGGCC 600  
TCCCAAAGTG CTGGGATTAC AGGCGTGAGC CACTGCGCCT TTCTTTGTAT 650 | REPEAT| p.636[C>T]| 
p.637/rs73558107[G>T]  
TTGTTCAAGT AATATACTGA AATATGTACT GTGCCTCCCA CTTTATGGAG 700  
GAGGAAACTG AGGCCAGCAA ATGAGGCTGT CATGGGAGGT GGAGACAGGA 750  
TTTGAACCTG CCTCAGTGCA GGAGGCTCAA GAGCCTCTGT CTTCTCTCAG 800 | p.757/rs12721105[C>A]  
GGCACTGTGT GGGAGGGTGA GAAGGAGGGA GGCCCACAGA GGCATGACCT 850  
CTGATTGCCA CTGTCACCTG GGCCCTGCTC TCTGAAGTCT CTGCCAAGCG 900  
GGGAGGTGGC CGGGGGAGGG CCCTGCTCTG TGCAGCCTCC CCTCCCCCGG 950  
CCCGCAGAGT TGAGCACAGA GGGACAGAGG CACGGAACCC CCAGAAATGT 1000 | Exon 1 | UTR| p.968/rs76214972[A>G]  
                                                   M   1 
CCCTCCTCAG AAACAGGCTC CAGGCCCTGC CTGCCCTGTG CCTCTGCGTG 1050  
S  L  L  R   N  R  L   Q  A  L   P  A  L  C   L  C  V  18  
CTGGTCCTGG CCTGCATTGG GGGTGAGAAG AAGTGGGTGG AGGGATGTGG 1100 | p.1088[T>G] 
 L  V  L   A  C  I  G                                  25 
GGCCCACACC TGGTGGGTGT GAGTGTGGCT GTGTGTCCTG TGGCTCTGTA 1150 | p.1130[T>C]| P.1150/rs148247675[A>G] 
GCCACGTGAG ACATGAGTAC GGAGTGTGTG CGTTTCATGG CGTGCGTATG 1200 | p.1192/rs113745034[G>A] 
CATGTGCGTG TCGGGGAGTG TGTGTGTCGG TGGCTGAGAG TGAAGTGTGA 1250 | p.1229[G>C] 
ATGTCACATT GGTACAAACT GGGATCATCT GTGTGTGTGC ACGTGCGTGC 1300  
GTGGAAGTGG GAGTATGCAG TCGTGGTAAA AAAGTGCATG TCTGTGTGCA 1350 | p.1325_1327[delGGT] 
TATGTGTATT TGTGTGCACC TGTCTCTCTG TGGGGTATGT GTGTGCAAAA 1400  
TATTTGAGTG TGTGGACATG TGTGAGGGGG TGAGTGTGTG CTGGTGTGTA 1450 | p.1430_1431[insG] 
CGTCTGTGTT TTGCATATGC ATTTTTTTTT TTTTTTTTGA GACGGAGTCT 1500 | REPEAT  
CACTCTGTCA CCCAGGCTGG AGTGCAGTGG TAGCAGTGGT GCGATCTTGG 1550  
CTCACTGCAT CATCCGCCTA CCCGTTTCAA GGGATTCTCC TGCCTCAGTC 1600  
TTCAGAGTAT TTGGGACTAC AGACACACGC CACCATGCCT GGCTAATTTT 1650 | REPEAT  
TTTTTTTTGA GACGGAGTCT CGCTCTGTTA CCCAGGCTGG AGTGCAGTGG 1700  
CGTGATCTTG GCTCACTGCA ACGTCCGCCT CCCGGGTTCA CGCCATTCTC 1750 | p.1702/rs12721102[G>A]| p.1719[C>A]| 
p.1733/rs12721111[C>T]  
CTGCCTCAGC CTCCCGAGTA GCTGGGACTA CAGGAGCCCA CCACCACGCC 1800  
TGGCTAATTT TTTGTATTTT TACTAGAGAC GGGGTTTCGC CGTGTTAGCC 1850 | p.1823[C>G] 
AGGATGGTCT CCATATCCTG ACCTCGTGAT CCGCCTGCCT CGGCCTTCCA 1900 | NOT SCANNED  
AAGTGCTAGG ATTATAGGCG TGAGCCACTG CGCCTGGCCA ATGCCTGGCT 1950 | REPEAT  
AATTTTTTTA TATTTTTGGT AGAGACAGGG TTTTGCCATG TTGCCCAGGC 2000  
TGGTCTTGAA ATCCTGACCT CAGGTGATCC GCCCGCCTTG GCCTCCCAAA 2050  
GTGCTGGGAT TACAGGCATG AGCCACCACG CCCGGCCATG TACTTTATGT 2100 | p.2063[C>G]| p.2099/rs111339708[G>T] 
TAAAATGGGA TCATATTCTA GATCAGCATT ATCCAGTAGA AATTTAAATT 2150  
TTTAATACAG GGCCAGGCAC GGTGGCTCAT GCCTGTAATC CCAGCACTTT 2200 | REPEAT  
CGGAGGCCGA GGCGGGTGGA TCGCAAGGTC AGGAGATTTG AGATCATCCT 2250  
GGCTAACAGA TGGGTAAAAA CCCATCTCTA CTAAAAATAC AAAAAATTAG 2300  
CCATGCATGG TGGCATGCGC CTGTAGTCCC AGCTACTCGG GAGGCTGAGG 2350  
CCGGAGAATC ACTTGAACCC GGGAGGCAGA GGTTGCAGTG AGCCGAGATC 2400  
GCGCCACTGC ATTCCAACCT GGGTGACAGA GCGAGACTCC GTCTGAAAAA 2450  
AAAAAAAAAT TTAACACGTA TGTAGACAAT GTGCAAGGCA CCATTCCATG 2500 | p.2467/rs115225947[C>T]| REPEAT  
TGCATCGTAT GTAGTAACTC TTAATTCTCA CGATAACCCT GAGGTAGATA 2550  
TTATTACCCC GTTCTACAAA AGGAGAAACA GTCCTGGGGA GACAGGATAA 2600 | p.2557[C>A]| p.2559/rs5155[C>T]  
GTCACCGGCC AAGGCACACA GCCAGCTACA TGTGGCCCCC GCGTGACGGC 2650 | p.2607/rs5156[G>A]| 
p.2623/rs5157[C>T] | p.2640/rs5158[C>T]| p.2641[G>A]  
TGGTCTCTGT AGGCGAGGCT TTGTCCAGAT GCGTGGGTAG AAGGTCTGGC 2700 | p.2678/rs148564866[G>C]|  
p.2683/rs12721109[G>A]  
CCGGAAAGAG GAACTGACAG CAAGGCTAAG CCAATGTCTG CCCCTGGGGG 2750 | p.2703/rs12721108[G>T]  
CAGAAAGTCA CCTCCTGCTC TCCCTCCACT GTCCACAGAG GTAGCTCAGA 2800 | p.2753/rs12721106[G>A]| 
p.2767/rs12721107[G>T]  
CAGGGTGGGG GTCACAGGAG AACGAAGGGA GAAGGGGGTA GTTCCTGGGC 2850  
AGCAAAATCA GGTGGTGAAG GGAGGCATCA GAGGATGGCA ATTAGAGAGG 2900 | p.2886/rs12709883[T<C] 
CCATTAGAGG GGAACCACAG GCAGACAGGG TGACAGGAGG GACTACTGAC 2950  
ACAAGGTGAA GAGATGGCCC AGCCGGACGG GGTGGCTCAC ATCTGTAATC 3000 | REPEAT | p.2971/rs5159[A>G]  
CCAGCATTTT GGGAGCCCGA GGTGGGTGGA TCACTTGAGG TCAGGAGTTC 3050  
GAGGCCCCAA CATGGCAAAA CCCCATCTCT TCTAAAAATA CAAAAATTAG 3100  
CCGGGCATGA TGGCAGATGC CTGTAATCCC TGCTACTCGG GAGGCTGAGG 3150  
CAGGAAAATT GCCTGAATCC AGGAGGTGGA GGTTGCAATG AGACGAGATC 3200  
 56 
ATGACACTGC ACTCCACCCT GGGCAACAGA GCAAGAGACT GACTCTGTCT 3250 | p.3213/rs28616151[T>C] 
CATAAAAAAA AAGAAAAAAG AAAAAAAAAA AGAGATGGCT GATGGTTAAA 3300  
GAGGGGTTAG CGGTCAGGGG ACACATAAGG GTAAAGGCAG GAGGCAAGAG 3350 | p.3348[G>A] 
GACTGGCAGG GGGCTGCCCC TGGGCCACCG GGAGCGACAC AGGATGAGCA 3400 | p.3363/rs60170431[G>A]| 
p.3380/rs12721104[G>A]  
TGGAGGGAAA GGGAGAAGGG GATTCTAGGG TCCCAGCCTA CCCAAGTTGC 3450  
CCTCTGGTTC CACCTAGCAT GCCAGCCAGA GGCCCAGGAA GGAACCCCGA 3500 | Exon 2 | p.3498/rs1132899[C>T]  
                  A   C  Q  P  E   A  Q  E   G  T  P   36 
GCCCCCCACC AAAGCTAAAG ATGAGTCGCT GGAGCCTGGT GAGGGGCAGG 3550 | p.3502/rs10423683[C>T]| 
p.3546/rs12691089[G>A]  
S  P  P  P   K  L  K   M  S  R   W  S  L  V   R  G  R  53 
ATGAAGGAGC TGCTGGAGAC AGTGGTGAAC AGGACCAGAG ACGGGTGGCA 3600 | p.3592/rs12691090[C>T]  
 M  K  E   L  L  E  T   V  V  N   R  T  R   D  G  W  Q 70 
ATGGTTCTGG TGAGGGTGTG CTGGGCTGGG TGGTGGGAGG GGACTCCTGG 3650 | REPEAT  
  W  F  W                                              73 
GTCTGAGGGA GGAGGGGCTG GGGCCTGGAC CCCTGAGTCT CAGGGAGGAG 3700 | p.3700[G>A] 
GAAAGGGTGG GAGTGGGGCT GTGACCCCTA GGTCTGGGAG GAGTGGAGGG 3750  
TTAGAGCTGA GAGCAGGAAC TCCTAGGTCA CAGAGAGGAG CGGATAAATG 3800 | p.3792/rs5165[G>A] 
GGGCAGAGAA CACCTGGGGA GAGCTGGGGC CTCCACTGTG ATGTCCTCTC 3850 | p.3847/rs186448850[T>C] 
TCCTGTAGGA GCCCGAGCAC CTTCCGGGGC TTCATGCAGA CCTACTATGA 3900 | Exon 3  
           S  P  S  T   F  R  G   F  M  Q   T  Y  Y  D 87 
CGACCACCTG AGGGACCTGG GTCCGCTCAC CAAGGCCTGG TTCCTCGAAT 3950 | p.3927/rs5167[T>G]  
  D  H  L   R  D  L   G  P  L  T   K  A  W   F  L  E   103 
CCAAAGACAG CCTCTTGAAG AAGACCCACA GCCTGTGCCC CAGGCTTGTC 4000 | p.3969/rs138548797[A>C] 
S  K  D  S   L  L  K   K  T  H   S  L  C  P   R  L  V  120 
TGTGGGGACA AGGACCAGGG TTAAAATGTT CATAAAAGCC AGGTGTGGTT 4050 | UTR | REPEAT| p.4012[G>A]  
 C  G  D   K  D  Q  G                                  127 
GTGGCGGGTG CCTGTAGTCC CAGCTACTCA GGAGGCTGAG GTAGGATGAT 4100  
GGCTTGAGCC CAGGAGTTCG AGACCAGCCT GGGCAACACA GCGAGATCTC 4150  
TTGGGGGTAA AACAAAAAGA AAAAAAAAAG TTCATACTTC TCCAATAAAT 4200 | p.4154/rs12709884[G>A]| 
p.4157/rs10425530[G>A] 
AAAGTCTCAC CTGTGTCCCT GTCTGGATCC TTCCCCAGTG TGGCCAGAAA 4250  
AAAACCCACC CCACTGCCTC CCAGGAATCA ATGAGTAGAA GAGGTGACAC 4300  
CTGATGGGGA AGGAAGAGTA GGGAGGTCGG GAAGGGTATC AAGGAATAAC 4350  
ACCCTATTGT GGGCTTGCGG AGAATGGGGG ACTTCAAGGC GTGTCAGTTT 4400  
CAGGAGGGTG AGGGCAGGAG CGTGGGTGGA GTCAGCAGGT CCCCATGATG 4450  
GCCCTCACTG AGAGCTTCGC CCTTGTCTCC TACAAGCTCT GACTCCATTC 4500  
CCAGTGGGCA CCCAGCACCT CCAACCCCTC CACAGCCCCC AACCCAGCCT 4550 | p.4533/rs112698600[C>T] 
CTGTCGGAGG CGAATTCTCA GAGTGAGGGT TCCCTGTCAC TTGAGAGAAG 4600 | p.4579/rs111356234[G>A] 
GTTCCCTGTG ACGTGACCTT GGGGGACGTC ATTGCCCTTT CTGTCCCCAC 4650 | p.4628/rs12721063[G>A] 
CCACCCCCTC CGCAGTTCTG TTGGCCAGGA CTTTGGCCTA GACAAAGGAT 4700 | p.4661/rs2288912[C>G] 
GGGGGTTGTG GCTGTGGAGC GGAAGTGGGT CTCAACCACT ATAAATCCTC 4750 | p.4746/rs2288911[T>G] 
TCTGTGCCCG TCCGGAGCTG GTGAGGACAG CCTGCCAGAG TCTGGTAAGA 4800 
AAGGGACTCA GGGTGCGGGG ACAGGGGGGC GTCAGCAGGG AGAGGGCAAA 4850 | p.4844/rs75463753[G>A] 
GATCGATAAA GCAGGAATTT TAAGAGGCAC AATATTAGAA GCCCGTGTTG 4900 | p.4895[G>A] 
GAACCATGAC TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG 4950 | p.4912[G>C] 
TGTGAGAGAG AGAGAGAGGG AGATGGAGTC TCGCTATGTA GCCCAGGCTA 5000 
GACTCAAACT CCTGGGCTCA AGCAATCCTC CTGCCTCAGC CTCCCCAGTA 5050 
GCTGGGACTA CAGGTGCACC ACCACACTCC ACAAAT                5086 
 
APOC2 ANNOTATED COLORED FASTA 
GGTTAGCGGT CAGGGGACAC ATAAGGGTAA AGGCAGGAGG CAAGAGGACT 50  
GGCAGGGGGC TGCCCTGGGC CACCGGGAGC GACACAGGAT GAGCATGGAG 100 | P.59/rs60170431[G>A]| P.65_66insC| 
P.75/rs12721104[G>A] 
GGAAAGGGAG AAGGGGATTC TAGGGTCCCA GCCTACCCAA GTTGCCCTCT 150  
GGTTCCACCT AGCATGCCAG CCAGAGGGCC CAGGAAGGAA CCCCGAGCCC 200| p.178_179delG| P.194/rs1132899[C>T]| 
P.198/rs10423683[C>T]  
CCCACCAAAG CTAAAGATGA GTCGCTGGAG CCTGGTGAGG GGCAGGATGA 250 | P.228/rs5164[G>A]| 
P.242/rs12691089[G/A] 
 57 
AGGAGCTGCT GGAGACAGTG GTGAACAGGA CCAGAGACGG GTGGCAATGG 300 | P.288/rs12691090[C>T]  
TTCTGGTGAG GGTGTGCTGG GCTGGGTGGT GGGAGGGGAC TCCTGGGTCT 350 | REPEAT  
GAGGGAGGAG GGGCTGGGGC CTGGACCCCT GAGTCTCAGG GAGGAGGAAA 400 | P.396[G>A] 
GGGTGGGAGT GGGGCTGTGA CCCCTAGGTC TGGGAGGAGT GGAGGGTTAG 450  
AGCTGAGAGC AGGAACTCCT AGGTCACAGA GAGGAGCGGA TAAATGGGGC 500 | P.488/rs5165[G>A]  
AGAGAACACC TGGGGAGAGC TGGGGCCTCC ACTGTGATGT CCTCTCTCCT 550 | P.543/rs186448850[T>C] 
GTAGGAGCCC GAGCACCTTC CGGGGCTTCA TGCAGACCTA CTATGACGAC 600  
CACCTGAGGG ACCTGGGTCC GCTCACCAAG GCCTGGTTCC TCGAATCCAA 650 | P.623/rs5167[T>G]  
AGACAGCCTC TTGAAGAAGA CCCACAGCCT GTGCCCCAGG CTTGTCTGTG 700 | P.665/rs138548797[A>C] 
GGGACAAGGA CCAGGGTTAA AATGTTCATA AAAGCCAGGT GTGGTTGTGG 750 | P.708[G>A]| REPEAT  
CGGGTGCCTG TAGTCCCAGC TACTCAGGAG GCTGAGGTAG GATGATGGCT 800  
TGAGCCCAGG AGTTCGAGAC CAGCCTGGGC AACACAGCGA GATCTCTTGG 850 | P.850/rs12709884[G>A]  
GGGTAAAACA AAAAGAAAAA AAAAAGTTCA TACTTCTCCA ATAAATAAAG 900 | P.853/rs10425530[G>A]  
TCTCACCTGT GTCCCTGTCT GGATCCTTCC CCAGTGTGGC CAGAAAAAAA 950  
CCCACCCCAC TGCCTCCCAG GAATCAATGA GTAGAAGAGG TGACACCTGA 1000  
TGGGGAAGGA AGAGTAGGGA GGTCGGGAAG GGTATCAAGG AATAACACCC 1050 | P.1042/rs12709885[A>T]  
TATTGTGGGC TTGCGGAGAA TGGGGGACTT CAAGGCGTGT CAGTTTCAGG 1100  
AGGGTGAGGG CAGGAGCGTG GGTGGAGTCA GCAGGTCCCC ATGATGGCCC 1150  
TCACTGAGAG CTTCGCCCTT GTCTCCTACA AGCTCTGACT CCATTCCCAG 1200 | P.1187/rs111782345[G>A] 
TGGGCACCCA GCACCTCCAA CCCCTCCACA GCCCCCAACC CAGCCTCTGT 1250 | P.1229/rs112698600[C>T] 
CGGAGGCGAA TTCTCAGAGT GAGGGTTCCC TGTCACTTGA GAGAAGGTTC 1300 | P.1275/rs111356234[G>A] 
CCTGTGACGT GACCTTGGGG GACGTCATTG CCCTTTCTGT CCCCACCCAC 1350 | P.1324/rs12721063[G/A] 
CCCCTCGGCA GTTCTGTTGG CCAGGACTTT GGCCTAGACA AAGGATGGGG 1400 | P.1357/rs2288912[G>C]  
GTTGTGGCTG TGGAGCGGAA GTGGGTCTCA ACCACTATAA AGCCTCTCTG 1450 | P.1442/rs2288911[G>T]| Exon 1| UTR  
TGCCCGTCCG GAGCTGGTGA GGACAGCCTG CCAGAGTCTG GTAAGAAAGG 1500  
GACTCAGGGT GCGGGGACAG GGGGGCGTCA GCAGGGAGAG GGCAAAGATC 1550 | P.1540/rs75463753[G>A] 
GATAAAGCAG GAATTTTAAG AGGCACAATA TTAGAAGCCC GTGTTGGAAC 1600 | P.1591/rs9304644[G>A] 
CATGACTGTG TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG TGTGTGTGTG 1650 | P.1608[G>C] 
AGAGAGAGAG AGAGGGAGAT GGAGTCTCGC TATGTAGCCC AGGCTAGACT 1700 | REPEAT  
CAAACTCCTG GGCTCAAGCA ATCCTCCTGC CTCAGCCTCC CCAGTAGCTG 1750  
GGACTACAGG TGCACCACCA CACTCCACAA ATCACAGAAT TTAGAACTGT 1800  
AGACTATTTG AGCTTCTGCT TAGAGTTAGG GTGGCTGAGG TGGGGAGGAT 1850 | REPEAT  
CCCTTGAGCC CAGGAGTTTG AGGATGCAGT GAGCTGTGAT CTTGCCACCG 1900 | P.1851/rs12709886[C>T] 
TGTTCCAGCC TGGGTGACAG AGAAACCCCA TTTCTAAAAA AGAGAAAGAA 1950  
AAAGGGATAG GTACAATGGC TCATGCCTGT AATCCCAGCA CTCTGGGAGG 2000 | REPEAT  
CCGAGGCGGG TGGATCACTT GAGGTCAGGA GTTCGACACC AGCCTTACCA 2050 | P.2003/rs187834478[G>A] 
GCATGGTGAA ACCGCATCTA TACTAAAAAT ACAAAAATTG GCCGGGTGTG 2100 | P.2090/rs12721072[G>A]  
GTAGCATATG CCTGTAATCC CAGCTATTCC AGAGGCTGAG ACAGGAGAAT 2150  
TGCTTGAACC CAGGAAGCGG AGGTTGCAGT GAGCCCAGAT CGTGCCACTG 2200 | P.2191/rs9304644[C>T]  
TACTCTAGCC TGGGTGACAG AGCAAGACTC AGTCTTGGCG GAAAAAAAGA 2250  
ATGAAAAAAT TTAAAAAACT AAAAAAGAAC TGTAGGCTGG GCGTGGTGGC 2300 | REPEAT| P.2258/rs116489256[A>C]  
TTACACTTGT AATCCAAACG CTTTGGGAGG CCAAGGCAAA CGGATCACTT 2350 | P.2339/rs115943687[A>G] 
GATGTCAGGA GTTGGAGACC AGCCTGGCCA ACATGGTGAA ACCCCGTCTC 2400 | P.2371[A>G] 
TACTAAAAAT ACAAAAATTA GACAGGCATG GTGGTGCATG CTTGTATTTC 2450 | P.2410/rs12721076[T>C]  
CAGTTACTCA GGAGGCTGAG GCAGGAGAAT CGCTCGAACC CGGAAGACAG 2500 | P.2486/rs9304645[G>A]  
AGGTTGCGGT GAGCCAAAAT TGCGCCATCG CACTCCAGCC TGGGCGAGAG 2550  
AACAAGACCT TGTCTTGGAA AAAAAAAAAG AATTGTAGAC CATTTGCTTG 2600 | P.2566/rs9304646[T>C]  
TGTTCTTTCT CCGGGGATCA GATCTCACCC TCTTTCTGCC GTACTTCCTC 2650  
ATCTCCTACG TGTGGATGAT GATATTGTGC CCTGTGCATG TTCTTCGTCA 2700  
CCAAAAGTGC CTCTCTCATA GAGCAGGTGA GAACTCAGTG AGGAGATGCA 2750  
GGGACATGAG GTCTGACTTA GGGCAGAGCC CTAAGGTAAC ACATTTGATC 2800  
TACTGTAGGT CCTTAATGGT GTCTGCAGAG CACCTCCCTG CACTGACTCA 2850  
GCCTTAGCAA AGGGCAGAGG CTTTGCTGTG TTCCCTGCTG GGCCCAGAAC 2900 | P.2870[G/T] 
TGTTTAGGTG CTCAAGAAAG CCTTCTAGGC TGGGCTCAGT GGCTCACACC 2950 | REPEAT | P.2935/rs11879392[C>G] | 
P.2938[A>G]  
TGTACTCCCA GCACCCTGGG GAGGCCGAGA TGGGAGGATC GCTTGAGCCC 3000  
AGGAGTTCCA GACCAGCCTG GGCAACAAAA CAAGTCTCCC ATCTCTACAA 3050 | P.3010/rs10419086[A>G]| 
P.3030/rs4803774[A>G]  
AAGAATAAAA ATTAGCAGCT GGGCATGGTG GCTCACGCCT GTAATTCCAG 3100 | REPEAT | P.3082_3083[insTGG]| 
P.3086/rs4803775[C>T]  
CACTTTGGGA GGCCAAGGCA GGCAAATCAC TTGAGGTTAG GAGTTCAAGA 3150  
CCAGCCTGGC CAACATGGTG AAACCCCATC TCTACTAAAA ATACAAAAAT 3200 | P.3154/rs145931717[G>A]| 
P.3193/rs148616221[A>G] 
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CAGGTGGGGC ACAGTGGCTC AAGCCTGTAA TCCTAGCACT TTGGGAGGCC 3250 | REPEAT| P.3234[T>C]  
AAGGTGGGCG GATCACGAGG TCAGAAGTTC GAGACCAGCC TGGCCAGCAT 3300 | P.3259/rs12721061[C>T]| 
P.3260/rs151176577[G>A]| P.3289/rs12721058[C>G] 
GGTGAAACCC CATCTCTACT AAAAATACAA AATATTAGCC GGGCATGGTG 3350 | P.3348/rs10420434[G>A]  
GCAGGTGCTT GTGATTCCAG CTCCTTGGGA GGCTGAGGCA GAAGAATTGC 3400  
TAGAACCCTG GAGGCAGAGG TTGCAGTGAG CCGAGAACAC GCCACTGCAC 3450 | P.3409[T>C] 
TCCAGCCTGG GTGACAGAGC GAGACTCCAT CTCAAAAAAT ACGAAAACAA 3500 | P.3459/rs12721062[G>C]  
AAATCAGCCG GGTGGTGGCG GGTGCCTGTA ATCCCAGCTA CTGGGGAGGC 3550 | REPEAT  
TGAGGCAGGA GAATTGCTTG AACCTGGGAG GTGGGGGTTG CAGTGAGCCA 3600 | P.3600/rs7256684[A>G]  
AGATTGCACC ACTGCACTCC AGCCTGGGCA ACAGAGTGAG ATTCCATCTC 3650 | P.3617[C>T] 
AAAAAAGAAA AAAATAATAA TTAAAATGTT AAAATCAGGA GTAGAATCAC 3700 | P.3692/rs12721060[T>G]  
AGAATGTTGG AAAGTGAGGC CCAAGAAGGG GGCTGTGTCC AAGTCCATGC 3750  
ATGGGAAACT TGACTGGGAC ACCGAGCACA CACAGAGCAG GATCTCAGTC 3800 | P.3778/rs5120[A>T]  
CCCCCCACCA GAGTGGGGCG TGACCACAGG AACAGCCGCC TCCAGTCAGC 3850 | P.3805/rs7257095[C>G]| 
P.3806/rs12709887[C>G]| P.3814/rs10422603[T>G]| P.3820/rs12709888[G>A] 
CTGCCACATG ACACCCCCTC AATGTTCCAG GTCTCTGGAC ACTATGGGCA 3900 | Exon 2 | UTR|  
                                                M  G   2 
P.3892/rs5121[C>T] 
CACGACTCCT CCCAGCTCTG TTTCTTGTCC TCCTGGTATT GGGATTTGGT 3950  
T  R  L  L   P  A  L   F  L  V   L  L  V  L   G  F     18 
GAGTGTGGGC TTCCGGGGAG GGAAGCCTTG GGGAGGGGAA TGAGCTCCAA 4000  
GCATCTTCCC AGCCCAGGCC CTTCTTACCT CTGCCTCTGC CCTCTCCTCT 4050  
TCTTCCTTCC TCCTTTCCCC CTGCTGCAGC CCCACGGGCT CTCCTGACAC 4100 | P.4086/rs114780592[G>A] 
ACTCTCCCCC TGCAGAGGTC CAGGGGACCC AACAGCCCCA GCAAGATGAG 4150 | P.4112/rs74500990[G>C]|  
                E  V   Q  G  T   Q  Q  P  Q   Q  D  E  30 
Exon 3 | P.4118/rs201709243[G>A] 
ATGCCTAGCC CGACCTTCCT CACCCAGGTG AAGGAATCTC TCTCCAGTTA 4200  
 M  P  S   P  T  F  L   T  Q  V   K  E  S   L  S  S  Y 47 
CTGGGAGTCA GCAAAGACAG CCGCCCAGAA CCTGTACGAG AAGACATACC 4250  
  W  E  S   A  K  T   A  A  Q  N   L  Y  E   K  T  Y   63 
TGCCCGCTGT AGATGAGAAA CTCAGGTAGC ACCTGCCCCT GGAGAAATGG 4300  
L  P  A  V   D  E  K   L  R                            72 
GGTCTGGCCC ATACCACCGA CTGCATCCAG GACCCAGAAG TTCAGGCCCC 4350 | P.4319/rs5123[G>A]| REPEAT  
AGCCCCTCCT CCCTCAGACC CAGGAGTCCA GGCCTCAGCC CCTCCTCCCT 4400  
CAGACCCAGG AGTCCAGGCC CCCAGCCCGT CCTCCCTCAG ACCCAGGAGT 4450 | P.4429/rs3745152[G>C]| 
P.4430_4431/rs35625559[insCTT] 
CCAGGCCCCC AGCCCCTCCT CCCTCAGACC CAGGAGTCCA GGTCCCCAGA 4500 | P.4458[C>T]| P.4460_4461[del1]| 
P.4477[G>A] | P.4493/rs4803776[T>C]  
CCCTCCTCCC TCAGACCCAG GAGTCCAGGC CCCCAGCCCC TCCTCCCTCT 4550 | P.4513[A>C]| P.4532[C>T]| 
P.4534_4535[del1] 
AACCATCTGT GCTTTCTCCC CAGGGACTTG TACAGCAAAA GCACAGCAGC 4600 | Exon 4| P.4587/rs5126[A>C]  
                           D  L   Y  S  K   S  T  A  A 81 
CATGAGCACT TACACAGGCA TTTTTACTGA CCAAGTTCTT TCTGTGCTGA 4650  
  M  S  T   Y  T  G   I  F  T  D   Q  V  L   S  V  L   97 
AGGGAGAGGA GTAACAGCCA GACCCCCCAT CAGTGGACAA GGGGAGAGTC 4700 | UTR  
K  G  E  E                                             101 
CCCTACTCCC CTGATCCCCC AGGTTCAGAC TGAGCTCCCC CTTCCCAGTA 4750  
GCTCTTGCAT CCTCCTCCCA ACTCTAGCCT GAATTCTTTT CAATAAAAAA 4800 | P.4754/rs7253690[C>T] 
TACAATTCAA GTTGCTTCTC ATGGATGGCA CTGCTTTTCT GAGGACTCAA 4850  
GGTGCCAAGA TGGAGGGGCT GACTCAGTCC AGCCAACATT TAATGAGCAC 4900 | P.4852/rs5127[G>T]|  
P.4853_4854/rs150448996[delT]| REPEAT  
CTACTTTATG TATGGAGCTC TAACCCATGG GTCCATGGGA ATAAAGCAGT 4950  
GAATAGTAAC AATAAATAAT CGTAACAGCA ATTAGAGACT AATCTTTATT 5000 | P.4971/rs1130742[C>T]| 
P.4973_4974/rs199828513[insT]   
GAAGTCCGGC TTTCTCTCTT TTATTTTTTT ATTTTTTGAG ACAGGGTTTC 5050 | P.5004/rs10421404[G>A]| REPEAT| 
P.5018_5022/rs78403558[del5]  
ACTCTGTCAC CCAGGCTGGA CAGCAGTGGT GCAATCTCGG CTCACTGCAC 5100  
CCTCCGCCTC CCAGGTTCCA GCGATTCTGT GTGCCTCAGC CTCTGGAGTA 5150  
GCTGGGATTA TGGGCATGTG CCACTGTGCA CGGCTAATGT TTGTATTTTT 5200  
AGTAGGGTTT TGCCAGTTGG CTAGGCTGGT CTCAAACTTC TGACCTCAAG 5250  
TGATCCACCC GCCTCAGCCT CCCAAAGTAC TGGGGTGACA GGCATGAGCC 5300  
ACCGCGCCAT GCCAAAATCC AGCCTTCTCA TTTGTAAAAT AACAAATCAT 5350 | P.5303/rs7257488[C>T]| 
P.5310/rs7258345[T>G]| P.5324/rs7257476[C>T]  
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AGACACAGCT AGTCCACAGT GGCCTCTGAC AGTCTCCAGT TGTTAACGGT 5400 | REPEAT | P.5398/rs12709889[G>A]  
GAATGGTGTC CAGGTTTTTG GCGTCCTGAA CAAAGAACTG GACAAAACGC 5450  
ACAAACAAAG CAAGGAAGGA ATGAAGGGAT TTATTGAAAA CGAACATACA 5500 | P.5491[C>T] 
CTAAACAGTG TGGGAGCGGG CCCAAGCATA TGGGTTCAAA AGCCCTGTTA 5550 | P.5512/rs12721064[G>A] 
CAGAATTTTT GGGAGTTTAA ATTCCCCCTA GAGGATTCCC CTTCCACTGG 5600 | P.5562[G>C]| P.5586/rs73558127[T>G] 
TTACTTCTGG TACACCCTAT GTAAATGGAG AGGATGAAGA AAAGTTACAA 5650 | P.5612[A>G] | P.5644[G>A] 
AGTCATTTAT GGCCTACCGG AGAGGATGTT TCCTGTTATA GCTGAAGTGA 5700  
ATTGGCCTTA TGTTCCCTGC CTCCCTATTT TCCTGCCTTA CAGTTGCTGG 5750  
ACTGACACAT TTTTTATTTT ATTTATTTTG TTTTGAGATA AGGTCTTGCT 5800 | REPEAT| P.5771_5775[del5]  
CTGTCGCCCA GGCTGAAGTG CAGTGGTGAG ATCTTGGCTT ACTGTAGCCT 5850 | P.5815/rs10423208[G>A]  
TGACCTTTTG GGCTCAAGAG ATCCTCCCAT CTCAGCCTCC CAAGTAGTTG 5900  
GGACTAGGGA TGCCCACTGC CACACCTGGC TAATTTTTTG TATTTTTAGT 5950 | P.5922/rs10422888[A>G]  
AGAGACGGGG TTTCGTCAAG TTGCCTAGGC TAGTCTCCAA TTCCTGGGCT 6000 | P.5965[G>A] 
CAAGCGATCT GCCCACCTTG CCCTTCCAAA GTGTTGGGAT TACGGGTGTG 6050 | P.6037/rs10402642[G>A]  
AACCACCGCA CCAGGCCTGG GCTGACACTT TAAACGTGCC ATTGCAATCA 6100  
GTGTATAATG GTCCCGTGGC AGAGGGAGAA TGGTGCCCAA GTCAGTACTT 6150  
CTTGGCTGGG ACCCAAGAAG ACAAACCTCT AGGGCCGGCG TGGTGGCTCA 6200 | REPEAT  
CGCCTGTAAT CCCAGCACTT TGGTTGGCTG AGGTGGGCAG ATCATCTGAG 6250 | P.6222[G>C] 
GTCAGGAGTT CAAGACCAGC CTGGCCAACA TGGTGAAACC TTGTCTCTAA 6300  
TAAAAACACA AAAATTAGCT AGGGGTGGCC CGCGCCTGTA ATCCCAGTTA 6350 | P.6334[G>A] 
CCTGGAGGCT GAGGCAGGAG AATTGCTTGT ACCCTGGAGG CGGAGATAGT 6400  
GCCACTGCAC TCCAGCCTGG GCAGCAGAGT GAGACTCC  
 
Figure 12. Annotated colored FASTA 
Red-color represents the NHW-specific variants, Blue-color represents the Black-specific variants, and Black-color represents 
the shared variants in the two populations. 
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3.3 SEQUENCING ANALYSIS 
Open-access software, haploview software, was used to analyze sequencing data, examine their 
MAF, select tagSNPs and visualize their LD structure. 
3.3.1 Common and rare variants 
3.3.1.1  NHWs 
A total of 113 sequencing variants were included in haploview analysis (excluding APOE-5230, 
and APOC1-4975). Out of 113 variants, 60 variants had MAF≥5% and were considered 
common, 21 variants had MAF 1-5% and were considered relatively less common, and 32 
variants had MAF<1% and were considered rare. Ninety-two percent of the common variants 
were reported (55 reported vs. 5 novel), while 53% of the rare variants were reported (28 
reported vs. 25 novel). Eighty-three percent (25/30) of the novel variation is rare as compared to 
the common novel variation (5/30=17%).  
3.3.1.2  Blacks 
A total of 174 variants were included in the haploview analysis (excluding APOE-5230, APOC2-
4458, APOC2-4460_4461, and APOC2-4532). Out of the 174 variants, 84 variants were 
considered common (MAF≥5%), 47 SNPs were considered less common (1%≤MAF<5%), and 
the remaining 43 SNPs were considered rare (MAF<1%). Ninety-two percent of the common 
variants were reported (77 reported, and 7 novel), while 61% of the rare variants were reported 
(55 reported, and 35 novel). Similar to NHWs, eighty percent of the novel variation in Blacks is 
rare while the remaining twenty percent is common.  
3.3.2 Selection of variants for genotyping 
We selected sequencing-identified tagSNPs, all sequencing-identified rare variants and HapMap 
tagSNPs covering the intergenic region to be genotyped in the entire datasets (623 NHWs and 
788 Blacks) for genotype-phenotype association analysis. 
3.3.2.1 Selection of sequencing-identified variants 
Haploview software was used to run tagger analysis on sequencing-identified variants that were 
discovered in the sequencing subsets and tagSNPs were selected in the two racial groups 
separately using MAF≥5% and r2=0.9 as a cut-off parameters.  
NHWs: Tagger results in NHWs are presented in Table 8 and Figure 13 illustrates their LD 
structure. In NHWs, 33 variants were selected as tagSNPs to capture 60 common variants in the 
sequenced regions in addition to 53 rare/less common variants with MAF<5% (see Table 9), and 
4 suspicious variants (APOE-4489, APOE-4490, APOC4-870, HCR2-801) were selected to be 






Table 8.  Tagger analysis results of APOE gene cluster sequencing variants in NHWs 
TagSNPs Alleles Captured APOC2-5303 APOC2-5324, APOC2-3600, APOC2-6037, APOC2-2191, APOC2-5310, APOC2-5815, APOC2-5303, APOC2-3030, APOC2-2566 APOC2-194APOC4-3498 APOC2-3086, APOC2-1357APOC4-4661, APOC4-2623, APOC2-1442APOC4-4746, APOC2-4493, APOC2-194APOC4-3498, APOC4-204, APOC2-3778 APOC2-5018 APOC4-1325del3, APOC2-2935, APOC4-2640, APOC2-5922, APOC2-2410, APOC2-5018  **APOC4-108 APOC4-92del3, APOC4-108, APOC4-150ins114 APOC2-3814 APOC2-5004, APOC2-3814, APOC2-2486rs9304645 APOC1-6026 APOC1-5926, APOC1-5240, APOC1-6026 **APOC2-4534 APOC2-4534, APOC2-4532 **APOC2-4429 APOC2-4429, APOC2-4430ins APOC1-720 APOC1-1870, APOC1-720 APOC2-4853 APOC2-5398rs12709889, APOC2-4853 APOC2-3348 APOC2-3010, APOC2-3348 APOE-5229 APOE-4075, APOE-5229 APOE-1163 APOE-1163 APOC1-4334 APOC1-4334 APOE-560 APOE-560 APOE-2440 APOE-2440 APOC2-623APOC4-3927 APOC2-623APOC4-3927 **APOC4-1733 APOC4-1733 **APOC4-1823 APOC4-1823 APOC1-2041 APOC1-2041 APOE-5361 APOE-5361 **APOC1-5053 APOC1-5053 HR2-188rs35136575 HCR2-188rs35136575 APOE-1998 APOE-1998 **APOE-624 APOE-624 APOE-3937 APOE-3937 **APOC2-4971 APOC2-4971  APOE-832 APOE-832 
Yellow-highlighted variants represent variants that were genotyped successfully. 





 Figure 13. LD plot of the APOE gene cluster sequencing common variants in NHWs 
Table 9.  Sequencing-identified less common/rare variants (MAF<5%) in NHWs sequencing subset 
Name Alleles NCBI rs no. Function Amino acid change MAF High HDL/ low TG (MAF) 
Low HDL/ high TG 
(MAF) 
APOE-1575 C>T rs769448 Intron1   0.021 0.043 0.000 
APOE-2294 C>T   Intron 2   0.005 0.011 0.000 
**APOE-2907 T>G rs769451 Intron 2   0.005 0.000 0.010 
APOE-3038 G>A rs111833428   Exon 3 Ala 23 Ala 0.005 0.011 0.000 
APOE-4310 T>A rs199768005 Exon 4 Val 254 Glu 0.005 0.011 0.000 
APOE-4528 C>T   3' UTR   0.005 0.011 0.000 
APOE-4737 C>G rs117656888 3'flanking   0.011 0.021 0.000 
**APOE-4951 A>C rs1081105 3'flanking  0.042 0.032 0.052 
**APOC1-607 G>A rs72654447 5'flanking   0.005 0.011 0.000 
**APOC1-655 A>T rs66807996 5'flanking   0.016 0.021 0.011 
**APOC1-659 G>C rs72654448 5'flanking   0.005 0.000 0.010 
APOC1-698 C>A rs72654449 5'flanking   0.011 0.011 0.010 
APOC1-703 C>T rs3207187 5'flanking  0.005 0.011 0.000 
APOC1-1170 G>A   intron1   0.005 0.011 0.000 
**APOC1-1276 C>G rs72654453 Exon2 Ile 16 Met 0.011 0.021 0.000 
APOC1-1294 T>G   intron2   0.005 0.011 0.000 
APOC1-1317 G>A rs12721048 intron2   0.011 0.021 0.000 
APOC1-1422 G>A   intron2   0.005 0.011 0.000 
APOC1-1566 G>A rs12691088 intron2  0.026 0.011 0.042 
**APOC1-1669 T>C   intron2   0.005 0.011 0.000 
APOC1-2629 G>A   Exon3  Arg 44 His 0.005 0.011 0.000 
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APOC1-2817 C>T   intron3   0.005 0.011 0.000 
APOC1-3423 G>A rs389261 intron3   0.005 0.000 0.010 
APOC1-3494 C>T   intron3   0.005 0.011 0.000 
APOC1-5641 T>G rs1064725 3'UTR  0.037 0.021 0.052 
APOC1-5773 G>A   3'flanking   0.005 0.011 0.000 
**APOC1-6122 G>C rs142134314 3'flanking   0.005 0.000 0.010 
**APOC1-6213 G>A   3'flanking   0.005 0.011 0.000 
HR1-292 C>G rs4803771 HCR-1  0.042 0.021 0.062 
HR1-362 C>A  HCR-1  0.011 0.011 0.010 
HR1-423 C>G  HCR-1  0.026 0.043 0.010 
HR1-575 A>G rs157599 HCR-1   0.005 0.000 0.010 
HR1-727 T>G rs149345 HCR-1   0.005 0.000 0.011 
HR2-365 C>A  HCR-2  0.011 0.011 0.010 
HR2-523 C>T rs118004808 HCR-2  0.026 0.021 0.031 
**APOC4-116 A>G   5’flanking   0.007 0.000 0.013 
APOC4-636 C>T   5’ flanking   0.005 0.000 0.010 
APOC4-968 A>G rs76214972 5’ UTR  0.037 0.011 0.062 
APOC4-1150 A>G rs148247675   Intron1   0.005 0.011 0.000 
APOC4-1229 G>C   Intron1   0.011 0.000 0.021 
**APOC4-2063 C>G   Intron1   0.005 0.000 0.011 
APOC4-2557 C>A   Intron1   0.005 0.000 0.010 
APOC4-2683 G>A rs12721109 Intron1  0.011 0.011 0.010 
APOC2-242C4-3546 G>A rs12691089 APOC4-exon2 (non-synonymous) Glycine 52 Aspartate 0.005 0.000 0.010 
APOC2-543C4-3847 T>C rs186448850 APOC4-intron2   0.011 0.000 0.021 
**APOC2-1324C4-4628 G>A rs12721063 APOC4-3'flanking/APOC2-5'flanking    0.021 0.021 0.021 
APOC2-1591 G>A   APOC2-intron1  0.005 0.000 0.010 
APOC2-1851 C>T rs12709886 intron1  0.037 0.011 0.062 
APOC2-2870 G>T   intron1   0.005 0.011 0.000 
**APOC2-2938 A>G   intron1   0.005 0.011 0.000 
**APOC2-3409 T>C   intron1   0.005 0.000 0.010 
**APOC2-4477 G>A   intron3   0.005 0.011 0.000 
APOC2-5644 G>A  3'flanking   0.011 0.011 0.010 
Blue-highlighted variants represent unique SNPs to the high HDL-C/low TG group, while red-highlighted 





African Blacks: In African Blacks, 58 SNPs were selected as tagSNPs to capture information of 
84 common variants (excluding APOC2-4458, and APOC2-4460 with low call rates) using 
MAF≥5%, r2=0.9 as cut-off values in addition to 90 rare variants with MAF<5%, and 4 
suspicious variants (APOC2-4458, APOC2-4460, APOC2-4532, and HCR2p801). Table 10 
summarizes tagger results and Figure 14 represents LD pattern of the common variants, and 
Table 11 summarizes less common/rare sequencing-identified variants. 
Table 10.  Tagger analysis results of the APOE gene cluster sequencing common variants in African Blacks 
Test Alleles Captured 
APOC2-2090 APOC2-2258, APOC2-4754, APOC2-3154, APOC2-3259, APOC2-4319, APOC2-2339, APOC2-4112, 
APOC2-2090, APOC2-5612, APOC2-3082 
APOC2-5310 APOC2-5303, APOC2-5310, APOC2-6037, APOC2-5324, APOC2-4430, APOC2-5815, APOC2-3600, 
APOC2-4429 
**APOC4-92 APOC4-92, APOC4-150, APOC4-108 
APOC2-198APOC4-
3502 
APOC4-3213, APOC4-757, APOC2-198APOC4-3502 




APOC2-3778 APOC2-3778, APOC2-3086 
APOC1-2041 APOC1-2041, APOE-1163 
HCR1-727 HCR1-727, APOC1-3423 
APOC1-6026 APOC1-6026, APOC1-5926 
APOC2-75C4-3380 APOC2-75APOC4-3380, APOC4-2971 


















**APOC2-2566 APOC2-2566, APOC2-3030 
**APOC1-1870 APOC1-1870 
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 Figure 14. LD plot of the APOE gene cluster sequencing common variants in Blacks 
 
Table 11. Sequencing-identified less common/rare variants (MAF<5%) in Blacks sequencing subset 
 





Low HDL-C/high TG 
(MAF) 
APOE-173 A>G  5'flanking  0.005 0.000 0.011 
APOE-308 C>T rs769445 5'flanking  0.005 0.000 0.011 
**APOE-494 C>T  5'flanking  0.005 0.010 0.000 
**APOE-526 T>C  5'flanking  0.005 0.010 0.000 
APOE-618 G>C  5'flanking  0.005 0.000 0.011 
APOE-624 T>C rs769446 5'flanking  0.005 0.010 0.000 
APOE-1231 G>A  intron1  0.011 0.010 0.011 
APOE-1279 C>A rs877973 intron1  0.048 0.062 0.033 
APOE-1539 A>G rs184686013 intron1  0.011 0.021 0.000 
**APOE-1591 G>T rs147236548 intron1  0.016 0.021 0.011 
APOE-2072 G>A rs189660912 intron 2  0.016 0.021 0.011 
APOE-2269 G>A rs61357706 intron 2  0.016 0.010 0.022 
APOE-2544 A>G rs115299243 intron 2  0.016 0.010 0.022 
**APOE-2576 G>A  intron 2  0.005 0.010 0.000 
APOE-3673 C>G rs769453 intron 3  0.005 0.000 0.011 
APOE-4036 C>T rs769455 exon 4 Arg 163 Cys 0.016 0.011 0.022 
APOE-4075 G>A rs7412 exon 4 Arg 176 Cys 0.042 0.062 0.021 
APOE-4569 G>T  3'UTR  0.005 0.010 0.000 
**APOE-4951 A>C rs1081105 3'flanking  0.042 0.042 0.043 
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APOE-5223 G>C  3'flanking  0.005 0.000 0.011 
APOE-5231 T>G  3'flanking  0.032 0.042 0.021 
APOC1-894 C>T rs190454394 5'flanking region  0.005 0.010 0.000 
APOC1-1166 G>A rs72654452 intron1  0.032 0.031 0.032 
APOC1-1526 C>T rs5114 intron2  0.047 0.062 0.032 
APOC1-1642 C>T  intron2  0.011 0.010 0.011 
**APOC1-2099 T>C  intron2  0.005 0.000 0.011 
**APOC1-2296 A>T rs185495905 intron2  0.005 0.010 0.000 
APOC1-3358 A>G  intron3  0.005 0.010 0.000 
APOC1-5240 C>G rs12721051 intron3  0.035 0.045 0.024 
**APOC1-5716 G>T rs12721055 3'flanking   0.026 0.031 0.021 
**APOC1-5717 G>C rs72654457 3'flanking   0.021 0.021 0.021 
**APOC1-6158 G>A  3'flanking   0.005 0.000 0.011 
HCR1-424 G>A rs117664574 HCR-1  0.011 0.021 0.000 
HCR2-523 C>T rs118004808 HCR-2  0.005 0.010 0.000 
**APOC4-65 C>T  5’ flanking   0.007 0.000 0.015 
**APOC4-233 C>T  5’ flanking   0.006 0.000 0.011 
**APOC4-245 G>T rs192072159  5’ flanking   0.006 0.000 0.011 
APOC4-368 A>G  5’ flanking   0.011 0.010 0.011 
**APOC4-438 G>A rs146656012 5’ flanking   0.006 0.000 0.011 
**APOC4-489 C>T rs140241604 5’ flanking   0.017 0.011 0.023 
APOC4-637 G>T rs113814026 5’ flanking   0.042 0.042 0.043 
APOC4-1088 T>G  intron1  0.005 0.000 0.011 
APOC4-1130 T>C  intron1  0.005 0.010 0.000 
APOC4-1192 G>A rs113745034   intron1  0.011 0.010 0.011 
APOC4-1325_1327 del3  intron1  0.043 0.064 0.022 
APOC4-1430_1431 insG  intron1  0.037 0.042 0.032 
**APOC4-1702 G>A rs12721102 intron1  0.006 0.011 0.000 
**APOC4-1719 C>A  intron1  0.006 0.011 0.000 
APOC4-2099 G>T rs111339708   intron1  0.011 0.010 0.011 
APOC4-2467 C>T rs115225947 intron1  0.021 0.021 0.021 
APOC4-2607 G>A rs5156 intron1  0.011 0.010 0.011 
APOC4-2640 C>T rs5158 intron1  0.032 0.042 0.021 
**APOC4-2641 G>A  intron1  0.005 0.000 0.011 
APOC4-2678 G>C rs148564866   intron1  0.005 0.000 0.011 
APOC4-2767 G>T rs12721107 intron1  0.021 0.031 0.011 
APOC4-3348 G>A  intron1  0.005 0.011 0.000 
**APOC2-59C4-3363 G>A rs60170431 APOC4-intron1  0.043 0.053 0.032 
APOC2-228 G>A rs5164 APOC4-exon2  Trp47Ter 0.005 0.000 0.011 
APOC2-288C4-3592 C>T rs12691090 APOC4-exon2  Asp67Asp 0.026 0.042 0.011 
APOC2-396C4-3700 G>A  APOC4-intron2  0.005 0.010 0.000 
APOC2-488C4-3792 G>A rs5165 APOC4-intron2  0.016 0.021 0.011 
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APOC2-708C4-4012 G>A  APOC4-exon3 Lys124Lys 0.005 0.000 0.011 
APOC2-1042C4-4346 A>T rs12709885 APOC4-3'/APOC2-5' 0.005 0.010 0.000 
APOC2-1187C4-4491 G>A rs111782345 APOC4-3'/APOC2-5' 0.005 0.000 0.011 
APOC2-1229C4-4533 C>T rs112698600 APOC4-3'/APOC2-5' 0.011 0.010 0.011 
**APOC2-1608C4-4912 G>C  APOC2-intron1  0.005 0.000 0.011 
**APOC2-2003 G>A rs187834478 intron1  0.016 0.021 0.011 
**APOC2-2371 A>G  intron1  0.005 0.010 0.000 
APOC2-2410 T>C rs12721076 intron1  0.032 0.042 0.021 
APOC2-2935 C>G rs11879392 intron1  0.027 0.042 0.011 
**APOC2-3193 A>G rs148616221  intron1  0.005 0.000 0.011 
APOC2-3234 T>C  intron1  0.005 0.010 0.000 
**APOC2-3260 G>A rs151176577  intron1  0.011 0.000 0.021 
**APOC2-3617 C>T  intron1  0.005 0.000 0.011 
APOC2-3692 T>G rs12721060 intron1  0.011 0.011 0.011 
**APOC2-3806 C>G rs12709887 intron1  0.043 0.053 0.032 
APOC2-3892 C>T rs5121 5’UTR  0.027 0.021 0.033 
APOC2-4086 G>A rs114780592 intron2  0.021 0.031 0.011 
APOC2-4118 G>A rs201709243 exon3 Val20 Ile 0.005 0.010 0.000 
APOC2-4513 A>C rs180809422  intron3  0.011 0.011 0.011 
APOC2-4587 A>C rs5126 exon4 Lys 77 Gln 0.044 0.044 0.043 
APOC2-4973_4974 insT rs199828513 3'flanking 0.005 0.000 0.011 
APOC2-5491 C>T  3'flanking   0.005 0.010 0.000 
APOC2-5512 G>A rs12721064 3'flanking   0.005 0.010 0.000 
APOC2-5562 G>C  3'flanking   0.021 0.010 0.032 
APOC2-5771_5775 delATTTA  3'flanking   0.005 0.011 0.000 
APOC2-5965 G>A  3'flanking   0.005 0.010 0.000 
**APOC2-6222 G>C  3'flanking   0.011 0.010 0.989 
APOC2-6334 G>A  3'flanking   0.026 0.031 0.021 
** SNPs that failed genotyping, blue-highlighted variants represent unique SNPs to the high HDL-C/low TG 





3.3.2.2 Selection of HapMap tagSNPs covering the intergenic regions 
HapMap genotypes data covering the entire 45.8 kb of APOE-C1-C4-C2 gene cluster mapping to 
(Ch19: 50,099,879 - 50,145,657) from two populations CEU and YRI were used to select 
tagSNPs. The tagSNPs results in CEU and YRI populations are summarized in Table 12 and 
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Table 13, respectively and their corresponding LD structures are illustrated in Figure 15 and 
Figure 16, respectively. 
Using cutoffs of MAF≥5%, r2=0.9, resulted in the selection of 15 tagSNPs in CEU to 
capture information for a total of 23 SNPs. Likewise 30 tagSNPs in YRI were selected to capture 
information for 35 SNPs. HapMap tagSNPs represent small portion of our sequencing-identified 
tagSNPs and only 7 tagSNPs out of the 15 HapMap tagSNPs in CEU and 7 HapMap tagSNPs 
out of 23 tagSNPs in YRI were mapped to the unsequenced intergenic regions and were added to 
the genotyping list. 
Table 12.  Tagger analysis results of APOE gene cluster based on HapMap data of CEU 
TagSNPs in CEU Alleles Captured rs2288912(C4-4661) rs2288912(C4-4661),rs7257476(C2-5324),rs1132899(C4-3498),rs2288911(C4-4746), rs5157(C4-2623),rs5120(3778) 
**rs5127 rs12709889(C2-5398),rs1130742(C2-4971),rs5127 rs584007 rs439401,rs584007 
**rs11083751 rs11083751 rs769450(APOE-2440) rs769450(APOE-2440) 
rs445925  rs445925 rs1064725(C1-5641) rs1064725(C1-5641) rs10421404(C2-5004) rs10421404(C2-5004) rs405509(APOE-832) rs405509 rs4420638(C1-6026) rs4420638 
rs5112 rs5112 
rs7259004 rs7259004 rs5167(C4-3927) rs5167 rs5158(C4-2640) rs5158 
rs4803770 rs4803770 
Yellow highlighted variants represent SNPs that located in the sequenced regions. 
(**) represent intergenic SNPs; red-colored: represent SNPs that failed genotyping and black bolded SNPs 
represent genotyped intergenic variants. 
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Table 13.  Tagger analysis results of APOE gene cluster HapMap common variants in YRI 
Test Alleles Captured rs5127 rs12709889(C2-5398), rs5127, rs1130742(C2-4971) rs5159(C4-2971) rs12721104(C2-75/C4-3380), rs5159 rs584007 rs584007, rs439401 rs2288911(C4-4746) rs2288912 (C4-4661), rs2288911 
**rs7259004 rs7259004 rs5114(C1-1526) rs5114 rs1132899(C2-194) rs1132899 rs10421404(C2-5004) rs10421404 rs4420638(C1-6026) rs4420638 rs5126 (C2-4587) rs5126 rs769450(APOE-2440) rs769450 **rs11878790 rs11878790 rs405509(APOE-832) rs405509 rs10424339(C1-3573) rs10424339 rs5167(C2-623) rs5167 
**rs445925 rs445925 rs5157(C4-2623) rs5157 rs10425530(C2-853) rs10425530 rs389261(C1-3423) rs389261 
**rs5112 rs5112 rs12709884(C2-850) rs12709884 rs157599(HCR1-575) rs157599 rs5155(C4-2559) rs5155 rs5120(C2-3778) rs5120 rs7257476(C2-5324) rs7257476 rs7412(APOE-4075) rs7412 **rs10424663 rs10424663 rs1081101(APOE-73) rs1081101 rs12721054(C1-5667) rs12721054 
**rs4803770 rs4803770 
Yellow highlighted variants represent SNPs that located in the sequenced regions. 
(**) represent intergenic variants; red-colored SNPs represent SNPs that failed genotyping 
and black bolded SNPs represent successfully genotyped variants. 
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Figure 16. LD plot of APOE gene cluster HapMap common variants in YRI 
3.4 GENOTYPING 
Initially, 103 variants were selected to be genotyped in the entire NHW dataset consisting of 90 
sequencing variants (33 tagSNPs, 53 rare variants, and 4 suspicious variants), 7 HapMap 
tagSNPs covering the intergenic regions, and 6 database common variants (according to Chip 
Bioinformatics and SeattleSNPs database) mapped to the sequenced regions. Because of the high 
degree of sequencing homology between the member genes in this cluster, we encountered high 
degree of nonspecific bindings in the sequencing and genotyping stages that resulted in 
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sequencing gaps (1550 bp in APOC1, and 49 bp in APOC4) and failing of 22 variants in the 
genotyping. 
In NHWs, a total of 22 variants were failed genotyping, including 6 tagSNPs (APOC4-
108, APOC2-4534, APOC2-4429, APOC4-1733, APOC4-1823, APOC2-4971), 15 rare variants 
(APOE-2907, APOE-4951, APOC1-607, APOC1-655, APOC1-659, APOC1-1276, APOC1-
1669, APOC1-6122, APOC1-6213, APOC4-116, APOC4-2063, APOC2-1324, APOC2-2938, 
APOC2-3409, APOC2-4477), and one HapMap intergenic variant (rs11083751). Eleven 
genotyped variants were excluded from the final statistical analyses, including 4 suspicious 
sequencing variants (APOE-4489, APOE-4490, APOC4-870, HCR2-801) that turned out to be 
not genuine, four common database SNPs [according to Chip Bioinformatics and SeattleSNPs 
database]; APOC1p1249/rs12721047, APOC2p3820/rs12709888, APOC2p4596/rs76186107, 
APOC2p228/rs5164 and one HapMap intergenic SNP; rs5127 turned out to be non-polymorphics 
in NHWs, APOE624 had low call rate and one variant (APOC1p5053) was out of HWE. 
Therefore, in NHWs a total of 70 variants were included in the association analyses. 
In Blacks, initially 160 variants were selected for genotyping: 152 sequencing variants 
(58 tagSNPs, 90 rare variants, and 4 suspicious sequencing variants), one common database 
variant (according to Chip Bioinformatics and SeattleSNPs database) mapped to the sequenced 
regions, and 7 HapMap intergenic tagSNPs. Since genotyping variants in this gene region is 
challenging, we ended up with the following 42 genotyping failures: 12 tag SNPs (APOC4-92, 
APOC2-4971, APOC2-2566, APOC1-1870, APOC2-2191, APOE-5229, APOC4-1823, APOC2-
850/C4-4154, APOC2-1442/C4-4746, APOC4-1733, APOC2-4534, APOC2-4971), 27 rare 
variants (APOE-494, APOE-526, APOE-1591, APOE-2576, APOE-4951, APOC1-2099, 
APOC1-2296, APOC1-5716, APOC1-5717, APOC1-6158, APOC4-65, APOC4-233, APOC4-
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245, APOC4-438, APOC4-489, APOC4-1702, APOC4-1719, APOC4-2641, APOC2-59/C4-
3363, APOC2-1608/C4-4912, APOC2-2003, APOC2-2371, APOC2-3193, APOC2-3260, 
APOC2-3617, APOC2-3806, and APOC2-6222), and the 4 suspicious sequencing variants 
(APOC2-4458, APOC2-4460, APOC2-4532, and HCR2p801). Nine variants were excluded from 
the final statistical analyses either because they were monopolymorphics (APOC1p5572), out of 
HWE (APOE1591, HCR2p632, APOC2p4493, rs11878790, APOC2p3348, rs10424663) or had 
low call rates (APOC2p2339 and APOE2544). Thus, a total of 108 successfully genotyped 
variants were considered for the association analyses in African Blacks. 
3.5 LD STRUCTURE AND TAGGER ANALYSIS OF THE GENOTYPED 
VARIANTS 
3.5.1  NHWs 
A total of 70 variants were successfully genotyped and considered for the genotype-phenotype 
association analyses (Table 14). Out of the 70 variants 65 were mapped to the sequenced 
regions, and the remaining 5 variants were HapMap variants mapped to the intergenic regions. 
Out of the 70 genotyped variants, 29 variants had MAF≥5% and were considered common, 10 
variants had 1%≤ MAF<5% and were considered relatively less common, and the remaining 31 




Table 14.  Quality parameters of the 70 genotyped variants in 623 NHWs  
Common Variants (MAF≥5%) 





1 APOE560/rs449647 45408564 A>T 0.162 0.27 99.70 5 5'flanking  APOE 
2 APOE832/rs405509 45408836 G>T 0.478 1.00 99.80 1f 5'flanking  APOE 
3 APOE1163/rs440446 45409167 G>C 0.360 0.47 100.00 4 intron1 APOE 
4 APOE1998rs769449 45410002 G>A 0.117 0.46 99.20 4 intron 2 APOE 
5 APOE2440/rs769450 45410444 G>A 0.401 0.51 99.40 5 intron 2 APOE 
6 APOE3937/rs429358 45411941 T>C 0.153 1.00 98.40 5 exon 4 APOE 
7 APOE4075/rs7412 45412079 C>T 0.081 0.81 99.50 5 exon 4 APOE 
8 APOE5361/rs1081106 45413365 T>C 0.085 1.00 99.80 3a 3'flanking APOE 
9 rs439401 45414451 C>T 0.359 0.38 97.80 1b Intergenic APOE 
(+6447bp) 
10 APOC1rs445925 45415640 G>A 0.110 1.00 99.00 No Data Intergenic  APOC1(-
1281bp) 
11 APOC1p720/rs72654451 45417640 insCGTT 0.231 0.88 99.80 4 5'flanking  APOC1 
12 APOC1p2041/rs3826688 45418961 G>A 0.342 0.76 97.30 5 intron2 APOC1 
13 APOC1p4334/rs12721046 45421254 G>A 0.153 0.84 98.10 6 intron3 APOC1 
14 APOC1p5926/rs56131196 45422846 G>A 0.189 0.51 99.20 No Data 3'flanking  APOC1 
15 APOC1p6026/rs4420638 45422946 A>G 0.156 0.01 89.30 No Data 3'flanking  APOC1 
16 rs4803770 45427353 C>G 0.377 0.99 95.40 5 Intergenic HCR1(-4bp) 
17 rs5112 45430280 G>C 0.464 0.98 91.80 4 APOAPOC1P1 HCR1(+2931
bp) 
18 rs7259004 45432557 C>G 0.117 1.00 98.20 6 APOAPOC1P1 HCR2 (-
6419bp) 
19 HR2p188/rs35136575 45439163 C>G 0.227 0.24 97.80 2a HCR2 HCR2 
20 APOC4p2623/rs5157 45447161 C>T 0.497 0.86 99.80 4 Intron1 APOC4 
21 APOC4p2640/rs5158 45447178 C>T 0.139 0.92 99.40 2b Intron1 APOC4 
22 APOC2p194C4p3498/rs1132
899 
45448036 C>T 0.486 0.66 99.50 5 APOC4-exon2  APOC4 
23 APOC2p623C4p3927/rs5167 45448465 T>G 0.360 0.28 100.00 5 exon3  APOAPOC4 
24 APOC2p1357C4p4661/rs228
8912 




25 APOC2p3778/rs5120 45451620 T>A 0.498 0.82 98.90 4 intron1 APOC2 
26 APOC2p4853/rs199828513 45452695 insT 0.279 0.27 99.20 No Data 3'flanking  APOC2 
27 APOC2p5004/rs10421404 45452845 C>T 0.183 0.43 99.00 No Data 3'flanking  APOC2 
28 APOC2p5310/rs7258345 45453151 T>G 0.466 0.92 98.20 No Data 3'flanking  APOC2 
29 APOC2p5398/rs12709889 45453240 G>A 0.276 0.34 97.10 6 3'flanking  APOC2 
Rare and less common variants (MAF<5%) 
# Variant Name Position Alleles MAF HWE-P %Geno Regulomedb 
score 
Function GENE 
1 APOE1575/rs769448 45409579 C>T 0.021 0.47 99.50 4 intron1 APOE 
2 APOE2907/rs769451 45410911 T>G 0.011 1.00 100.00 5 intron 2 APOE 
3 APOE3038/rs111833428   45411042 G>A 0.002 1.00 99.20 5 exon 3 APOE 
4 APOE3106/rs769452 45411110 T>C 0.001 1.00 99.70 5 exon 3 APOE 
5 APOE4310/rs199768005 45412314 T>A 0.004 1.00 99.80 5 exon 4 APOE 
6 APOE4528 45412532 C>T 0.001 1.00 100.00 5 3' UTR APOE 
7 APOE4737/rs117656888 45412741 C>G 0.008 1.00 99.50 5 3'flanking APOE 
8 APOC1p698/rs72654449 45417618 C>A 0.004 1.00 99.20 4 5'flanking  APOC1 
9 APOC1p703/rs3207187 45417623 C>T 0.001 1.00 99.50 4 5'flanking  APOC1 
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10 APOC1p1170 45418090 G>A 0.001 1.00 97.90 2b intron1 APOC1 
11 APOC1p1294 45418214 A>C 0.001 1.00 99.40 4 intron2 APOC1 
12 APOC1p1317/rs12721048 45418237 G>A 0.002 1.00 97.80 4 intron2 APOC1 
13 APOC1p1422 45418342 G>A 0.002 1.00 100.00 4 intron2 APOC1 
14 APOC1p1566/rs12691088 45418486 G>A 0.006 1.00 97.10 2b intron2 APOC1 
15 APOC1p2629 45419549 G>A 0.001 1.00 99.40 4 exon3 APOC1 
16 APOC1p2817 45419737 C>T 0.003 1.00 97.40 2b intron3 APOC1 
17 APOC1p3423/rs389261 45420343 G>A 0.002 1.00 97.60 No Data intron3 APOC1 
18 APOC1p3494 45420414 C>T 0.002 1.00 99.70 No Data intron3 APOC1 
19 APOC1p5641/rs1064725 45422561 T>G 0.039 1.00 99.20 No Data 3'UTR APOC1 
20 APOC1p5773 45422693 G>A 0.001 1.00 97.10 No Data 3'flanking  APOC1 
21 HCR1p292/rs4803771 45427648 C>G 0.024 0.61 98.20 4 HCR1 HCR1 
22 HCR1p362 45427718 C>A 0.002 1.00 97.60 2a HCR1 HCR1 
23 HCR1p423 45427779 C>G 0.026 0.67 99.50 4 HCR1 HCR1 
24 HCR1p575/rs157599 45427931 A>G 0.002 1.00 99.70 3a HCR1 HCR1 
25 HCR1p727/rs149345 45428083 T>G 0.002 1.00 98.60 3a HCR1 HCR1 
26 HCR2p365 45439340 C>A 0.004 1.00 98.10 2b HCR2 HCR2 
27 HCR2p523 45439498 C>T 0.023 1.00 96.00 2b HCR2 HCR2 
28 APOC4p636 45445174 C>T 0.001 1.00 96.60 No Data 5’ flanking  APOC4 
29 APOC4p968/rs76214972 45445506 A>G 0.036 0.88 99.70 4 5’ UTR APOC4 
30 APOC4p1150/rs148247675 45445688 A>G 0.002 1.00 96.80 5 Intron1 APOC4 
31 APOC4p1229 45445767 G>C 0.002 1.00 99.70 2b Intron1 APOC4 
32 APOC4p2557 45447095 C>A 0.001 1.00 99.50 4 Intron1 APOC4 
33 APOC4p2683/rs12721109 45447221 G>A 0.024 0.61 98.20 2b Intron1 APOC4 
34 APOC4p2703/rs12721108 45447241 G>T 0.008 1.00 99.40 2a Intron1 APOC4 
35 APOC2p242C4p3546/rs126910
89 
45448084 G>A 0.003 1.00 99.70 5 APOC4-exon2  APOC4 
36 APOC2p543C4p3847C/rs18644
8850 
45448385 T>C 0.002 1.00 98.10 5 APOC4-
intron2 
APOC4 
37 APOC2p1591C4p4895 45449433 G>A 0.001 1.00 99.70 4 APOC2-
intron1 
APOC2 
38 APOC2p1851/rs12709886 45449693 G>A 0.037 0.84 99.20 6 intron1 APOC2 
39 APOC2p2870 45450712 G>T 0.004 1.00 99.70 4 intron1 APOC2 
40 APOC2p3348/rs10420434 45451190 G>A 0.037 0.84 99.50 No Data intron1 APOC2 
41 APOC2p5644 45453486 G>A 0.009 1.00 95.70 6 3'flanking  APOC2 
Red-colored variants represent database and HapMap intergenic variants. HWE-P (Hardy Weinberg 
equilibrium), MAF (minor allele frequency), Position (chromosomal position corresponds to NCBI db SNPs 
build 138). 
Tagger analysis of the genotyped variants in NHWs using cut-off MAF≥0.048, and 
r2=0.9 selected 23 tagSNPs to capture 29 SNPs. Results of Tagger analysis were shown in Table 
15 and their LD structure was shown in Figure 17. 
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Table 15.  Tagger results of the 29 genotyped common variants in NHWs (MAF≥0.048, r2=0.9)   
Bin Test Alleles Captured 
1 APOC4p2623/rs5157 APOC4p2623/rs5157, APOC2p194APOC4p3498/rs1132899, 
APOC2p3778/rs5120, APOC2p1357APOC4p4661/rs2288912 
2 APOC2p4853/rs199828513 APOC2p5398/rs12709889, APOC2p4853/rs199828513 
3 APOC1p2041/rs3826688 APOC1p2041/rs3826688, rs439401 
4 APOC1p5926/rs56131196 APOC1p6026/rs4420638, APOC1p5926/rs56131196 
5 APOE2440/rs769450 APOE2440/rs769450 
6 APOE3937/rs429358 APOE3937/rs429358 
7 APOE5361/rs1081106 APOE5361/rs1081106 
8 APOC1rs445925 APOC1rs445925 
9 APOE1163/rs440446 APOE1163/rs440446 
10 APOC2p5310/rs7258345 APOC2p5310/rs7258345 
11 APOC1p720/rs72654451 APOC1p720/rs72654451 
12 APOC2p5004/rs10421404 APOC2p5004/rs10421404 
13 APOE560/rs449647 APOE560/rs449647 
14 APOC4p2640/rs5158 APOC4p2640/rs5158 
15 HCR2p188/rs35136575 HCR2p188/rs35136575 
16 rs5112 rs5112 
17 APOE832/rs405509 APOE832/rs405509 
18 APOE4075/rs7412 APOE4075/rs7412 
19 APOE1998/rs769449 APOE1998/rs769449 
20 APOC2p623C4p3927/rs5167 APOC2p623C4p3927/rs5167 
21 APOC1p4334/rs12721046 APOC1p4334/rs12721046 
22 rs4803770 rs4803770 




Figure 17. LD plot of the 29 genotyped common variants (MAF≥0.048, r2=0.9) in NHWs 
 
3.5.2 African Blacks 
A total of 108 variants were successfully genotyped in 788 Blacks and were considered for the 
genotype-phenotype association analyses. 103 variants were mapped to the sequenced regions 
and the remaining 5 variants were mapped to the intergenic regions. Out of the 108 variants, 48 
variants had MAF≥5% and were considered common, 31 variants had MAF 1-5% and were 
considered less common, and 29 variants had MAF<1% and were considered rare. The MAF, 
HWE, and call rate information of the 108 genotyped variants in Blacks were summarized in 
Table 16.  
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Table 16.  Quality parameters of the 108 genotyped variants in 788 Blacks  
Common Variants with (MAF≥5%) 
# Variant name Position Alleles MAF HWE-P %Geno 
regulome 
db score Function Gene name 
1 APOE73/rs1081101 45408077 C>T 0.061 0.284 99.3 4 5'flanking APOE 
2 APOE560/rs449647 45408564 A>T 0.374 0.498 96.6 5 5'flanking APOE 
3 APOE832/rs405509 45408836 G>T 0.253 0.128 99.0 1f 5'flanking APOE 
4 APOE1163/rs440446 45409167 G>C 0.100 0.862 93.6 4 intron1 APOE 
5 APOE1279/rs877973 45409283 C>A 0.060 0.557 99.5 4 intron1 APOE 
6 APOE2440/rs769450 45410444 G>A 0.387 0.241 90.1 5 intron 2 APOE 
7 APOE3937/rs429358 45411941 T>C 0.266 0.659 98.0 5 exon 4 APOE 
8 APOE4075/rs7412 45412079 G>A 0.061 1.000 99.0 5 exon 4 APOE 
9 rs439401 45414451 C>T 0.109 0.043 97.4 1b Intergenic  APOE(+6447) 
10 APOC1rs445925 45415640 G>A 0.297 0.800 97.7 No Data Intergenic  APOC1 
11 APOC1p720ins4/rs71962921 45417640 insCGTT 0.274 0.233 97.8 4 5'flanking  APOC1 
12 APOC1p1331/rs10408994 45418251 G>A 0.067 0.059 98.0 4 intron2 APOC1 
13 APOC1p1526/rs5114 45418446 C>T 0.058 0.467 98.0 4 intron2 APOC1 
14 APOC1p1684/rs12709881 45418604 G>A 0.098 0.564 99.0 4 intron2 APOC1 
15 APOC1p3423/rs389261 45420343 G>A 0.331 0.980 95.0 No Data intron3 APOC1 
16 APOC1p3573/rs10424339 45420493 G>A 0.140 0.732 97.3 No Data intron3 APOC1 
17 APOC1p5006/rs112528434 45421926 G>T 0.086 0.436 89.3 No Data intron3 APOC1 
18 APOC1p5053/rs12721052 45421973 delG 0.223 0.395 98.7 No Data intron3 APOC1 
19 APOC1p5667/rs12721054 45422587 A>G 0.145 0.238 91.6 6 3'UTR APOC1 
20 APOC1p5926/rs56131196 45422846 G>A 0.175 0.806 96.9 No Data 3'flanking  APOC1 
21 rs4803770 45427353 C>G 0.270 0.489 96.9 5 HCR-1 HCR1(3) 
22 HCR1p575/rs157599 45427931 A>G 0.357 0.983 89.6 3a HCR-1 HCR1 
23 rs5112 45430280 C>G 0.477 0.211 91.4 4 APC1P1 APOC1P1/HCR1 
24 rs7259004 45432557 G>C 0.302 0.134 97.3 6 APC1P1 HCR2  
25 HCR2p188/rs35136575 45439163 C>G 0.155 0.067 97.5 2a HCR-2 HCR2 
26 APOC4p2559/rs5155 45447097 C>T 0.099 1.000 98.7 4 Intron1 APOC4 
27 APOC4p2623/rs5157 45447161 C>T 0.173 0.627 97.9 4 Intron1 APOC4 
28 APOC2p75C4p3380/rs12721104 45447918 G>A 0.138 1.000 98.2 5 C4-intron1 APOC4 
29 APOC2p194C4p3498/rs1132899 45448036 C>T 0.239 0.604 99.0 5 C4-exon2  APOC4 
30 APOC2p623C4p3927/rs5167 45448465 T>G 0.459 0.597 98.6 5 C4-exon3 APOC4 
31 APOC2p853C4p4157/rs10425530 45448695 G>A 0.111 0.530 97.8 6 C4-3' UTR APOC4 
32 APOC2p1357C4p4661/rs2288912 45449199 G>C 0.257 0.882 97.9 1a C4-3’/C2-5' APOC2/APOC4 
33 APOC2p1540C4p4844/rs75463753 45449382 G>A 0.108 0.365 92.6 4 C2-intron1 APOC2 
34 APOC2p2486/rs9304645 45450328 G>A 0.368 0.094 97.5 4 Intron1 APOC2 
35 APOC2p3010/rs10419086 45450852 A>G 0.124 0.539 92.2 6 Intron1 APOC2 
36 APOC2p3778/rs5120 45451620 A>T 0.182 0.384 98.8 4 Intron1 APOC2 
37 APOC2p3805/rs7257095 45451647 C>G 0.165 0.303 98.2 2a Intron1 APOC2 
38 APOC2p3814/rs10422603 45451656 T>G 0.301 0.706 96.3 2b Intron1 APOC2 
39 APOC2p4319/rs5123 45452161 G>A 0.059 0.074 97.0 No Data Intron3 APOC2 
40 APOC2p4587/rs5126 45452429 A>C 0.050 0.918 94.1 5 exon4 APOC2 
41 APOC2p4754/rs7253690 45452596 G>A 0.061 0.101 98.8 5 exon4 APOC2 
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42 APOC2p4853/rs150448996 45452694 delT 0.274 0.822 96.6 No Data 3'flanking  APOC2 
43 APOC2p5004/rs10421404 45452845 C>T 0.293 0.170 98.2 No Data 3'flanking  APOC2 
44 APOC2p5310/rs7258345 45453151 G>T 0.305 0.192 90.9 No Data 3'flanking  APOC2 
45 APOC2p5398/rs12709889 45453239 G>A 0.259 1.000 97.7 6 3'flanking  APOC2 
46 APOC2p5586/rs73558127 45453427 T>G 0.100 0.376 96.5 No Data 3'flanking  APOC2 
47 APOC2p5815/rs10423208 45453656 A>G 0.316 0.818 97.8 5 3'flanking  APOC2 
48 APOC2p5922/rs10422888 45453763 A>G 0.078 0.891 93.2 5 3'flanking  APOC2 
Rare and less common variants (MAF<5%) 
# Variant name Position Alleles MAF HWE-P %Geno regulome db score Function Gene name 
1 APOE173 45408177 A>G 0.002 1.000 99.6 3a 5'flanking APOE 
2 APOE308/rs769445 45408312 C>T 0.007 1.000 99.6 4 5'flanking APOE 
3 APOE618 45408622 G>C 0.001 1.000 99.6 4 5'flanking APOE 
4 APOE624/rs769446 45408628 T>C 0.008 1.000 91.9 3a 5'flanking APOE 
5 APOE1109/rs9282609 45409113 C>T 0.042 0.070 99.1 4 Splice site APOE 
6 APOE1231 45409235 G>A 0.012 1.000 99.5 2b Intron1 APOE 
7 APOE1539/rs184686013 45409543 A>G 0.009 0.101 99.1 4 Intron1 APOE 
8 APOE2072/rs189660912 45410076 G>A 0.008 1.000 99.2 4 Intron 2 APOE 
9 APOE2269/rs6135770 45410273 G>A 0.017 1.000 98.0 5 Intron 2 APOE 
10 APOE3673/rs769453 45411677 C>G 0.007 1.000 99.3 5 Intron 3 APOE 
11 APOE4036/rs769455 45412040 C>T 0.020 0.512 97.9 5 Exon 4 APOE 
12 APOE4569 45412573 G>T 0.001 1.000 99.3 5 3'UTR APOE 
13 APOE5223 45413227 C>G 0.005 1.000 100.0 2b 3'flanking APOE 
14 APOE5231 45413235 T>G 0.027 0.197 99.2 2b 3'flanking APOE 
15 APOC1p894/rs190454394 45417814 C>T 0.002 1.000 98.8 4 5'flanking  APOC1 
16 APOC1p1166/rs72654452 45418086 C>T 0.031 0.334 99.5 2b Intron1 APOC1 
17 APOC1p1642 45418562 C>T 0.011 1.000 99.3 4 Intron2 APOC1 
18 APOC1p3358 45420278 A>G 0.002 1.000 94.3 No Data Intron3 APOC1 
19 HCR1p424/rs117664574 45427779 G>A 0.007 1.000 99.0 4 HCR-1 HCR1 
20 HCR2p286 45439261 G>A 0.046 0.399 98.6 2a HCR-2 HCR2 
21 HCR2p523/rs118004808 45439498 C>T 0.003 1.000 99.2 2b HCR-2 HCR2 
22 APOC4p368 45444906 T>C 0.002 1.000 98.3 6 5’ flanking  APOC4 
23 APOC4p637/rs113814026 45445175 G>T 0.046 1.000 98.7 No Data 5’ flanking  APOC4 
24 APOC4p757/rs12721105 45445295 G>T 0.038 0.591 99.7 5 5’ flanking  APOC4 
25 APOC4p1088 45445626 T>G 0.001 1.000 98.2 2b Intron1 APOC4 
26 APOC4p1130 45445668 T>C 0.001 1.000 99.1 5 Intron1 APOC4 
27 APOC4p1192/rs113745034 45445730 G>A 0.012 1.000 94.9 4 Intron1 APOC4 
28 APOC4p1325del3 45445863 del3 0.024 1.000 98.7 4 Intron1 APOC4 
29 APOC4p1430ins 45445968 insG 0.034 1.000 87.7 5 Intron1 APOC4 
30 APOC4p2099/rs111339708 45446637 G>T 0.015 1.000 99.0 No Data Intron1 APOC4 
31 APOC4p2467/rs115225947 45447005 G>A 0.014 1.000 99.1 5 Intron1 APOC4 
32 APOC4p2607/rs5156 45447145 G>A 0.013 1.000 96.0 4 Intron1 APOC4 
33 APOC4p2640/rs5158 45447178 C>T 0.021 1.000 98.7 2b Intron1 APOC4 
34 APOC4p2678/rs148564866 45447216 G>C 0.009 1.000 98.3 2b Intron1 APOC4 
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35 APOC4p2767/rs127721107 45447305 G>T 0.025 1.000 97.8 4 Intron1 APOC4 
36 APOC4p3348 45447886 G>A 0.001 1.000 98.8 5 Intron1 APOC4 
37 APOC2p228/rs5164 45448070 G>A 0.007 1.000 98.4 5 C4-exon2  APOC4 
38 APOC2p288C4p3592/rs12691090 45448130 C>T 0.027 1.000 98.3 5 C4-exon2  APOC4 
39 APOC2p396C4p3700 45448238 G>A 0.001 1.000 95.8 5 C4-intron2 APOC4 
40 APOC2p488C4p3792/rs5165 45448330 G>A 0.015 1.000 98.0 5 C4-intron2 APOC4 
41 APOC2p665C4p3969/rs138548797 45448507 A>C 0.009 1.000 98.7 No Data C4-exon3 APOC4 
42 APOC2p708C4p4012 45448550 G>A 0.001 1.000 98.4 6 C4-exon3 APOC4 
43 APOC2p1042C4p4346/rs12709885 45448884 A>T 0.018 0.420 99.0 5 C4-3'/C2-5' APOC2/APOC4 
44 APOC2p1187C4p4491/rs111782345 45449029 G>A 0.018 1.000 95.3 5 C4-3'/C2-5' APOC2/APOC4 
45 APOC2p1229C4p4533/rs112698600 45449071 C>T 0.014 1.000 97.8 2b C4-3'/C2-5' APOC2/APOC4 
46 APOC2p1275C4p4579/rs111356234 45449117 G>A 0.035 0.775 98.3 4 C4-3'/C2-5' APOC2/APOC4 
47 APOC2p2935/rs11879392 45450777 C>G 0.014 1.000 96.6 2b Intron1 APOC2 
48 APOC2p3692/rs12721060 45451534 T>G 0.017 1.000 87.3 No Data Intron1 APOC2 
49 APOC2p3892/rs5121 45451734 C>T 0.036 1.000 96.6 5 Exon2 APOC2 
50 APOC2p4086/rs114780592 45451928 G>A 0.028 1.000 98.7 4 Intron2 APOC2 
51 APOC2p4118/rs201709243 45451960 G>A 0.001 1.000 96.2 4 Exon3 APOC2 
52 APOC2p4513/rs180809422 45452355 A>C 0.014 0.235 90.3 5 Intron3 APOC2 
53 APOC2p4973/rs199828513 45452814 A>G 0.008 1.000 93.5 No Data 3'flanking  APOC2 
54 APOC2p5018/rs78403558 45452859 delCTTTT 0.035 1.000 99.3 5 3'flanking  APOC2 
55 APOC2p5491 45453332 C>T 0.001 1.000 98.8 6 3'flanking  APOC2 
56 APOC2p5512/rs12721064 45453353 C>T 0.008 1.000 100.0 6 3'flanking  APOC2 
57 APOC2p5562 45453403 G>C 0.018 1.000 96.7 No Data 3'flanking  APOC2 
58 APOC2p5771 45453612 delATTTA 0.005 1.000 97.1 6 3'flanking  APOC2 
59 APOC2p5965 45453806 G>A 0.001 1.000 99.1 5 3'flanking  APOC2 
60 APOC2p6334 45454175 G>A 0.009 1.000 99.5 No Data 3'flanking  APOC2 
Red-colored variants represent database and HapMap intergenic variants. HWE-P (Hardy Weinberg 
equilibrium), MAF (minor allele frequency), Position (chromosomal position corresponds to NCBI db SNPs 
build 138). 
Tagger analysis of the genotyped common variants using MAF≥4.8%, r2=0.9, identified 
41 variants as tag-SNPs to capture information for 48 variants. Table 17 represents tagger 




Table 17.  Tagger results of the 48 common genotyped variants (MAF≥0.048, r2=0.9) in Blacks 
Bin Test Alleles Captured 
1 APOC2p3814/rs10422603 APOC2p5004/rs10421404, APOC2p3814/rs10422603 
2 APOC2p4319/rs5123 APOC2p4754/rs7253690, APOC2p4319/rs5123 
3 APOC2p5310/rs7258345 APOC2p5815/rs10423208, APOC2p5310/rs7258345 
4 APOC2p5398/rs12709889 APOC2p5398/rs12709889, APOC2p4853/rs150448996 
5 APOC1p5006/rs112528434 APOC1p5006/rs112528434, APOC1p1684/rs12709881 
6 rs439401 rs439401, APOE1163/rs440446 
7 APOE1279/rs877973 APOC1p1526/rs5114, APOE1279/rs877973 
8 APOC2p3010/rs10419086 APOC2p3010/rs10419086 
9 APOC1p3423/rs389261 APOC1p3423/rs389261 
10 HCR2p188/rs35136575 HCR2p188/rs35136575 
11 APOC1p5667/rs12721054 APOC1p5667/rs12721054 
12 APOC2p5586/rs73558127 APOC2p5586/rs73558127 
13 APOC2p3805/rs7257095 APOC2p3805rs7257095 
14 APOE560/rs449647 APOE560r/s449647 
15 APOC2p623C4p3927/rs5167 APOC2p623C4p3927/rs5167 
16 APOC1p5053/rs12721052 APOC1p5053/rs12721052 
17 APOC1rs445925 APOC1rs445925 
18 APOC2p4587/rs5126 APOC2p4587/rs5126 
19 HCR1p575/rs157599 HCR1p575/rs157599 
20 APOE4075/rs7412 APOE4075/rs7412 
21 APOC2p853C4p4157/rs10425530 APOC2p853C4p4157/rs10425530 
22 APOC2p1357C4p4661/rs2288912 APOC2p1357C4p4661/rs2288912 
23 APOC1p1331/rs10408994 APOC1p1331/rs10408994 
24 rs4803770 rs4803770 
25 APOC4p2623rs5157 APOC4p2623/rs5157 
26 APOE73/rs1081101 APOE73/rs1081101 
27 APOC2p1540C4p4844/rs75463753 APOC2p1540C4p4844/rs75463753 
28 APOE2440/rs769450 APOE2440/rs769450 
29 APOC2p75C4p3380/rs12721104 APOC2p75C4p3380/rs12721104 
30 APOE832/rs405509 APOE832/rs405509 
31 APOC2p5922/rs10422888 APOC2p5922/rs10422888 
32 APOC2p2486/rs9304645 APOC2p2486/rs9304645 
33 APOC2p3778/rs5120 APOC2p3778/rs5120 
34 APOC1p720ins4/rs71962921 APOC1p720ins4/rs71962921 
35 APOC1p5926/rs56131196 APOC1p5926/rs56131196 
36 rs7259004 rs7259004 
37 APOC4p2559/rs5155 APOC4p2559/rs5155 
38 rs5112 rs5112 
39 APOE3937/rs429358 APOE3937/rs429358 
40 APOC1p3573/rs10424339 APOC1p3573/rs10424339 
41 APOC2p194C4p3498/rs1132899 APOC2p194C4p3498/rs1132899 
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 Figure 18. LD plot of the 48 common genotyped variants (MAF≥4.8%, r2=0.09) in Blacks 
3.5.3 Shared genotyped variants in NHWs and Blacks 
Twenty-seven variants genotyped in both populations were considered for the genotype-
phenotype association analyses. Twenty-three variants showed significant difference in their 
MAF in the two racial groups (P<0.05) (see Table 18). The LD structure (Figure 19 and Figure 
20) of the 27 shared variants is different in the two population groups whereas markers tend to be 
much strongly correlated in NHWs than in Blacks except these two variants 
APOC2p5398/rs12709889, and APOC2p4853/rs199828513 were found to be in complete LD in 
both racial groups. As expected fewer variants were selected as tagSNPs in NHWs than in 
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Blacks to capture information for the total 27 variants (22 tagSNPs in NHWs vs. 25 tagSNPs in 
Blacks) because of their high correlation in NHWs (Table 19). 
Table 18.  Minor allele frequency of the 27 shared genotyped variants in both racial groups 
# Name Position Associated Allele MAF in Blacks MAF in NHWs P value 
1 APOE560/rs449647 45408564 T 0.369 0.162 7.12E-34 
2 APOE832/rs405509 45408836 T 0.252 0.478 2.23E-35 
3 APOE1163/rs440446 45409167 C 0.100 0.360 1.25E-58 
4 APOE2440/rs769450 45410444 A 0.387 0.401 0.4687 
5 APOE3937/rs429358 45411941 C 0.264 0.153 2.00E-12 
6 APOE4075/rs7412 45412079 T 0.061 0.081 0.0364 
7 rs439401 45414451 T 0.109 0.359 9.98E-55 
8 APOC1rs445925 45415640 A 0.298 0.110 4.88E-33 
9 APOC1p720 45417640 G 0.274 0.231 0.0108 
10 APOC1p3423/rs389261 45420343 A 0.331 0.002 6.94E-107 
11 APOC1p5926/rs56131196 45422846 A 0.175 0.189 0.3285 
12 rs4803770 45427353 G 0.270 0.377 2.69E-09 
13 HCR1p575/rs157599 45427931 G 0.360 0.002 5.35E-120 
14 rs5112 45430280 C 0.520 0.464 0.0052 
15 rs7259004 45432557 G 0.698 0.117 1.77E-202 
16 HCR2p188/rs35136575 45439163 G 0.155 0.227 1.49E-06 
17 HCR2p523 45439498 T 0.003 0.023 1.22E-06 
18 APOC4p2623/rs5157 45447161 T 0.173 0.497 5.14E-74 
19 APOC4p2640/rs5158 45447178 T 0.021 0.139 2.34E-32 
20 APOC2p194C4p3498/rs1132899 45448036 T 0.238 0.486 2.87E-42 
21 APOC2p623C4p3927/rs5167 45448465 G 0.459 0.360 1.26E-07 
22 APOC2p1357C4p4661/rs2288912 45449199 C 0.258 0.497 2.28E-40 
23 APOC2p3778rs5120 45451620 T 0.185 0.502 4.44E-70 
24 APOC2p4853/rs199828513 45452695 W 0.274 0.279 0.7703 
25 APOC2p5004/rs10421404 45452845 T 0.290 0.183 5.70E-11 
26 APOC2p5310r/s7258345 45453151 T 0.307 0.534 3.38E-32 
27 APOC2p5398/rs12709889 45453240 A 0.259 0.276 0.3 






Table 19.  Tagger results of the 27 shared genotyped markers in NHWs and Blacks 
Tagger results of the 27 shared genotyped markers in NHWs 
Bin Test Alleles Captured 
1 APOC4p2623/rs5157 APOC2p3778/rs5120, APOC2p1357APOC4p4661/rs2288912, APOC4p2623/rs5157, APOC2p194APOC4p3498/rs1132899 
2 APOC2p5398/rs12709889 APOC2p5398/rs12709889, APOC2p4853/rs199828513 
3 HCR1p575/rs157599 HCR1p575/rs157599, APOC1p3423/rs389261 
4 APOC2p5310/rs7258345 APOC2p5310/rs7258345 
5 rs5112 rs5112 
6 APOE3937/rs429358 APOE3937/rs429358 
7 rs4803770 rs4803770 
8 APOE4075rs7412 APOE4075rs7412 
9 rs439401 rs439401 
10 HR2p523 HR2p523 
11 APOC4p2640/rs5158 APOC4p2640/rs5158 
12 APOC1p720 APOC1p720 
13 rs7259004 rs7259004 
14 APOE832/rs405509 APOE832/rs405509 
15 APOC2p623C4p3927/rs5167 APOC2p623C4p3927/rs5167 
16 APOC1p5926/rs56131196 APOC1p5926/rs56131196 
17 APOE560/rs449647 APOE560r/s449647 
18 APOE1163/rs440446 APOE1163/rs440446 
19 HR2p188/rs35136575 HR2p188/rs35136575 
20 APOE2440/rs769450 APOE2440/rs769450 
21 APOC2p5004/rs10421404 APOC2p5004/rs10421404 
22 APOC1rs445925 APOC1rs445925 
Tagger results of the 27 shared genotyped markers in Blacks 
Bin Test Alleles Captured 
1 APOE1163/rs440446 APOE1163/rs440446, rs439401 
2 APOC2p4853rs199828513 APOC2p5398/rs12709889, APOC2p4853/rs199828513 
3 APOC2p5310/rs7258345 APOC2p5310/rs7258345 
4 APOC2p194C4p3498/rs1132899 APOC2p194C4p3498/rs1132899 
5 APOC1p5926/rs56131196 APOC1p5926/rs56131196 
6 APOC1p720 APOC1p720 
7 rs4803770 rs4803770 
8 APOE4075/rs7412 APOE4075/rs7412 
9 HR2p523 HR2p523 
10 APOC2p5004rs10421404 APOC2p5004rs10421404 
11 rs5112 rs5112 
12 APOE2440/rs769450 APOE2440/rs769450 
13 APOC2p623C4p3927/rs5167 APOC2p623C4p3927/rs5167 
14 APOE832/rs405509 APOE832/rs405509 
15 APOC1rs445925 APOC1rs445925 
16 HR2p188/rs35136575 HR2p188/rs35136575 
17 APOC4p2623/rs5157 APOC4p2623/rs5157 
18 APOE560/rs449647 APOE560/rs449647 
19 HR1p575/rs157599 HR1p575/rs157599 
20 APOC1p3423/rs389261 APOC1p3423/rs389261 
21 APOC4p2640/rs5158 APOC4p2640/rs5158 
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22 APOE3937/rs429358 APOE3937/rs429358 
23 rs7259004 rs7259004 
24 APOC2p3778/rs5120 APOC2p3778/rs5120 
25 APOC2p1357APOC4p4661/rs2288912 APOC2p1357APOC4p4661/rs2288912 
 
 
Figure 19. LD plot of the 27 genotyped shared markers in NHWs 
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3.6 ASSOCIATION RESULTS WITH LIPID TRAITS 
3.6.1 Single-locus association analysis 
Twenty variants in NHWs and twenty-four variants in Blacks with MAF>1% showed significant 
associations with at least one lipid trait.  
3.6.1.1  NHWs 
Table 20 presents the single-locus association results in NHWs, Table 21-23 summaries the 
lipid traits mean values distribution among the genotype groups, and Figure 21 showed LD plot 
of the 20 variants with significant associations. Twenty variants with MAF>1% showed 
significant associations with at least one lipid trait in NHWs. As expected, APOE2 
(APOE4075/rs7412) and APOE4 (APOE3937/rs429358) alleles showed significant associations 
with LDL-C (β=-21.84; P=1.84E-07, and β=8.10; P=0.0103), TC (β=-19.46; P=9.50E-06, 
β=6.82; P=0.0383), and apoB (β=-5.60; P=9.70E-13, and β=2.14; P=0.0005) with E2 allele 
having stronger effect than E4 allele. Ten additional SNPs showed significant associations with 
LDL-C: APOE560/rs449647 (β=-7.12; P=0.0247), APOE2440/rs769450 (β=4.89; P=0.0378), 
APOC1rs445925 (β=-12.58; P=0.0005), APOC1p4334/rs12721046 (β=6.93; P=0.0306), 
APOC1p5641/rs1064725 (β=11.99; P=0.0415), APOC1p5926/rs56131196 (β=7.24; P=0.0142), 
APOC1p6026/rs4420638 (β=6.97; P=0.0260), rs4803770 (β=5.52; P=0.0197), rs7259004 (β=-
9.78; P=0.0050), and APOC4p2683/rs12721109 (β=-19.14; P=0.0092).   APOC1rs445925 was in 
moderate LD with E2 allele (r2=0.68) and the other three variants, APOC1p4334/rs12721046 
(r2=0.52), APOC1p5926/rs56131196 (r2=0.73), and APOC1p6026/rs4420638 (r2=0.70) were in 
moderate LD with E4 allele. While APOC1p5926/rs56131196 was in strong LD with these two 
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variants; APOC1p4334/rs12721046 (r2=0.78), and APOC1p6026/rs4420638 (r2=0.98), the 
intergenic SNP rs4803770 was in moderate LD with APOE2440/rs769450 (r2=0.41). Only two 
SNPs showed significant associations with HDL-C; APOE1575rs769448 (β=0.08; P=0.0197), 
and HCR2p188/rs35136575 (β=0.03; P=0.0330) and they are not in LD with each other.  
In addition to the APOE2/E4 alleles, ten additional SNPs showed significant associations 
with TC; APOE560/rs449647 (β=-6.71; P=0.0428), APOE1998/rs769449 (β=8.31; P=0.0285), 
APOE2440/rs769450 (β=6.88; P=0.0051), APOC1rs445925 (β=-13.5; P=0.00032), 
APOC1p5641/rs1064725 (β=13.65; P=0.02631), APOC1p5926/rs56131196 (β=6.69; 
P=0.03046), APOC1p6026/rs4420638 (β=6.79; P=0.04018), rs4803770 (β=6.08; P=0.01385), 
rs5112 (β=-4.95; P=0.04462), and rs7259004 (β=-9.06; P=0.01342). Three variants 
APOE1998rs769449 (r2=0.72), APOC1p5926/rs56131196 (r2=0.73), and 
APOC1p6026/rs4420638 (r2=0.70) were in moderate LD with E4 allele, while APOC1rs445925 
was in moderate LD with E2 allele (r2=0.68). APOC1p5926/rs56131196 and 
APOC1p6026/rs4420638 were in complete LD (r2=0.98) and this SNP rs4803770 was in 
moderate LD with APOE2440/rs769450 (r2=0.41).   
Six variants showed significant associations with TG; APOE832/rs405509 (β=-0.07; 
P=0.0033), APOE1163/rs440446 (β=-0.08; P=0.0018), APOE2440/rs769450 (β=0.06; 
P=0.0082), rs439401 (β=-0.06; P=0.0194), APOC1p2041/rs3826688 (β=-0.08; P=0.0011), and 
APOC4p2683/rs12721109 (β=-0.16; P=0.0329). APOE832/rs405509 was in moderate LD with 
these two variants APOE1163/rs440446 (r2=0.60), and APOE2440/rs769450 (r2=0.61).  
rs439401 was in strong LD with APOC1p2041/rs3826688 (r2=0.98) and in moderate LD with 
APOE1163/rs440446 (r2=0.56).  
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Seven variants in addition to E2/E4 alleles showed significant associations with apoB; 
APOE832/rs405509 (β=1.46; P=0.0009), APOE1998/rs769449 (β=2.03; P=0.0030), 
APOC1rs445925 (β=-3.78; P=5.20E-08), APOC1p4334/rs12721046 (β=1.59; P=0.00983), 
APOC1p5926/rs56131196 (β=1.75; P=0.00229), APOC1p6026/rs4420638 (β=1.43; P=0.01775), 
and APOC4p2683/rs12721109 (β=-4.99; P=0.00057). The association of these two variants, 
APOE1998/rs769449 and APOC1rs445925, seem to be not independent because of their LD with 
E4/E2 alleles (r2=0.72; r2=0.68, respectively). Similarly the association of these three variants 
(APOC1p4334/rs12721046, APOC1p5926/rs56131196, and APOC1p6026/rs4420638) is more 
likely due to their moderate LD with E4 (r2= 0.52, 0.73, 0.70). Only two SNPs showed marginal 
significant association with apoA1; rs7259004 (β=6.89; P=0.0460), and HCR2p188/rs35136575 
(β=5.16; P=0.0496) and none of them was in LD with each other.   
We observed thirteen variants in addition to the E2/E4 alleles have multiple associations 
with lipid traits implying their pleiotrophic effects. Three variants, APOC1rs445925, 
APOC1p5926/rs56131196, and APOC1p6026/rs4420638, had significant associations with 3 
LDL-related traits (LDL-C, TC, and ApoB) more likely due to their moderate LD with E2/E4 
alleles. Eight other variants showed significant associations with 2 LDL-related traits, 
APOE560/rs449647, APOC1p5641/rs1064725, rs4803770, APOE1998/rs769449, 
APOC1p4334/rs12721046, APOC4p2683/rs12721109, APOE2440/rs769450, and rs7259004. 
The last variant showed significant association with apoA1 in addition to its association with 2 
LDL-related traits.   APOC4p2683/rs12721109 and APOE2440/rs769450 variants showed 
significant association with TG in addition to their effect on 2 LDL-related traits.  
APOE832/rs405509 had significant associations with TG and apoB, while 
HCR2p188/rs35136575 had significant associations with HDL-C, and apoA1. The remaining 
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five variants showed evidence of association with a single lipid trait; APOE1575/rs769448 
showed significant association only with HDL-C, while the other three variants; 
APOE1163/rs440446, rs439401, and APOC1p2041/rs3826688 showed significant association 
only with TG, and rs5112 showed significant association only with TC. 
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Table 20. Single-locus association results with lipid traits in NHWs 
Variant LDL-C HDL-Ca TC TGa ApoBa ApoA1 
Nucleotide position Function RegulomeDB score MAF Beta p_value Beta 
p_valu
e Beta p_value Beta p_value Beta p_value Beta p_value 
APOE560/rs449647 5'flanking  5 0.161 -7.12 0.0247 -0.01 0.3526 -6.71 0.0428 -0.02 0.5229 -0.95 0.129 -1.57 0.6175 
APOE832/rs405509 5'flanking  1f 0.4775 0.42 0.8542 0.01 0.4031 -0.68 0.7757 -0.07 0.0033 1.46 0.0009 -1.80 0.4173 
APOE1163/rs440446 intron1 4 0.3604 -2.59 0.281 0.01 0.2865 -4.26 0.0893 -0.08 0.0018 0.56 0.2319 -0.19 0.9349 
APOE1575/rs769448 intron1 4 0.021 0.75 0.9232 0.08 0.0197 1.88 0.8165 -0.09 0.2323 0.94 0.5204 3.44 0.6394 
APOE1998/rs769449 intron 2 4 0.1165 6.95 0.0551 -0.01 0.58 8.31 0.0285 0.01 0.6867 2.03 0.003 -4.38 0.2048 
APOE2440/rs769450 intron 2 5 0.4015 4.89 0.0378 0.003 0.7725 6.88 0.0051 0.06 0.0082 0.15 0.7422 0.70 0.7656 
APOE2907/rs769451 intron 2 5 0.0112 0.45 0.9668 0.05 0.339 -1.93 0.8649 -0.05 0.6157 -0.22 0.9196 3.70 0.7379 
APOE3038/rs111833428 exon 3 5 0.0016 27.34 0.3354 0.10 0.4366 33.80 0.2567 0.16 0.5766 13.81 0.0342 3.29 0.9205 
APOE3106/rs769452 exon 3 5 0.0008 18.03 0.6522 0.20 0.2787 21.30 0.611 -0.22 0.5865 9.15 0.1602 29.79 0.3649 
APOE3937/rs429358 exon 4 5 0.1525 8.10 0.0103 -0.02 0.2233 6.82 0.0383 0.01 0.7069 2.14 0.0005 -3.66 0.2399 
APOE4075/rs7412 exon 4 5 0.0806 -21.84 1.84E-07 -0.01 0.4524 -19.46 9.50E-06 0.01 0.7438 -5.60 9.70E-13 5.12 0.2081 
APOE4310/rs199768005 exon 4 5 0.004 -32.56 0.0705 0.01 0.8927 -46.88 0.01279 -0.40 0.026 1.05 0.822 -35.74 0.1245 
APOE4528 3' UTR 5 0.0008 -12.30 0.7585 0.24 0.1926 36.03 0.38978 0.92 0.0232 *** *** *** *** 
APOE4737/rs117656888 3'flanking 5 0.0081 13.58 0.2867 0.12 0.0487 23.15 0.08353 0.09 0.5084 1.60 0.5203 -5.55 0.6576 
APOE5361/rs1081106 3'flanking 3a 0.0852 4.00 0.3272 0.03 0.0915 4.62 0.27914 -0.01 0.8928 0.12 0.8813 3.30 0.4318 
rs439401 intergenic region 1b 0.3596 -1.76 0.4521 0.01 0.5449 -2.82 0.24856 -0.06 0.0194 0.39 0.3975 0.91 0.6915 
rs445925 intergenic region No Data 0.1094 -12.58 0.0005 -0.02 0.2723 -13.53 0.00032 0.01 0.8251 -3.78 5.20E-08 3.53 0.3231 
APOC1p698/rs72654449 5'flanking  4 0.004 -14.29 0.4275 -0.02 0.7892 -23.70 0.20878 -0.17 0.3425 -2.77 0.55052 -4.70 0.8413 
APOC1p703/rs3207187 5'flanking  4 0.0008 12.09 0.7629 *** *** 52.40 0.21236 -0.07 0.8607 -0.88 0.89283 102.96 0.0016 
APOC1p720/rs72654451 5'flanking  4 0.2299 -3.67 0.1768 -0.02 0.086 -4.42 0.12017 0.01 0.7351 -0.82 0.11683 -0.46 0.8612 
APOC1p1170 intron1 2b 0.0008 -41.75 0.2956 0.40 0.0333 -29.40 0.48393 -0.61 0.1281 7.14 0.27763 18.30 0.5723 
APOC1p1294 intron2 4 0.0008 -6.76 0.866 0.27 0.1533 13.45 0.74854 -0.10 0.8036 3.07 0.63865 27.03 0.4118 
APOC1p1317/rs12721048 intron2 4 0.0016 13.48 0.6321 0.32 0.0162 34.50 0.24424 -0.01 0.9701 11.18 0.01598 66.89 0.0042 
APOC1p1422 intron2 4 0.0016 -51.98 0.0657 0.18 0.183 -53.33 0.07215 -0.49 0.0838 1.88 0.77425 -26.52 0.4203 
APOC1p1566/rs12691088 intron2 2b 0.0058 3.19 0.835 -0.07 0.3064 -2.77 0.86244 -0.08 0.6183 -4.95 0.12948 -27.45 0.0915 
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APOC1p2041/rs3826688 intron2 5 0.3424 -2.38 0.3246 0.01 0.3985 -3.60 0.15405 -0.08 0.0011 0.30 0.51703 0.24 0.9176 
APOC1p2629 exon3 4 0.0008 -47.60 0.2349 0.30 0.1117 -24.89 0.55247 -0.02 0.9634 -5.12 0.43402 2.54 0.9383 
APOC1p2817 intron3 2b 0.0033 -5.57 0.7794 0.13 0.2246 8.17 0.69433 0.04 0.8334 -4.46 0.23676 21.20 0.27 
APOC1p3423/rs389261 intron3 No Data 0.0025 -18.83 0.4163 -0.18 0.0994 -32.02 0.18592 -0.02 0.9169 -3.50 0.35153 -21.68 0.2583 
APOC1p3494 intron3 No Data 0.0016 73.63 0.0092 0.26 0.0478 103.78 0.00044 0.40 0.1643 5.38 0.41256 -1.39 0.9662 
APOC1p4334/rs12721046 intron3 6 0.1522 6.93 0.0306 -0.0001 0.9967 5.95 0.07734 0.02 0.4787 1.59 0.00983 -2.11 0.4956 
APOC1p5641/rs1064725 3'UTR No Data 0.0388 11.99 0.0415 0.03 0.3253 13.65 0.02631 -0.05 0.4064 2.00 0.09267 -4.32 0.4728 
APOC1p5773 3'flanking  No Data 0.0008 -11.49 0.7742 0.24 0.1956 37.56 0.36991 0.93 0.0211 *** *** *** *** 
APOC1p5926/rs56131196 3'flanking  No Data 0.1885 7.24 0.0142 -0.01 0.6146 6.69 0.03046 0.01 0.7677 1.75 0.00229 -2.59 0.3695 
APOC1p6026/rs4420638 3'flanking  No Data 0.1556 6.97 0.026 -0.01 0.57 6.79 0.04018 0.03 0.3924 1.43 0.01775 -1.10 0.716 
rs4803770 HCR1 5 0.3779 5.52 0.0197 0.003 0.7653 6.08 0.01385 0.04 0.0801 0.56 0.21851 0.02 0.9937 
HCR1p292/rs4803771 HCR1 4 0.0245 3.86 0.596 -0.02 0.5402 1.40 0.85412 0.02 0.8188 0.68 0.64404 -5.81 0.4273 
HCR1p362 HCR1 2a 0.0025 -14.29 0.5362 0.001 0.9915 -3.80 0.87495 0.30 0.203 2.07 0.75319 -3.48 0.9159 
HCR1p423 HCR1 4 0.0258 -6.26 0.3686 0.06 0.091 -7.84 0.28132 -0.12 0.08 2.10 0.14804 11.09 0.1293 
HCR1p575/rs157599 HCR1 3a 0.0024 -19.28 0.4063 -0.18 0.0996 -32.24 0.18436 -0.02 0.926 -3.48 0.35815 -21.80 0.2531 
HCR1p727/rs149345 HCR1 3a 0.0024 -19.80 0.3919 -0.18 0.1015 -33.23 0.16946 -0.03 0.9053 -3.47 0.35832 -21.70 0.2544 
rs5112 APOC1P1 4 0.4633 -4.61 0.0515 -0.01 0.6533 -4.95 0.04462 -0.02 0.3217 -0.15 0.75492 -0.67 0.7769 
rs7259004 APOC1P1 6 0.1176 -9.78 0.005 0.01 0.7115 -9.06 0.01342 0.05 0.2103 -1.33 0.05153 6.89 0.046 
HCR2p188/rs35136575 HCR2 2a 0.2274 -3.15 0.2324 0.03 0.033 -2.25 0.41394 -0.03 0.283 -0.48 0.36635 5.16 0.0496 
HCR2p365 HCR2 2b 0.0041 2.62 0.8844 -0.02 0.8182 -6.50 0.72951 -0.20 0.266 3.05 0.41812 10.58 0.581 
HCR2p523 HCR2 2b 0.0226 3.50 0.6577 -0.03 0.3751 8.10 0.3266 0.02 0.7664 1.04 0.47773 3.82 0.6061 
APOC4p636 5’ flanking  No Data 0.0008 54.33 0.1769 -0.36 0.0564 63.55 0.13031 0.73 0.0732 *** *** *** *** 
APOC4p968/rs76214972 5’ UTR 4 0.0362 -1.85 0.7658 -0.03 0.3434 -5.60 0.38784 0.02 0.8085 1.25 0.29092 2.03 0.733 
APOC4p1150/rs148247675  Intron1 5 0.0017 73.90 0.009 0.26 0.0474 103.80 0.00043 0.39 0.1698 5.53 0.3975 -1.61 0.9608 
APOC4p1229 Intron1 2b 0.0016 18.29 0.5205 -0.36 0.0073 16.99 0.57007 0.68 0.0186 *** *** *** *** 
APOC4p2557 Intron1 4 0.0008 -35.35 0.3781 -0.27 0.1454 -57.38 0.17273 0.12 0.7681 -5.26 0.42411 -14.77 0.6541 
APOC4p2623/rs5157 Intron1 4 0.4976 -1.55 0.4962 -0.01 0.4816 -0.35 0.88515 0.02 0.3751 -0.30 0.49795 0.34 0.8797 
APOC4p2640/rs5158 Intron1 2b 0.1381 -1.55 0.6408 0.02 0.1402 -1.79 0.60759 -0.04 0.2219 0.35 0.59389 -1.45 0.662 
APOC4p2683/rs12721109 Intron1 2b 0.0237 -19.14 0.0092 0.03 0.3859 -12.75 0.09785 -0.16 0.0329 -4.99 0.00057 -9.31 0.1964 
APOC4p2703/rs12721108 Intron1 2a 0.0081 1.93 0.8798 -0.04 0.5344 -9.51 0.47603 -0.15 0.2384 -1.23 0.59732 -9.00 0.4435 
APOC2p194-
C4p3498/rs1132899 C4-exon2  5 0.4863 -1.91 0.4071 -0.01 0.4295 -0.62 0.79728 0.02 0.3465 -0.12 0.79089 1.35 0.5467 
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APOC2p242-
C4p3546/rs12691089 C4-exon2  5 0.0032 2.18 0.9136 -0.01 0.9111 -5.18 0.80551 -0.16 0.4444 -1.80 0.69724 0.65 0.9778 
APOC2p543-
C4p3847/rs186448850 C4-intron2 5 0.0016 18.71 0.5103 -0.36 0.0074 17.51 0.55783 0.68 0.0171 *** *** *** *** 
APOC2p623-C4p3927/rs5167 C4-exon3  5 0.3596 4.19 0.0824 -0.001 0.9252 2.94 0.24431 -0.004 0.8759 0.11 0.81626 -1.01 0.6722 
APOC2p1357-
C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.4968 0.74 0.745 0.01 0.5896 -0.65 0.78596 -0.02 0.3813 0.19 0.66177 0.03 0.988 
APOC2p1591-C4p4895 C2-intron1 4 0.0008 54.17 0.1764 -0.36 0.0511 62.97 0.13292 0.73 0.0712 *** *** *** *** 
APOC2p1851/rs12709886 intron1 6 0.0372 -1.31 0.8311 -0.02 0.4118 -4.49 0.48475 0.03 0.5845 1.35 0.2357 5.83 0.3078 
APOC2p2870 intron1 4 0.004 53.09 0.003 0.03 0.7577 58.43 0.00179 0.12 0.5116 6.33 0.05291 -36.20 0.0279 
APOC2p3348/rs10420434 intron1 No Data 0.0371 -6.86 0.264 0.05 0.1052 -2.44 0.70432 -0.09 0.1736 -1.24 0.3101 6.94 0.2529 
APOC2p3778/rs5120 intron1 4 0.4976 1.24 0.5845 0.01 0.5135 -1.32 0.57843 -0.02 0.2809 0.14 0.74796 0.29 0.8954 
APOC2p4853/rs199828513 3'flamking  No Data 0.2783 4.36 0.0943 -0.01 0.3208 2.44 0.37077 0.01 0.6741 0.21 0.6757 -2.81 0.2692 
APOC2p5004/rs10421404 3'flanking  No Data 0.1823 -2.35 0.418 0.02 0.2558 -3.09 0.30928 -0.03 0.3591 0.26 0.63942 1.64 0.5604 
APOC2p5310/rs7258345 3'flanking  No Data 0.4649 1.99 0.3817 -0.002 0.8455 -0.13 0.95612 -0.01 0.8191 0.36 0.41406 -1.16 0.6041 
APOC2p5398/rs12709889 3'flanking  6 0.276 3.95 0.1322 -0.01 0.274 1.98 0.47012 0.01 0.5974 0.06 0.91243 -3.11 0.233 
APOC2p5644 3'flanking  6 0.0092 20.49 0.0948 0.01 0.8947 14.86 0.24546 -0.10 0.4103 1.74 0.42698 7.67 0.4929 
Yellow-highlighted values represent significant p-values; (*) unavailable results because of missing phenotype data for subjects carry the rare allele, Nucleotide position is according to the 
reference sequence (Accession # AF261279.1); Ch. Position: chromosomal position is according to NCBI build 138; MAF: minor allele frequency; LDL-C: low-density lipoprotein cholesterol; 
HDL-C: high-density lipoprotein cholesterol; TC: total cholesterol; TG: triglyceride; ApoB: apolipoprotein B; ApoA1: apolipoprotein A1; a Cox-Box transformed variables; Age, Gender, 








Table 21. Genotype-specific means (± SD) of LDL-C and HDL-C for genotyped SNPs in NHWs  
 LDL-C HDL-Ca 
Variant name Function RegulomeDB score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 
APOE560/rs449647 5'flanking 5 0.161 AA/AT/TT 433/176/12 139.19/132.29/124.15 38.8/45.3/36.3 -7.12 0.0247 50.95/49.6/50.65 14.4/13.4/11.0 -0.01 0.3526 
APOE832/rs405509 5'flanking 1f 0.4775 GG/GT/TT 170/310/142 135.68/138.13/136.32 40.3/42.7/37.3 0.42 0.8542 50.07/50.56/51.17 13.9/14.0/14.2 0.01 0.4031 
APOE1163/rs440446 intron1 4 0.3604 CC/GC/GG 76/297/250 130.59/137.86/137.91 37.8/40.7/41.7 -2.59 0.281 51.8/50.73/50.04 13.8/14.3/13.7 0.01 0.2865 
APOE1575/rs769448 intron1 4 0.021 CC/CT/TT 595/24/1 136.96/137.36/142.42 41.3/29.6/NA 0.75 0.9232 50.27/55.4/70.05 13.8/17.1/NA 0.08 0.0197 
APOE1998/rs769449 intron 2 4 0.1165 AA/AG/GG 6/132/480 160.24/141.21/135.47 19.9/41.4/40.7 6.95 0.0551 48.13/50.11/50.79 9.6/14.0/14.1 -0.01 0.58 
APOE2440/rs769450 intron 2 5 0.4015 AA/GA/GG 95/307/217 144.97/136.5/133.97 40.1/40.9/40.9 4.89 0.0378 50.42/50.88/50.12 15.4/13.5/14.2 0.003 0.7725 
APOE2907/rs769451 intron 2 5 0.0112 GT/TT 14/609 137.43/136.98 36.6/40.9 0.45 0.9668 52.84/50.53 11.4/14.1 0.05 0.339 
APOE3038/rs111833428 exon 3 5 0.0016 AG/GG 2/616 164.05/136.78 57.3/40.9 27.34 0.3354 55.59/50.51 4.2/14.1 0.10 0.4366 
APOE3106/rs769452 exon 3 5 0.0008 TC/TT 1/620 154.92/136.93 NA/40.9 18.03 0.6522 61.96/50.57 NA/14.1 0.20 0.2787 
APOE3937/rs429358 exon 4 5 0.1525 CC/CT/TT 14/159/440 153.24/142.39/134.84 23.3/39.4/41.2 8.10 0.0103 47.93/49.89/51.01 12.7/14.1/14.1 -0.02 0.2233 
APOE4075/rs7412 exon 4 5 0.0806 CC/TC/TT 523/94/3 140.26/120.22/73.75 39.2/44.6/37.0 -21.84 1.84E-07 50.76/49.16/54.02 14.3/12.6/16.1 -0.01 0.4524 
APOE4310/rs199768005 exon 4 5 0.004 TA/TT 5/617 105/137.26 35.7/40.8 -32.56 0.0705 50.32/50.54 10.5/14.0 0.01 0.8927 
APOE4528 3' UTR 5 0.0008 CC/CT 622/1 137.01/124.75 40.8/NA -12.30 0.7585 50.56/64.69 14.0/NA 0.24 0.1926 
APOE4737/rs117656888 3'flanking 5 0.0081 CC/GC 610/10 136.68/150.24 40.7/52.3 13.58 0.2867 50.4/58.73 13.9/20.1 0.12 0.0487 
APOE5361/rs1081106 3'flanking 3a 0.0852 CC/TC/TT 4/98/520 163.88/138.72/136.47 28.8/37.4/41.5 4.00 0.3272 54.27/52.26/50.19 17.2/14.3/13.9 0.03 0.0915 
rs439401 intergenic region 1b 0.3596 CC/CT/TT 255/270/84 136.61/139.86/129.57 39.4/42.1/39.8 -1.76 0.4521 50.14/50.35/51.41 13.6/14.6/13.6 0.01 0.5449 
APOC1rs445925 intergenic region No Data 0.1094 AA/GA/GG 7/121/489 100.87/129/139.75 55.8/41.5/39.6 -12.58 0.0005 46.15/49.94/50.91 15.2/13.2/14.2 -0.02 0.2723 
APOC1p698/rs72654449 5'flanking 4 0.004 CA/CC 5/613 122.75/136.92 21.6/40.9 -14.29 0.4275 48.45/50.65 12.8/14.1 -0.02 0.7892 
APOC1p703/rs3207187 5'flanking 4 0.0008 CC/CT 619/1 136.94/148.98 40.9/NA 12.09 0.7629 *** *** *** *** 
APOC1p720/rs72654451 5'flanking 4 0.2299 II/WI/WW 31/224/367 140.13/132.63/139.44 45.0/41.0/40.3 -3.67 0.1768 47.92/49.79/51.31 12.8/13.4/14.5 -0.02 0.086 
APOC1p1170 intron1 2b 0.0008 GA/GG 1/609 94.93/136.57 NA/40.7 -41.75 0.2956 77.93/50.64 NA/14.1 0.40 0.0333 
APOC1p1294 intron2 4 0.0008 AA/AC 618/1 136.83/130.1 40.8/NA -6.76 0.866 50.57/71.84 14.0/NA 0.27 0.1533 
APOC1p1317/rs12721048 intron2 4 0.0016 GA/GG 2/607 150.98/137.55 38.8/40.6 13.48 0.6321 74.31/50.58 11.3/14.0 0.32 0.0162 
APOC1p1422 intron2 4 0.0016 GA/GG 2/621 85.21/137.16 14.7/40.8 -51.98 0.0657 61.07/50.55 7.1/14.0 0.18 0.183 
APOC1p1566/rs12691088 intron2 2b 0.0058 GA/GG 7/598 139.78/136.62 31.2/41.0 3.19 0.835 48.07/50.63 21.0/14.0 -0.07 0.3064 
APOC1p2041/rs3826688 intron2 5 0.3424 AA/GA/GG 73/269/264 127.94/139.99/137.23 39.9/42.4/39.8 -2.38 0.3246 52.15/50.6/50.26 14.5/14.4/13.7 0.01 0.3985 
APOC1p2629 exon3 4 0.0008 GA/GG 1/618 89.64/137.14 NA/40.8 -47.60 0.2349 74.09/50.6 NA/14.0 0.30 0.1117 
APOC1p2817 intron3 2b 0.0033 CC/CT 603/4 136.39/130.83 40.5/22.8 -5.57 0.7794 50.49/57.95 14.0/13.0 0.13 0.2246 
APOC1p3423/rs389261 intron3 No Data 0.0025 GA/GG 3/605 118.03/136.72 3.2/40.8 -18.83 0.4163 41.42/50.59 5/14.0 -0.18 0.0994 
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APOC1p3494 intron3 No Data 0.0016 CC/CT 619/2 136.81/210.37 40.5/98.3 73.63 0.0092 50.54/72.29 13.9/38.2 0.26 0.0478 
APOC1p4334/rs12721046 intron3 6 0.1522 AA/GA/GG 13/160/438 156.43/140.12/134.82 30.1/41.8/40.3 6.93 0.0306 45.6/51.2/50.56 8.1/14.5/14.1 -0.0001 0.9967 
APOC1p5641/rs1064725 3'UTR No Data 0.0388 GG/GT/TT 1/46/571 182.23/147.16/136.24 NA/49.0/40.1 11.99 0.0415 53.95/51.58/50.49 NA/12.4/14.2 0.03 0.3253 
APOC1p5773 3'flanking No Data 0.0008 GA/GG 1/604 125.4/136.86 NA/40.9 -11.49 0.7742 64.58/50.52 NA/14.1 0.24 0.1956 
APOC1p5926/rs56131196 3'flanking No Data 0.1885 AA/GA/GG 19/195/404 154.08/140.17/134.32 29.1/42.7/40.0 7.24 0.0142 47.37/50.67/50.75 11.2/14.1/14.2 -0.01 0.6146 
APOC1p6026/rs4420638 3'flanking No Data 0.1556 AA/GA/GG 405/129/22 134.61/137.65/157.81 40.1/42.6/35.1 6.97 0.026 50.73/51.06/47.64 14.1/15.4/11.2 -0.01 0.57 
rs4803770 HCR1 5 0.3779 CC/GC/GG 229/281/84 132.08/139.47/141.86 43.1/39.1/35.6 5.52 0.0197 49.8/51.14/49.72 13.5/13.7/14.6 0.003 0.7653 
HCR1p292/rs4803771 HCR1 4 0.0245 CC/CG/GG 583/28/1 136.96/140.3/151.37 41.2/38.5/NA 3.86 0.596 50.51/50.04/33.57 14.1/13.4/NA -0.02 0.5402 
HCR1p362 HCR1 2a 0.0025 CA/CC 3/605 122.75/136.98 35.9/40.9 -14.29 0.5362 54.67/50.49 32.5/14.0 0.001 0.9915 
HCR1p423 HCR1 4 0.0258 CC/CG/GG 589/30/1 137.58/131.7/119.83 40.9/32.7/NA -6.26 0.3686 50.48/53.78/54.15 14.0/13.5/NA 0.06 0.091 
HCR1p575/rs157599 HCR1 3a 0.0024 AA/AG 618/3 137.14/118.01 40.9/3.2 -19.28 0.4063 50.65/41.6 14.0/5.0 -0.18 0.0996 
HCR1p727/rs149345 HCR1 3a 0.0024 TG/TT 3/611 117.41/137.05 3.2/40.8 -19.80 0.3919 41.69/50.72 5.0/14.1 -0.18 0.1015 
rs5112 APOC1P1 4 0.4633 CC/GC/GG 123/284/165 128.41/138.56/138.35 39.4/42.5/38.1 -4.61 0.0515 50.33/50.31/50.79 14.1/14.2/14.3 -0.01 0.6533 
rs7259004 APOC1P1 6 0.1176 CC/CG/GG 476/128/8 139.62/127.55/136.46 41.0/34.0/48.6 -9.78 0.005 50.51/50.11/56.11 14.2/13.9/12.8 0.01 0.7115 
HCR2p188/rs35136575 HCR2 2a 0.2274 CC/GC/GG 369/203/37 138.79/134.82/134.1 41.5/39.4/37.3 -3.15 0.2324 49.76/51.64/51.86 14.2/13.9/12.8 0.03 0.033 
HCR2p365 HCR2 2b 0.0041 CA/CC 5/606 139.15/136.56 47.3/40.7 2.62 0.8844 49.01/50.56 12.6/14.0 -0.02 0.8182 
HCR2p523 HCR2 2b 0.0226 CC/CT 571/27 136.48/139.97 40.6/47.5 3.50 0.6577 50.56/47.97 14.2/11.1 -0.03 0.3751 
APOC4p636 5’ flanking No Data 0.0008 CC/CT 601/1 137.18/191.27 40.9/NA 54.33 0.1769 50.49/31.26 14.1/NA -0.36 0.0564 
APOC4p968/rs76214972 5’ UTR 4 0.0362 AA/AG 576/45 137.18/135.34 40.8/42.0 -1.85 0.7658 50.73/49.07 14.1/13.8 -0.03 0.3434 
APOC4p1150/rs148247675 Intron1 5 0.0017 AA/GA 601/2 136.38/210.21 40.5/98.3 73.90 0.009 50.43/72.29 13.8/38.2 0.26 0.0474 
APOC4p1229 Intron1 2b 0.0016 GC/GG 2/619 155.09/136.99 49.6/40.8 18.29 0.5205 34.08/50.66 5.7/14.0 -0.36 0.0073 
APOC4p2557 Intron1 4 0.0008 CA/CC 1/619 101.86/137 NA/40.8 -35.35 0.3781 34.71/50.63 NA/14.1 -0.27 0.1454 
APOC4p2623/rs5157 Intron1 4 0.4976 CC/CT/TT 155/315/152 138/137.55/134.89 40.3/40.2/42.9 -1.55 0.4962 51.28/50.4/50.19 14.4/14.1/13.5 -0.01 0.4816 
APOC4p2640/rs5158 Intron1 2b 0.1381 CC/CT/TT 459/149/11 137.39/135.98/133.59 40.1/43.6/35.3 -1.55 0.6408 50.38/50.84/59.86 13.9/14.4/15.2 0.02 0.1402 
APOC4p2683/rs12721109 Intron1 2b 0.0237 AA/AG/GG 1/27/584 120.81/117.3/137.95 NA/48.3/40.4 -19.14 0.0092 68.58/51.11/50.6 NA/12.2/14.1 0.03 0.3859 
APOC4p2703/rs12721108 Intron1 2a 0.0081 GG/GT 609/10 136.91/138.84 41.0/27.6 1.93 0.8798 50.69/47.23 14.1/8.4 -0.04 0.5344 
APOC2p194-C4p3498/rs1132899 C4-exon2 5 0.4863 CC/CT/TT 160/317/143 139.55/136.4/135.81 40.7/39.8/43.2 -1.91 0.4071 51.44/50.19/50.27 14.5/14.1/13.5 -0.01 0.4295 
APOC2p242-C4p3546/rs12691089 C4-exon2 5 0.0032 AG/GG 4/617 139.21/137.04 25.8/40.9 2.18 0.9136 50.34/50.61 13.8/14.1 -0.01 0.9111 
APOC2p543-C4p3847/rs186448850 C4-intron2 5 0.0016 CT/TT 2/609 155.44/136.92 49.6/40.9 18.71 0.5103 33.96/50.54 5.7/14.0 -0.36 0.0074 
APOC2p623-C4p3927/rs5167 C4-exon3 5 0.3596 GG/TG/TT 74/300/249 141.08/138.79/133.61 36.0/40.9/42.0 4.19 0.0824 51.38/50.12/50.9 14.9/13.7/14.3 -0.001 0.9252 
APOC2p1357-C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.4968 CC/CG/GG 155/316/151 136.3/136.98/137.79 42.8/40.0/40.7 0.74 0.745 50.37/50.37/51.28 13.3/14.3/14.3 0.01 0.5896 
APOC2p1591-C4p4895 C2-intron1 4 0.0008 GA/GG 1/620 190.9/136.96 NA/40.8 54.17 0.1764 31.06/50.64 NA/14.0 -0.36 0.0511 
 98 
Cont. Table 21 
APOC2p1851/rs12709886 intron1 6 0.0372 GA/GG 46/572 135.89/137.2 42.0/40.7 -1.31 0.8311 49.18/50.69 13.4/14.1 -0.02 0.4118 
APOC2p2870 intron1 4 0.004 GG/GT 616/5 136.62/189.62 40.4/62.6 53.09 0.003 50.58/53.91 14.0/25.2 0.03 0.7577 
APOC2p3348/rs10420434 intron1 No Data 0.0371 GA/GG 46/574 130.8/137.63 41.0/40.8 -6.86 0.264 53.83/50.33 16.3/13.8 0.05 0.1052 
APOC2p3778/rs5120 intron1 4 0.4976 AA/AT/TT 154/305/157 137.73/137.42/135.27 40.2/39.6/43.9 1.24 0.5845 51.27/50.52/50.26 14.4/14.3/13.5 0.01 0.5135 
APOC2p4853/rs199828513 3'flamking No Data 0.2783 DD/WD/WW 316/260/42 134.46/139.37/142.11 41.1/41.3/36.1 4.36 0.0943 51.01/49.98/50.19 14.1/13.7/15.7 -0.01 0.3208 
APOC2p5004/rs10421404 3'flanking No Data 0.1823 CC/CT/TT 416/177/24 138.15/133.69/139.56 40.6/42.0/34.1 -2.35 0.418 50.38/50.53/54.51 14.1/14.1/13.7 0.02 0.2558 
APOC2p5310/rs7258345 3'flanking No Data 0.4649 GG/TG/TT 133/303/176 138.69/138.01/134.9 41.0/38.7/43.4 1.99 0.3817 50.87/50.35/51.03 14.3/13.9/14.2 -0.002 0.8455 
APOC2p5398/rs12709889 3'flanking 6 0.276 AA/GA/GG 41/252/312 141.78/138.36/134.24 36.6/40.9/41.1 3.95 0.1322 50.64/49.73/51.18 15.9/13.4/14.3 -0.01 0.274 
APOC2p5644 3'flanking 6 0.0092 AG/GG 11/585 156.45/136.18 41.7/40.8 20.49 0.0948 50.04/50.43 10.7./14.2 0.01 0.8947 
a Cox-Box transformed variables. 
MAF: minor allele frequency. 
LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol. 
Age, Gender, Smoking, and BMI are significant covariates that were included in the final model. 










Table 22. Genotype-specific means (± SD) of TC and TG for genotyped SNPs in NHWs 
 TC TGa 
Variant name Function RegulomeDB score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 
APOE560/rs449647 5'flanking 5 0.161 AA/AT/TT 433/176/12 218.99/212.89/202.5 42.5/45.1/46.4 -6.71 0.0428 139.61/134.35/133.8 68.2/59.3/67.0 -0.02 0.5229 
APOE832/rs405509 5'flanking 1f 0.4775 GG/GT/TT 170/310/142 216.51/218.33/214.93 42.7/46.0/39.1 -0.68 0.7757 148.79/135.95/129.7 71.4/63.4/62.4 -0.07 0.0033 
APOE1163/rs440446 intron1 4 0.3604 CC/GC/GG 76/297/250 209.86/216.67/219.53 38.1/43.8/44.7 -4.26 0.0893 123.14/135.63/145.12 56.1/65.4/67.8 -0.08 0.0018 
APOE1575/rs769448 intron1 4 0.021 CC/CT/TT 595/24/1 216.84/218.67/220.93 43.8/37.5/NA 1.88 0.8165 138.4/130.89/34.9 66.3/48.8/NA -0.09 0.2323 
APOE1998/rs769449 intron 2 4 0.1165 AA/AG/GG 6/132/480 242.18/222.31/215.21 25.3/44.7/43.2 8.31 0.0285 179.59/135.92/138 80.3/63.7/66.0 0.01 0.6867 
APOE2440/rs769450 intron 2 5 0.4015 AA/GA/GG 95/307/217 226.44/217.25/211.92 42.8/44.6/41.8 6.88 0.0051 148.93/137.7/132.05 67.2/64.5/65.2 0.06 0.0082 
APOE2907/rs769451 intron 2 5 0.0112 GT/TT 14/609 215.12/217.03 41.9/43.6 -1.93 0.8649 124.87/138.24 48.8/66.1 -0.05 0.6157 
APOE3038/rs111833428 exon 3 5 0.0016 AG/GG 2/616 250.2/216.77 63.6/43.6 33.80 0.2567 146.64/138.14 10.6/66.0 0.16 0.5766 
APOE3106/rs769452 exon 3 5 0.0008 TC/TT 1/620 238.11/216.93 NA/43.6 21.30 0.611 101.15/137.96 NA/65.7 -0.22 0.5865 
APOE3937/rs429358 exon 4 5 0.1525 CC/CT/TT 14/159/440 229.3/221.27/214.71 26.6/42.9/43.3 6.82 0.0383 142.88/138.64/137.37 74.6/64.4/65.4 0.01 0.7069 
APOE4075/rs7412 exon 4 5 0.0806 CC/TC/TT 523/94/3 219.92/201.81/164.37 42.4/46.8/29.1 -19.46 9.50E-06 137.8/138.76/179.42 65.0/70.1/93.6 0.01 0.7438 
APOE4310/rs199768005 exon 4 5 0.004 TA/TT 5/617 171.03/217.35 42.6/43.5 -46.88 0.01279 78.12/138.52 20.5/65.9 -0.40 0.026 
APOE4528 3' UTR 5 0.0008 CC/CT 622/1 216.93/252.76 43.6/NA 36.03 0.38978 137.65/311.89 65.5/NA 0.92 0.0232 
APOE4737/rs117656888 3'flanking 5 0.0081 CC/GC 610/10 216.53/239.47 42.8/79.1 23.15 0.08353 137.88/153.84 65.6/79.0 0.09 0.5084 
APOE5361/rs1081106 3'flanking 3a 0.0852 CC/TC/TT 4/98/520 255.84/218.31/216.42 31.7/42.3/43.8 4.62 0.27914 186.18/134.11/138.33 76.3/65.6/65.7 -0.01 0.8928 
rs439401 intergenic region 1b 0.3596 CC/CT/TT 255/270/84 217.84/218.43/209.8 43.5/45.4/37.5 -2.82 0.24856 143.91/135.33/129.53 66.6/65.0/63.0 -0.06 0.0194 
APOC1rs445925 intergenic region No Data 0.1094 AA/GA/GG 7/121/489 178.72/207.77/219.45 53.0/42.1/42.6 -13.53 0.00032 150.57/139.2/137.03 62.1/73.1/63.7 0.01 0.8251 
APOC1p698/rs72654449 5'flanking 4 0.004 CA/CC 5/613 193.51/217 24.7/43.7 -23.70 0.20878 109.41/137.85 29.6/65.9 -0.17 0.3425 
APOC1p703/rs3207187 5'flanking 4 0.0008 CC/CT 619/1 216.89/268.82 43.5/NA 52.40 0.21236 138.15/118.38 65.9/NA -0.07 0.8607 
APOC1p720/rs72654451 5'flanking 4 0.2299 II/WI/WW 31/224/367 216.21/213.01/219.56 44.3/44.1/43.1 -4.42 0.12017 142.81/138.71/137.05 61.0/70.8/63.1 0.01 0.7351 
APOC1p1170 intron1 2b 0.0008 GA/GG 1/609 187.55/216.79 NA/43.5 -29.40 0.48393 70.3/138.55 NA/66.1 -0.61 0.1281 
APOC1p1294 intron2 4 0.0008 AA/AC 618/1 216.82/230.18 43.5/NA 13.45 0.74854 137.94/119.94 65.9/NA -0.10 0.8036 
APOC1p1317/rs12721048 intron2 4 0.0016 GA/GG 2/607 251.51/217.24 11.3/43.3 34.50 0.24424 138.26/137.77 81.3/65.1 -0.01 0.9701 
APOC1p1422 intron2 4 0.0016 GA/GG 2/621 164.28/217.16 31.1/43.5 -53.33 0.07215 85.16/138.1 46.7/65.7 -0.49 0.0838 
APOC1p1566/rs12691088 intron2 2b 0.0058 GA/GG 7/598 214.02/216.77 36.5/43.7 -2.77 0.86244 130.06/138.08 78.5/65.9 -0.08 0.6183 
APOC1p2041/rs3826688 intron2 5 0.3424 AA/GA/GG 73/269/264 208.35/218.41/218.56 37.2/45.6/43.6 -3.60 0.15405 122.52/133.62/144.45 59.9/63.3/66.8 -0.08 0.0011 
APOC1p2629 exon3 4 0.0008 GA/GG 1/618 192.39/217.2 NA/43.6 -24.89 0.55247 124.61/138.12 NA/65.7 -0.02 0.9634 
APOC1p2817 intron3 2b 0.0033 CC/CT 603/4 216.34/224.48 43.1/28.0 8.17 0.69433 138.22/132.67 66.3/26.9 0.04 0.8334 
APOC1p3423/rs389261 intron3 No Data 0.0025 GA/GG 3/605 185.1/216.81 21.2/43.4 -32.02 0.18592 132.55/138.06 72.0/66.0 -0.02 0.9169 
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APOC1p3494 intron3 No Data 0.0016 CC/CT 619/2 216.76/320.11 42.8/153.4 103.78 0.00044 137.8/197.85 65.7/84.9 0.40 0.1643 
APOC1p4334/rs12721046 intron3 6 0.1522 AA/GA/GG 13/160/438 233.5/219.8/215.22 33.9/44.1/43.4 5.95 0.07734 161.1/137.57/137.8 71.8/63.8/66.4 0.02 0.4787 
APOC1p5641/rs1064725 3'UTR No Data 0.0388 GG/GT/TT 1/46/571 259.34/228.98/216.15 NA/45.2/43.4 13.65 0.02631 108.18/134.02/138.5 NA/68.9/65.6 -0.05 0.4064 
APOC1p5773 3'flanking No Data 0.0008 GA/GG 1/604 254.09/216.74 NA/43.8 37.56 0.36991 313.01/137.37 NA/65.4 0.93 0.0211 
APOC1p5926/rs56131196 3'flanking No Data 0.1885 AA/GA/GG 19/195/404 229.72/220.53/214.39 31.3/44.8/43.1 6.69 0.03046 144.93/137.9/137.39 69.4/66.6/65.4 0.01 0.7677 
APOC1p6026/rs4420638 3'flanking No Data 0.1556 AA/GA/GG 405/129/22 214.64/218.18/235.77 43.2/44.6/38.8 6.79 0.04018 137.4/139.11/153.86 65.2/63.6/77.5 0.03 0.3924 
rs4803770 HCR1 5 0.3779 CC/GC/GG 229/281/84 210.83/219.75/221.05 41.2/43.7/43.5 6.08 0.01385 134.33/140.66/144.51 66.7/67.0/63.2 0.04 0.0801 
HCR1p292/rs4803771 HCR1 4 0.0245 CC/CG/GG 583/28/1 217.05/216.36/248.27 44.1/37.6/NA 1.40 0.85412 138.16/130.59/300.06 65.5/62.2/NA 0.02 0.8188 
HCR1p362 HCR1 2a 0.0025 CA/CC 3/605 213.1/216.88 19.7/43.7 -3.80 0.87495 186.45/137.65 81.3/65.5 0.30 0.203 
HCR1p423 HCR1 4 0.0258 CC/CG/GG 589/30/1 217.22/209.32/203.05 43.1/40.8/NA -7.84 0.28132 139.12/115.81/142.97 66.3/51.5/NA -0.12 0.08 
HCR1p575/rs157599 HCR1 3a 0.0024 AA/AG 618/3 217.25/185.31 43.6/21.2 -32.24 0.18436 138.02/132.76 65.8/72.0 -0.02 0.926 
HCR1p727/rs149345 HCR1 3a 0.0024 TG/TT 3/611 184.31/217.22 21.2/43.4 -33.23 0.16946 131.91/137.89 72.0/65.9 -0.03 0.9053 
rs5112 APOC1P1 4 0.4633 CC/GC/GG 123/284/165 208.18/218.08/218.71 38.1/44.7/44.1 -4.95 0.04462 134.65/136.13/139.61 68.2/64.2/64.0 -0.02 0.3217 
rs7259004 APOC1P1 6 0.1176 CC/CG/GG 476/128/8 218.82/207.45/218.26 43.5/36.3/54.2 -9.06 0.01342 135.49/147.31/121.5 63.6/74.3/42.6 0.05 0.2103 
HCR2p188/rs35136575 HCR2 2a 0.2274 CC/GC/GG 369/203/37 217.48/215.6/212.29 45.0/39.3/44.9 -2.25 0.41394 138.5/136.9/132.18 63.1/69.0/61.4 -0.03 0.283 
HCR2p365 HCR2 2b 0.0041 CA/CC 5/606 210.22/216.65 51.3/43.3 -6.50 0.72951 110.77/138.24 42.7/66.1 -0.20 0.266 
HCR2p523 HCR2 2b 0.0226 CC/CT 571/27 216.31/224.33 43.4/44.7 8.10 0.3266 138.42/139.96 66.2/60.6 0.02 0.7664 
APOC4p636 5’ flanking No Data 0.0008 CC/CT 601/1 217.16/280.36 43.5/NA 63.55 0.13031 137.96/275.05 65.6/NA 0.73 0.0732 
APOC4p968/rs76214972 5’ UTR 4 0.0362 AA/AG 576/45 217.5/211.93 43.7/42.1 -5.60 0.38784 138/137.87 66.3/59.4 0.02 0.8085 
APOC4p1150/rs148247675 Intron1 5 0.0017 AA/GA 601/2 216.26/319.6 42.6/153.4 103.80 0.00043 137.73/196.79 65.5/84.9 0.39 0.1698 
APOC4p1229 Intron1 2b 0.0016 GC/GG 2/619 233.67/217.04 60.1/43.5 16.99 0.57007 245.77/137.64 24.0/65.6 0.68 0.0186 
APOC4p2557 Intron1 4 0.0008 CA/CC 1/619 160.39/217.07 NA/43.5 -57.38 0.17273 135.71/137.99 NA/65.9 0.12 0.7681 
APOC4p2623/rs5157 Intron1 4 0.4976 CC/CT/TT 155/315/152 216.43/217.92/215.73 42.9/43.6/44.4 -0.35 0.88515 135.81/136.86/142.57 65.7/62.7/71.8 0.02 0.3751 
APOC4p2640/rs5158 Intron1 2b 0.1381 CC/CT/TT 459/149/11 217.61/215.36/216.86 42.0/49.0/33.7 -1.79 0.60759 139.65/133.48/121.82 67.4/61.5/58.6 -0.04 0.2219 
APOC4p2683/rs12721109 Intron1 2b 0.0237 AA/AG/GG 1/27/584 204.3/204.19/217.79 NA/60.0/42.7 -12.75 0.09785 69.01/121.05/139.06 NA/67.2/65.9 -0.16 0.0329 
APOC4p2703/rs12721108 Intron1 2a 0.0081 GG/GT 609/10 217.09/207.6 43.8/33.1 -9.51 0.47603 137.98/111.71 65.7/43.4 -0.15 0.2384 
APOC2p194-
C4p3498/rs1132899 C4-exon2 5 0.4863 CC/CT/TT 160/317/143 218.31/216.28/217.16 43.3/43.4/44.3 -0.62 0.79728 136.29/135.87/143.8 65.2/61.7/72.3 0.02 0.3465 
APOC2p242-
C4p3546/rs12691089 C4-exon2 5 0.0032 AG/GG 4/617 211.98/217.12 26.7/43.6 -5.18 0.80551 115.55/138.14 63.9/65.8 -0.16 0.4444 
APOC2p543-
C4p3847/rs186448850 C4-intron2 5 0.0016 CT/TT 2/609 234/216.86 60.1/43.7 17.51 0.55783 246.13/137.59 24.0/65.3 0.68 0.0171 
APOC2p623-












1a 0.4968 CC/CG/GG 155/316/151 217.56/217.08/216.26 44.4/43.7/42.6 -0.65 0.78596 143.66/135.77/136.19 73.4/61.6/66.0 -0.02 0.3813 
APOC2p1591-C4p4895 C2-intron1 4 0.0008 GA/GG 1/620 279.62/216.99 NA/43.5 62.97 0.13292 275.28/137.77 NA/65.6 0.73 0.0712 
APOC2p1851/rs12709886 intron1 6 0.0372 GA/GG 46/572 213.01/217.48 42.4/43.7 -4.49 0.48475 140.23/137.95 59.2/66.5 0.03 0.5845 
APOC2p2870 intron1 4 0.004 GG/GT 616/5 216.62/274.94 42.7/96.4 58.43 0.00179 137.83/157.24 65.7/79.6 0.12 0.5116 
APOC2p3348/rs10420434 intron1 No Data 0.0371 GA/GG 46/574 214.96/217.38 37.0/44.1 -2.44 0.70432 130.78/138.84 74.3/65.0 -0.09 0.1736 
APOC2p3778/rs5120 intron1 4 0.4976 AA/AT/TT 154/305/157 215.87/216.86/218.48 42.5/42.7/46.2 -1.32 0.57843 134.51/136.63/143.81 63.7/62.5/73.2 -0.02 0.2809 
APOC2p4853/rs199828513 3'flamking No Data 0.2783 DD/WD/WW 316/260/42 215.57/218.43/219.64 44.6/43.0/40.1 2.44 0.37077 138.01/138.21/139.6 68.6/62.4/67.6 0.01 0.6741 
APOC2p5004/rs10421404 3'flanking No Data 0.1823 CC/CT/TT 416/177/24 218.5/212.98/219.46 41.9/47.7/37.0 -3.09 0.30928 139.84/134.54/131.31 68.0/61.5/63.5 -0.03 0.3591 
APOC2p5310/rs7258345 3'flanking No Data 0.4649 GG/TG/TT 133/303/176 217.14/216.27/217.27 43.5/42.7/43.7 -0.13 0.95612 137.94/134.99/141.53 64.4/61.1/72.8 -0.01 0.8191 
APOC2p5398/rs12709889 3'flanking 6 0.276 AA/GA/GG 41/252/312 219.86/217.27/215.5 40.6/42.5/44.4 1.98 0.47012 139.76/138.57/137.76 67.7/62.7/68.7 0.01 0.5974 
APOC2p5644 3'flanking 6 0.0092 AG/GG 11/585 230.97/216.28 42.0/43.5 14.86 0.24546 123.92/138.57 53.6/66.2 -0.10 0.4103 
a Cox-Box transformed variables. 
MAF: minor allele frequency. 
TC: total cholesterol; TG: triglyceride. 
Age, Gender, Smoking, and BMI are significant covariates that were included in the final model. 









Table 23. Genotype-specific means (± SD) of ApoB and ApoA1 for genotyped SNPs in NHWs 
 ApoBa ApoA1 
Variant name Function RegulomeDB score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 
APOE560/rs449647 5'flanking 5 0.161 AA/AT/TT 433/176/12 88.92/84.42/90.53 23.4/24.7/13.2 -0.95 0.129 150.06/149.21/141.94 34.5/29.0/24.3 -1.57 0.6175 
APOE832/rs405509 5'flanking 1f 0.4775 GG/GT/TT 170/310/142 81.67/89.51/91.58 26.1/22.6/22.9 1.46 0.0009 151.84/149.07/148.29 34.4/32.5/34.0 -1.80 0.4173 
APOE1163/rs440446 intron1 4 0.3604 CC/GC/GG 76/297/250 88.2/89.54/85.95 23.0/23.5/24.8 0.56 0.2319 153.72/147.42/151.01 30.9/32.7/34.6 -0.19 0.9349 
APOE1575/rs769448 intron1 4 0.021 CC/CT/TT 595/24/1 87.88/90.73/93.77 24.3/17.4/NA 0.94 0.5204 149.53/144.71/224.9 33.2/37.3/NA 3.44 0.6394 
APOE1998/rs769449 intron 2 4 0.1165 AA/AG/GG 6/132/480 93.32/93.83/85.99 23.2/22.4/24.1 2.03 0.003 159.38/145.16/151.06 32.5/35.0/32.9 -4.38 0.2048 
APOE2440/rs769450 intron 2 5 0.4015 AA/GA/GG 95/307/217 89.59/87.42/87.95 24.1/23.9/24.1 0.15 0.7422 152.48/148.5/149.87 36.4/31.6/34.5 0.70 0.7656 
APOE2907/rs769451 intron 2 5 0.0112 GT/TT 14/609 87.57/87.92 32.9/23.8 -0.22 0.9196 153.23/149.54 21.6/33.6 3.70 0.7379 
APOE3038/rs111833428 exon 3 5 0.0016 AG/GG 2/616 140.55/87.71 NA/23.8 13.81 0.0342 152.88/149.59 NA/33.4 3.29 0.9205 
APOE3106/rs769452 exon 3 5 0.0008 TC/TT 1/620 121.87/87.93 NA/23.9 9.15 0.1602 179.31/149.54 NA/33.4 29.79 0.3649 
APOE3937/rs429358 exon 4 5 0.1525 CC/CT/TT 14/159/440 90.86/94.72/85.3 17.2/22.9/24.1 2.14 0.0005 138.97/147.69/150.56 34.4/36.3/32.3 -3.66 0.2399 
APOE4075/rs7412 exon 4 5 0.0806 CC/TC/TT 523/94/3 90.92/73.55/32.32 23.0/21.1/17.1 -5.60 9.70E-13 148.66/154.66/149.98 33.4/33.6/14.5 5.12 0.2081 
APOE4310/rs199768005 exon 4 5 0.004 TA/TT 5/617 92.47/87.91 45.3/23.9 1.05 0.822 114.13/149.7 11.9/33.3 -35.74 0.1245 
APOE4528 3' UTR 5 0.0008 CC/CT 622/1 *** *** *** *** *** *** *** *** 
APOE4737/rs117656888 3'flanking 5 0.0081 CC/GC 610/10 87.82/93.42 24.0/22.9 1.60 0.5203 149.66/144.12 33.3/44.1 -5.55 0.6576 
APOE5361/rs1081106 3'flanking 3a 0.0852 CC/TC/TT 4/98/520 107.81/86.35/88.01 28.0/23.3/24.0 0.12 0.8813 152.9/152.7/149.1 10.8/35.9/33.1 3.30 0.4318 
rs439401 intergenic region 1b 0.3596 CC/CT/TT 255/270/84 85.66/91.09/85.24 24.8/23.5/22.6 0.39 0.3975 149.41/147.97/152.86 32.7/35.3/28.7 0.91 0.6915 
APOC1rs445925 intergenic region No Data 0.1094 AA/GA/GG 7/121/489 50.38/79.28/90.44 27.9/23.8/22.9 -3.78 5.20E-08 152.11/152.68/148.68 15.1/36.1/32.8 3.53 0.3231 
APOC1p698/rs72654449 5'flanking 4 0.004 CA/CC 5/613 77.26/88 16.2/24.0 -2.77 0.55052 145.12/149.76 3.7/33.5 -4.70 0.8413 
APOC1p703/rs3207187 5'flanking 4 0.0008 CC/CT 619/1 87.93/83.81 24.0/NA -0.88 0.89283 149.23/251.77 33.0/NA 102.96 0.0016 
APOC1p720/rs72654451 5'flanking 4 0.2299 II/WI/WW 31/224/367 82.72/86.9/89.18 27.6/24.6/23.1 -0.82 0.11683 156.43/147.39/150.62 39.6/33.3/32.7 -0.46 0.8612 
APOC1p1170 intron1 2b 0.0008 GA/GG 1/609 113.69/87.76 NA/24.1 7.14 0.27763 168.25/149.95 NA/33.0 18.30 0.5723 
APOC1p1294 intron2 4 0.0008 AA/AC 618/1 87.88/98.11 24.0/NA 3.07 0.63865 149.49/176.37 33.4/NA 27.03 0.4118 
APOC1p1317/rs12721048 intron2 4 0.0016 GA/GG 2/607 130.48/87.94 17.4/23.9 11.18 0.01598 216.08/149.57 43.8/33.2 66.89 0.0042 
APOC1p1422 intron2 4 0.0016 GA/GG 2/621 93.79/87.9 NA/24.0 1.88 0.77425 123.27/149.68 NA/33.4 -26.52 0.4203 
APOC1p1566/rs12691088 intron2 2b 0.0058 GA/GG 7/598 69.72/88.14 9.3/23.9 -4.95 0.12948 123.04/150.35 24.9/33.0 -27.45 0.0915 
APOC1p2041/rs3826688 intron2 5 0.3424 AA/GA/GG 73/269/264 83.5/91.49/85.59 21.0/23.6/24.8 0.30 0.51703 151.51/148.58/149.85 27.1/34.5/33.7 0.24 0.9176 
APOC1p2629 exon3 4 0.0008 GA/GG 1/618 69.33/88.11 NA/24.0 -5.12 0.43402 152.46/149.93 NA/33.3 2.54 0.9383 
APOC1p2817 intron3 2b 0.0033 CC/CT 603/4 87.84/71.24 23.8/6.9 -4.46 0.23676 149.33/170.37 33.6/34.2 21.20 0.27 
APOC1p3423/rs389261 intron3 No Data 0.0025 GA/GG 3/605 74.76/87.94 10.7/23.8 -3.50 0.35153 128.16/149.72 12.2/33.6 -21.68 0.2583 
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APOC1p3494 intron3 No Data 0.0016 CC/CT 619/2 87.88/107.03 24.0/NA 5.38 0.41256 149.65/148.26 33.4/NA -1.39 0.9662 
APOC1p4334/rs12721046 intron3 6 0.1522 AA/GA/GG 13/160/438 102.6/90.83/86.13 25.1/22.7/24.2 1.59 0.00983 143.94/148.57/150.28 27.8/34.4/33.2 -2.11 0.4956 
APOC1p5641/rs1064725 3'UTR No Data 0.0388 GG/GT/TT 1/46/571 53.28/98.46/87.22 NA/25.9/23.6 2.00 0.09267 151.6/145.08/150.14 NA/28.1/33.8 -4.32 0.4728 
APOC1p5773 3'flanking No Data 0.0008 GA/GG 1/604 *** *** *** *** *** *** *** *** 
APOC1p5926/rs56131196 3'flanking No Data 0.1885 AA/GA/GG 19/195/404 97.38/91.68/85.37 22.9/23.0/24.2 1.75 0.00229 138.59/149.26/150.3 29.6/35.8/32.2 -2.59 0.3695 
APOC1p6026/rs4420638 3'flanking No Data 0.1556 AA/GA/GG 405/129/22 85.38/89.53/97.75 24.2/23.2/21.6 1.43 0.01775 150.61/151.88/142.57 32.2/36.8/30.4 -1.10 0.716 
rs4803770 HCR1 5 0.3779 CC/GC/GG 229/281/84 85.8/89.24/88.61 23.5/24.5/20.4 0.56 0.21851 148.59/150.64/147.18 34.5/32.1/35.1 0.02 0.9937 
HCR1p292/rs4803771 HCR1 4 0.0245 CC/CG/GG 583/28/1 87.78/89.74/101.01 23.7/30.3/NA 0.68 0.64404 149.65/145.25/126.7 33.4/33.6/NA -5.81 0.4273 
HCR1p362 HCR1 2a 0.0025 CA/CC 3/605 94.53/87.84 NA/24.1 2.07 0.75319 146/149.46 NA/33.5 -3.48 0.9159 
HCR1p423 HCR1 4 0.0258 CC/CG/GG 589/30/1 87.52/98.35/78.55 23.6/30.1/NA 2.10 0.14804 149.16/160.49/169.19 33.2/38.2/NA 11.09 0.1293 
HCR1p575/rs157599 HCR1 3a 0.0024 AA/AG 618/3 88.02/74.88 24.0/10.7 -3.48 0.35815 149.8/128.13 33.4/12.2 -21.80 0.2531 
HCR1p727/rs149345 HCR1 3a 0.0024 TG/TT 3/611 74.72/87.81 10.7/23.8 -3.47 0.35832 128.14/149.71 12.2/33.4 -21.70 0.2544 
rs5112 APOC1P1 4 0.4633 CC/GC/GG 123/284/165 86.97/88.52/88.35 21.1/25.6/23.3 -0.15 0.75492 147.66/150.29/149.24 32.7/33.8/35.7 -0.67 0.7769 
rs7259004 APOC1P1 6 0.1176 CC/CG/GG 476/128/8 89.05/82.56/94.13 23.3/24.3/35.9 -1.33 0.05153 147.93/153/173.55 32.3/37.7/22.4 6.89 0.046 
HCR2p188/rs35136575 HCR2 2a 0.2274 CC/GC/GG 369/203/37 88.13/88.97/79.55 23.5/25.5/20.6 -0.48 0.36635 146.45/154.06/151.77 32.8/34.8/29.8 5.16 0.0496 
HCR2p365 HCR2 2b 0.0041 CA/CC 5/606 99.1/87.77 32.0/23.9 3.05 0.41812 159.91/149.39 31.6/33.5 10.58 0.581 
HCR2p523 HCR2 2b 0.0226 CC/CT 571/27 87.49/91.33 23.8/26.3 1.04 0.47773 149.23/153.04 33.7/31.3 3.82 0.6061 
APOC4p636 5’ flanking No Data 0.0008 CC/CT 601/1 *** *** *** *** *** *** *** *** 
APOC4p968/rs76214972 5’ UTR 4 0.0362 AA/AG 576/45 87.57/92.24 23.8/26.3 1.25 0.29092 149.5/151.52 33.9/26.9 2.03 0.733 
APOC4p1150/rs148247675 Intron1 5 0.0017 AA/GA 601/2 87.74/107.42 23.9/NA 5.53 0.3975 149.68/148.08 33.3/NA -1.61 0.9608 
APOC4p1229 Intron1 2b 0.0016 GC/GG 2/619 *** *** *** *** *** *** *** *** 
APOC4p2557 Intron1 4 0.0008 CA/CC 1/619 68.6/87.95 NA/24.0 -5.26 0.42411 134.92/149.59 NA/33.4 -14.77 0.6541 
APOC4p2623/rs5157 Intron1 4 0.4976 CC/CT/TT 155/315/152 89.47/87.43/87.27 23.5/24.9/22.5 -0.30 0.49795 151.15/147.68/151.88 32.5/32.5/35.8 0.34 0.8797 
APOC4p2640/rs5158 Intron1 2b 0.1381 CC/CT/TT 459/149/11 87.34/90.18/81.09 23.6/25.2/24.6 0.35 0.59389 150.47/147/160.11 33.8/32.3/27.4 -1.45 0.662 
APOC4p2683/rs12721109 Intron1 2b 0.0237 AA/AG/GG 1/27/584 53.83/71.26/88.65 NA/23.5/23.8 -4.99 0.00057 202.37/133.19/150.53 NA/30.4/33.6 -9.31 0.1964 
APOC4p2703/rs12721108 Intron1 2a 0.0081 GG/GT 609/10 88.02/83.12 24.0/16.8 -1.23 0.59732 149.85/140.86 33.6/20.4 -9.00 0.4435 
APOC2p194-
C4p3498/rs1132899 C4-exon2 5 0.4863 CC/CT/TT 160/317/143 89.22/87.06/88.46 23.1/25.1/22.5 -0.12 0.79089 150.64/147.15/153.66 32.2/32.5/36.5 1.35 0.5467 
APOC2p242-
C4p3546/rs12691089 C4-exon2 5 0.0032 AG/GG 4/617 80.57/87.96 0.6/24.0 -1.80 0.69724 150.3/149.65 3.8/33.4 0.65 0.9778 
APOC2p543-
C4p3847/rs186448850 C4-intron2 5 0.0016 CT/TT 2/609 *** *** *** *** *** *** *** *** 
APOC2p623-
C4p3927/rs5167 C4-exon3 5 0.3596 GG/TG/TT 74/300/249 88.12/88.12/87.59 19.2/25.5/23.3 0.11 0.81626 150.17/148.48/150.92 32.6/32.5/34.7 -1.01 0.6722 
 
 104 






1a 0.4968 CC/CG/GG 155/316/151 87.57/87.5/89.09 22.2/24.9/23.9 0.19 0.66177 152.58/146.48/152.73 35.5/32.5/32.4 0.03 0.988 
APOC2p1591-C4p4895 C2-intron1 4 0.0008 GA/GG 1/620 *** *** *** *** *** *** *** *** 
APOC2p1851/rs12709886 intron1 6 0.0372 GA/GG 46/572 92.79/87.56 28.6/23.5 1.35 0.2357 154.75/148.94 29.9/33.6 5.83 0.3078 
APOC2p2870 intron1 4 0.004 GG/GT 616/5 87.71/110.92 23.9/16.9 6.33 0.05291 149.98/113.84 33.2/43.7 -36.20 0.0279 
APOC2p3348/rs10420434 intron1 No Data 0.0371 GA/GG 46/574 84/88.23 27.1/23.8 -1.24 0.3101 156.21/149.31 35.7/32.8 6.94 0.2529 
APOC2p3778/rs5120 intron1 4 0.4976 AA/AT/TT 154/305/157 88.77/87.16/87.61 24.1/24.7/22.2 0.14 0.74796 153.3/146.82/152.67 32.1/32.4/35.5 0.29 0.8954 
APOC2p4853/rs199828513 3'flamking No Data 0.2783 DD/WD/WW 316/260/42 87.77/87.53/91.29 23.6/25.2/19.6 0.21 0.6757 151.65/146.49/150.53 35.5/30.1/33.1 -2.81 0.2692 
APOC2p5004/rs10421404 3'flanking No Data 0.1823 CC/CT/TT 416/177/24 87.5/87.88/91.32 23.3/24.6/26.0 0.26 0.63942 149.13/148.48/158.91 32.7/34.8/28.8 1.64 0.5604 
APOC2p5310/rs7258345 3'flanking No Data 0.4649 GG/TG/TT 133/303/176 89.54/87.89/86.85 22.7/25.4/22.5 0.36 0.41406 151.44/146.73/153.03 30.8/32.7/35.6 -1.16 0.6041 
APOC2p5398/rs12709889 3'flanking 6 0.276 AA/GA/GG 41/252/312 90.49/87.02/87.9 19.5/25.1/23.2 0.06 0.91243 150.8/146.25/151.97 33.6/30.5/35.8 -3.11 0.233 
APOC2p5644 3'flanking 6 0.0092 AG/GG 11/585 94.14/87.4 30.6/23.7 1.74 0.42698 156.78/149.16 27.7/33.8 7.67 0.4929 
a Cox-Box transformed variables. 
MAF: minor allele frequency. 
ApoB: Apolipoprotein B;ApoA1: apolipoprotein A1. 
Age, Gender, Smoking, and BMI are significant covariates that were included in the final model. 




Figure 21. LD plot of the 20 common variants (MAF≥1%) with significant associations in NHWs 
3.6.1.2  African Blacks 
Single-locus association results with lipid traits in Blacks are shown in Table 24, the distribution 
of lipid traits adjusted means among the genotype groups are presented in Table 25-27, and 
Figure 22 represents the LD structure of the 24 variants with significant associations in Blacks. 
Twenty-four variants (0.0135≤MAF≤0.366) showed evidence of associations with at least one 
lipid trait (5.35E-07 ≤ P ≤ 0.048). More associations were observed with LDL-C followed by 
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TC, TG, and apoB. The established association of APOE2/E4 alleles with LDL-C is replicated in 
African Blacks. E2 allele was observed to be associated with lower LDL-C (β=-2.05, P=5.35E-
07), TC (β=-0.82, P=0.0001), apoB (β=-2.35, P=0.0356), and higher apoA1 (β=3.85, 
P=0.00008), while E4 allele was observed to be associated only with higher LDL-C (β=0.46, 
P=0.0317).  
Eleven variants, in addition to the APOE2/E4 alleles, showed significant associations 
with LDL-C; APOE560/rs449647 (β=0.58, P=0.0031), APOE832/rs405509 (β=0.60, P=0.0044), 
APOE2269/rs6135770 (β=-2.05, P=0.0064), APOE4036/rs769455 (β=-2.23, P=0.0009), 
APOC1p720/rs71962921 (β=-0.57, P=0.0084), APOC1p5667/rs127210054 (β=-0.77, P=0.0063), 
APOC2p1357C4p4661/rs2288912 (β=0.51, P=0.020), APOC2p1540C4p4844/rs75463753 
(β=0.8, P=0.0114), APOC2p2486/rs9304645 (β=-0.54, P=0.0084), APOC2p5815/rs10423208 
(β=0.42, P=0.0474), and APOC2p5922/rs10422888 (β=0.98, P=0.0079). None of the variants 
that showed evidence of association with LDL-C were correlated with either E2/E4 allele. 
However, most of them were correlated with each other. APOE560/rs449647 and 
APOE832/rs405509 were in moderate LD (r2=0.32), while APOE2269/rs6135770 and 
APOE4036/rs769455 were in complete LD. APOC1p720/rs71962921 and 
APOC1p5667/rs127210054 were in moderate LD (r2=0.44), and similarly 
APOC2p1357C4p4661/rs2288912 and APOC2p1540C4p4844/rs75463753 were in moderate LD 
(r2=0.32). More interestingly, none of the LDL-associated variants was in LD with E2/E4 alleles 
and their effects on LDL-C seem to be independent of E2/E4. 
Only two variants showed significant associations with HDL-C: rs439401 (β-0.60, 
P=0.044), and APOC1p3573/rs10424339 (β=0.55, P=0.045). In addition to the E2 allele, seven 
variants showed significant associations with TC, APOE560/rs449647 (β=0.2, P=0.017), 
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APOE4036/rs769455 (β=-0.9, P=0.0129), APOC1p5667/rs127210054 (β=-0.3, P=0.047), 
APOC2p1357C4p4661/rs2288912 (β=0.3, P=0.0153), APOC2p1540C4p4844/rs75463753 
(β=0.4, P=0.011), APOC2p3778/rs5120 (β=0.3, P=0.012), and APOC2p5922/rs10422888 
(β=0.5, P=0.0129). APOC2p3778/rs5120 was in moderate LD with multiple variants; 
APOC2p1357C4p4661/rs2288912 (r2=0.60), APOC2p1540C4p4844/rs75463753 (r2=0.49) and 
their effect seem to be not independent. However, none of the TC-associated variants was in LD 
with E2/E4 allele and their effects seem to be independents. 
Seven variants were associated with TG; APOE73/rs1081101 (β=0.04, P=0.0093), 
APOE4036/rs769455 (β=0.06, P=0.037), APOC1p5667/rs127210054 (β=-0.03, P=0.007), 
APOC1p5926/rs56131196 (β=-0.02, P=0.0442), APOC4p757/rs12721105 (β=0.06, P=0.0005), 
APOC4p2640/rs5158 (β=-0.05, P=0.035), and APOC2p2935/rs11879392 (β=-0.07, P=0.028). 
Moderate LDs were observed between APOE73/rs1081101 and APOE4036/rs769455   (r2=0.29), 
and between APOC1p5926/rs56131196 and APOC1p5667/rs127210054 (r2=0.47). On the other 
hand, APOC4p2640/rs5158 and APOC2p2935/rs11879392 were in strong LD (r2=0.84).  
In addition to APOE2, 4 variants showed significant associations with apoB: 
APOE1163/rs440446 (β=2.3, P=0.0109), APOC4p2623/rs5157 (β=1.4, P=0.044), 
APOC2p1042C4p4346/rs12709885 (β=-4.4, P=0.024), and APOC2p1357C4p4661/rs2288912 
(β=1.4, P=0.023). While APOC4p2623/rs5157 was in moderate LD with 
APOC2p1357C4p4661/rs2288912 (r2=0.58), these two variants (APOE1163/rs440446, and 
APOC2p1042C4p4346/rs12709885) seem to have independent effect on apoB. In addition to the 
APOE2 allele, two more variants showed significant associations with apoA1: 
APOC1p720/rs71962921 (β=1.0, P=0.048), and APOC2p1042C4p4346/rs12709885 (β=5.9, 
P=0.0007) and they were not in LD with each other. 
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Seven variants, in addition to the APOE2 allele, showed significant associations with 
multiple lipid traits in Blacks while the remaining sixteen variants showed single associations. 
Only one variant: APOC2p1357C4p4661/rs2288912 showed significant associations with the 3 
LDL-related traits (LDL-C, TC, and apoB). Six variants showed significant associations with 2 
LDL-related traits (LDL-C, and TC): APOE560/rs449647, APOE4036/rs769455, 
APOC1p5667/rs12721054, APOC2p1540C4p4844/rs75463753, APOC2p3778/rs5120, and 
APOC2p5922/rs10422888. Two of the variants that had associations with 2 LDL-related traits 
(LDL-C, and TC) were associated also with TG: APOE4036/rs769455, and 
APOC1p5667/rs12721054. 
The remaining sixteen variants showed evidence of association with single lipid trait, 
including APOE4 allele. In addition to the APOE4 allele, four other variants showed single 
association with LDL-C: APOE832/rs405509, APOE2269/rs6135770, APOC1p720/rs71962921, 
APOC2p2486/rs9304645, and APOC2p5815/rs10423208. Two variants showed single 
association with HDL-C: rs439401, and APOC1p3573/rs10424339. Five variants showed single 
association with TG: APOE73/rs1081101, APOC1p5926/rs56131196, APOC4p757/rs12721105, 
APOC4p2640/rs5158, and APOC2p2935/rs118793392. Three variants showed single association 








 Table 24.  Single-locus association results with lipid traits in African Blacks  
 LDL-Ca HDL-Ca TCa TGa ApoBa ApoA1a 
Variant name function regulome db score MAF Beta p_value Beta p_value Beta p_value Beta p_value Beta p_value Beta p_value 
APOE73/rs1081101 5'flanking 4 0.0611 -0.62 0.111 0.30 0.42732 -0.20 0.3283 0.038 0.0093 0.65 0.54877 -0.003 0.99719 
APOE173 5'flanking 3a 0.002 -1.14 0.5979 -2.10 0.32058 0.41 0.7151 0.037 0.7028 3.20 0.59226 6.86 0.19127 
APOE308/rs769445 5'flanking 4 0.0072 -0.37 0.7576 -1.06 0.34278 -0.06 0.9218 0.056 0.2065 1.87 0.55135 3.21 0.2461 
APOE560/rs449647 5'flanking 5 0.3663 0.58 0.0031 -0.18 0.35635 0.25 0.0177 -0.001 0.8482 0.92 0.09509 -0.49 0.31886 
APOE618 5'flanking 4 0.0006 -2.85 0.4432 -12.25 0.00079 -3.62 0.0634 0.025 0.856 4.15 0.68762 -18.42 0.04342 
APOE624/rs769446 5'flanking 3a 0.0077 -2.86 0.0214 0.65 0.56874 -1.25 0.044 0.005 0.9096 -4.19 0.20373 3.55 0.20204 
APOE832/rs405509 5'flanking 1f 0.2561 0.60 0.0044 -0.19 0.36119 0.22 0.0529 0.003 0.7457 0.66 0.26113 -0.67 0.19928 
APOE1109/rs9282609 Splice site 4 0.0415 0.05 0.9183 0.61 0.17876 0.12 0.6321 0.023 0.1814 1.38 0.27683 0.24 0.83418 
APOE1163/rs440446 intron1 4 0.1004 0.44 0.1791 -0.54 0.09464 0.12 0.4748 0.023 0.0537 2.30 0.01093 -0.44 0.58046 
APOE1231 intron1 2b 0.0125 -0.71 0.4139 -0.27 0.755 -0.46 0.3315 -0.030 0.3441 -1.71 0.47484 -1.12 0.59594 
APOE1279/rs877973 intron1 4 0.0597 -0.15 0.7208 0.51 0.19812 0.04 0.8544 -0.029 0.0513 -0.45 0.68467 1.06 0.27597 
APOE1539/rs184686013 intron1 4 0.0086 -1.03 0.2862 1.35 0.15682 -0.33 0.5172 0.002 0.9546 0.23 0.93296 4.24 0.0738 
APOE2072/rs189660912 intron 2 4 0.0079 -0.50 0.6433 -0.40 0.70658 -0.40 0.4796 0.009 0.8229 0.70 0.81486 -1.35 0.61188 
APOE2269/rs6135770 intron 2 5 0.0169 -2.05 0.0064 0.77 0.29121 -0.69 0.0771 0.040 0.1489 -2.56 0.22005 1.09 0.55027 
APOE2440/rs769450 intron 2 5 0.387 0.20 0.3409 -0.02 0.93935 0.11 0.3081 -0.003 0.7396 -0.50 0.37248 -0.17 0.73856 
APOE3673/rs769453 intron 3 5 0.0066 -0.37 0.7649 -1.10 0.34567 -0.07 0.9054 0.037 0.4242 2.02 0.5386 3.93 0.17574 
APOE3937/rs429358 exon 4 5 0.2656 0.46 0.0317 -0.14 0.50743 0.17 0.1323 -0.008 0.3075 0.05 0.9371 -1.00 0.05924 
APOE4036/rs769455 exon 4 5 0.02 -2.23 0.0009 -0.46 0.48274 -0.87 0.0129 0.056 0.0372 -3.45 0.06644 -0.71 0.66412 
APOE4075/rs7412 exon 4 5 0.0605 -2.05 5.35E-07 0.75 0.06615 -0.82 0.0001 -0.018 0.2376 -2.35 0.03564 3.85 0.00008 
APOE4569 3'UTR 5 0.0007 8.87 0.0173 5.29 0.14968 5.12 0.0089 0.073 0.5976 14.25 0.1684 15.53 0.08835 
APOE5223 3'flanking 2b 0.0051 -2.25 0.0874 0.39 0.763 -0.94 0.1738 0.006 0.9078 -2.54 0.51655 1.29 0.70886 
APOE5231 3'flanking 2b 0.027 -0.10 0.8587 -0.18 0.76449 -0.03 0.9208 -0.023 0.2836 -0.82 0.60359 -0.03 0.98493 
rs439401 intragenic region 1b 0.1092 0.39 0.1933 -0.60 0.04448 0.07 0.6621 0.011 0.3401 1.42 0.0862 -0.50 0.50161 
APOC1rs445925 intragenic region No Data 0.299 -0.01 0.9509 0.10 0.64004 -0.01 0.8983 -0.007 0.3748 -0.31 0.59161 0.36 0.48026 
APOC1p720ins4/rs71962921 5'flanking region 4 0.2737 -0.57 0.0084 0.27 0.20872 -0.20 0.0741 -0.013 0.1137 -1.10 0.06438 1.03 0.04836 
APOC1p894/rs190454394 5'flanking region 4 0.002 3.70 0.0852 0.74 0.72955 1.71 0.1317 0.021 0.7907 8.19 0.17048 0.40 0.93927 
APOC1p1166/rs72654452 intron1 2b 0.0308 0.49 0.3678 -0.61 0.25404 0.31 0.2783 0.028 0.163 0.98 0.51091 -1.09 0.40589 
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APOC1p1331/rs10408994 intron2 4 0.0666 0.62 0.1238 0.35 0.38621 0.34 0.1116 0.016 0.2862 -0.83 0.46727 -0.66 0.50656 
APOC1p1526/rs5114 intron2 4 0.0579 -0.05 0.9053 0.55 0.1745 0.12 0.5876 -0.025 0.1117 -0.22 0.84865 1.38 0.165 
APOC1p1642 intron2 4 0.0103 -1.05 0.2648 -0.59 0.53986 -0.64 0.2132 -0.019 0.5831 -1.86 0.47702 -1.90 0.4104 
APOC1p1684/rs12709881 intron2 4 0.0973 -0.51 0.1179 0.40 0.20729 -0.16 0.364 -0.017 0.1541 -1.48 0.09465 0.73 0.34454 
APOC1p3358 intron3 No Data 0.0021 -0.25 0.9068 3.44 0.10895 0.34 0.7632 0.003 0.9727 -3.96 0.50955 -2.34 0.6601 
APOC1p3423/rs389261 intron3 No Data 0.331 0.19 0.3556 0.24 0.26136 0.12 0.2958 -0.002 0.8116 -0.04 0.94719 -0.36 0.48713 
APOC1p3573/rs10424339 intron3 No Data 0.1396 -0.02 0.9374 0.55 0.0455 0.07 0.6371 0.001 0.9096 -0.71 0.36467 0.40 0.55931 
APOC1p5006/rs112528434 intron3 No Data 0.085 -0.38 0.2887 0.32 0.3879 -0.10 0.6053 -0.018 0.1732 -1.22 0.2099 0.67 0.44123 
APOC1p5053/rs12721052 intron3 No Data 0.22 0.30 0.1905 -0.31 0.16174 0.13 0.2728 0.004 0.6524 0.66 0.29256 -0.42 0.4506 
APOC1p5667/rs12721054 3'UTR 6 0.1446 -0.77 0.0063 0.23 0.42209 -0.30 0.0474 -0.028 0.007 -1.01 0.18808 1.01 0.14096 
APOC1p5926/rs56131196 3'flanking region No Data 0.1745 -0.22 0.3925 0.31 0.22541 -0.05 0.7296 -0.019 0.0442 -0.70 0.33774 0.87 0.17334 
rs4803770 HCR-1 5 0.2695 0.38 0.081 -0.27 0.21475 0.18 0.1102 0.005 0.5732 0.90 0.13554 -0.53 0.32036 
HCR1p424/rs117664574 HCR-1 4 0.0073 -0.58 0.6076 2.06 0.06453 0.12 0.8344 0.025 0.5525 2.07 0.5106 5.74 0.04801 
HCR1p575/rs157599 HCR-1 3a 0.3595 0.17 0.4067 0.19 0.36879 0.08 0.469 -0.004 0.6132 0.27 0.64249 -0.63 0.22016 
rs5112 APC1P1 4 0.4797 0.10 0.6073 0.25 0.18503 0.16 0.1091 0.010 0.1818 0.54 0.31703 0.80 0.0924 
rs7259004 APC1P1 6 0.302 -0.02 0.9061 0.29 0.15235 0.09 0.3976 0.006 0.4328 0.37 0.51449 0.83 0.10102 
HCR2p188/rs35136575 HCR-2 2a 0.1546 -0.16 0.5327 0.30 0.23716 0.01 0.9184 0.005 0.604 -0.61 0.4015 0.85 0.18117 
HCR2p286 HCR-2 2a 0.0457 0.79 0.0785 -0.70 0.11626 0.31 0.1847 0.026 0.1292 1.37 0.27692 -0.59 0.59403 
HCR2p523/rs118004808 HCR-2 2b 0.0026 2.74 0.1418 0.02 0.99167 1.17 0.2362 0.034 0.6289 6.71 0.19588 -0.21 0.96328 
APOC4p368 5’ flanking region 6 0.0019 1.04 0.6283 0.33 0.87548 0.71 0.529 0.088 0.2641 -1.39 0.81479 -0.69 0.8967 
APOC4p637/rs113814026 5’ flanking region No Data 0.0452 -0.23 0.6127 0.10 0.82864 -0.13 0.5832 -0.013 0.4457 1.34 0.29549 0.14 0.90262 
APOC4p757/rs12721105 5’ flanking region 5 0.0376 0.14 0.778 -0.19 0.69377 0.13 0.6192 0.063 0.0005 0.45 0.7436 -1.40 0.23935 
APOC4p1088 intron1 2b 0.0013 -2.69 0.3048 -4.26 0.10128 -1.51 0.2767 0.182 0.0633 -2.07 0.7775 -4.80 0.45794 
APOC4p1130 intron1 5 0.0007 -0.71 0.8491 9.46 0.00979 1.50 0.4435 0.097 0.48 -21.03 0.04207 14.38 0.11483 
APOC4p1192/rs113745034 intron1 4 0.0124 -0.63 0.4823 0.35 0.69302 -0.31 0.5056 -0.008 0.8015 2.83 0.26681 3.44 0.12841 
APOC4p1325del3 intron1 4 0.0245 0.70 0.2711 0.30 0.63292 0.28 0.4099 -0.040 0.0909 1.71 0.33255 -0.31 0.84012 
APOC4p1430ins intron1 5 0.0341 0.32 0.5609 0.69 0.22691 0.35 0.229 -0.009 0.6459 1.43 0.35841 2.68 0.05543 
APOC4p2099/rs111339708 intron1 No Data 0.0141 -0.83 0.3026 0.35 0.6678 -0.42 0.3367 -0.033 0.2745 1.19 0.59549 3.04 0.13403 
APOC4p2467/rs115225947 intron1 5 0.0141 0.68 0.4056 0.03 0.96646 0.30 0.4923 -0.027 0.3794 -0.42 0.85407 -2.52 0.2125 
APOC4p2559/rs5155 intron1 4 0.0986 -0.27 0.4028 -0.20 0.53148 -0.22 0.209 -0.008 0.4908 -0.98 0.27438 -1.47 0.06609 
APOC4p2607/rs5156 intron1 4 0.0129 -1.04 0.235 0.43 0.62963 -0.49 0.2981 -0.029 0.3791 1.60 0.50775 3.60 0.10172 
APOC4p2623/rs5157 intron1 4 0.1723 0.28 0.2703 -0.14 0.59553 0.13 0.3287 0.001 0.9481 1.43 0.04428 0.78 0.21466 
APOC4p2640/rs5158 intron1 2b 0.0213 0.55 0.414 -0.29 0.66191 0.01 0.9712 -0.052 0.0353 1.44 0.44596 -1.12 0.4997 
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APOC4p2678/rs148564866 intron1 2b 0.0086 -0.61 0.555 0.07 0.94518 -0.31 0.584 0.041 0.288 0.87 0.76308 2.67 0.29564 
APOC4p2767/rs127721107 intron1 4 0.0254 0.35 0.5788 0.56 0.37292 0.16 0.6279 -0.007 0.7599 3.15 0.07284 2.17 0.1601 
APOC4p3348 intron1 5 0.0007 -2.86 0.4403 11.56 0.00153 0.74 0.7067 -0.230 0.0947 -9.98 0.33555 14.52 0.11008 
APOC2p75-C4p3380/rs12721104 C4-intron1 5 0.1368 0.02 0.9358 -0.11 0.69346 -0.01 0.9244 0.015 0.1633 -0.07 0.92847 -1.25 0.06839 
APOC2p194-C4p3498/rs1132899 C4-exon2  5 0.2368 0.21 0.3615 -0.14 0.53341 0.11 0.3546 -0.001 0.8783 0.95 0.13191 0.88 0.11098 
APOC2p228/rs5164 C4-exon2  5 0.0066 -0.78 0.5126 -0.72 0.54187 -0.43 0.4953 0.036 0.4138 2.49 0.4501 3.31 0.25501 
APOC2p288-C4p3592/rs12691090 C4-exon2  5 0.0272 -0.02 0.9753 0.75 0.21469 0.02 0.9419 -0.008 0.7262 1.96 0.24561 2.00 0.17721 
APOC2p396-C4p3700 C4-intron2 5 0.0007 -4.47 0.2324 5.90 0.11176 -1.40 0.4802 -0.139 0.3161 -9.04 0.38386 11.51 0.21156 
APOC2p488-C4p3792/rs5165 C4-intron2 5 0.0146 0.13 0.8735 -0.04 0.96019 -0.07 0.8663 -0.025 0.4059 -0.83 0.71058 -1.54 0.43321 
APOC2p623-C4p3927/rs5167 C4-exon3 5 0.4594 -0.37 0.0527 0.05 0.77107 -0.16 0.1057 0.007 0.3421 -0.54 0.31017 0.19 0.6794 
APOC2p665-C4p3969/rs138548797 C4-exon3 No Data 0.0086 0.18 0.8649 -0.06 0.94985 0.00 0.9938 0.017 0.6686 4.09 0.15807 -2.07 0.41707 
APOC2p708-C4p4012 C4-exon3 6 0.0007 -1.33 0.7212 -7.15 0.05187 -1.34 0.4936 0.287 0.0381 6.46 0.53306 -9.42 0.30174 
APOC2p853-C4p4157/rs10425530 C4-3' UTR 6 0.11 -0.20 0.5315 0.24 0.43314 -0.06 0.7051 -0.004 0.7518 -0.53 0.5399 1.17 0.12757 
APOC2p1042-C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 0.0178 -1.25 0.0855 1.10 0.13505 -0.55 0.1548 -0.035 0.1866 -4.39 0.02431 5.95 0.00071 
APOC2p1187-C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 0.0178 0.21 0.7773 0.58 0.44007 0.17 0.6739 -0.013 0.6376 3.17 0.13276 3.23 0.08379 
APOC2p1229-C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b 0.014 -0.17 0.8398 0.83 0.31821 0.04 0.9328 -0.007 0.8154 2.78 0.23927 3.20 0.12314 
APOC2p1275-C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 0.0352 -0.95 0.0752 -0.18 0.7323 -0.48 0.0954 0.006 0.7493 -0.23 0.87888 0.35 0.79182 
APOC2p1357-C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.2581 0.51 0.0202 0.05 0.80869 0.28 0.0153 -0.007 0.3614 1.37 0.02344 0.80 0.13323 
APOC2p1540-C4p4844/rs75463753 C2-intron1 4 0.1079 0.80 0.0114 0.09 0.77127 0.42 0.0111 -0.008 0.5 1.08 0.21814 0.48 0.5384 
APOC2p2486/rs9304645 intron1 4 0.3655 -0.54 0.0084 0.09 0.65299 -0.20 0.0737 0.011 0.1406 -0.21 0.7176 0.75 0.13555 
APOC2p2935/rs11879392 intron1 2b 0.0135 0.87 0.317 0.57 0.49871 0.27 0.5399 -0.069 0.0285 0.44 0.85516 0.18 0.93035 
APOC2p3010/rs10419086 intron1 6 0.1253 0.03 0.9215 0.15 0.62186 -0.05 0.7439 -0.017 0.1272 -0.91 0.2581 -1.32 0.06568 
APOC2p3692/rs12721060 intron1 No Data 0.0172 -0.19 0.8123 0.76 0.3536 -0.04 0.9297 -0.015 0.6229 2.28 0.31473 3.01 0.14108 
APOC2p3778/rs5120 intron1 4 0.1845 0.60 0.0158 0.08 0.74123 0.33 0.0129 -0.0001 0.9937 1.11 0.10763 0.79 0.19964 
APOC2p3805/rs7257095 intron1 2a 0.1649 0.35 0.1883 -0.16 0.53621 0.13 0.3551 -0.003 0.7465 0.72 0.33716 -0.55 0.40568 
APOC2p3814/rs10422603 intron1 2b 0.3008 -0.30 0.1716 0.25 0.23836 -0.08 0.4714 0.012 0.1454 -0.10 0.87424 0.97 0.06515 
APOC2p3892/rs5121 exon2 5 0.0358 -0.21 0.6957 -0.03 0.95269 -0.11 0.6979 0.004 0.8416 -0.03 0.98356 0.20 0.87741 
APOC2p4086/rs114780592 intron2 4 0.0278 -0.04 0.9509 0.49 0.40801 -0.02 0.9506 -0.004 0.8486 3.05 0.0669 1.53 0.29745 
APOC2p4118/rs201709243 exon3 4 0.0007 -6.14 0.1016 *** *** 0.52 0.7926 *** *** -2.87 0.7826 *** *** 
APOC2p4319/rs5123 intron3 No Data 0.0592 0.19 0.6268 -0.14 0.71873 0.15 0.4796 -0.008 0.6025 -0.25 0.82293 0.49 0.61561 
APOC2p4513/rs180809422 intron3 5 0.0135 0.46 0.5715 0.82 0.32552 0.34 0.438 -0.021 0.5011 2.64 0.26202 3.47 0.09379 
APOC2p4587/rs5126 exon4 5 0.0499 -0.14 0.757 0.12 0.80049 -0.07 0.771 -0.011 0.5193 1.71 0.18011 0.68 0.54818 
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APOC2p4754/rs7253690 exon4 5 0.0606 0.26 0.5088 -0.01 0.9801 0.25 0.2212 -0.004 0.787 0.19 0.85817 1.17 0.22087 
APOC2p4853/rs150448996 3'flamking region No Data 0.2736 0.10 0.6544 -0.18 0.40916 -0.02 0.8445 0.001 0.9083 -0.05 0.93724 -0.86 0.10718 
APOC2p4973/rs199828513 3'flamking region No Data 0.0082 -1.49 0.1714 -0.60 0.58323 -0.79 0.1664 0.010 0.8053 3.46 0.24889 0.16 0.95293 
APOC2p5004/rs10421404 3'flanking region No Data 0.2908 -0.34 0.1149 0.16 0.46461 -0.11 0.3371 0.011 0.1599 -0.04 0.94186 0.61 0.24821 
APOC2p5018/rs78403558 3'flanking region 5 0.0352 0.77 0.1368 0.00 0.9939 0.30 0.2761 -0.024 0.2111 1.27 0.37773 0.36 0.77793 
APOC2p5310/rs7258345 3'flanking region No Data 0.3067 0.37 0.1018 0.11 0.61363 0.17 0.1497 -0.010 0.216 0.29 0.63627 -0.42 0.44209 
APOC2p5398/rs12709889 3'flanking region 6 0.2587 0.19 0.3893 -0.12 0.59063 0.02 0.8441 -0.001 0.9294 0.16 0.79862 -0.63 0.24337 
APOC2p5491 3'flanking region 6 0.0007 7.19 0.053 6.53 0.0762 4.21 0.0315 -0.040 0.775 -8.06 0.43745 -5.71 0.53224 
APOC2p5512/rs12721064 3'flanking region 6 0.0083 -1.02 0.3246 0.05 0.96332 -0.10 0.8634 0.087 0.0297 -2.23 0.43911 0.10 0.96886 
APOC2p5562 3'flanking region No Data 0.0175 -0.41 0.6012 -0.67 0.37221 -0.21 0.5949 -0.015 0.6109 -0.92 0.67145 0.65 0.73492 
APOC2p5586/rs73558127 3'flanking region No Data 0.1001 -0.58 0.0713 0.47 0.13813 -0.23 0.1778 -0.008 0.485 0.13 0.88663 1.00 0.20571 
APOC2p5771 3'flanking region 6 0.0047 *** *** -0.58 0.67563 *** *** 0.031 0.5541 *** *** -1.10 0.74972 
APOC2p5815/rs10423208 3'flanking region 5 0.3164 0.42 0.0474 0.03 0.8759 0.18 0.117 -0.010 0.203 0.34 0.55855 -0.43 0.41044 
APOC2p5922/rs10422888 3'flanking region 5 0.0784 0.98 0.0079 -0.01 0.98595 0.48 0.0129 0.015 0.2582 1.47 0.14838 0.05 0.95405 
APOC2p5965 3'flanking region 5 0.0013 2.76 0.295 2.75 0.29064 1.58 0.2542 -0.006 0.9512 -10.45 0.15456 -2.79 0.66578 
APOC2p6334 3'flanking region No Data 0.0096 1.76 0.0678 0.60 0.52729 0.94 0.0628 0.014 0.6886 3.15 0.2415 -2.30 0.33277 
yellow highlighted values represent significant p-value; MAF: minor allele frequency; LDL-C: low-density lipoprotein cholesterol; ApoB: apolipoprotein B; TG: triglyceride; HDL-C: 





Table 25.  Genotype-specific means (± SD) of LDL-C and HDL-C genotyped SNPs in African Blacks    
           LDL-Ca HDL-Ca 
Variant name Function regulome db score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 
APOE73/rs1081101 5'flanking 4 0.0611 CC/CT/TT 660/82/5 109.82/104.38/99.53 34.8/33.9/34.1 -0.62 0.111 47.72/49.03/48.5 12.6/13.7/5.6 0.30 0.42732 
APOE173 5'flanking 3a 0.002 AA/GA 746/3 109.16/99.49 34.7/40.5 -1.14 0.5979 47.84/40.69 12.7/11.2 -2.10 0.32058 
APOE308/rs769445 5'flanking 4 0.0072 CC/TC 739/10 109.16/106.69 34.6/42.5 -0.37 0.7576 47.86/44.21 12.7/11.0 -1.06 0.34278 
APOE560/rs449647 5'flanking 5 0.3663 AA/AT/TT 300/334/105 105.33/110.93/115.09 33.1/36.0/33.4 0.58 0.0031 48.06/47.85/46.63 12.5/13.0/12.7 -0.18 0.35635 
APOE618 5'flanking 4 0.0006 GC/GG 1/763 83.39/109.35 NA/34.5 -2.85 0.4432 13.45/47.78 NA/12.6 -12.25 0.00079 
APOE624/rs769446 5'flanking 3a 0.0077 TC/TT 9/690 85.79/109.43 33.9/34.4 -2.86 0.0214 49.89/47.71 15.1/12.9 0.65 0.56874 
APOE832/rs405509 5'flanking 1f 0.2561 GG/GT/TT 428/267/61 105.85/114.09/111.31 34.0/36.1/30.7 0.60 0.0044 47.91/48.13/45.19 12.9/12.7/11.3 -0.19 0.36119 
APOE1109/rs9282609 Splice site 4 0.0415 CC/TC/TT 686/55/4 109.01/109/110.06 34.7/33.6/31.7 0.05 0.9183 47.63/50.15/49.36 12.6/13.7/6.6 0.61 0.17876 
APOE1163/rs440446 intron1 4 0.1004 CC/CG/GG 8/126/569 106.24/113.53/108.52 22.4/36.0/34.7 0.44 0.1791 45.27/46.49/48.41 14.2/12.5/12.8 -0.54 0.09464 
APOE1231 intron1 2b 0.0125 GA/GG 19/729 102.61/109.3 30.1/34.8 -0.71 0.4139 46.84/47.87 11.5/12.7 -0.27 0.755 
APOE1279/rs877973 intron1 4 0.0597 AA/CA/CC 3/81/664 75.36/111.5/109.08 40.0/39.9/34.0 -0.15 0.7208 49.78/49.36/47.61 11.2/12.3/12.7 0.51 0.19812 
APOE1539/rs184686013 intron1 4 0.0086 AA/AG/GG 733/11/1 109.19/102.23/77.29 34.6/30.1/NA -1.03 0.2862 47.68/54.07/46.37 12.7/13.5/NA 1.35 0.15682 
APOE2072/rs189660912 intron 2 4 0.0079 GA/GG 12/734 103.59/109.27 21.4/34.9 -0.50 0.6433 46.66/47.85 15.0/12.7 -0.40 0.70658 
APOE2269/rs6135770 intron 2 5 0.0169 GA/GG 25/723 92.91/110.08 30.6/34.6 -2.05 0.0064 50.39/47.78 12.6/12.7 0.77 0.29121 
APOE2440/rs769450 intron 2 5 0.387 AA/AG/GG 107/308/261 112.51/109.87/108.31 37.6/35.0/33.7 0.20 0.3409 46.94/48.89/47.64 13.4/13.3/12.3 -0.02 0.93935 
APOE3673/rs769453 intron 3 5 0.0066 CC/GC 738/9 109.07/106.76 34.4/44.5 -0.37 0.7649 47.85/44.06 12.7/11.5 -1.10 0.34567 
APOE3937/rs429358 exon 4 5 0.2656 CC/CT/TT 58/285/406 109.67/113.33/106.49 31.8/35.5/34.3 0.46 0.0317 46.45/47.78/48 12.5/12.0/13.3 -0.14 0.50743 
APOE4036/rs769455 exon 4 5 0.02 CC/TC/TT 708/27/1 109.86/91.6/71.5 34.4/28.0/NA -2.23 0.0009 47.95/48.87/15.7 12.7/12.5/NA -0.46 0.48274 
APOE4075/rs7412 exon 4 5 0.0605 AA/GA/GG 2/84/670 50.48/95.05/111.16 6.8/30.7/34.7 -2.05 5.35E-07 50.84/49.96/47.54 12.7/11.5/12.8 0.75 0.06615 
APOE4569 3'UTR 5 0.0007 GG/GT 746/1 109.02/201.25 34.6/NA 8.87 0.0173 47.84/66.63 12.7/NA 5.29 0.14968 
APOE5223 3'flanking 2b 0.0051 CC/CG 758/8 109.45/90.42 34.5/28.8 -2.25 0.0874 47.74/48.97 12.7/12.1 0.39 0.763 
APOE5231 3'flanking 2b 0.027 GG/GT/TT 2/36/708 93.74/109.69/109.12 32.2/36.0/34.7 -0.10 0.8587 51.97/46.78/47.88 NA/11.1/12.8 -0.18 0.76449 
rs439401 intragenic region 1b 0.1092 CC/CT/TT 587/130/15 108.47/112.63/109.57 34.9/34.5/23.2 0.39 0.1933 48.34/46.18/44.72 12.8/12.4/12.1 -0.60 0.04448 
APOC1rs445925 intragenic region No Data 0.299 AA/GA/GG 68/310/367 108.26/109.76/109.34 35.4/33.8/34.7 -0.01 0.9509 47.56/48.18/47.55 12.3/12.0/13.2 0.10 0.64004 
APOC1p720ins4/rs71962921 5'flanking  4 0.2737 II/WI/WW 60/279/396 100.36/107.87/111.26 36.7/34.7/34.4 -0.57 0.0084 48.48/48.36/47.27 11.6/12.3/13.2 0.27 0.20872 
APOC1p894/rs190454394 5'flanking  4 0.002 CC/CT 740/3 108.86/142.2 34.6/39.3 3.70 0.0852 47.81/50.62 12.7/21.6 0.74 0.72955 
APOC1p1166/rs72654452 intron1 2b 0.0308 CC/CT/TT 715/42/2 108.8/116.01/91.06 34.2/38.4/11.9 0.49 0.3678 47.84/46.05/44.23 12.5/15.1/12.2 -0.61 0.25404 
APOC1p1331/rs10408994 intron2 4 0.0666 AG/GG 98/639 113.82/108.81 32.4/34.9 0.62 0.1238 48.89/47.56 14.7/12.4 0.35 0.38621 
APOC1p1526/rs5114 intron2 4 0.0579 CC/CT/TT 657/77/3 108.95/112.62/75.24 33.9/40.4/40.0 -0.05 0.9053 47.54/49.45/49.82 12.8/12.5/11.2 0.55 0.1745 
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APOC1p1642 intron2 4 0.0103 CC/CT 742/16 109.44/100.1 34.6/31.8 -1.05 0.2648 47.86/45.82 12.7/11.7 -0.59 0.53986 
APOC1p1684/rs12709881 intron2 4 0.0973 AA/GA/GG 8/130/617 85.21/108.63/109.75 39.5/37.5/33.9 -0.51 0.1179 47.84/49.16/47.6 8.5/12.3/12.7 0.40 0.20729 
APOC1p3358 intron3 No Data 0.0021 AA/GA 706/3 109.04/105.39 35.0/16.6 -0.25 0.9068 47.78/59.16 12.8/10.3 3.44 0.10895 
APOC1p3423/rs389261 intron3 No Data 0.331 AA/GA/GG 79/317/318 110.34/110.1/108.09 31.8/34.3/36.0 0.19 0.3556 48.12/48.58/47.01 12.8/14.0/11.5 0.24 0.26136 
APOC1p3573/rs10424339 intron3 No Data 0.1396 AA/GA/GG 16/174/541 102.24/109.75/109.18 27.8/31.9/35.7 -0.02 0.9374 45.5/50.39/47.19 13.9/13.8/12.2 0.55 0.0455 
APOC1p5006/rs112528434 intron3 No Data 0.085 GG/GT/TT 573/101/7 110.62/110.94/87.02 34.3/38.4/39.6 -0.38 0.2887 47.76/48.84/49.39 12.9/13.4/7.8 0.32 0.3879 
APOC1p5053/rs12721052 intron3 No Data 0.22 DD/WD/WW 42/247/465 117.3/109.24/108.24 37.7/35.8/33.3 0.30 0.1905 46.26/47.2/48.25 12.4/13.0/12.4 -0.31 0.16174 
APOC1p5667/rs12721054 3'UTR 6 0.1446 AA/GA/GG 507/163/18 111.06/107.84/87.84 34.4/37.1/28.9 -0.77 0.0063 47.56/48.09/49.87 13.0/12.9/10.7 0.23 0.42209 
APOC1p5926/rs56131196 3'flanking  No Data 0.1745 AA/AG/GG 21/214/494 107.45/108.09/109.77 44.0/34.7/34.2 -0.22 0.3925 49.89/48.35/47.53 9.9/12.3/13.1 0.31 0.22541 
rs4803770 HCR-1 5 0.2695 CC/GC/GG 393/278/57 108.62/108.21/121.09 33.9/34.9/36.8 0.38 0.081 48.61/47.03/47.95 12.4/13.3/11.2 -0.27 0.21475 
HCR1p424/rs117664574 HCR-1 4 0.0073 AG/GG 11/733 104.69/109.12 38.8/34.6 -0.58 0.6076 54.72/47.7 13.2/12.7 2.06 0.06453 
HCR1p575/rs157599 HCR-1 3a 0.3595 AA/AG/GG 282/309/92 108.34/108.93/111.46 35.5/33.9/32.7 0.17 0.4067 47.6/48.7/48.8 11.6/14.1/12.6 0.19 0.36879 
rs5112 APC1P1 4 0.4797 CC/GC/GG 201/331/166 110.1/109.54/111.98 34.7/35.0/33.7 0.10 0.6073 46.88/48.82/48.57 11.9/12.2313.8 0.25 0.18503 
rs7259004 APC1P1 6 0.302 CC/CG/GG 74/289/368 111.32/108/109.83 33.5/35.4/34.3 -0.02 0.9061 48.65/48.54/47.07 13.3/13.2/12.2 0.29 0.15235 
HCR2p188/rs35136575 HCR-2 2a 0.1546 CC/GC/GG 530/178/25 109.72/107.36/109.53 34.7/34.6/37.3 -0.16 0.5327 47.26/49.37/46.84 12.3/13.8/13.7 0.30 0.23716 
HCR2p286 HCR-2 2a 0.0457 AA/AG/GG 3/62/676 104.96/117.78/108.53 19.3/39.8/34.1 0.79 0.0785 40.61/45.9/47.95 12.9/12.6/12.8 -0.70 0.11626 
HCR2p523/rs118004808 HCR-2 2b 0.0026 CC/TC 742/4 109.04/133.43 34.6/32.2 2.74 0.1418 47.78/47.96 12.7/18.0 0.02 0.99167 
APOC4p368 5’ flanking  6 0.0019 TC/TT 3/749 116.63/109.09 25.2/34.7 1.04 0.6283 50.1/47.75 29.7/12.7 0.33 0.87548 
APOC4p637/rs113814026 5’ flanking  No Data 0.0452 GG/GT/TT 685/68/1 109.16/110.12/33.76 34.2/35.9/NA -0.23 0.6127 47.73/48.19/41.63 12.7/12.1/NA 0.10 0.82864 
APOC4p757/rs12721105 5’ flanking  5 0.0376 GG/GT/TT 708/53/2 109.13/109.85/115.39 34.6/34.7/0.8 0.14 0.778 47.83/46.7/54.95 12.5/13.3/37.2 -0.19 0.69377 
APOC4p1088 intron1 2b 0.0013 GT/TT 2/736 87.39/109.34 41.9/34.6 -2.69 0.3048 34.51/47.87 19.7/12.7 -4.26 0.10128 
APOC4p1130 intron1 5 0.0007 CT/TT 1/744 100.46/109.12 NA/34.7 -0.71 0.8491 82.19/47.76 NA/12.7 9.46 0.00979 
APOC4p1192/rs113745034 intron1 4 0.0124 GA/GG 18/695 104.03/109.18 39.1/34.7 -0.63 0.4823 48.92/47.83 12.4/12.9 0.35 0.69302 
APOC4p1325del3 intron1 4 0.0245 WD/WW 36/706 114.84/108.99 34.4/34.6 0.70 0.2711 49.06/47.81 16.2/12.5 0.30 0.63292 
APOC4p1430ins intron1 5 0.0341 II/WI/WW 1/45/622 104.28/110.81/108.33 NA/29.3/34.8 0.32 0.5609 28.01/51.13/47.62 NA/11.9/13.2 0.69 0.22691 
APOC4p2099/rs111339708 intron1 No Data 0.0141 GG/GT 735/22 109.41/102.23 34.6/36.2 -0.83 0.3026 47.75/48.85 12.7/12.7 0.35 0.6678 
APOC4p2467/rs115225947 intron1 5 0.0141 GA/GG 21/736 115.18/108.98 38.8/34.4 0.68 0.4056 48.04/47.79 14.5/12.7 0.03 0.96646 
APOC4p2559/rs5155 intron1 4 0.0986 CC/CT/TT 616/132/7 109.2/108.23/93.93 34.2/35.1/23.7 -0.27 0.4028 47.79/47.95/37.85 12.7/12.4/12.5 -0.20 0.53148 
APOC4p2607/rs5156 intron1 4 0.0129 AG/GG 19/702 100.55/109.48 37.2/34.9 -1.04 0.235 49.11/47.76 12.5/12.8 0.43 0.62963 
APOC4p2623/rs5157 intron1 4 0.1723 CC/CT/TT 506/220/20 107.96/111.8/106.4 34.5/35.4/31.9 0.28 0.2703 47.74/48.15/42.77 12.9/12.5/8.5 -0.14 0.59553 
APOC4p2640/rs5158 intron1 2b 0.0213 CC/CT 723/31 108.83/113.04 34.6/31.4 0.55 0.414 47.8/46.98 12.5/15.3 -0.29 0.66191 
APOC4p2678/rs148564866 intron1 2b 0.0086 GC/GG 13/726 103.53/109.31 32.1/34.7 -0.61 0.555 47.93/47.81 12.0/12.8 0.07 0.94518 
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APOC4p2767/rs127721107 intron1 4 0.0254 GG/GT 697/38 109.12/112.5 34.6/36.8 0.35 0.5788 47.63/49.33 12.8/11.6 0.56 0.37292 
APOC4p3348 intron1 5 0.0007 AG/GG 1/742 84.76/109.22 NA/34.6 -2.86 0.4403 90.23/47.79 NA/12.6 11.56 0.00153 
APOC2p75-
C4p3380/rs12721104 C4-intron1 5 0.1368 AA/GA/GG 14/174/562 106.69/109.64/108.85 29.7/36.1/34.2 0.02 0.9358 42.19/48.31/47.79 16.0/12.8/12.6 -0.11 0.69346 
APOC2p194-
C4p3498/rs1132899 C4-exon2  5 0.2368 CC/CT/TT 434/282/40 107.42/112.24/104.09 33.9/35.5/32.8 0.21 0.3615 47.94/47.82/46.02 12.9/12.4/12.2 -0.14 0.53341 
APOC2p228/rs5164 C4-exon2  5 0.0066 AG/GA/GG 9/1/730 101.28/110.29/109.33 31.4/NA/34.7 -0.78 0.5126 48.31/21.33/47.81 11.9/NA/12.7 -0.72 0.54187 
APOC2p288-
C4p3592/rs12691090 C4-exon2  5 0.0272 CC/CT 698/41 109.21/109.85 34.5/38.0 -0.02 0.9753 47.64/49.98 12.8/11.9 0.75 0.21469 
APOC2p396-C4p3700 C4-intron2 5 0.0007 GA/GG 1/719 68.26/109.69 NA/34.8 -4.47 0.2324 68.22/47.77 NA/12.8 5.90 0.11176 
APOC2p488-C4p3792/rs5165 C4-intron2 5 0.0146 GA/GG 22/715 109.02/109.11 24.8/34.9 0.13 0.8735 47.63/47.84 12.3/12.8 -0.04 0.96019 
APOC2p623-C4p3927/rs5167 C4-exon3 5 0.4594 GG/GT/TT 164/367/223 106.02/108.97/112.39 33.8/34.6/34.8 -0.37 0.0527 47.74/47.89/47.38 13.0/12.5/12.9 0.05 0.77107 
APOC2p665-
C4p3969/rs138548797 C4-exon3 No Data 0.0086 AA/CA 729/13 108.93/110.64 34.5/39.0 0.18 0.8649 47.81/47.51 12.8/11.9 -0.06 0.94985 
APOC2p708-C4p4012 C4-exon3 6 0.0007 GA/GG 1/739 96.57/109.29 NA/34.7 -1.33 0.7212 24.53/47.82 NA/12.7 -7.15 0.05187 
APOC2p853-
C4p4157/rs10425530 C4-3' UTR 6 0.11 AA/GA/GG 7/153/587 95/109.14/109.57 17.7/35.7/34.4 -0.20 0.5315 46.9/48.65/47.54 14.3/12.8/12.7 0.24 0.43314 
APOC2p1042-
C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 0.0178 AA/TA/TT 720/23/1 109.64/95.95/116.41 34.8/26.9/NA -1.25 0.0855 47.7/51.29/53.52 12.7/11.9/NA 1.10 0.13505 
APOC2p1187-
C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 0.0178 AG/GG 26/691 110.91/108.93 37.5/34.6 0.21 0.7773 49.54/47.8 10.1/12.9 0.58 0.44007 
APOC2p1229-
C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b 0.014 CC/CT 714/21 109.09/107.88 34.6/38.8 -0.17 0.8398 47.74/50.43 12.7/12.0 0.83 0.31821 
APOC2p1275-
C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 0.0352 GA/GG 52/687 101.79/109.92 30.9/34.8 -0.95 0.0752 47.4/47.82 14.6/12.6 -0.18 0.7323 
APOC2p1357-
C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.2581 CC/GC/GG 50/288/411 113.84/112.38/106.7 35.0/35.9/33.4 0.51 0.0202 46.71/48.36/47.62 11.4/12.6/13.0 0.05 0.80869 
APOC2p1540-
C4p4844/rs75463753 C2-intron1 4 0.1079 AA/GA/GG 11/128/558 118.79/114.78/107.23 41.9/34.5/34.6 0.80 0.0114 47.48/47.99/47.65 14.1/11.8/13.2 0.09 0.77127 
APOC2p2486/rs9304645 intron1 4 0.3655 AA/GA/GG 89/364/292 104.84/107.27/112.78 36.7/33.5/34.4 -0.54 0.0084 47.83/47.89/47.32 14.5/12.4/12.5 0.09 0.65299 
APOC2p2935/rs11879392 intron1 2b 0.0135 CC/GC 707/19 108.91/116.82 34.6/39.3 0.87 0.317 47.79/49.99 12.6/17.5 0.57 0.49871 
APOC2p3010/rs10419086 intron1 6 0.1253 AA/AG/GG 539/150/14 109.73/109.62/109.09 35.5/33.3/22.0 0.03 0.9215 47.78/48.88/46.09 12.7/13.8/11.1 0.15 0.62186 
APOC2p3692/rs12721060 intron1 No Data 0.0172 GT/TT 23/633 107.76/109.43 37.3/34.9 -0.19 0.8123 50.36/47.98 11.5/13.0 0.76 0.3536 
APOC2p3778/rs5120 intron1 4 0.1845 AA/AT/TT 500/232/23 107.58/111.87/120.21 34.8/34.2/30.3 0.60 0.0158 47.62/48.02/47.5 13.0/11.9/14.4 0.08 0.74123 
APOC2p3805/rs7257095 intron1 2a 0.1649 CC/CG/GG 509/213/16 108.23/110.64/117.89 34.0/36.1/35.4 0.35 0.1883 47.93/47.64/45.13 13.0/12.1/12.5 -0.16 0.53621 
APOC2p3814/rs10422603 intron1 2b 0.3008 GG/GT/TT 63/309/352 107.1/108.14/110.88 39.3/34.3/34.3 -0.30 0.1716 48.94/48.34/47.37 14.7/12.4/12.7 0.25 0.23836 
APOC2p3892/rs5121 exon2 5 0.0358 CC/TC/TT 675/50/1 109.5/105.9/125.78 35.3/28.2/NA -0.21 0.6957 47.88/47.21/57.02 12.9/10.9/NA -0.03 0.95269 
APOC2p4086/rs114780592 intron2 4 0.0278 GA/GG 42/700 109.37/109.04 37.5/34.5 -0.04 0.9509 49.23/47.69 12.5/12.7 0.49 0.40801 
APOC2p4118/rs201709243 exon3 4 0.0007 GA/GG 1/722 62.68/109.3 NA/34.8 -6.14 0.1016 *** *** *** *** 
APOC2p4319/rs5123 intron3 No Data 0.0592 AA/GA/GG 6/74/649 112.84/110.41/109.17 21.9/34.0/34.9 0.19 0.6268 48.08/47.3/47.88 8.9/13.2/12.7 -0.14 0.71873 
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APOC2p4513/rs180809422 intron3 5 0.0135 AA/AC/CC 666/17/1 108.77/115.46/90.54 34.4/35.7/NA 0.46 0.5715 47.73/50.5/52.34 12.9/12.7/NA 0.82 0.32552 
APOC2p4587/rs5126 exon4 5 0.0499 AA/CA/CC 636/70/1 109.47/111.18/34.61 34.6/36.8/NA -0.14 0.757 47.83/48.33/42.04 12.8/12.0/NA 0.12 0.80049 
APOC2p4754/rs7253690 exon4 5 0.0606 AA/GA/GG 6/79/670 113.2/110.92/109.17 21.9/32.8/34.8 0.26 0.5088 47.92/47.81/47.77 8.9/13.4/12.7 -0.01 0.9801 
APOC2p4853/rs150448996 3'flamking  No Data 0.2736 DD/WD/WW 386/284/57 108.19/111.6/106.19 33.5/36.4/34.6 0.10 0.6544 48.34/47.18/47.93 13.1/12.1/13.7 -0.18 0.40916 
APOC2p4973/rs199828513 3'flamking  No Data 0.0082 WI/WW 12/704 96.67/109.4 35.9/34.3 -1.49 0.1714 45.89/47.98 11.4/12.9 -0.60 0.58323 
APOC2p5004/rs10421404 3'flanking  No Data 0.2908 CC/CT/TT 370/326/56 111.01/107.73/106.6 34.1/34.1/38.2 -0.34 0.1149 47.43/47.85/48.84 12.6/12.4/15.5 0.16 0.46461 
APOC2p5018/rs78403558 3'flanking  5 0.0352 DD/WD/WW 1/51/708 125.58/115.27/108.7 NA/36.5/34.4 0.77 0.1368 63.14/47.35/47.77 NA/15.3/12.5 0.00 0.9939 
APOC2p5310/rs7258345 3'flanking  No Data 0.3067 GG/GT/TT 326/313/57 107.52/108.38/115.79 35.7/33.8/27.7 0.37 0.1018 47.88/48.51/48.08 13.3/12.6/12.4 0.11 0.61363 
APOC2p5398/rs12709889 3'flanking  6 0.2587 AA/GA/GG 50/279/405 106.53/111.31/107.46 32.2/36.2/33.6 0.19 0.3893 47.86/47.3/48.09 13.7/12.0/13.2 -0.12 0.59063 
APOC2p5491 3'flanking  6 0.0007 CC/TC 742/1 108.89/184.16 34.4/NA 7.19 0.053 47.76/70.37 12.7/NA 6.53 0.0762 
APOC2p5512/rs12721064 3'flanking  6 0.0083 CC/CT 753/13 109.45/100.18 34.5/31.2 -1.02 0.3246 47.75/47.73 12.7/10.4 0.05 0.96332 
APOC2p5562 3'flanking  No Data 0.0175 CG/GG 24/704 105.94/109.08 36.0/34.7 -0.41 0.6012 45.55/47.83 11.8/12.8 -0.67 0.37221 
APOC2p5586/rs73558127 3'flanking  No Data 0.1001 GG/GT/TT 9/127/589 93.17/107.05/110.17 40.0/36.9/34.3 -0.58 0.0713 47.55/49.36/47.38 13.2/11.9/12.9 0.47 0.13813 
APOC2p5771 3'flanking  6 *** *** *** *** *** *** *** 45.84/47.8 13.9/12.6 -0.58 0.67563 
APOC2p5815/rs10423208 3'flanking  5 0.3164 AA/GA/GG 340/323/72 108.02/108.74/117.45 35.9/34.6/28.4 0.42 0.0474 47.59/48.15/47.14 13.0/12.6/12.3 0.03 0.8759 
APOC2p5922/rs10422888 3'flanking  5 0.0784 AA/AG/GG 597/99/5 107.54/119.18/97.09 34.2/35.4/41.2 0.98 0.0079 47.93/47.55/52.87 12.6/12.9/30.7 -0.01 0.98595 
APOC2p5965 3'flanking  5 0.0013 GA/GG 2/743 138.11/109.1 75.9/34.5 2.76 0.295 57.22/47.78 19.5/12.7 2.75 0.29064 
APOC2p6334 3'flanking  No Data 0.0096 GA/GG 15/746 123.57/109.11 26.5/34.6 1.76 0.0678 49.99/47.73 16.1/12.5 0.60 0.52729 
LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol. 
a Cox-Box transformed variables. 
Age, Gender, Smoking, BMI, Waist, Jobmin, Staff level were included in the final model as covariates. 






Table 26. Genotype-specific means (± SD) of TC and TG genotyped SNPs in African Blacks 
      TCa TGa 
Variant name Function regulome db score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 
APOE73/rs1081101 5'flanking 4 0.0611 CC/CT/TT 660/82/5 172.52/168.95/165.88 38.8/39.9/34.5 -0.20 0.3283 69.19/76.65/92.6 29.8/34.0/55.5 0.038 0.0093 
APOE173 5'flanking 3a 0.002 AA/GA 746/3 171.99/177.58 39.0/13.7 0.41 0.7151 70.13/73.71 30.6/30.4 0.037 0.7028 
APOE308/rs769445 5'flanking 4 0.0072 CC/TC 739/10 172.04/170.26 39.0/36.3 -0.06 0.9218 70.03/77.84 30.7/23.3 0.056 0.2065 
APOE560/rs449647 5'flanking 5 0.3663 AA/AT/TT 300/334/105 168.65/173.25/177.78 37.3/40.2/37.3 0.25 0.0177 70.73/69.69/70.08 31.6/28.9/31.7 -0.001 0.8482 
APOE618 5'flanking 4 0.0006 GC/GG 1/763 110.73/172.23 NA/38.7 -3.62 0.0634 68.05/70.26 NA/30.5 0.025 0.856 
APOE624/rs769446 5'flanking 3a 0.0077 TC/TT 9/690 149.63/172.21 36.3/38.7 -1.25 0.044 69.92/70.44 27.6/30.6 0.005 0.9096 
APOE832/rs405509 5'flanking 1f 0.2561 GG/GT/TT 428/267/61 169.18/176.96/170.86 38.8/39.5/34.5 0.22 0.0529 69.98/71.39/68.15 31.2/30.0/30.0 0.003 0.7457 
APOE1109/rs9282609 Splice site 4 0.0415 CC/TC/TT 686/55/4 171.7/173.68/176.55 38.8/39.8/31.0 0.12 0.6321 69.83/73.46/88.67 30.5/28.6/66.8 0.023 0.1814 
APOE1163/rs440446 intron1 4 0.1004 CC/CG/GG 8/126/569 170.43/175.07/172.02 34.5/39.6/39.0 0.12 0.4748 92.59/72.71/69.62 59.4/28.8/30.5 0.023 0.0537 
APOE1231 intron1 2b 0.0125 GA/GG 19/729 163.93/172.25 38.1/38.9 -0.46 0.3315 67.34/70.14 38.4/30.4 -0.030 0.3441 
APOE1279/rs877973 intron1 4 0.0597 AA/CA/CC 3/81/664 162.54/174.33/171.91 25.5/43.6/38.4 0.04 0.8544 60.01/64.63/70.92 23.2/26.1/31.1 -0.029 0.0513 
APOE1539/rs184686013 intron1 4 0.0086 AA/AG/GG 733/11/1 171.95/169.31/139.83 38.8/39.8/NA -0.33 0.5172 70.28/66.57/80.4 30.7/27.1/NA 0.002 0.9546 
APOE2072/rs189660912 intron 2 4 0.0079 GA/GG 12/734 164.23/172.16 31.3/39.0 -0.40 0.4796 68.98/70.12 25.0/30.7 0.009 0.8229 
APOE2269/rs6135770 intron 2 5 0.0169 GA/GG 25/723 160.71/172.86 35.5/38.8 -0.69 0.0771 79.21/69.84 37.5/30.0 0.040 0.1489 
APOE2440/rs769450 intron 2 5 0.387 AA/AG/GG 107/308/261 175.27/173.72/170.84 42.5/39.9/37.2 0.11 0.3081 69.13/70.46/70.84 29.1/30.7/31.3 -0.003 0.7396 
APOE3673/rs769453 intron 3 5 0.0066 CC/GC 738/9 171.92/169.91 38.9/37.3 -0.07 0.9054 70.23/74.25 30.7/23.4 0.037 0.4242 
APOE3937/rs429358 exon 4 5 0.2656 CC/CT/TT 58/285/406 171.28/175.76/169.72 35.1/39.9/38.7 0.17 0.1323 67.14/69.52/70.98 27.5/30.9/30.7 -0.008 0.3075 
APOE4036/rs769455 exon 4 5 0.02 CC/TC/TT 708/27/1 172.65/158.44/126.63 38.7/34.7/NA -0.87 0.0129 69.45/83.67 29.8/42.8 0.056 0.0372 
APOE4075/rs7412 exon 4 5 0.0605 AA/GA/GG 2/84/670 132.98/159.61/173.83 26.7/35.6/39.0 -0.82 0.0001 49.67/68.01/70.51 16.9/29.1/30.8 -0.018 0.2376 
APOE4569 3'UTR 5 0.0007 GG/GT 746/1 171.93/285.01 38.7/NA 5.12 0.0089 70.08/77.54 30.6/NA 0.073 0.5976 
APOE5223 3'flanking 2b 0.0051 CC/CG 758/8 172.3/153.66 38.8/21.6 -0.94 0.1738 70.38/70.64 30.7/29.6 0.006 0.9078 
APOE5231 3'flanking 2b 0.027 GG/GT/TT 2/36/708 177.07/171.06/172.08 NA/40.3/38.9 -0.03 0.9208 68.24/66.1/70.39 17.7/32.2/30.6 -0.023 0.2836 
rs439401 intragenic  1b 0.1092 CC/CT/TT 587/130/15 171.84/173.4/170.9 39.4/38.1/29.0 0.07 0.6621 69.35/71.64/77.45 30.2/29.1/48.4 0.011 0.3401 
APOC1rs445925 intragenic  No Data 0.299 AA/GA/GG 68/310/367 171.23/172.47/172.52 39.6/36.7/39.6 -0.01 0.8983 69.27/69.27/71.63 30.9/28.9/31.9 -0.007 0.3748 
APOC1p720ins4/rs71962921 5'flanking  4 0.2737 II/WI/WW 60/279/396 164.47/171.23/173.59 38.6/39.4/38.8 -0.20 0.0741 66.67/68.98/71.51 27.9/29.7/31.4 -0.013 0.1137 
APOC1p894/rs190454394 5'flanking  4 0.002 CC/CT 740/3 171.74/205.36 38.8/53.9 1.71 0.1317 70.01/68.41 30.5/15.2 0.021 0.7907 
APOC1p1166/rs72654452 intron1 2b 0.0308 CC/CT/TT 715/42/2 171.47/181.29/148.14 38.3/43.5/17.7 0.31 0.2783 69.6/78.54/69.87 30.0/39.4/31.8 0.028 0.163 
APOC1p1331/rs10408994 intron2 4 0.0666 AG/GG 98/639 177.72/171.39 38.9/39.1 0.34 0.1116 73.13/69.81 32.7/30.4 0.016 0.2862 
APOC1p1526/rs5114 intron2 4 0.0579 CC/CT/TT 657/77/3 171.74/176.03/162.64 38.4/44.1/25.5 0.12 0.5876 70.84/65.76/59.97 31.1/26.7/23.2 -0.025 0.1117 
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APOC1p1642 intron2 4 0.0103 CC/CT 742/16 172.35/161.09 38.7/40.2 -0.64 0.2132 70.09/69.91 30.2/40.5 -0.019 0.5831 
APOC1p1684/rs12709881 intron2 4 0.0973 AA/GA/GG 8/130/617 156.49/171.71/172.5 39.8/41.6/38.2 -0.16 0.364 70.29/66.84/70.55 42.3/28.2/30.4 -0.017 0.1541 
APOC1p3358 intron3 No Data 0.0021 AA/GA 706/3 171.94/176.29 39.2/26.1 0.34 0.7632 70.07/64.64 30.7/4.6 0.003 0.9727 
APOC1p3423/rs389261 intron3 No Data 0.331 AA/GA/GG 79/317/318 173.68/173.27/170.57 35.1/39.4/39.9 0.12 0.2958 70.17/69.28/71.2 29.1/29.3/32.2 -0.002 0.8116 
APOC1p3573/rs10424339 intron3 No Data 0.1396 AA/GA/GG 16/174/541 164.72/174.52/171.68 36.4/36.2/39.9 0.07 0.6371 83.79/67.92/70.5 31.9/30.3/30.7 0.001 0.9096 
APOC1p5006/rs112528434 intron3 No Data 0.085 GG/GT/TT 573/101/7 173.47/174.06/156.23 38.6/43.1/39.0 -0.10 0.6053 70.4/66.8/75.44 30.7/29.8/48.7 -0.018 0.1732 
APOC1p5053/rs12721052 intron3 No Data 0.22 DD/WD/WW 42/247/465 178.43/172.75/171 44.3/40.3/37.1 0.13 0.2728 69.77/71.12/69.87 29.5/31.2/30.3 0.004 0.6524 
APOC1p5667/rs12721054 3'UTR 6 0.1446 AA/GA/GG 507/163/18 173.87/170.98/153.32 38.8/41.5/31.7 -0.30 0.0474 72.28/66.04/65.85 31.3/27.9/31.8 -0.028 0.007 
APOC1p5926/rs56131196 3'flanking  No Data 0.1745 AA/AG/GG 21/214/494 170.86/171.58/172.33 41.2/39.1/38.7 -0.05 0.7296 60.05/68.66/71.08 25.6/30.4/30.9 -0.019 0.0442 
rs4803770 HCR-1 5 0.2695 CC/GC/GG 393/278/57 171.64/170.95/185.27 38.0/39.2/42.8 0.18 0.1102 69.84/69.66/74.13 30.4/29.8/36.3 0.005 0.5732 
HCR1p424/rs117664574 HCR-1 4 0.0073 AG/GG 11/733 174.18/171.92 39.3/38.9 0.12 0.8344 72.62/70.09 24.5/30.7 0.025 0.5525 
HCR1p575/rs157599 HCR-1 3a 0.3595 AA/AG/GG 282/309/92 171.82/172.01/175.29 38.9/39.5/34.8 0.08 0.469 71.87/68.48/70.03 33.0/28.6/29.2 -0.004 0.6132 
rs5112 APC1P1 4 0.4797 CC/GC/GG 201/331/166 171.13/173.37/177.09 39.3/38.4/37.2 0.16 0.1091 68.98/70.65/72.02 31.9/29.7/32.1 0.010 0.1818 
rs7259004 APC1P1 6 0.302 CC/CG/GG 74/289/368 176.55/171.72/171.5 37.8/39.2/39.1 0.09 0.3976 70.51/70.37/69.79 29.6/30.0/31.5 0.006 0.4328 
HCR2p188/rs35136575 HCR-2 2a 0.1546 CC/GC/GG 530/178/25 171.86/171.73/172.93 39.1/38.8/40.7 0.01 0.9184 69.43/71.86/64.97 30.2/31.6/26.4 0.005 0.604 
HCR2p286 HCR-2 2a 0.0457 AA/AG/GG 3/62/676 153.32/180.43/171.37 28.6/41.5/38.7 0.31 0.1847 45.01/77.9/69.6 8.3/34.1/30.2 0.026 0.1292 
HCR2p523/rs118004808 HCR-2 2b 0.0026 CC/TC 742/4 171.93/194.43 38.8/44.3 1.17 0.2362 70.19/71.25 30.6/13.4 0.034 0.6289 
APOC4p368 5’ flanking  6 0.0019 TC/TT 3/749 184.54/171.95 37.8/38.9 0.71 0.529 88.72/70.33 37.2/30.6 0.088 0.2641 
APOC4p637/rs113814026 5’ flanking  No Data 0.0452 GG/GT/TT 685/68/1 172.06/172.49/85.95 38.6/38.1/NA -0.13 0.5832 70.59/69.02/44.6 30.7/30.9/NA -0.013 0.4457 
APOC4p757/rs12721105 5’ flanking  5 0.0376 GG/GT/TT 708/53/2 171.91/173.9/184.62 38.6/40.0/43.8 0.13 0.6192 69.34/84.01/72.01 30.0/36.9/29.0 0.063 0.0005 
APOC4p1088 intron1 2b 0.0013 GT/TT 2/736 146.52/172.31 48.8/38.9 -1.51 0.2767 113.92/70.15 63.6/30.5 0.182 0.0633 
APOC4p1130 intron1 5 0.0007 CT/TT 1/744 198.57/171.99 NA/38.9 1.50 0.4435 83.99/70.21 NA/30.6 0.097 0.48 
APOC4p1192/rs113745034 intron1 4 0.0124 GA/GG 18/695 166.8/172.17 44.7/38.9 -0.31 0.5056 70.29/70.26 39.1/30.5 -0.008 0.8015 
APOC4p1325del3 intron1 4 0.0245 WD/WW 36/706 176.47/171.96 35.7/39.0 0.28 0.4099 61.96/70.6 22.0/30.9 -0.040 0.0909 
APOC4p1430ins intron1 5 0.0341 II/WI/WW 1/45/622 144.75/178.76/170.96 NA/35.8/39.2 0.35 0.229 63.94/67.93/70.05 NA/28.8/30.6 -0.009 0.6459 
APOC4p2099/rs111339708 intron1 No Data 0.0141 GG/GT 735/22 172.27/164.72 38.7/42.9 -0.42 0.3367 70.28/66.38 30.0/38.0 -0.033 0.2745 
APOC4p2467/rs115225947 intron1 5 0.0141 GA/GG 21/736 177.8/171.89 42.9/38.7 0.30 0.4923 62.56/70.49 20.4/30.8 -0.027 0.3794 
APOC4p2559/rs5155 intron1 4 0.0986 CC/CT/TT 616/132/7 172.28/170.33/144.83 38.3/39.3/30.3 -0.22 0.209 70.33/69.56/74.26 29.8/32.4/41.2 -0.008 0.4908 
APOC4p2607/rs5156 intron1 4 0.0129 AG/GG 19/702 163.6/172.41 43.8/39.0 -0.49 0.2981 68.08/70.39 40.6/30.6 -0.029 0.3791 
APOC4p2623/rs5157 intron1 4 0.1723 CC/CT/TT 506/220/20 170.66/175.33/164.71 39.3/38.4/35.3 0.13 0.3287 70.08/69.51/75.22 30.0/29.4/41.4 0.001 0.9481 
APOC4p2640/rs5158 intron1 2b 0.0213 CC/CT 723/31 171.84/171.36 38.8/33.7 0.01 0.9712 70.51/59.46 30.5/19.6 -0.052 0.0353 
APOC4p2678/rs148564866 intron1 2b 0.0086 GC/GG 13/726 165.62/172.23 32.1/39.1 -0.31 0.584 77.27/70 31.2/30.4 0.041 0.288 
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APOC4p2767/rs127721107 intron1 4 0.0254 GG/GT 697/38 171.99/175.77 38.7/44.1 0.16 0.6279 70.58/68.95 30.7/29.5 -0.007 0.7599 
APOC4p3348 intron1 5 0.0007 AG/GG 1/742 183.75/172.05 NA/39.0 0.74 0.7067 35.82/70.21 NA/30.6 -0.230 0.0947 
APOC2p75-
C4p3380/rs12721104 C4-intron1 5 0.1368 AA/GA/GG 14/174/562 165.15/172.76/171.78 39.0/40.5/38.2 -0.01 0.9244 81.44/72.36/69.17 46.0/32.2/29.2 0.015 0.1633 
APOC2p194-
C4p3498/rs1132899 C4-exon2  5 0.2368 CC/CT/TT 434/282/40 170.08/175.69/164.97 39.0/38.7/34.4 0.11 0.3546 70.04/70.4/68.5 30.1/30.0/33.0 -0.001 0.8783 
APOC2p228/rs5164 C4-exon2  5 0.0066 AG/GA/GG 9/1/730 164.83/154.22/172.26 34.6/NA/39.1 -0.43 0.4953 78.63/113.47/70.16 42.0/NA/30.4 0.036 0.4138 
APOC2p288-
C4p3592/rs12691090 C4-exon2  5 0.0272 CC/CT 698/41 172.07/173.5 38.7/45.2 0.02 0.9419 70.45/68.6 30.7/28.8 -0.008 0.7262 
APOC2p396-C4p3700 C4-intron2 5 0.0007 GA/GG 1/719 144.11/172.63 NA/39.2 -1.40 0.4802 40.57/70.3 NA/30.6 -0.139 0.3161 
APOC2p488-
C4p3792/rs5165 C4-intron2 5 0.0146 GA/GG 22/715 169.39/172.03 26.1/39.4 -0.07 0.8663 63.29/70.23 20.8/30.9 -0.025 0.4059 
APOC2p623-
C4p3927/rs5167 C4-exon3 5 0.4594 GG/GT/TT 164/367/223 168.86/171.92/174.54 38.9/39.2/37.7 -0.16 0.1057 70.36/70.44/68.91 28.6/30.5/31.1 0.007 0.3421 
APOC2p665-
C4p3969/rs138548797 C4-exon3 No Data 0.0086 AA/CA 729/13 171.82/172.47 38.8/45.3 0.00 0.9938 70/73.28 30.5/41.2 0.017 0.6686 
APOC2p708-C4p4012 C4-exon3 6 0.0007 GA/GG 1/739 145.97/172.21 NA/38.9 -1.34 0.4936 136.39/70.13 NA/30.6 0.287 0.0381 
APOC2p853-
C4p4157/rs10425530 C4-3' UTR 6 0.11 AA/GA/GG 7/153/587 154.39/172.94/172.12 19.7/41.6/38.2 -0.06 0.7051 68.14/70.48/70.05 43.0/31.0/29.9 -0.004 0.7518 
APOC2p1042-
C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 0.0178 AA/TA/TT 720/23/1 172.53/159.97/173.87 39.1/31.2/NA -0.55 0.1548 70.31/66.75/39.45 30.5/32.9/NA -0.035 0.1866 
APOC2p1187-
C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 0.0178 AG/GG 26/691 175.33/171.82 43.6/38.8 0.17 0.6739 69.46/70.07 36.6/30.3 -0.013 0.6376 
APOC2p1229-
C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b 0.014 CC/CT 714/21 171.91/173.08 38.9/45.0 0.04 0.9328 70.05/69.98 30.2/37.8 -0.007 0.8154 
APOC2p1275-
C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 0.0352 GA/GG 52/687 163.72/172.87 33.9/39.2 -0.48 0.0954 72.04/70.06 33.8/30.4 0.006 0.7493 
APOC2p1357-
C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.2581 CC/GC/GG 50/288/411 175.4/176.37/169.04 37.4/39.7/38.1 0.28 0.0153 65.22/70.65/70.21 30.3/31.5/30.0 -0.007 0.3614 
APOC2p1540-
C4p4844/rs75463753 C2-intron1 4 0.1079 AA/GA/GG 11/128/558 185.45/177.57/169.95 36.9/38.3/39.1 0.42 0.0111 75.36/68.12/70.53 26.4/30.9/30.3 -0.008 0.5 
APOC2p2486/rs9304645 intron1 4 0.3655 AA/GA/GG 89/364/292 169.03/170.07/174.92 40.7/37.6/39.2 -0.20 0.0737 74.7/70.34/68.75 32.0/31.3/28.9 0.011 0.1406 
APOC2p2935/rs11879392 intron1 2b 0.0135 CC/GC 707/19 171.98/177.14 39.0/41.7 0.27 0.5399 70.68/56.3 31.0/15.3 -0.069 0.0285 
APOC2p3010/rs10419086 intron1 6 0.1253 AA/AG/GG 539/150/14 172.94/171.72/170.36 39.8/38.0/28.3 -0.05 0.7439 70.9/64.67/80.16 30.9/24.1/47.0 -0.017 0.1272 
APOC2p3692/rs12721060 intron1 No Data 0.0172 GT/TT 23/633 171.96/172.46 43.3/39.3 -0.04 0.9297 67.99/70.4 36.3/30.8 -0.015 0.6229 





APOC2p3805/rs7257095 intron1 2a 0.1649 CC/CG/GG 509/213/16 171.27/172.82/181.24 38.3/40.8/33.6 0.13 0.3551 70.52/69.28/62.61 32.0/27.7/21.0 -0.003 0.7465 
APOC2p3814/rs10422603 intron1 2b 0.3008 GG/GT/TT 63/309/352 171.23/171.5/173.16 45.9/37.8/38.8 -0.08 0.4714 73.55/70.31/68.57 31.9/30.5/29.8 0.012 0.1454 
APOC2p3892/rs5121 exon2 5 0.0358 CC/TC/TT 675/50/1 172.5/167.84/201.55 39.7/28.7/NA -0.11 0.6979 70.57/68.38/86.62 31.2/26.5/NA 0.004 0.8416 
APOC2p4086/rs114780592 intron2 4 0.0278 GA/GG 42/700 172.27/171.92 43.0/38.7 -0.02 0.9506 68.73/70.31 28.2/30.8 -0.004 0.8486 
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APOC2p4118/rs201709243 exon3 4 0.0007 GA/GG 1/722 179.84/172.13 NA/39.1 0.52 0.7926 *** *** *** *** 
APOC2p4319/rs5123 intron3 No Data 0.0592 AA/GA/GG 6/74/649 176.63/174.09/171.69 17.9/38.9/39.1 0.15 0.4796 79.96/66.14/70.1 30.0/28.4/30.6 -0.008 0.6025 
APOC2p4513/rs180809422 intron3 5 0.0135 AA/AC/CC 666/17/1 171.48/182.63/147.07 38.7/42.8/NA 0.34 0.438 69.7/74.06/39.14 30.2/40.3/NA -0.021 0.5011 
APOC2p4587/rs5126 exon4 5 0.0499 AA/CA/CC 636/70/1 172.47/174.05/87.92 39.1/39.1/NA -0.07 0.771 70.44/69.87/43.72 30.8/32.5/NA -0.011 0.5193 
APOC2p4754/rs7253690 exon4 5 0.0606 AA/GA/GG 6/79/670 176.79/176.46/171.75 17.9/37.8/38.9 0.25 0.2212 80.33/67.52/70.67 30.0/28.0/30.9 -0.004 0.787 
APOC2p4853/rs150448996 3'flamking  No Data 0.2736 DD/WD/WW 386/284/57 171.97/173.3/169.32 37.4/40.9/41.4 -0.02 0.8445 70.45/70.09/69.45 32.4/28.1/31.5 0.001 0.9083 
APOC2p4973/rs199828513 3'flamking  No Data 0.0082 WI/WW 12/704 158.47/172.45 42.8/38.5 -0.79 0.1664 76.49/70.11 46.3/30.4 0.010 0.8053 
APOC2p5004/rs10421404 3'flanking  No Data 0.2908 CC/CT/TT 370/326/56 173.36/170.73/171 38.5/37.8/44.3 -0.11 0.3371 69.07/71.11/74.63 29.8/31.4/32.8 0.011 0.1599 
APOC2p5018/rs78403558 3'flanking  5 0.0352 DD/WD/WW 1/51/708 201.27/176.34/171.67 NA/39.6/38.7 0.30 0.2761 63.63/64.03/70.79 NA/21.8/31.1 -0.024 0.2111 
APOC2p5310/rs7258345 3'flanking  No Data 0.3067 GG/GT/TT 326/313/57 170.54/172.14/177.55 40.3/38.2/29.6 0.17 0.1497 70.87/69.31/68.65 29.8/31.4/33.4 -0.010 0.216 
APOC2p5398/rs12709889 3'flanking  6 0.2587 AA/GA/GG 50/279/405 169.1/173.21/171.05 37.8/40.8/37.6 0.02 0.8441 66.62/70.44/70.46 28.7/28.3/32.4 -0.001 0.9294 
APOC2p5491 3'flanking  6 0.0007 CC/TC 742/1 171.71/265.05 38.6/NA 4.21 0.0315 70.01/55.11 30.5/NA -0.040 0.775 
APOC2p5512/rs12721064 3'flanking  6 0.0083 CC/CT 753/13 172.17/170.04 38.7/35.3 -0.10 0.8634 70.02/87.21 30.5/33.9 0.087 0.0297 
APOC2p5562 3'flanking  No Data 0.0175 CG/GG 24/704 168.35/171.94 38.4/39.0 -0.21 0.5949 67.09/70.25 31.1/30.5 -0.015 0.6109 
APOC2p5586/rs73558127 3'flanking  No Data 0.1001 GG/GT/TT 9/127/589 154.43/170.57/172.77 45.8/40.7/38.7 -0.23 0.1778 80.41/67.13/70.25 39.2/30.0/29.8 -0.008 0.485 
APOC2p5771 3'flanking  6 *** *** *** *** *** *** *** 78.25/70.26 39.4/30.4 0.031 0.5541 
APOC2p5815/rs10423208 3'flanking  5 0.3164 AA/GA/GG 340/323/72 170.83/172.31/178 40.4/39.2/30.3 0.18 0.117 70.84/70.33/67.09 29.8/31.1/32.8 -0.010 0.203 
APOC2p5922/rs10422888 3'flanking  5 0.0784 AA/AG/GG 597/99/5 170.44/182.24/164.13 38.3/40.1/51.6 0.48 0.0129 69.37/72.64/72.93 30.1/31.3/31.5 0.015 0.2582 
APOC2p5965 3'flanking  5 0.0013 GA/GG 2/743 208.01/171.97 93.3/38.7 1.58 0.2542 61.69/70.14 10.6/30.6 -0.006 0.9512 
APOC2p6334 3'flanking  No Data 0.0096 GA/GG 15/746 188.71/171.92 31.0/38.7 0.94 0.0628 73.45/70.12 28.7/30.6 0.014 0.6886 
TG:triglyceride; TC: total cholesterol; a Cox-Box transformed variables; Age, Gender, Smoking, BMI, Waist, Jobmin, Staff level were included in the final 





Table 27. Genotype-specific means (± SD) of ApoB and ApoA1 genotyped SNPs in African Blacks 
          ApoBa ApoA1a 
Variant name Function regulome db score MAF Genotype GT Count AdjMean GT_SD Beta p_value AdjMean GT_SD Beta p_value 





APOE173 5'flanking 3a 0.002 AA/GA 746/3 66.5/72.76 21.8/14.2 3.20 0.59226 136.65/157.72 27.6/32.9 6.86 0.19127 
APOE308/rs769445 5'flanking 4 0.0072 CC/TC 739/10 66.47/70.18 21.8/21.5 1.87 0.55135 136.6/146.23 27.6/28.1 3.21 0.2461 
APOE560/rs449647 5'flanking 5 0.3663 AA/AT/TT 300/334/105 65.41/66.78/69.26 22.9/21.9/18.9 0.92 0.09509 137.15/136.83/133.49 28.1/27.1/30.4 -0.49 0.31886 





APOE624/rs769446 5'flanking 3a 0.0077 TC/TT 9/690 57.76/66.77 13.5/21.9 -4.19 0.20373 146.85/136.47 18.7/27.9 3.55 0.20204 
APOE832/rs405509 5'flanking 1f 0.2561 GG/GT/TT 428/267/61 65.72/68.69/66.11 21.6/22.1/21.5 0.66 0.26113 137.58/136.56/132.03 28.2/27.3/26.8 -0.67 0.19928 
APOE1109/rs9282609 Splice site 4 0.0415 CC/TC/TT 686/55/4 66.07/71.5/56.8 21.4/24.4/28.8 1.38 0.27683 136.58/139.25/126.95 27.4/32.1/27.3 0.24 0.83418 
APOE1163/rs440446 intron1 4 0.1004 CC/CG/GG 8/126/569 73.38/71.01/66.01 15.1/22.5/21.6 2.30 0.01093 131.72/136.2/137.15 25.8/27.4/27.9 -0.44 0.58046 
APOE1231 intron1 2b 0.0125 GA/GG 19/729 62.87/66.6 18.1/21.9 -1.71 0.47484 133.54/136.87 28.3/27.6 -1.12 0.59594 
APOE1279/rs877973 intron1 4 0.0597 AA/CA/CC 3/81/664 51.79/67.05/66.53 6.6/24.2/21.6 -0.45 0.68467 129.68/140.9/136.39 33.5/25.8/27.8 1.06 0.27597 
APOE1539/rs184686013 intron1 4 0.0086 AA/AG/GG 733/11/1 66.43/70.12/48.6 21.8/20.5/NA 0.23 0.93296 136.35/156.58/122.97 27.6/31.3/NA 4.24 0.0738 
APOE2072/rs189660912 intron 2 4 0.0079 GA/GG 12/734 67.45/66.55 10.5/22.0 0.70 0.81486 133.01/136.88 31.9/27.7 -1.35 0.61188 
APOE2269/rs6135770 intron 2 5 0.0169 GA/GG 25/723 61.69/66.98 19.9/21.8 -2.56 0.22005 140/136.7 29.2/27.8 1.09 0.55027 
APOE2440/rs769450 intron 2 5 0.387 AA/AG/GG 107/308/261 65.5/67.83/67.87 22.4/21.8/20.9 -0.50 0.37248 134.99/138.74/137.19 26.9/28.3/28.4 -0.17 0.73856 
APOE3673/rs769453 intron 3 5 0.0066 CC/GC 738/9 66.4/70.47 21.7/22.5 2.02 0.5386 136.5/148.37 27.7/28.4 3.93 0.17574 
APOE3937/rs429358 exon 4 5 0.2656 CC/CT/TT 58/285/406 65.25/67.46/66.46 20.4/22.6/21.6 0.05 0.9371 128.85/136.59/137.88 25.0/27.5/28.2 -1.00 0.05924 
APOE4036/rs769455 exon 4 5 0.02 CC/TC/TT 708/27/1 66.89/60.39/48.19 21.7/22.7/NA -3.45 0.06644 136.77/138.61/79.6 27.4/27.5/NA -0.71 0.66412 
APOE4075/rs7412 exon 4 5 0.0605 AA/GA/GG 2/84/670 45.96/63.02/67.16 27.7/18.2/22.2 -2.35 0.03564 172.7/145.92/135.3 47.7/26.7/27.4 3.85 0.00008 
APOE4569 3'UTR 5 0.0007 GG/GT 746/1 66.46/96.65 21.8/NA 14.25 0.1684 136.83/185.08 27.7/NA 15.53 0.08835 
APOE5223 3'flanking 2b 0.0051 CC/CG 758/8 66.75/61.28 21.9/17.7 -2.54 0.51655 136.65/140.31 27.7/22.0 1.29 0.70886 
APOE5231 3'flanking 2b 0.027 GG/GT/TT 2/36/708 50.22/66.27/66.55 17.5/21.6/21.9 -0.82 0.60359 125.57/138.13/136.85 88.2/22.9/27.8 -0.03 0.98493 
rs439401 intragenic region 1b 0.1092 CC/CT/TT 587/130/15 65.65/69.73/66.92 21.8/22.6/17.8 1.42 0.0862 137.09/135.48/134.62 27.8/27.8/25.6 -0.50 0.50161 
APOC1rs445925 intragenic region No Data 0.299 AA/GA/GG 68/310/367 67.55/65.84/67.5 23.1/21.2/22.2 -0.31 0.59161 137.99/137.53/136.18 27.3/27.7/28.1 0.36 0.48026 
APOC1p720ins4/rs71962921 5'flanking  4 0.2737 II/WI/WW 60/279/396 62.61/65.77/67.67 21.4/21.6/22.1 -1.10 0.06438 135.77/140.58/134.24 24.5/27.4/28.3 1.03 0.04836 
APOC1p894/rs190454394 5'flanking  4 0.002 CC/CT 740/3 66.39/83.3 21.8/18.1 8.19 0.17048 136.85/137.78 27.7/28.4 0.40 0.93927 
APOC1p1166/rs72654452 intron1 2b 0.0308 CC/CT/TT 715/42/2 66.43/69.71/58.03 21.8/23.5/6.5 0.98 0.51091 136.77/133.56/128.31 27.8/27.3/12.3 -1.09 0.40589 
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APOC1p1331/rs10408994 intron2 4 0.0666 AG/GG 98/639 65.22/66.91 20.9/22.0 -0.83 0.46727 134.89/136.82 29.1/27.5 -0.66 0.50656 
APOC1p1526/rs5114 intron2 4 0.0579 CC/CT/TT 657/77/3 66.45/67.64/51.76 21.6/24.8/6.6 -0.22 0.84865 136.21/141.93/129.69 28.0/26.1/33.5 1.38 0.165 
APOC1p1642 intron2 4 0.0103 CC/CT 742/16 66.75/62.78 21.9/19.4 -1.86 0.47702 136.9/131.29 27.7/29.6 -1.90 0.4104 
APOC1p1684/rs12709881 intron2 4 0.0973 AA/GA/GG 8/130/617 49.71/65.76/67 9.7/23.1/21.7 -1.48 0.09465 128.67/140.21/136.26 23.6/26.2/28.0 0.73 0.34454 
APOC1p3358 intron3 No Data 0.0021 AA/GA 706/3 66.41/59 22.0/31.7 -3.96 0.50955 136.79/129.19 28.0/16.1 -2.34 0.6601 
APOC1p3423/rs389261 intron3 No Data 0.331 AA/GA/GG 79/317/318 65.53/67.06/66.54 20.1/21.6/22.6 -0.04 0.94719 133.68/137.66/137.23 29.8/28.0/26.9 -0.36 0.48713 
APOC1p3573/rs10424339 intron3 No Data 0.1396 AA/GA/GG 16/174/541 63.34/65.58/67.09 14.8/19.7/22.7 -0.71 0.36467 128.38/139.71/136.32 19.1/29.5/27.3 0.40 0.55931 
APOC1p5006/rs112528434 intron3 No Data 0.085 GG/GT/TT 573/101/7 67.71/67.25/49.23 21.7/22.7/9.0 -1.22 0.2099 136.73/139.26/137.09 27.9/28.5/15.1 0.67 0.44123 
APOC1p5053/rs12721052 intron3 No Data 0.22 DD/WD/WW 42/247/465 70.33/66.93/66.24 22.6/21.8/21.9 0.66 0.29256 133.78/136.4/137.22 24.3/28.9/27.0 -0.42 0.4506 
APOC1p5667/rs12721054 3'UTR 6 0.1446 AA/GA/GG 507/163/18 67.33/67.34/55.54 21.9/21.2/19.3 -1.01 0.18808 135.85/140.83/134.9 28.3/26.6/29.6 1.01 0.14096 
APOC1p5926/rs56131196 3'flanking  No Data 0.1745 AA/AG/GG 21/214/494 58.05/66.99/66.81 26.0/21.8/21.8 -0.70 0.33774 141.08/138.62/136.05 25.0/27.1/28.2 0.87 0.17334 
rs4803770 HCR-1 5 0.2695 CC/GC/GG 393/278/57 65.83/66.43/71.57 21.7/21.6/24.4 0.90 0.13554 137.95/135.57/136.07 26.5/30.1/24.9 -0.53 0.32036 
HCR1p424/rs117664574 HCR-1 4 0.0073 AG/GG 11/733 71.83/66.46 37.0/21.6 2.07 0.5106 154.41/136.55 36.0/27.5 5.74 0.04801 
HCR1p575/rs157599 HCR-1 3a 0.3595 AA/AG/GG 282/309/92 66.91/66.92/68.27 22.7/20.7/22.2 0.27 0.64249 139.3/136.05/136.6 27.1/28.9/26.5 -0.63 0.22016 
rs5112 APC1P1 4 0.4797 CC/GC/GG 201/331/166 66.7/67.09/68.92 22.6/21.7/21.6 0.54 0.31703 133.36/139.51/137.98 26.1/29.0/27.0 0.80 0.0924 
rs7259004 APC1P1 6 0.302 CC/CG/GG 74/289/368 67.71/66.77/66.22 19.5/21.6/22.6 0.37 0.51449 138.36/138.41/134.76 30.2/25.5/28.8 0.83 0.10102 
HCR2p188/rs35136575 HCR-2 2a 0.1546 CC/GC/GG 530/178/25 67.35/63.27/73.02 22.0/21.2/22.5 -0.61 0.4015 135.93/138.83/139.95 27.5/28.4/22.1 0.85 0.18117 
HCR2p286 HCR-2 2a 0.0457 AA/AG/GG 3/62/676 39.84/72.35/66.09 25.4/23.5/21.6 1.37 0.27692 99.8/138.38/136.61 39.6/28.1/27.5 -0.59 0.59403 
HCR2p523/rs118004808 HCR-2 2b 0.0026 CC/TC 742/4 66.44/80.18 21.9/14.8 6.71 0.19588 136.79/135.78 27.8/23.2 -0.21 0.96328 
APOC4p368 5’ flanking  6 0.0019 TC/TT 3/749 63.48/66.95 3.8/21.7 -1.39 0.81479 135.24/136.61 47.1/27.7 -0.69 0.8967 
APOC4p637/rs113814026 5’ flanking  No Data 0.0452 GG/GT/TT 685/68/1 66.4/69.81/52.26 21.5/23.3/NA 1.34 0.29549 136.63/138.36/93.9 27.8/26.0/NA 0.14 0.90262 
APOC4p757/rs12721105 5’ flanking  5 0.0376 GG/GT/TT 708/53/2 66.65/67.05/74.54 21.9/21.2/2.9 0.45 0.7436 137.13/132.16/137.02 27.9/24.5/52.0 -1.40 0.23935 
APOC4p1088 intron1 2b 0.0013 GT/TT 2/736 61.84/66.56 12.6/21.9 -2.07 0.7775 122.5/136.86 33.6/27.8 -4.80 0.45794 
APOC4p1130 intron1 5 0.0007 CT/TT 1/744 25.33/66.55 NA/21.8 -21.03 0.04207 181.19/136.78 NA/27.7 14.38 0.11483 
APOC4p1192/rs113745034 intron1 4 0.0124 GA/GG 18/695 72.18/66.29 25.1/21.8 2.83 0.26681 146.73/136.51 24.1/28.1 3.44 0.12841 
APOC4p1325del3 intron1 4 0.0245 WD/WW 36/706 69.67/66.4 18.1/22.0 1.71 0.33255 136.28/136.88 34.2/27.3 -0.31 0.84012 
APOC4p1430ins intron1 5 0.0341 II/WI/WW 1/45/622 74.06/68.25/65.56 NA/21.6/22.1 1.43 0.35841 92.72/146.32/135.42 NA/24.5/28.2 2.68 0.05543 
APOC4p2099/rs111339708 intron1 No Data 0.0141 GG/GT 735/22 66.63/69.07 21.8/23.8 1.19 0.59549 136.41/145.3 27.9/22.1 3.04 0.13403 
APOC4p2467/rs115225947 intron1 5 0.0141 GA/GG 21/736 65.91/66.7 24.1/21.9 -0.42 0.85407 129.33/136.92 28.4/27.7 -2.52 0.2125 
APOC4p2559/rs5155 intron1 4 0.0986 CC/CT/TT 616/132/7 66.99/65/61.61 22.2/20.6/13.4 -0.98 0.27438 137.4/134.05/118.2 27.6/28.4/21.3 -1.47 0.06609 
APOC4p2607/rs5156 intron1 4 0.0129 AG/GG 19/702 69.78/66.44 24.9/21.9 1.60 0.50775 147.1/136.41 23.5/28.1 3.60 0.10172 
APOC4p2623/rs5157 intron1 4 0.1723 CC/CT/TT 506/220/20 65.29/70.07/63.46 21.6/22.7/15.2 1.43 0.04428 135.23/140.47/127.95 27.9/27.0/25.3 0.78 0.21466 
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APOC4p2640/rs5158 intron1 2b 0.0213 CC/CT 723/31 66.45/69.11 22.0/17.3 1.44 0.44596 136.85/133.75 27.5/32.3 -1.12 0.4997 
APOC4p2678/rs148564866 intron1 2b 0.0086 GC/GG 13/726 68.5/66.46 27.4/21.7 0.87 0.76308 145.03/136.63 35.1/27.6 2.67 0.29564 
APOC4p2767/rs127721107 intron1 4 0.0254 GG/GT 697/38 66.3/72.91 21.7/25.5 3.15 0.07284 136.45/143.13 27.6/30.5 2.17 0.1601 
APOC4p3348 intron1 5 0.0007 AG/GG 1/742 46/66.52 NA/21.9 -9.98 0.33555 181.29/136.74 NA/27.6 14.52 0.11008 
APOC2p75-
C4p3380/rs12721104 C4-intron1 5 0.1368 AA/GA/GG 14/174/562 66.87/66.3/66.63 14.1/21.7/22.2 -0.07 0.92847 119.74/135.5/137.55 23.1/27.2/27.9 -1.25 0.06839 
APOC2p194-
C4p3498/rs1132899 C4-exon2  5 0.2368 CC/CT/TT 434/282/40 65.25/68.96/64.74 21.6/22.9/15.7 0.95 0.13191 134.91/140.58/133.11 27.4/27.5/29.4 0.88 0.11098 
APOC2p228/rs5164 C4-exon2  5 0.0066 AG/GA/GG 9/1/730 71.19/78.12/66.48 29.3/NA/21.8 2.49 0.4501 151.28/103.03/136.67 18.4/NA/27.8 3.31 0.25501 
APOC2p288-
C4p3592/rs12691090 C4-exon2  5 0.0272 CC/CT 698/41 66.31/70.55 21.7/25.9 1.96 0.24561 136.44/142.55 27.6/29.1 2.00 0.17721 
APOC2p396-C4p3700 C4-intron2 5 0.0007 GA/GG 1/719 47.55/66.81 NA/21.9 -9.04 0.38386 172.07/136.63 NA/27.9 11.51 0.21156 
APOC2p488-C4p3792/rs5165 C4-intron2 5 0.0146 GA/GG 22/715 64.63/66.62 17.4/22.0 -0.83 0.71058 132.2/136.93 25.4/27.7 -1.54 0.43321 
APOC2p623-C4p3927/rs5167 C4-exon3 5 0.4594 GG/GT/TT 164/367/223 63.91/68.02/66.36 22.8/22.5/20.1 -0.54 0.31017 134.53/138.92/134.05 27.8/27.4/27.7 0.19 0.6794 
APOC2p665-
C4p3969/rs138548797 C4-exon3 No Data 0.0086 AA/CA 729/13 66.32/75.01 21.8/26.4 4.09 0.15807 136.97/130.35 27.8/18.5 -2.07 0.41707 
APOC2p708-C4p4012 C4-exon3 6 0.0007 GA/GG 1/739 79.3/66.53 NA/21.9 6.46 0.53306 108.23/136.83 NA/27.7 -9.42 0.30174 
APOC2p853-
C4p4157/rs10425530 C4-3' UTR 6 0.11 AA/GA/GG 7/153/587 58.99/66.53/66.84 17.7/24.4/21.2 -0.53 0.5399 123.03/141.36/135.63 37.6/28.3/27.4 1.17 0.12757 
APOC2p1042-
C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 0.0178 AA/TA/TT 720/23/1 66.89/57.22/62.23 21.6/26.5/NA -4.39 0.02431 136.16/156.91/140.36 27.5/29.9/NA 5.95 0.00071 
APOC2p1187-
C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 0.0178 AG/GG 26/691 72.68/66.23 21.6/21.8 3.17 0.13276 146.19/136.63 22.5/28.0 3.23 0.08379 
APOC2p1229-
C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b 0.014 CC/CT 714/21 66.32/72.07 21.8/24.4 2.78 0.23927 136.53/145.91 27.9/20.9 3.20 0.12314 
APOC2p1275-
C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 0.0352 GA/GG 52/687 66.08/66.63 20.4/22.0 -0.23 0.87888 137.8/136.61 30.2/27.6 0.35 0.79182 
APOC2p1357-
C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a 0.2581 CC/GC/GG 50/288/411 66.99/69.37/64.75 17.8/22.7/21.3 1.37 0.02344 130.59/141.26/134.21 27.7/27.0/27.6 0.80 0.13323 
APOC2p1540-
C4p4844/rs75463753 C2-intron1 4 0.1079 AA/GA/GG 11/128/558 67.06/68.51/65.68 14.8/23.3/21.8 1.08 0.21814 132.61/138.59/135.96 29.5/27.3/28.4 0.48 0.5384 
APOC2p2486/rs9304645 intron1 4 0.3655 AA/GA/GG 89/364/292 66.34/66.3/66.87 23.7/22.1/21.0 -0.21 0.7176 142.16/135.72/135.49 34.5/26.2/26.9 0.75 0.13555 
APOC2p2935/rs11879392 intron1 2b 0.0135 CC/GC 707/19 66.34/66.92 22.0/16.8 0.44 0.85516 136.85/137.68 27.6/32.7 0.18 0.93035 
APOC2p3010/rs10419086 intron1 6 0.1253 AA/AG/GG 539/150/14 67.99/64.76/69.3 22.3/20.8/15.5 -0.91 0.2581 138.46/132.88/136.43 28.7/24.9/26.7 -1.32 0.06568 
APOC2p3692/rs12721060 intron1 No Data 0.0172 GT/TT 23/633 71.63/66.93 23.9/21.4 2.28 0.31473 145.71/136.94 20.4/28.2 3.01 0.14108 
APOC2p3778/rs5120 intron1 4 0.1845 AA/AT/TT 500/232/23 66/68.31/69.94 22.2/21.8/12.2 1.11 0.10763 135.48/138.99/135.74 28.2/26.9/28.6 0.79 0.19964 
APOC2p3805/rs7257095 intron1 2a 0.1649 CC/CG/GG 509/213/16 66.08/67.81/68.2 21.3/23.2/23.9 0.72 0.33716 137.15/135.93/131.19 28.0/26.7/28.2 -0.55 0.40568 
APOC2p3814/rs10422603 intron1 2b 0.3008 GG/GT/TT 63/309/352 67.74/66.13/66.92 24.3/22.8/20.7 -0.10 0.87424 141.98/137.67/135.22 32.6/27.0/27.5 0.97 0.06515 
APOC2p3892/rs5121 exon2 5 0.0358 CC/TC/TT 675/50/1 66.57/65.72/76.29 22.3/16.6/NA -0.03 0.98356 136.66/136.88/142.71 28.1/24.5/NA 0.20 0.87741 
APOC2p4086/rs114780592 intron2 4 0.0278 GA/GG 42/700 72.68/66.2 25.8/21.6 3.05 0.0669 141.16/136.52 28.7/27.6 1.53 0.29745 
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APOC2p4118/rs201709243 exon3 4 0.0007 GA/GG 1/722 60.37/66.56 NA/22.0 -2.87 0.7826 *** *** *** *** 
APOC2p4319/rs5123 intron3 No Data 0.0592 AA/GA/GG 6/74/649 72.9/64.68/66.64 18.3/19.5/22.1 -0.25 0.82293 138.85/138.09/136.47 27.8/29.2/27.6 0.49 0.61561 
APOC2p4513/rs180809422 intron3 5 0.0135 AA/AC/CC 666/17/1 65.74/73.83/55.79 21.9/24.1/NA 2.64 0.26202 136.12/146.66/154.65 27.8/22.4/NA 3.47 0.09379 
APOC2p4587/rs5126 exon4 5 0.0499 AA/CA/CC 636/70/1 66.24/70.29/52.22 21.9/20.8/NA 1.71 0.18011 136.48/139.92/94.63 2798/27.0/NA 0.68 0.54818 
APOC2p4754/rs7253690 exon4 5 0.0606 AA/GA/GG 6/79/670 72.96/66.14/66.87 18.3/18.1/22.2 0.19 0.85817 138.53/140.71/136.3 27.8/30.2/27.5 1.17 0.22087 
APOC2p4853/rs150448996 3'flamking  No Data 0.2736 DD/WD/WW 386/284/57 65.87/68.51/61.64 20.7/23.7/20.5 -0.05 0.93724 138.01/136.14/131.65 28.1/27.0/29.2 -0.86 0.10718 
APOC2p4973/rs199828513 3'flamking  No Data 0.0082 WI/WW 12/704 74.02/66.82 25.3/21.5 3.46 0.24889 137.16/137.23 11.9/28.1 0.16 0.95293 
APOC2p5004/rs10421404 3'flanking  No Data 0.2908 CC/CT/TT 370/326/56 66.9/66.25/68.08 20.7/22.6/23.8 -0.04 0.94186 135.82/136.31/141.93 27.8/26.7/32.4 0.61 0.24821 
APOC2p5018/rs78403558 3'flanking  5 0.0352 DD/WD/WW 1/51/708 81.34/68.78/66.53 NA/22.5/21.8 1.27 0.37773 137.17/138.07/136.62 NA/34.0/27.3 0.36 0.77793 
APOC2p5310/rs7258345 3'flanking  No Data 0.3067 GG/GT/TT 326/313/57 66.36/67.39/66.36 23.1/21.2/16.0 0.29 0.63627 138.01/137.46/134.06 29.1/27.2/24.4 -0.42 0.44209 
APOC2p5398/rs12709889 3'flanking  6 0.2587 AA/GA/GG 50/279/405 61.99/68.59/65.74 21.1/23.1/20.9 0.16 0.79862 132.9/136/137.54 28.8/26.3/28.3 -0.63 0.24337 
APOC2p5491 3'flanking  6 0.0007 CC/TC 742/1 66.49/49.23 21.9/NA -8.06 0.43745 136.83/119.12 27.7/NA -5.71 0.53224 
APOC2p5512/rs12721064 3'flanking  6 0.0083 CC/CT 753/13 66.78/61.92 21.9/17.5 -2.23 0.43911 136.65/136.54 27.9/17.3 0.10 0.96886 
APOC2p5562 3'flanking  No Data 0.0175 CG/GG 24/704 64.44/66.45 19.8/22.0 -0.92 0.67145 139.29/136.71 39.5/27.4 0.65 0.73492 
APOC2p5586/rs73558127 3'flanking  No Data 0.1001 GG/GT/TT 9/127/589 71.92/66.13/66.69 28.0/21.4/22.1 0.13 0.88663 146/138.61/136.4 29.2/25.2/28.3 1.00 0.20571 
APOC2p5771 3'flanking  6 *** *** *** *** *** *** *** 133.2/136.85 20.8/27.7 -1.10 0.74972 
APOC2p5815/rs10423208 3'flanking  5 0.3164 AA/GA/GG 340/323/72 66.03/66.9/66.84 23.3/21.5/17.8 0.34 0.55855 137.38/136.77/133.59 29.4/27.0/23.8 -0.43 0.41044 
APOC2p5922/rs10422888 3'flanking  5 0.0784 AA/AG/GG 597/99/5 66.04/70.45/60.04 21.7/21.5/30.7 1.47 0.14838 136.82/137.93/129.97 27.2/30.2/38.3 0.05 0.95405 
APOC2p5965 3'flanking  5 0.0013 GA/GG 2/743 44.73/66.55 10.8/21.9 -10.45 0.15456 127.8/136.82 7.9/27.8 -2.79 0.66578 
APOC2p6334 3'flanking  No Data 0.0096 GA/GG 15/746 72.76/66.62 15.3/21.9 3.15 0.2415 130.12/136.79 30.5/27.5 -2.30 0.33277 
LDL-C: low-density lipoprotein cholesterol; ApoB: Apolipoprotein B; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol. 
a Cox-Box transformed variables. 
Age, Gender, Smoking, BMI, Waist, Jobmin, Staff level were included in the final model as covariates. 







Figure 22. LD plot of the 24 common variants (MAF>1%) with significant associations in Blacks 
3.6.2 Gene-based association analysis 
3.6.2.1  NHWs 
Table 28 presents the gene-based association results with lipid traits in NHWs. The genetic 
variation of APOE-C1-C4-C2 gene cluster showed significant associations with LDL-C, TC and 




Table 28.  Gene-based association results with lipid traits in NHWs 
Gene-based test based on all 63 SNPs 
Lipid trait Chr Gene nSNPs Test P-value Best.SNP SNP.p-value HDL_C 19 APOE 63 86.15598 0.136 APOC1p1317/rs12721048 0.016159 LDL_C 19 APOE 63 164.5623 0.000428 APOE4075/rs7412 1.84E-07 TG 19 APOE 63 91.74789 0.07955 APOC1p2041/rs3826688 0.001125 TC 19 APOE 63 170.0197 0.000288 APOE4075/rs7412 9.51E-06 ApoB 19 APOE 63 200.5421 3.60E-05 APOE4075/rs7412 9.65E-13 ApoA1 19 APOE 63 56.50568 0.607 APOC1p1317/rs12721048 0.00423 
Gene-based test based on 29 common SNPs (MAF≥5%) 
lipid trait Chr Gene nSNPs Test P-value Best.SNP SNP.p-value HDL_C 19 APOE 29 26.29908 0.507 HCR2p188/rs35136575 0.033039 LDL_C 19 APOE 29 110.0057 0.00105 APOE4075/rs7412 1.84E-07 TG 19 APOE 29 56.96919 0.05774 APOC1p2041/rs3826688 0.001125 TC 19 APOE 29 96.86054 0.00276 APOE4075/rs7412 9.51E-06 ApoB 19 APOE 29 150.0422 4.00E-05 APOE4075/rs7412 9.65E-13 ApoA1 19 APOE 29 20.71344 0.634 rs7259004 0.04602 
yellow-highlighted values represent significant p-value; 
nSNPs: represents the number of SNPs included in the analysis; Test: represent the overall test statistic; 
Pvalue: the overall p-value; SNP.pvalue: p-value of the best SNPs contributed to the significance. 
 
 
3.6.2.2  African Blacks 
Table 29 gives the gene-based association results with lipid traits in Blacks. The genetic 
variation of APOE-C1-C4-C2 gene cluster showed significant associations with LDL-C, TC, and 









Table 29.  Gene-based association results with lipid traits in Blacks 
Gene-based test on all 106 SNPs 
Lipid 
Trait Chr Gene nSNPs Test Pvalue Best.SNP SNP.pvalue HDL_C 19 APOE 106 123.1083 0.231 APOE618 0.00079 LDL_C 19 APOE 106 215.9868 0.001159 APOE4075/rs7412 5.35E-07 TG 19 APOE 106 134.5834 0.134 APOC4p757/rs12721105 0.000522 TC 19 APOE 106 159.0945 0.03628 APOE4075/rs7412 0.000118 ApoB 19 APOE 106 121.2497 0.23 APOE1163/rs440446 0.010931 ApoA1 19 APOE 106 163.1894 0.02868 APOE4075/rs7412 8.47E-05 
Gene-based test on 47 SNPs with MAF≥5% 
Lipid 
Trait Chr Gene nSNPs Test Pvalue Best.SNP SNP.pvalue HDL_C 19 APOE 47 46.73669 0.452 rs439401 0.044476 LDL_C 19 APOE 47 137.8881 0.000652 APOE4075/rs7412 5.35E-07 TG 19 APOE 47 62.28504 0.167 APOC1p5667/rs12721054 0.006986 TC 19 APOE 47 94.13141 0.01742 APOE4075/rs7412 0.000118 ApoB 19 APOE 47 60.36205 0.208 APOE1163/rs440446 0.010931 ApoA1 19 APOE 47 84.34323 0.03789 APOE4075/rs7412 8.47E-05 
yellow-highlighted values represent significant p-value; 
nSNPs: represents the number of SNPs included in the analysis; Test: represent the overall test statistic; 
Pvalue: the overall p-value; SNP.pvalue: p-value of the best SNPs contributed to the significance. 
3.6.3 Haplotype-based association analysis 
3.6.3.1  NHWs 
The haplotype-based association results with lipid traits are summarized in Tables 30-38 and 
their corresponding p-values of 4-SNP windows plots are summarized in Figure 23. Multiple 
windows showed significant global p-values with LDL-C, TC, and apoB, confirming the single-
locus association results. The top significant global p-values with LDL-C were seen with 
windows 8, 9, 10, and 11 that were mapped to APOE2/E4 alleles. The significant haplotype 
associations in the remaining windows were derived from common/uncommon variants with 
significant single association with LDL-C. On the other hand, the significant associations seen 
with the windows 60-63, seem to be attributed to a rare variant APOC2p2870. We observed 
similar pattern of haplotype association results with TC as it was seen with LDL-C. Multiple 
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windows showed significant global p-value with apoB, confirming the single effect of 
common/uncommon variants with MAF>1%, except one region that mapped to windows 19 and 
20 where the association seems to come from a rare variant with MAF<1%  
(APOC1p1317/rs12721048).  
We observed multiple windows to be associated with HDL-C, where 
common/uncommon variants (MAF>1%) contributed to the observed effects. However, three 
regions that are mapped to windows 19, 20, 49, and 57, the effects seem to be derived from rare 
variants with MAF<1% (APOC1p1170, APOC1p1317/rs12721048, APOC4p1229, and 
APOC2p543C4p3847/rs186448850). Likewise, multiple windows showed significant association 
with apoA1, confirming the single effect of common/uncommon variants with MAF>1%, except 
two regions mapped to windows 18, 19, and 20 where the effects seem to be derived from rare 
variants (MAF<1%), including APOC1p703/rs3207187, and APOC1p1317/rs12721048. For TG, 
we also observed association in multiple windows containing common/uncommon variants 
(MAF>1%) that showed associations in single-locus analyses. In addition, we observed 
association with TG in windows 33, 47, 48, 49, and 58 that contained rare variants (MAF<1%), 


























Figure 23. Haplotype based association plots with lipid traits in NHWs 
The X-axis has the genotyped markers that included in each window and the Y-axis has the –log (global p-value), 
the red line represent the significance threshold of the global haplotype p-value, each line is corresponding to 
one window, all lines underneath the red line means non- significant global p-value and vice versa.
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Table 30.  Haplotype-based association results with LDL-C, TC, and TG in NHWs 
HAPLOTYPE WINDOWS LDL-C TC TGa 
wind w.snp Function RegulomeDB score Genotype MAF Beta Single-p hap_P Beta Single-p hap_P Beta Single-p hap_P 
1 APOE560/rs449647 5' flanking 5 AA/AT/TT 0.16103 -7.12 0.02468 0.0089 -6.71 0.042839 0.00004 -0.02 0.52293 0.00429 
1 APOE832/rs405509 5' flanking 1f GG/GT/TT 0.47749 0.42 0.85418 NA -0.68 0.77567 NA -0.07 0.00333 NA 
1 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 -2.59 0.28095 NA -4.26 0.089292 NA -0.08 0.00181 NA 
1 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.75 0.92317 NA 1.88 0.816453 NA -0.09 0.23228 NA 
2 APOE832/rs405509 5' flanking 1f GG/GT/TT 0.47749 0.42 0.85418 0.39226 -0.68 0.77567 0.163716 -0.07 0.00333 0.01963 
2 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 -2.59 0.28095 NA -4.26 0.089292 NA -0.08 0.00181 NA 
2 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.75 0.92317 NA 1.88 0.816453 NA -0.09 0.23228 NA 
2 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 6.95 0.05505 NA 8.31 0.028503 NA 0.01 0.68668 NA 
3 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 -2.59 0.28095 0.00352 -4.26 0.089292 0.000125 -0.08 0.00181 0.01936 
3 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.75 0.92317 NA 1.88 0.816453 NA -0.09 0.23228 NA 
3 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 6.95 0.05505 NA 8.31 0.028503 NA 0.01 0.68668 NA 
3 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 4.89 0.03784 NA 6.88 0.005137 NA 0.06 0.00823 NA 
4 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.75 0.92317 0.01832 1.88 0.816453 0.000787 -0.09 0.23228 0.05026 
4 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 6.95 0.05505 NA 8.31 0.028503 NA 0.01 0.68668 NA 
4 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 4.89 0.03784 NA 6.88 0.005137 NA 0.06 0.00823 NA 
4 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.45 0.96677 NA -1.93 0.864877 NA -0.05 0.61567 NA 
5 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 6.95 0.05505 0.01014 8.31 0.028503 0.000508 0.01 0.68668 0.03436 
5 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 4.89 0.03784 NA 6.88 0.005137 NA 0.06 0.00823 NA 
5 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.45 0.96677 NA -1.93 0.864877 NA -0.05 0.61567 NA 
5 APOE3038/rs111833428 exon 3 5 AG/GG 0.00162 27.34 0.33535 NA 33.8 0.256747 NA 0.16 0.57655 NA 
6 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 4.89 0.03784 0.15188 6.88 0.005137 0.028183 0.06 0.00823 0.07083 
6 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.45 0.96677 NA -1.93 0.864877 NA -0.05 0.61567 NA 
6 APOE3038/rs111833428 exon 3 5 AG/GG 0.00162 27.34 0.33535 NA 33.8 0.256747 NA 0.16 0.57655 NA 
6 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 18.03 0.65224 NA 21.3 0.611017 NA -0.22 0.5865 NA 
7 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.45 0.96677 0.03391 -1.93 0.864877 0.116849 -0.05 0.61567 0.84883 
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7 APOE3038/rs111833428 exon 3 5 AG/GG 0.00162 27.34 0.33535 NA 33.8 0.256747 NA 0.16 0.57655 NA 
7 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 18.03 0.65224 NA 21.3 0.611017 NA -0.22 0.5865 NA 
7 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 8.10 0.01033 NA 6.82 0.038251 NA 0.01 0.70692 NA 
8 APOE3038/rs111833428 exon 3 5 AG/GG 0.00162 27.34 0.33535 2.03E-07 33.8 0.256747 0.000002 0.16 0.57655 0.94386 
8 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 18.03 0.65224 NA 21.3 0.611017 NA -0.22 0.5865 NA 
8 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 8.10 0.01033 NA 6.82 0.038251 NA 0.01 0.70692 NA 
8 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -21.84 1.84E-07 NA -19.46 9.51E-06 NA 0.01 0.74378 NA 
9 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 18.03 0.65224 2.09E-07 21.3 0.611017 0.000006 -0.22 0.5865 0.14904 
9 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 8.10 0.01033 NA 6.82 0.038251 NA 0.01 0.70692 NA 
9 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -21.84 1.84E-07 NA -19.46 9.51E-06 NA 0.01 0.74378 NA 
9 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 -32.56 0.07050 NA -46.88 0.012787 NA -0.4 0.02603 NA 
10 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 8.10 0.01033 1.12E-07 6.82 0.038251 0.000008 0.01 0.70692 0.69342 
10 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -21.84 1.84E-07 NA -19.46 9.51E-06 NA 0.01 0.74378 NA 
10 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 -32.56 0.07050 NA -46.88 0.012787 NA -0.4 0.02603 NA 
10 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 -12.30 0.75854 NA 36.03 0.389779 NA 0.92 0.02316 NA 
11 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -21.84 1.84E-07 1.02E-06 -19.46 9.51E-06 0.000053 0.01 0.74378 0.94227 
11 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 -32.56 0.07050 NA -46.88 0.012787 NA -0.4 0.02603 NA 
11 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 -12.30 0.75854 NA 36.03 0.389779 NA 0.92 0.02316 NA 
11 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 13.58 0.28672 NA 23.15 0.083533 NA 0.09 0.50843 NA 
12 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 -32.56 0.07050 0.57192 -46.88 0.012787 0.535682 -0.4 0.02603 0.92319 
12 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 -12.30 0.75854 NA 36.03 0.389779 NA 0.92 0.02316 NA 
12 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 13.58 0.28672 NA 23.15 0.083533 NA 0.09 0.50843 NA 
12 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 4.00 0.32719 NA 4.62 0.279139 NA -0.01 0.89282 NA 
13 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 -12.30 0.75854 0.52351 36.03 0.389779 0.136851 0.92 0.02316 0.0646 
13 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 13.58 0.28672 NA 23.15 0.083533 NA 0.09 0.50843 NA 
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13 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 4.00 0.32719 NA 4.62 0.279139 NA -0.01 0.89282 NA 
13 rs439401 intergenic 1b CC/CT/TT 0.35961 -1.76 0.45214 NA -2.82 0.248555 NA -0.06 0.01936 NA 
14 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 13.58 0.28672 0.00103 23.15 0.083533 0.000253 0.09 0.50843 0.15678 
14 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 4.00 0.32719 NA 4.62 0.279139 NA -0.01 0.89282 NA 
14 rs439401 intergenic 1b CC/CT/TT 0.35961 -1.76 0.45214 NA -2.82 0.248555 NA -0.06 0.01936 NA 
14 rs445925 intergenic no data AA/GA/GG 0.1094 -12.58 0.00047 NA -13.53 0.000315 NA 0.01 0.8251 NA 
15 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 4.00 0.32719 0.00103 4.62 0.279139 0.000262 -0.01 0.89282 0.10807 
15 rs439401 intergenic 1b CC/CT/TT 0.35961 -1.76 0.45214 NA -2.82 0.248555 NA -0.06 0.01936 NA 
15 rs445925 intergenic no data AA/GA/GG 0.1094 -12.58 0.00047 NA -13.53 0.000315 NA 0.01 0.8251 NA 
15 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -14.29 0.42751 NA -23.7 0.208777 NA -0.17 0.34254 NA 
16 rs439401 intergenic 1b CC/CT/TT 0.35961 -1.76 0.45214 0.00041 -2.82 0.248555 0.000103 -0.06 0.01936 0.06712 
16 rs445925 intergenic no data AA/GA/GG 0.1094 -12.58 0.00047 NA -13.53 0.000315 NA 0.01 0.8251 NA 
16 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -14.29 0.42751 NA -23.7 0.208777 NA -0.17 0.34254 NA 
16 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 12.09 0.76286 NA 52.4 0.212361 NA -0.07 0.86073 NA 
17 rs445925 intergenic no data AA/GA/GG 0.1094 -12.58 0.00047 0.00119 -13.53 0.000315 0.001228 0.01 0.8251 0.53944 
17 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -14.29 0.42751 NA -23.7 0.208777 NA -0.17 0.34254 NA 
17 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 12.09 0.76286 NA 52.4 0.212361 NA -0.07 0.86073 NA 
17 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -3.67 0.17680 NA -4.42 0.120168 NA 0.01 0.73507 NA 
18 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -14.29 0.42751 0.23845 -23.7 0.208777 0.168715 -0.17 0.34254 0.3244 
18 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 12.09 0.76286 NA 52.4 0.212361 NA -0.07 0.86073 NA 
18 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -3.67 0.17680 NA -4.42 0.120168 NA 0.01 0.73507 NA 
18 APOC1p1170 intron 1 2b GA/GG 0.00082 -41.75 0.29561 NA -29.4 0.483929 NA -0.61 0.12814 NA 
19 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 12.09 0.76286 0.35821 52.4 0.212361 0.253998 -0.07 0.86073 0.48431 
19 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -3.67 0.17680 NA -4.42 0.120168 NA 0.01 0.73507 NA 
19 APOC1p1170 intron 1 2b GA/GG 0.00082 -41.75 0.29561 NA -29.4 0.483929 NA -0.61 0.12814 NA 
19 APOC1p1294 intron 2 4 AA/AC 0.00081 -6.76 0.86595 NA 13.45 0.748544 NA -0.1 0.80361 NA 
20 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -3.67 0.17680 0.41389 -4.42 0.120168 0.27284 0.01 0.73507 0.59971 
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20 APOC1p1170 intron 1 2b GA/GG 0.00082 -41.75 0.29561 NA -29.4 0.483929 NA -0.61 0.12814 NA 
20 APOC1p1294 intron 2 4 AA/AC 0.00081 -6.76 0.86595 NA 13.45 0.748544 NA -0.1 0.80361 NA 
20 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 13.48 0.63208 NA 34.5 0.244241 NA -0.01 0.9701 NA 
21 APOC1p1170 intron 1 2b GA/GG 0.00082 -41.75 0.29561 0.19634 -29.4 0.483929 0.604101 -0.61 0.12814 0.07733 
21 APOC1p1294 intron 2 4 AA/AC 0.00081 -6.76 0.86595 NA 13.45 0.748544 NA -0.1 0.80361 NA 
21 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 13.48 0.63208 NA 34.5 0.244241 NA -0.01 0.9701 NA 
21 APOC1p1422 intron 2 4 GA/GG 0.00161 -51.98 0.06572 NA -53.33 0.072147 NA -0.49 0.0838 NA 
22 APOC1p1294 intron 2 4 AA/AC 0.00081 -6.76 0.86595 0.64566 13.45 0.748544 0.748724 -0.1 0.80361 0.23179 
22 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 13.48 0.63208 NA 34.5 0.244241 NA -0.01 0.9701 NA 
22 APOC1p1422 intron 2 4 GA/GG 0.00161 -51.98 0.06572 NA -53.33 0.072147 NA -0.49 0.0838 NA 
22 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 3.19 0.83505 NA -2.77 0.862436 NA -0.08 0.61826 NA 
23 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 13.48 0.63208 0.6467 34.5 0.244241 0.408575 -0.01 0.9701 0.00392 
23 APOC1p1422 intron 2 4 GA/GG 0.00161 -51.98 0.06572 NA -53.33 0.072147 NA -0.49 0.0838 NA 
23 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 3.19 0.83505 NA -2.77 0.862436 NA -0.08 0.61826 NA 
23 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 -2.38 0.32461 NA -3.6 0.154054 NA -0.08 0.00113 NA 
24 APOC1p1422 intron 2 4 GA/GG 0.00161 -51.98 0.06572 0.42704 -53.33 0.072147 0.228581 -0.49 0.0838 0.00374 
24 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 3.19 0.83505 NA -2.77 0.862436 NA -0.08 0.61826 NA 
24 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 -2.38 0.32461 NA -3.6 0.154054 NA -0.08 0.00113 NA 
24 APOC1p2629 exon 3 4 GA/GG 0.00081 -47.60 0.23493 NA -24.89 0.552467 NA -0.02 0.96335 NA 
25 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 3.19 0.83505 0.61842 -2.77 0.862436 0.391799 -0.08 0.61826 0.00545 
25 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 -2.38 0.32461 NA -3.6 0.154054 NA -0.08 0.00113 NA 
25 APOC1p2629 exon 3 4 GA/GG 0.00081 -47.60 0.23493 NA -24.89 0.552467 NA -0.02 0.96335 NA 
25 APOC1p2817 intron 3 2b CC/CT 0.00329 -5.57 0.77937 NA 8.17 0.694332 NA 0.04 0.83338 NA 
26 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 -2.38 0.32461 0.33229 -3.6 0.154054 0.279497 -0.08 0.00113 0.0056 
26 APOC1p2629 exon 3 4 GA/GG 0.00081 -47.60 0.23493 NA -24.89 0.552467 NA -0.02 0.96335 NA 
26 APOC1p2817 intron 3 2b CC/CT 0.00329 -5.57 0.77937 NA 8.17 0.694332 NA 0.04 0.83338 NA 
26 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -18.83 0.41632 NA -32.02 0.18592 NA -0.02 0.91687 NA 
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27 APOC1p2629 exon 3 4 GA/GG 0.00081 -47.60 0.23493 0.86905 -24.89 0.552467 0.365178 -0.02 0.96335 0.4951 
27 APOC1p2817 intron 3 2b CC/CT 0.00329 -5.57 0.77937 NA 8.17 0.694332 NA 0.04 0.83338 NA 
27 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -18.83 0.41632 NA -32.02 0.18592 NA -0.02 0.91687 NA 
27 APOC1p3494 intron 3 no data CC/CT 0.00161 73.63 0.00916 NA 103.78 0.000437 NA 0.4 0.16425 NA 
28 APOC1p2817 intron 3 2b CC/CT 0.00329 -5.57 0.77937 0.0693 8.17 0.694332 0.091732 0.04 0.83338 0.60749 
28 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -18.83 0.41632 NA -32.02 0.18592 NA -0.02 0.91687 NA 
28 APOC1p3494 intron 3 no data CC/CT 0.00161 73.63 0.00916 NA 103.78 0.000437 NA 0.4 0.16425 NA 
28 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 6.93 0.03064 NA 5.95 0.077337 NA 0.02 0.47873 NA 
29 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -18.83 0.41632 0.0069 -32.02 0.18592 0.015589 -0.02 0.91687 0.63268 
29 APOC1p3494 intron 3 no data CC/CT 0.00161 73.63 0.00916 NA 103.78 0.000437 NA 0.4 0.16425 NA 
29 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 6.93 0.03064 NA 5.95 0.077337 NA 0.02 0.47873 NA 
29 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 11.99 0.04148 NA 13.65 0.026307 NA -0.05 0.40638 NA 
30 C1p3494 intron 3 no data CC/CT 0.00161 73.63 0.00916 0.0034 103.78 0.000437 0.000104 0.4 0.16425 0.06454 
30 C1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 6.93 0.03064 NA 5.95 0.077337 NA 0.02 0.47873 NA 
30 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 11.99 0.04148 NA 13.65 0.026307 NA -0.05 0.40638 NA 
30 C1p5773 3' flanking no data GA/GG 0.00083 -11.49 0.77418 NA 37.56 0.369912 NA 0.93 0.02109 NA 
31 C1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 6.93 0.03064 0.00162 5.95 0.077337 0.019841 0.02 0.47873 0.18191 
31 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 11.99 0.04148 NA 13.65 0.026307 NA -0.05 0.40638 NA 
31 APOC1p5773 3' flanking no data GA/GG 0.00083 -11.49 0.77418 NA 37.56 0.369912 NA 0.93 0.02109 NA 
31 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 7.24 0.01416 NA 6.69 0.030458 NA 0.01 0.76774 NA 
32 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 11.99 0.04148 0.0046 13.65 0.026307 0.000544 -0.05 0.40638 0.05217 
32 C1p5773 3' flanking no data GA/GG 0.00083 -11.49 0.77418 NA 37.56 0.369912 NA 0.93 0.02109 NA 
32 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 7.24 0.01416 NA 6.69 0.030458 NA 0.01 0.76774 NA 
32 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 6.97 0.02600 NA 6.79 0.040182 NA 0.03 0.39236 NA 
33 APOC1p5773 3' flanking no data GA/GG 0.00083 -11.49 0.77418 0.00026 37.56 0.369912 0.000111 0.93 0.02109 0.0314 
33 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 7.24 0.01416 NA 6.69 0.030458 NA 0.01 0.76774 NA 
33 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 6.97 0.02600 NA 6.79 0.040182 NA 0.03 0.39236 NA 
 
 137 
Cont. Table 30 
33 rs4803770 HCR1 5 CC/GC/GG 0.37795 5.52 0.01966 NA 6.08 0.01385 NA 0.04 0.0801 NA 
34 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 7.24 0.01416 0.00073 6.69 0.030458 0.000464 0.01 0.76774 0.18627 
34 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 6.97 0.02600 NA 6.79 0.040182 NA 0.03 0.39236 NA 
34 rs4803770 HCR1 5 CC/GC/GG 0.37795 5.52 0.01966 NA 6.08 0.01385 NA 0.04 0.0801 NA 
34 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 3.86 0.59596 NA 1.4 0.854119 NA 0.02 0.81882 NA 
35 rs4420638 3 'flanking no data AA/GA/GG 0.15558 6.97 0.02600 0.00365 6.79 0.040182 0.004402 0.03 0.39236 0.20392 
35 rs4803770 HCR1 5 CC/GC/GG 0.37795 5.52 0.01966 NA 6.08 0.01385 NA 0.04 0.0801 NA 
35 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 3.86 0.59596 NA 1.4 0.854119 NA 0.02 0.81882 NA 
35 HCR1p362 HCR1 2a CA/CC 0.00247 -14.29 0.53623 NA -3.8 0.874948 NA 0.3 0.20302 NA 
36 rs4803770 HCR1 5 CC/GC/GG 0.37795 5.52 0.01966 0.17009 6.08 0.01385 0.138271 0.04 0.0801 0.13468 
36 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 3.86 0.59596 NA 1.4 0.854119 NA 0.02 0.81882 NA 
36 HCR1p362 HCR1 2a CA/CC 0.00247 -14.29 0.53623 NA -3.8 0.874948 NA 0.3 0.20302 NA 
36 HCR1p423 HCR1 4 CC/CG/GG 0.02581 -6.26 0.36857 NA -7.84 0.28132 NA -0.12 0.07997 NA 
37 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 3.86 0.59596 0.54038 1.4 0.854119 0.499584 0.02 0.81882 0.29791 
37 HCR1p362 HCR1 2a CA/CC 0.00247 -14.29 0.53623 NA -3.8 0.874948 NA 0.3 0.20302 NA 
37 HCR1p423 HCR1 4 CC/CG/GG 0.02581 -6.26 0.36857 NA -7.84 0.28132 NA -0.12 0.07997 NA 
37 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -19.28 0.40626 NA -32.24 0.184365 NA -0.02 0.92604 NA 
38 HCR1p362 HCR1 2a CA/CC 0.00247 -14.29 0.53623 0.38555 -3.8 0.874948 0.312672 0.3 0.20302 0.1552 
38 HCR1p423 HCR1 4 CC/CG/GG 0.02581 -6.26 0.36857 NA -7.84 0.28132 NA -0.12 0.07997 NA 
38 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -19.28 0.40626 NA -32.24 0.184365 NA -0.02 0.92604 NA 
38 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -19.80 0.39188 NA -33.23 0.169457 NA -0.03 0.90531 NA 
39 HCR1p423 HCR1 4 CC/CG/GG 0.02581 -6.26 0.36857 0.18545 -7.84 0.28132 0.101051 -0.12 0.07997 0.3228 
39 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -19.28 0.40626 NA -32.24 0.184365 NA -0.02 0.92604 NA 
39 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -19.80 0.39188 NA -33.23 0.169457 NA -0.03 0.90531 NA 
39 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -4.61 0.05150 NA -4.95 0.04462 NA -0.02 0.32168 NA 
40 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -19.28 0.40626 0.00038 -32.24 0.184365 0.00091 -0.02 0.92604 0.65253 
40 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -19.80 0.39188 NA -33.23 0.169457 NA -0.03 0.90531 NA 
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40 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -4.61 0.05150 NA -4.95 0.04462 NA -0.02 0.32168 NA 
40 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -9.78 0.00499 NA -9.06 0.013416 NA 0.05 0.21034 NA 
41 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -19.80 0.39188 0.00274 -33.23 0.169457 0.010431 -0.03 0.90531 0.17356 
41 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -4.61 0.05150 NA -4.95 0.04462 NA -0.02 0.32168 NA 
41 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -9.78 0.00499 NA -9.06 0.013416 NA 0.05 0.21034 NA 
41 HR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -3.15 0.23237 NA -2.25 0.41394 NA -0.03 0.28305 NA 
42 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -4.61 0.05150 0.00205 -4.95 0.04462 0.014051 -0.02 0.32168 0.14811 
42 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -9.78 0.00499 NA -9.06 0.013416 NA 0.05 0.21034 NA 
42 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -3.15 0.23237 NA -2.25 0.41394 NA -0.03 0.28305 NA 
42 HCR2p365 HCR2 2b CA/CC 0.00409 2.62 0.88437 NA -6.5 0.729513 NA -0.2 0.26595 NA 
43 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -9.78 0.00499 0.03754 -9.06 0.013416 0.075596 0.05 0.21034 0.06479 
43 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -3.15 0.23237 NA -2.25 0.41394 NA -0.03 0.28305 NA 
43 HCR2p365 HCR2 2b CA/CC 0.00409 2.62 0.88437 NA -6.5 0.729513 NA -0.2 0.26595 NA 
43 HCR2p523 HCR2 2b CC/CT 0.02258 3.50 0.65774 NA 8.1 0.326605 NA 0.02 0.76638 NA 
44 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -3.15 0.23237 0.57661 -2.25 0.41394 0.594348 -0.03 0.28305 0.71972 
44 HCR2p365 HCR2 2b CA/CC 0.00409 2.62 0.88437 NA -6.5 0.729513 NA -0.2 0.26595 NA 
44 HCR2p523 HCR2 2b CC/CT 0.02258 3.50 0.65774 NA 8.1 0.326605 NA 0.02 0.76638 NA 
44 APOC4p636 5' flanking no data CC/CT 0.00083 54.33 0.17687 NA 63.55 0.130313 NA 0.73 0.07317 NA 
45 HCR2p365 HCR2 2b CA/CC 0.00409 2.62 0.88437 0.88247 -6.5 0.729513 0.71721 -0.2 0.26595 0.96689 
45 HCR2p523 HCR2 2b CC/CT 0.02258 3.50 0.65774 NA 8.1 0.326605 NA 0.02 0.76638 NA 
45 APOC4p636 5' flanking no data CC/CT 0.00083 54.33 0.17687 NA 63.55 0.130313 NA 0.73 0.07317 NA 
45 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -1.85 0.76580 NA -5.6 0.387837 NA 0.02 0.80852 NA 
46 HCR2p523 HCR2 2b CC/CT 0.02258 3.50 0.65774 0.03044 8.1 0.326605 0.001176 0.02 0.76638 0.16964 
46 APOC4p636 5' flanking no data CC/CT 0.00083 54.33 0.17687 NA 63.55 0.130313 NA 0.73 0.07317 NA 
46 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -1.85 0.76580 NA -5.6 0.387837 NA 0.02 0.80852 NA 
46 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 73.90 0.00896 NA 103.8 0.000431 NA 0.39 0.16983 NA 
47 APOC4p636 5' flanking no data CC/CT 0.00083 54.33 0.17687 0.02617 63.55 0.130313 0.003271 0.73 0.07317 0.00572 
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47 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -1.85 0.76580 NA -5.6 0.387837 NA 0.02 0.80852 NA 
47 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 73.90 0.00896 NA 103.8 0.000431 NA 0.39 0.16983 NA 
47 APOC4p1229 intron 1 2b GC/GG 0.00161 18.29 0.52047 NA 16.99 0.570069 NA 0.68 0.01859 NA 
48 APOC4p968/rs76214972 5' UTR 4 AA/AG 0.03623 -1.85 0.76580 0.23507 -5.6 0.387837 0.098741 0.02 0.80852 0.04053 
48 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 73.90 0.00896 NA 103.8 0.000431 NA 0.39 0.16983 NA 
48 APOC4p1229 intron 1 2b GC/GG 0.00161 18.29 0.52047 NA 16.99 0.570069 NA 0.68 0.01859 NA 
48 APOC4p2557 intron 1 4 CA/CC 0.00081 -35.35 0.37814 NA -57.38 0.172729 NA 0.12 0.7681 NA 
49 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 73.90 0.00896 0.17526 103.8 0.000431 0.133074 0.39 0.16983 0.03019 
49 APOC4p1229 intron 1 2b GC/GG 0.00161 18.29 0.52047 NA 16.99 0.570069 NA 0.68 0.01859 NA 
49 APOC4p2557 intron 1 4 CA/CC 0.00081 -35.35 0.37814 NA -57.38 0.172729 NA 0.12 0.7681 NA 
49 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -1.55 0.49622 NA -0.35 0.885145 NA 0.02 0.3751 NA 
50 APOC4p1229 intron 1 2b GC/GG 0.00161 18.29 0.52047 0.73404 16.99 0.570069 0.888123 0.68 0.01859 0.12497 
50 APOC4p2557 intron 1 4 CA/CC 0.00081 -35.35 0.37814 NA -57.38 0.172729 NA 0.12 0.7681 NA 
50 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -1.55 0.49622 NA -0.35 0.885145 NA 0.02 0.3751 NA 
50 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 -1.55 0.64078 NA -1.79 0.607587 NA -0.04 0.22194 NA 
51 APOC4p2557 intron 1 4 CA/CC 0.00081 -35.35 0.37814 0.05301 -57.38 0.172729 0.438605 0.12 0.7681 0.17205 
51 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -1.55 0.49622 NA -0.35 0.885145 NA 0.02 0.3751 NA 
51 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 -1.55 0.64078 NA -1.79 0.607587 NA -0.04 0.22194 NA 
51 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -19.14 0.00923 NA -12.75 0.097846 NA -0.16 0.03289 NA 
52 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -1.55 0.49622 0.06026 -0.35 0.885145 0.5248 0.02 0.3751 0.24847 
52 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 -1.55 0.64078 NA -1.79 0.607587 NA -0.04 0.22194 NA 
52 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -19.14 0.00923 NA -12.75 0.097846 NA -0.16 0.03289 NA 
52 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 1.93 0.87976 NA -9.51 0.476026 NA -0.15 0.23842 NA 
53 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 -1.55 0.64078 0.05313 -1.79 0.607587 0.510489 -0.04 0.22194 0.23658 
53 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -19.14 0.00923 NA -12.75 0.097846 NA -0.16 0.03289 NA 
53 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 1.93 0.87976 NA -9.51 0.476026 NA -0.15 0.23842 NA 
53 APOC2p194APOC4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -1.91 0.40706 NA -0.62 0.797285 NA 0.02 0.34646 NA 
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54 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -19.14 0.00923 0.03968 -12.75 0.097846 0.370766 -0.16 0.03289 0.11065 
54 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 1.93 0.87976 NA -9.51 0.476026 NA -0.15 0.23842 NA 
54 APOC2p194APOC4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -1.91 0.40706 NA -0.62 0.797285 NA 0.02 0.34646 NA 
54 APOC2p242APOC4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 2.18 0.91357 NA -5.18 0.805514 NA -0.16 0.44443 NA 
55 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 1.93 0.87976 0.64722 -9.51 0.476026 0.855425 -0.15 0.23842 0.60501 
55 APOC2p194APOC4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -1.91 0.40706 NA -0.62 0.797285 NA 0.02 0.34646 NA 
55 APOC2p242APOC4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 2.18 0.91357 NA -5.18 0.805514 NA -0.16 0.44443 NA 
55 APOC2p543APOC4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 
18.71 0.51026 NA 17.51 0.557831 NA 0.68 0.01713 NA 
56 APOC2p194APOC4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -1.91 0.40706 0.30687 -0.62 0.797285 0.526107 0.02 0.34646 0.56818 
56 APOC2p242APOC4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 2.18 0.91357 NA -5.18 0.805514 NA -0.16 0.44443 NA 
56 APOC2p543APOC4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 
18.71 0.51026 NA 17.51 0.557831 NA 0.68 0.01713 NA 
56 APOC2p623APOC4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 4.19 0.08239 NA 2.94 0.244306 NA -0.003 0.8759 NA 
57 APOC2p242APOC4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 2.18 0.91357 0.24138 -5.18 0.805514 0.348494 -0.16 0.44443 0.63305 
57 APOC2p543APOC4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 
18.71 0.51026 NA 17.51 0.557831 NA 0.68 0.01713 NA 
57 APOC2p623APOC4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 4.19 0.08239 NA 2.94 0.244306 NA -0.003 0.8759 NA 
57 APOC2p1357APOC4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 
0.74 0.74503 NA -0.65 0.785955 NA -0.02 0.38126 NA 
58 APOC2p543APOC4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 
18.71 0.51026 0.14814 17.51 0.557831 0.194087 0.68 0.01713 0.02882 
58 APOC2p623APOC4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 4.19 0.08239 NA 2.94 0.244306 NA -0.003 0.8759 NA 
58 APOC2p1357APOC4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 
0.74 0.74503 NA -0.65 0.785955 NA -0.02 0.38126 NA 
58 APOC2p1591APOC4p4895 C2-intron1 4 GA/GG 0.00081 54.17 0.17639 NA 62.97 0.132918 NA 0.73 0.0712 NA 
59 APOC2p623APOC4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 4.19 0.08239 0.25789 2.94 0.244306 0.365463 -0.003 0.8759 0.45685 
59 APOC2p1357APOC4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 
0.74 0.74503 NA -0.65 0.785955 NA -0.02 0.38126 NA 
59 APOC4p4895C2p1591 C2-intron1 4 GA/GG 0.00081 54.17 0.17639 NA 62.97 0.132918 NA 0.73 0.0712 NA 
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59 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -1.31 0.83107 NA -4.49 0.484754 NA 0.03 0.58453 NA 
60 APOC2p1357APOC4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 
0.74 0.74503 0.01273 -0.65 0.785955 0.005339 -0.02 0.38126 0.35045 
60 APOC2p1591APOC4p4895 C2-intron1 4 GA/GG 0.00081 54.17 0.17639 NA 62.97 0.132918 NA 0.73 0.0712 NA 
60 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -1.31 0.83107 NA -4.49 0.484754 NA 0.03 0.58453 NA 
60 APOC2p2870 intron 1 4 GG/GT 0.00403 53.09 0.00302 NA 58.43 0.001792 NA 0.12 0.51156 NA 
61 APOC4p4895C2p1591 C2-intron1 4 GA/GG 0.00081 54.17 0.17639 0.00606 62.97 0.132918 0.004771 0.73 0.0712 0.19575 
61 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -1.31 0.83107 NA -4.49 0.484754 NA 0.03 0.58453 NA 
61 APOC2p2870 intron 1 4 GG/GT 0.00403 53.09 0.00302 NA 58.43 0.001792 NA 0.12 0.51156 NA 
61 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -6.86 0.26403 NA -2.44 0.704321 NA -0.09 0.17358 NA 
62 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -1.31 0.83107 0.03314 -4.49 0.484754 0.029432 0.03 0.58453 0.44984 
62 APOC2p2870 intron 1 4 GG/GT 0.00403 53.09 0.00302 NA 58.43 0.001792 NA 0.12 0.51156 NA 
62 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -6.86 0.26403 NA -2.44 0.704321 NA -0.09 0.17358 NA 
62 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 1.24 0.58450 NA -1.32 0.578429 NA -0.02 0.28092 NA 
63 APOC2p2870 intron 1 4 GG/GT 0.00403 53.09 0.00302 0.02068 58.43 0.001792 0.012336 0.12 0.51156 0.31341 
63 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -6.86 0.26403 NA -2.44 0.704321 NA -0.09 0.17358 NA 
63 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 1.24 0.58450 NA -1.32 0.578429 NA -0.02 0.28092 NA 
63 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 4.36 0.09431 NA 2.44 0.370769 NA 0.01 0.67415 NA 
64 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -6.86 0.26403 0.22036 -2.44 0.704321 0.143722 -0.09 0.17358 0.30086 
64 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 1.24 0.58450 NA -1.32 0.578429 NA -0.02 0.28092 NA 
64 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 4.36 0.09431 NA 2.44 0.370769 NA 0.01 0.67415 NA 
64 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 -2.35 0.41805 NA -3.09 0.30928 NA -0.03 0.35914 NA 
65 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 1.24 0.58450 0.35134 -1.32 0.578429 0.367397 -0.02 0.28092 0.42887 
65 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 4.36 0.09431 NA 2.44 0.370769 NA 0.01 0.67415 NA 
65 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 -2.35 0.41805 NA -3.09 0.30928 NA -0.03 0.35914 NA 
65 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 1.99 0.38168 NA -0.13 0.956125 NA -0.01 0.81914 NA 
66 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 4.36 0.09431 0.37269 2.44 0.370769 0.682314 0.01 0.67415 0.78539 
66 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 -2.35 0.41805 NA -3.09 0.30928 NA -0.03 0.35914 NA 
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66 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 1.99 0.38168 NA -0.13 0.956125 NA -0.01 0.81914 NA 
66 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 3.95 0.13225 NA 1.98 0.470115 NA 0.01 0.59738 NA 
67 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 -2.35 0.41805 0.12235 -3.09 0.30928 0.50223 -0.03 0.35914 0.63438 
67 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 1.99 0.38168 NA -0.13 0.956125 NA -0.01 0.81914 NA 
67 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 3.95 0.13225 NA 1.98 0.470115 NA 0.01 0.59738 NA 
67 APOC2p5644 3' flanking 6 AG/GG 0.00923 20.49 0.09475 NA 14.86 0.245457 NA -0.1 0.41034 NA 
wind: 4-SNPs haplotype window; w.snps: SNPs that were included in each window; p-value: single-locus p-value; hap-P: haplotype global p-
value; a Cox-Box transformed data. 
 
 
Table 31.  Haplotype-based association results with HDL-C in NHWs 
HDL-Ca 
wind w.snp Function RegulomeDB score Genotype MAF Beta Single-p hap_P 
1 APOE560/rs449647 5' flanking 5 AA/AT/TT 0.16103 -0.01 0.35257 0.08734 
1 APOE832/rs405509 5' flanking 1f GG/GT/TT 0.47749 0.01 0.40306 NA 
1 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.01 0.2865 NA 
1 APOE1575rs769448 intron 1 4 CC/CT/TT 0.02097 0.08 0.01974 NA 
2 APOE832/rs405509 5' flanking 1f GG/GT/TT 0.47749 0.01 0.40306 0.20875 
2 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.01 0.2865 NA 
2 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.08 0.01974 NA 
2 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 -0.01 0.58003 NA 
3 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.01 0.2865 0.10469 
3 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.08 0.01974 NA 
3 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 -0.01 0.58003 NA 
3 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.003 0.77245 NA 
4 APOE1575/rs769448 intron 1 4 CC/CT/TT 0.02097 0.08 0.01974 0.12196 
4 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 -0.01 0.58003 NA 
4 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.003 0.77245 NA 
4 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.05 0.33896 NA 
5 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 -0.01 0.58003 0.62753 
5 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.003 0.77245 NA 
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5 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.05 0.33896 NA 
5 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 0.1 0.43657 NA 
6 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.003 0.77245 0.44317 
6 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.05 0.33896 NA 
6 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 0.1 0.43657 NA 
6 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 0.2 0.27872 NA 
7 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 0.05 0.33896 0.16371 
7 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 0.1 0.43657 NA 
7 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 0.2 0.27872 NA 
7 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 -0.02 0.22334 NA 
8 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 0.1 0.43657 0.26639 
8 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 0.2 0.27872 NA 
8 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 -0.02 0.22334 NA 
8 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -0.01 0.45241 NA 
9 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 0.2 0.27872 0.42211 
9 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 -0.02 0.22334 NA 
9 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -0.01 0.45241 NA 
9 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 0.01 0.89267 NA 
10 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 -0.02 0.22334 0.44664 
10 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -0.01 0.45241 NA 
10 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 0.01 0.89267 NA 
10 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 0.24 0.19264 NA 
11 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -0.01 0.45241 0.11795 
11 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 0.01 0.89267 NA 
11 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 0.24 0.19264 NA 
11 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 0.12 0.04872 NA 
12 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 0.01 0.89267 0.03008 
12 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 0.24 0.19264 NA 
12 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 0.12 0.04872 NA 
12 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.03 0.09145 NA 
13 APOE4528 3'UTR (exon 4) 5 CC/CT 0.0008 0.24 0.19264 0.02997 
13 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 0.12 0.04872 NA 
13 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.03 0.09145 NA 
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13 rs439401 intergenic 1b CC/CT/TT 0.35961 0.01 0.54485 NA 
14 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 0.12 0.04872 0.08392 
14 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.03 0.09145 NA 
14 rs439401 intergenic 1b CC/CT/TT 0.35961 0.01 0.54485 NA 
14 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -0.02 0.27231 NA 
15 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.03 0.09145 0.39059 
15 rs439401 intergenic 1b CC/CT/TT 0.35961 0.01 0.54485 NA 
15 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -0.02 0.27231 NA 
15 APOC1p698 5'flanking 4 CA/CC 0.00405 -0.02 0.78922 NA 
16 rs439401 intergenic 1b CC/CT/TT 0.35961 0.01 0.54485 0.50844 
16 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -0.02 0.27231 NA 
16 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -0.02 0.78922 NA 
16 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.02 0.08599 NA 
17 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -0.02 0.27231 0.17293 
17 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -0.02 0.78922 NA 
17 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.02 0.08599 NA 
17 APOC1p1170 intron 1 2b GA/GG 0.00082 0.4 0.03328 NA 
18 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -0.02 0.78922 0.1064 
18 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.02 0.08599 NA 
18 APOC1p1170 intron 1 2b GA/GG 0.00082 0.4 0.03328 NA 
18 APOC1p1294 intron 2 4 AA/AC 0.00081 0.27 0.15333 NA 
19 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.02 0.08599 0.00048 
19 APOC1p1170 intron 1 2b GA/GG 0.00082 0.4 0.03328 NA 
19 APOC1p1294 intron 2 4 AA/AC 0.00081 0.27 0.15333 NA 
19 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 0.32 0.01616 NA 
20 APOC1p1170 intron 1 2b GA/GG 0.00082 0.4 0.03328 0.00024 
20 APOC1p1294 intron 2 4 AA/AC 0.00081 0.27 0.15333 NA 
20 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 0.32 0.01616 NA 
20 APOC1p1422 intron 2 4 GA/GG 0.00161 0.18 0.18304 NA 
21 APOC1p1294 intron 2 4 AA/AC 0.00081 0.27 0.15333 0.24439 
21 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 0.32 0.01616 NA 
21 APOC1p1422 intron 2 4 GA/GG 0.00161 0.18 0.18304 NA 
21 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -0.07 0.30637 NA 
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22 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 0.32 0.01616 0.54426 
22 APOC1p1422 intron 2 4 GA/GG 0.00161 0.18 0.18304 NA 
22 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -0.07 0.30637 NA 
22 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.01 0.39851 NA 
23 APOC1p1422 intron 2 4 GA/GG 0.00161 0.18 0.18304 0.78818 
23 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -0.07 0.30637 NA 
23 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.01 0.39851 NA 
23 APOC1p2629 exon 3 4 GA/GG 0.00081 0.3 0.11169 NA 
24 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -0.07 0.30637 0.71336 
24 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.01 0.39851 NA 
24 APOC1p2629 exon 3 4 GA/GG 0.00081 0.3 0.11169 NA 
24 APOC1p2817 intron 3 2b CC/CT 0.00329 0.13 0.2246 NA 
25 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.01 0.39851 0.67141 
25 APOC1p2629 exon 3 4 GA/GG 0.00081 0.3 0.11169 NA 
25 APOC1p2817 intron 3 2b CC/CT 0.00329 0.13 0.2246 NA 
25 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -0.18 0.09939 NA 
26 APOC1p2629 exon 3 4 GA/GG 0.00081 0.3 0.11169 0.22049 
26 APOC1p2817 intron 3 2b CC/CT 0.00329 0.13 0.2246 NA 
26 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -0.18 0.09939 NA 
26 APOC1p3494 intron 3 no data CC/CT 0.00161 0.26 0.04784 NA 
27 APOC1p2817 intron 3 2b CC/CT 0.00329 0.13 0.2246 0.76271 
27 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -0.18 0.09939 NA 
27 APOC1p3494 intron 3 no data CC/CT 0.00161 0.26 0.04784 NA 
27 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 -0.0001 0.99672 NA 
28 APOC1p3423/rs389261 intron 3 no data GA/GG 0.00247 -0.18 0.09939 0.79698 
28 APOC1p3494 intron 3 no data CC/CT 0.00161 0.26 0.04784 NA 
28 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 -0.0001 0.99672 NA 
28 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 0.03 0.32535 NA 
29 APOC1p3494 intron 3 no data CC/CT 0.00161 0.26 0.04784 0.07767 
29 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 -0.0001 0.99672 NA 
29 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 0.03 0.32535 NA 
29 APOC1p5773 3' flanking no data GA/GG 0.00083 0.24 0.19556 NA 
30 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 -0.0001 0.99672 0.45722 
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30 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 0.03 0.32535 NA 
30 APOC1p5773 3' flanking no data GA/GG 0.00083 0.24 0.19556 NA 
30 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 -0.01 0.6146 NA 
31 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 0.03 0.32535 0.53541 
31 APOC1p5773 3' flanking no data GA/GG 0.00083 0.24 0.19556 NA 
31 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 -0.01 0.6146 NA 
31 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 -0.01 0.56998 NA 
32 APOC1p5773 3' flanking no data GA/GG 0.00083 0.24 0.19556 0.63232 
32 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 -0.01 0.6146 NA 
32 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 -0.01 0.56998 NA 
32 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.003 0.76528 NA 
33 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 -0.01 0.6146 0.87834 
33 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 -0.01 0.56998 NA 
33 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.003 0.76528 NA 
33 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 -0.02 0.54022 NA 
34 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 -0.01 0.56998 0.91218 
34 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.003 0.76528 NA 
34 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 -0.02 0.54022 NA 
34 HCR1p362 HCR1 2a CA/CC 0.00247 0.001 0.99148 NA 
35 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.003 0.76528 0.50275 
35 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 -0.02 0.54022 NA 
35 HCR1p362 HCR1 2a CA/CC 0.00247 0.001 0.99148 NA 
35 HCR1p423 HCR1 4 CC/CG/GG 0.02581 0.06 0.09096 NA 
36 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 -0.02 0.54022 0.23626 
36 HCR1p362 HCR1 2a CA/CC 0.00247 0.001 0.99148 NA 
36 HCR1p423 HCR1 4 CC/CG/GG 0.02581 0.06 0.09096 NA 
36 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -0.18 0.09959 NA 
37 HCR1p362 HCR1 2a CA/CC 0.00247 0.001 0.99148 0.12504 
37 HCR1p423 HCR1 4 CC/CG/GG 0.02581 0.06 0.09096 NA 
37 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -0.18 0.09959 NA 
37 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -0.18 0.10151 NA 
38 HCR1p423 HCR1 4 CC/CG/GG 0.02581 0.06 0.09096 0.10382 
38 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -0.18 0.09959 NA 
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38 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -0.18 0.10151 NA 
38 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.01 0.65328 NA 
39 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -0.18 0.09959 0.2921 
39 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -0.18 0.10151 NA 
39 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.01 0.65328 NA 
39 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 0.01 0.71147 NA 
40 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -0.18 0.10151 0.03689 
40 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.01 0.65328 NA 
40 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 0.01 0.71147 NA 
40 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 0.03 0.03304 NA 
41 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.01 0.65328 0.09258 
41 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 0.01 0.71147 NA 
41 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 0.03 0.03304 NA 
41 HCR2p365 HCR2 2b CA/CC 0.00409 -0.02 0.81824 NA 
42 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 0.01 0.71147 0.10734 
42 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 0.03 0.03304 NA 
42 HCR2p365 HCR2 2b CA/CC 0.00409 -0.02 0.81824 NA 
42 HCR2p523 HCR2 2b CC/CT 0.02258 -0.03 0.37507 NA 
43 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 0.03 0.03304 0.02013 
43 HCR2p365 HCR2 2b CA/CC 0.00409 -0.02 0.81824 NA 
43 HCR2p523 HCR2 2b CC/CT 0.02258 -0.03 0.37507 NA 
43 APOC4p636 5' flanking no data CC/CT 0.00083 -0.36 0.0564 NA 
44 HCR2p365 HCR2 2b CA/CC 0.00409 -0.02 0.81824 0.49618 
44 HCR2p523 HCR2 2b CC/CT 0.02258 -0.03 0.37507 NA 
44 APOC4p636 5' flanking no data CC/CT 0.00083 -0.36 0.0564 NA 
44 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -0.03 0.34336 NA 
45 HCR2p523 HCR2 2b CC/CT 0.02258 -0.03 0.37507 0.57223 
45 APOC4p636 5' flanking no data CC/CT 0.00083 -0.36 0.0564 NA 
45 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -0.03 0.34336 NA 
45 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 0.26 0.04737 NA 
46 APOC4p636 5' flanking no data CC/CT 0.00083 -0.36 0.0564 0.26683 
46 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -0.03 0.34336 NA 
46 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 0.26 0.04737 NA 
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46 APOC4p1229 intron 1 2b GC/GG 0.00161 -0.36 0.00733 NA 
47 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 -0.03 0.34336 0.3462 
47 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 0.26 0.04737 NA 
47 APOC4p1229 intron 1 2b GC/GG 0.00161 -0.36 0.00733 NA 
47 APOC4p2557 intron 1 4 CA/CC 0.00081 -0.27 0.14545 NA 
48 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 0.26 0.04737 0.43724 
48 APOC4p1229 intron 1 2b GC/GG 0.00161 -0.36 0.00733 NA 
48 APOC4p2557 intron 1 4 CA/CC 0.00081 -0.27 0.14545 NA 
48 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.01 0.48156 NA 
49 APOC4p1229 intron 1 2b GC/GG 0.00161 -0.36 0.00733 0.01224 
49 APOC4p2557 intron 1 4 CA/CC 0.00081 -0.27 0.14545 NA 
49 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.01 0.48156 NA 
49 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.02 0.14018 NA 
50 APOC4p2557 intron 1 4 CA/CC 0.00081 -0.27 0.14545 0.7013 
50 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.01 0.48156 NA 
50 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.02 0.14018 NA 
50 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 0.03 0.38586 NA 
51 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.01 0.48156 0.76319 
51 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.02 0.14018 NA 
51 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 0.03 0.38586 NA 
51 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -0.04 0.53441 NA 
52 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.02 0.14018 0.75905 
52 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 0.03 0.38586 NA 
52 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -0.04 0.53441 NA 
52 APOC4p3498C2p194/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.01 0.42951 NA 
53 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 0.03 0.38586 0.72787 
53 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -0.04 0.53441 NA 
53 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.01 0.42951 NA 
53 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -0.01 0.91107 NA 
54 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -0.04 0.53441 0.24838 
54 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.01 0.42951 NA 
54 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -0.01 0.91107 NA 
54 APOC2p543C4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 -0.36 0.0074 NA 
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55 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.01 0.42951 0.33125 
55 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -0.01 0.91107 NA 
55 APOC2p543C4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 -0.36 0.0074 NA 
55 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 -0.001 0.92518 NA 
56 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -0.01 0.91107 0.09285 
56 APOC2p543C4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 -0.36 0.0074 NA 
56 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 -0.001 0.92518 NA 
56 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.01 0.58956 NA 
57 APOC2p543C4p3847/rs186448850 C4-intron2 5 CT/TT 0.00164 -0.36 0.0074 0.00316 
57 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 -0.001 0.92518 NA 
57 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.01 0.58956 NA 
57 APOC2p1591C4p4895 C2-intron1 4 GA/GG 0.00081 -0.36 0.05115 NA 
58 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 -0.001 0.92518 0.0822 
58 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.01 0.58956 NA 
58 APOC2p1591C4p4895 C2-intron1 4 GA/GG 0.00081 -0.36 0.05115 NA 
58 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -0.02 0.41183 NA 
59 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.01 0.58956 0.68608 
59 APOC2p1591C4p4895 C2-intron1 4 GA/GG 0.00081 -0.36 0.05115 NA 
59 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -0.02 0.41183 NA 
59 APOC2p2870 intron 1 4 GG/GT 0.00403 0.03 0.7577 NA 
60 APOC2p1591C4p4895 C2-intron1 4 GA/GG 0.00081 -0.36 0.05115 0.2064 
60 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -0.02 0.41183 NA 
60 APOC2p2870 intron 1 4 GG/GT 0.00403 0.03 0.7577 NA 
60 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 0.05 0.10518 NA 
61 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 -0.02 0.41183 0.47918 
61 APOC2p2870 intron 1 4 GG/GT 0.00403 0.03 0.7577 NA 
61 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 0.05 0.10518 NA 
61 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.01 0.51351 NA 
62 APOC2p2870 intron 1 4 GG/GT 0.00403 0.03 0.7577 0.23867 
62 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 0.05 0.10518 NA 
62 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.01 0.51351 NA 
62 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 -0.01 0.32077 NA 
63 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 0.05 0.10518 0.28973 
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63 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.01 0.51351 NA 
63 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 -0.01 0.32077 NA 
63 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.02 0.25579 NA 
64 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.01 0.51351 0.20798 
64 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 -0.01 0.32077 NA 
64 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.02 0.25579 NA 
64 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 -0.002 0.84552 NA 
65 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 -0.01 0.32077 0.299 
65 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.02 0.25579 NA 
65 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 -0.002 0.84552 NA 
65 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 -0.01 0.27402 NA 
66 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.02 0.25579 0.53685 
66 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 -0.002 0.84552 NA 
66 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 -0.01 0.27402 NA 
66 APOC2p5644 3' flanking 6 AG/GG 0.00923 0.01 0.89469 NA 
wind: 4-SNPs haplotype window; w.snps: SNPs that were included in each window; p-value: single-locus p-value; hap-P: haplotype global p-



















Table 32.  Haplotype-based association results with ApoB, and ApoA1 in NHWs 
HAPLOTYPE WINDOWS ApoBa ApoA1 
wind w.snp Function RegulomeDB svore Genotype MAF Beta Single-p hap_P Beta Single-p hap_P 
1 APOE560/rs449647 5' flanking 5 AA/AT/TT 0.16103 -0.95 0.12896 0.00002 -1.57 0.61755 0.63079 
1 APOE832rs405509 5' flanking 1f GG/GT/TT 0.47749 1.46 0.0009 NA -1.8 0.41735 NA 
1 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.56 0.23194 NA -0.19 0.9349 NA 
1 APOE1575rs769448 intron 1 4 CC/CT/TT 0.02097 0.94 0.52039 NA 3.44 0.63942 NA 
2 APOE832rs405509 5' flanking 1f GG/GT/TT 0.47749 1.46 0.0009 0.00041 -1.8 0.41735 0.30357 
2 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.56 0.23194 NA -0.19 0.9349 NA 
2 APOE1575rs769448 intron 1 4 CC/CT/TT 0.02097 0.94 0.52039 NA 3.44 0.63942 NA 
2 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 2.03 0.00297 NA -4.38 0.20481 NA 
3 APOE1163/rs440446 intron 1 4 CC/GC/GG 0.36035 0.56 0.23194 8.05E-07 -0.19 0.9349 0.51661 
3 APOE1575rs769448 intron 1 4 CC/CT/TT 0.02097 0.94 0.52039 NA 3.44 0.63942 NA 
3 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 2.03 0.00297 NA -4.38 0.20481 NA 
3 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.15 0.74223 NA 0.7 0.76559 NA 
4 APOE1575rs769448 intron 1 4 CC/CT/TT 0.02097 0.94 0.52039 0.02649 3.44 0.63942 0.71919 
4 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 2.03 0.00297 NA -4.38 0.20481 NA 
4 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.15 0.74223 NA 0.7 0.76559 NA 
4 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 -0.22 0.9196 NA 3.7 0.73794 NA 
5 APOE1998/rs769449 intron 2 4 AA/AG/GG 0.1165 2.03 0.00297 0.01761 -4.38 0.20481 0.5894 
5 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.15 0.74223 NA 0.7 0.76559 NA 
5 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 -0.22 0.9196 NA 3.7 0.73794 NA 
5 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 13.81 0.03418 NA 3.29 0.92048 NA 
6 APOE2440/rs769450 intron 2 5 AA/GA/GG 0.40145 0.15 0.74223 0.09646 0.7 0.76559 0.86069 
6 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 -0.22 0.9196 NA 3.7 0.73794 NA 
6 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 13.81 0.03418 NA 3.29 0.92048 NA 
6 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 9.15 0.1602 NA 29.79 0.3649 NA 
7 APOE2907/rs769451 intron 2 5 GT/TT 0.01124 -0.22 0.9196 0.00266 3.7 0.73794 0.35441 
7 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 13.81 0.03418 NA 3.29 0.92048 NA 
7 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 9.15 0.1602 NA 29.79 0.3649 NA 
7 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 2.14 0.0005 NA -3.66 0.23988 NA 
8 APOE3038/rs111833428   exon 3 5 AG/GG 0.00162 13.81 0.03418 4.37E-14 3.29 0.92048 0.0907 
8 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 9.15 0.1602 NA 29.79 0.3649 NA 
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8 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 2.14 0.0005 NA -3.66 0.23988 NA 
8 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -5.6 9.65E-13 NA 5.12 0.20813 NA 
9 APOE3106/rs769452 exon 3 5 TC/TT 0.00081 9.15 0.1602 8.32E-13 29.79 0.3649 0.35899 
9 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 2.14 0.0005 NA -3.66 0.23988 NA 
9 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -5.6 9.65E-13 NA 5.12 0.20813 NA 
9 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 1.05 0.82199 NA -35.74 0.12454 NA 
10 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.15253 2.14 0.0005 9.72E-13 -3.66 0.23988 0.28206 
10 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -5.6 9.65E-13 NA 5.12 0.20813 NA 
10 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 1.05 0.82199 NA -35.74 0.12454 NA 
10 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 1.6 0.5203 NA -5.55 0.6576 NA 
11 APOE4075/rs7412 exon 4 5 CC/TC/TT 0.08065 -5.6 9.65E-13 5.19E-11 5.12 0.20813 0.27626 
11 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 1.05 0.82199 NA -35.74 0.12454 NA 
11 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 1.6 0.5203 NA -5.55 0.6576 NA 
11 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.12 0.88128 NA 3.3 0.43184 NA 
12 APOE4310/rs199768005 exon 4 5 TA/TT 0.00402 1.05 0.82199 0.71494 -35.74 0.12454 0.34024 
12 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 1.6 0.5203 NA -5.55 0.6576 NA 
12 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.12 0.88128 NA 3.3 0.43184 NA 
12 rs439401 intergenic 1b CC/CT/TT 0.35961 0.39 0.39749 NA 0.91 0.69151 NA 
13 APOE4737/rs117656888 3'flanking 5 CC/GC 0.00806 1.6 0.5203 2.35E-06 -5.55 0.6576 0.43609 
13 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.12 0.88128 NA 3.3 0.43184 NA 
13 rs439401 intergenic 1b CC/CT/TT 0.35961 0.39 0.39749 NA 0.91 0.69151 NA 
13 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -3.78 5.17E-08 NA 3.53 0.32306 NA 
14 APOE5361/rs1081106 3'flanking 3a CC/TC/TT 0.08521 0.12 0.88128 1.91E-06 3.3 0.43184 0.60969 
14 rs439401 intergenic 1b CC/CT/TT 0.35961 0.39 0.39749 NA 0.91 0.69151 NA 
14 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -3.78 5.17E-08 NA 3.53 0.32306 NA 
14 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -2.77 0.55052 NA -4.7 0.84127 NA 
15 rs439401 intergenic 1b CC/CT/TT 0.35961 0.39 0.39749 7.14E-07 0.91 0.69151 0.27455 
15 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -3.78 5.17E-08 NA 3.53 0.32306 NA 
15 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -2.77 0.55052 NA -4.7 0.84127 NA 
15 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 -0.88 0.89283 NA 102.96 0.00165 NA 
16 APOC1rs445925 intergenic no data AA/GA/GG 0.1094 -3.78 5.17E-08 7.77E-08 3.53 0.32306 0.18289 
16 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -2.77 0.55052 NA -4.7 0.84127 NA 
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16 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 -0.88 0.89283 NA 102.96 0.00165 NA 
16 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.82 0.11683 NA -0.46 0.86119 NA 
17 APOC1p698/rs72654449 5'flanking 4 CA/CC 0.00405 -2.77 0.55052 0.25344 -4.7 0.84127 0.21401 
17 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 -0.88 0.89283 NA 102.96 0.00165 NA 
17 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.82 0.11683 NA -0.46 0.86119 NA 
17 APOC1p1170 intron 1 2b GA/GG 0.00082 7.14 0.27763 NA 18.3 0.57227 NA 
18 APOC1p703/rs3207187 5'flanking 4 CC/CT 0.00081 -0.88 0.89283 0.19599 102.96 0.00165 0.03024 
18 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.82 0.11683 NA -0.46 0.86119 NA 
18 APOC1p1170 intron 1 2b GA/GG 0.00082 7.14 0.27763 NA 18.3 0.57227 NA 
18 APOC1p1294 intron 2 4 AA/AC 0.00081 3.07 0.63865 NA 27.03 0.4118 NA 
19 APOC1p720/rs72654451 5'flanking 4 II/WI/WW 0.2299 -0.82 0.11683 0.01494 -0.46 0.86119 0.02329 
19 APOC1p1170 intron 1 2b GA/GG 0.00082 7.14 0.27763 NA 18.3 0.57227 NA 
19 APOC1p1294 intron 2 4 AA/AC 0.00081 3.07 0.63865 NA 27.03 0.4118 NA 
19 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 11.18 0.01598 NA 66.89 0.00423 NA 
20 APOC1p1170 intron 1 2b GA/GG 0.00082 7.14 0.27763 0.01839 18.3 0.57227 0.03642 
20 APOC1p1294 intron 2 4 AA/AC 0.00081 3.07 0.63865 NA 27.03 0.4118 NA 
20 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 11.18 0.01598 NA 66.89 0.00423 NA 
20 APOC1p1422 intron 2 4 GA/GG 0.00161 1.88 0.77425 NA -26.52 0.42032 NA 
21 APOC1p1294 intron 2 4 AA/AC 0.00081 3.07 0.63865 0.69399 27.03 0.4118 0.76922 
21 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 11.18 0.01598 NA 66.89 0.00423 NA 
21 APOC1p1422 intron 2 4 GA/GG 0.00161 1.88 0.77425 NA -26.52 0.42032 NA 
21 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -4.95 0.12948 NA -27.45 0.09146 NA 
22 APOC1p1317/rs12721048 intron 2 4 GA/GG 0.00164 11.18 0.01598 0.66989 66.89 0.00423 0.91771 
22 APOC1p1422 intron 2 4 GA/GG 0.00161 1.88 0.77425 NA -26.52 0.42032 NA 
22 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -4.95 0.12948 NA -27.45 0.09146 NA 
22 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.3 0.51703 NA 0.24 0.91759 NA 
23 APOC1p1422 intron 2 4 GA/GG 0.00161 1.88 0.77425 0.24701 -26.52 0.42032 0.26215 
23 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -4.95 0.12948 NA -27.45 0.09146 NA 
23 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.3 0.51703 NA 0.24 0.91759 NA 
23 APOC1p2629 exon 3 4 GA/GG 0.00081 -5.12 0.43402 NA 2.54 0.93833 NA 
24 APOC1p1566/rs12691088 intron 2 2b GA/GG 0.00579 -4.95 0.12948 0.08378 -27.45 0.09146 0.87228 
24 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.3 0.51703 NA 0.24 0.91759 NA 
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24 APOC1p2629 exon 3 4 GA/GG 0.00081 -5.12 0.43402 NA 2.54 0.93833 NA 
24 APOC1p2817 intron 3 2b CC/CT 0.00329 -4.46 0.23676 NA 21.2 0.27005 NA 
25 APOC1p2041/rs3826688 intron 2 5 AA/GA/GG 0.34241 0.3 0.51703 0.19514 0.24 0.91759 0.98712 
25 APOC1p2629 exon 3 4 GA/GG 0.00081 -5.12 0.43402 NA 2.54 0.93833 NA 
25 APOC1p2817 intron 3 2b CC/CT 0.00329 -4.46 0.23676 NA 21.2 0.27005 NA 
25 APOC1p3423rs389261 intron 3 no data GA/GG 0.00247 -3.5 0.35153 NA -21.68 0.2583 NA 
26 APOC1p2629 exon 3 4 GA/GG 0.00081 -5.12 0.43402 0.20128 2.54 0.93833 0.9918 
26 APOC1p2817 intron 3 2b CC/CT 0.00329 -4.46 0.23676 NA 21.2 0.27005 NA 
26 APOC1p3423rs389261 intron 3 no data GA/GG 0.00247 -3.5 0.35153 NA -21.68 0.2583 NA 
26 APOC1p3494 intron 3 no data CC/CT 0.00161 5.38 0.41256 NA -1.39 0.96622 NA 
27 APOC1p2817 intron 3 2b CC/CT 0.00329 -4.46 0.23676 0.01678 21.2 0.27005 0.82389 
27 APOC1p3423rs389261 intron 3 no data GA/GG 0.00247 -3.5 0.35153 NA -21.68 0.2583 NA 
27 APOC1p3494 intron 3 no data CC/CT 0.00161 5.38 0.41256 NA -1.39 0.96622 NA 
27 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 1.59 0.00983 NA -2.11 0.49556 NA 
28 APOC1p3423rs389261 intron 3 no data GA/GG 0.00247 -3.5 0.35153 0.01486 -21.68 0.2583 0.55738 
28 APOC1p3494 intron 3 no data CC/CT 0.00161 5.38 0.41256 NA -1.39 0.96622 NA 
28 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 1.59 0.00983 NA -2.11 0.49556 NA 
28 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 2 0.09267 NA -4.32 0.47284 NA 
29 C1p3494 intron 3 no data CC/CT 0.00161 5.38 0.41256 0.00809 -1.39 0.96622 0.85336 
29 C1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 1.59 0.00983 NA -2.11 0.49556 NA 
29 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 2 0.09267 NA -4.32 0.47284 NA 
29 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 1.75 0.00229 NA -2.59 0.3695 NA 
30 APOC1p4334/rs12721046 intron 3 6 AA/GA/GG 0.15221 1.59 0.00983 0.01101 -2.11 0.49556 0.71384 
30 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 2 0.09267 NA -4.32 0.47284 NA 
30 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 1.75 0.00229 NA -2.59 0.3695 NA 
30 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 1.43 0.01775 NA -1.1 0.71599 NA 
31 APOC1p5641/rs1064725 3'UTR no data GG/GT/TT 0.03883 2 0.09267 0.00011 -4.32 0.47284 0.51634 
31 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 1.75 0.00229 NA -2.59 0.3695 NA 
31 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 1.43 0.01775 NA -1.1 0.71599 NA 
31 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.56 0.21851 NA 0.02 0.99367 NA 
32 APOC1p5926/rs56131196 3' flanking no data AA/GA/GG 0.18851 1.75 0.00229 0.00131 -2.59 0.3695 0.5184 
32 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 1.43 0.01775 NA -1.1 0.71599 NA 
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32 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.56 0.21851 NA 0.02 0.99367 NA 
32 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 0.68 0.64404 NA -5.81 0.42728 NA 
33 APOC1p6026/rs4420638 3 'flanking no data AA/GA/GG 0.15558 1.43 0.01775 0.01945 -1.1 0.71599 0.79712 
33 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.56 0.21851 NA 0.02 0.99367 NA 
33 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 0.68 0.64404 NA -5.81 0.42728 NA 
33 HCR1p362 HCR1 2a CA/CC 0.00247 2.07 0.75319 NA -3.48 0.91586 NA 
34 rs4803770 HCR1 5 CC/GC/GG 0.37795 0.56 0.21851 0.3828 0.02 0.99367 0.56196 
34 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 0.68 0.64404 NA -5.81 0.42728 NA 
34 HCR1p362 HCR1 2a CA/CC 0.00247 2.07 0.75319 NA -3.48 0.91586 NA 
34 HCR1p423 HCR1 4 CC/CG/GG 0.02581 2.1 0.14804 NA 11.09 0.12932 NA 
35 HCR1p292/rs4803771 HCR1 4 CC/CG/GG 0.02451 0.68 0.64404 0.43162 -5.81 0.42728 0.26826 
35 HCR1p362 HCR1 2a CA/CC 0.00247 2.07 0.75319 NA -3.48 0.91586 NA 
35 HCR1p423 HCR1 4 CC/CG/GG 0.02581 2.1 0.14804 NA 11.09 0.12932 NA 
35 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -3.48 0.35815 NA -21.8 0.25308 NA 
36 HCR1p362 HCR1 2a CA/CC 0.00247 2.07 0.75319 0.2894 -3.48 0.91586 0.18676 
36 HCR1p423 HCR1 4 CC/CG/GG 0.02581 2.1 0.14804 NA 11.09 0.12932 NA 
36 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -3.48 0.35815 NA -21.8 0.25308 NA 
36 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -3.47 0.35832 NA -21.7 0.25437 NA 
37 HCR1p423 HCR1 4 CC/CG/GG 0.02581 2.1 0.14804 0.34557 11.09 0.12932 0.2714 
37 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -3.48 0.35815 NA -21.8 0.25308 NA 
37 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -3.47 0.35832 NA -21.7 0.25437 NA 
37 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.15 0.75492 NA -0.67 0.77688 NA 
38 HCR1p575/rs157599 HCR1 3a AA/AG 0.00242 -3.48 0.35815 0.15272 -21.8 0.25308 0.10958 
38 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -3.47 0.35832 NA -21.7 0.25437 NA 
38 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.15 0.75492 NA -0.67 0.77688 NA 
38 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -1.33 0.05153 NA 6.89 0.04602 NA 
39 HCR1p727/rs149345 HCR1 3a TG/TT 0.00244 -3.47 0.35832 0.36908 -21.7 0.25437 0.06537 
39 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.15 0.75492 NA -0.67 0.77688 NA 
39 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -1.33 0.05153 NA 6.89 0.04602 NA 
39 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -0.48 0.36635 NA 5.16 0.04957 NA 
40 rs5112 APOC1P1 4 CC/GC/GG 0.46329 -0.15 0.75492 0.314 -0.67 0.77688 0.10135 
40 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -1.33 0.05153 NA 6.89 0.04602 NA 
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40 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -0.48 0.36635 NA 5.16 0.04957 NA 
40 HCR2p365 HCR2 2b CA/CC 0.00409 3.05 0.41812 NA 10.58 0.58105 NA 
41 rs7259004 APOC1P1 6 CC/CG/GG 0.11765 -1.33 0.05153 0.35093 6.89 0.04602 0.06601 
41 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -0.48 0.36635 NA 5.16 0.04957 NA 
41 HCR2p365 HCR2 2b CA/CC 0.00409 3.05 0.41812 NA 10.58 0.58105 NA 
41 HCR2p523 HCR2 2b CC/CT 0.02258 1.04 0.47773 NA 3.82 0.60612 NA 
42 HCR2p188/rs35136575 HCR2 2a CC/GC/GG 0.22742 -0.48 0.36635 0.1967 5.16 0.04957 0.35493 
42 HCR2p365 HCR2 2b CA/CC 0.00409 3.05 0.41812 NA 10.58 0.58105 NA 
42 HCR2p523 HCR2 2b CC/CT 0.02258 1.04 0.47773 NA 3.82 0.60612 NA 
42 C4p968/rs76214972 5'UTR 4 AA/AG 0.03623 1.25 0.29092 NA 2.03 0.73303 NA 
43 HCR2p365 HCR2 2b CA/CC 0.00409 3.05 0.41812 0.4537 10.58 0.58105 0.9155 
43 HCR2p523 HCR2 2b CC/CT 0.02258 1.04 0.47773 NA 3.82 0.60612 NA 
43 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 1.25 0.29092 NA 2.03 0.73303 NA 
43 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 5.53 0.3975 NA -1.61 0.96085 NA 
44 HCR2p523 HCR2 2b CC/CT 0.02258 1.04 0.47773 0.62842 3.82 0.60612 0.91367 
44 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 1.25 0.29092 NA 2.03 0.73303 NA 
44 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 5.53 0.3975 NA -1.61 0.96085 NA 
44 APOC4p2557 intron 1 4 CA/CC 0.00081 -5.26 0.42411 NA -14.77 0.65409 NA 
45 APOC4p968/rs76214972 5'UTR 4 AA/AG 0.03623 1.25 0.29092 0.71365 2.03 0.73303 0.96118 
45 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 5.53 0.3975 NA -1.61 0.96085 NA 
45 APOC4p2557 intron 1 4 CA/CC 0.00081 -5.26 0.42411 NA -14.77 0.65409 NA 
45 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.3 0.49795 NA 0.34 0.87974 NA 
46 APOC4p1150/rs148247675   intron 1 5 AA/GA 0.00166 5.53 0.3975 0.91812 -1.61 0.96085 0.94395 
46 APOC4p2557 intron 1 4 CA/CC 0.00081 -5.26 0.42411 NA -14.77 0.65409 NA 
46 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.3 0.49795 NA 0.34 0.87974 NA 
46 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.35 0.59389 NA -1.45 0.66203 NA 
47 APOC4p2557 intron 1 4 CA/CC 0.00081 -5.26 0.42411 0.00177 -14.77 0.65409 0.71382 
47 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.3 0.49795 NA 0.34 0.87974 NA 
47 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.35 0.59389 NA -1.45 0.66203 NA 
47 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -4.99 0.00057 NA -9.31 0.19641 NA 
48 APOC4p2623/rs5157 intron 1 4 CC/CT/TT 0.49759 -0.3 0.49795 0.00245 0.34 0.87974 0.66721 
48 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.35 0.59389 NA -1.45 0.66203 NA 
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48 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -4.99 0.00057 NA -9.31 0.19641 NA 
48 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -1.23 0.59732 NA -9 0.44345 NA 
49 APOC4p2640/rs5158 intron 1 2b CC/CT/TT 0.13813 0.35 0.59389 0.00287 -1.45 0.66203 0.6402 
49 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -4.99 0.00057 NA -9.31 0.19641 NA 
49 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -1.23 0.59732 NA -9 0.44345 NA 
49 APOC2p194APOC4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.12 0.79089 NA 1.35 0.54665 NA 
50 APOC4p2683/rs12721109 intron 1 2b AA/AG/GG 0.02369 -4.99 0.00057 0.00471 -9.31 0.19641 0.49843 
50 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -1.23 0.59732 NA -9 0.44345 NA 
50 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.12 0.79089 NA 1.35 0.54665 NA 
50 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -1.8 0.69724 NA 0.65 0.97779 NA 
51 APOC4p2703/rs12721108 intron 1 2a GG/GT 0.00808 -1.23 0.59732 0.96882 -9 0.44345 0.93596 
51 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.12 0.79089 NA 1.35 0.54665 NA 
51 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -1.8 0.69724 NA 0.65 0.97779 NA 
51 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 0.11 0.81626 NA -1.01 0.67218 NA 
52 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.48629 -0.12 0.79089 0.89426 1.35 0.54665 0.04259 
52 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -1.8 0.69724 NA 0.65 0.97779 NA 
52 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 0.11 0.81626 NA -1.01 0.67218 NA 
52 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.19 0.66177 NA 0.03 0.988 NA 
53 APOC2p242C4p3546/rs12691089 C4-exon2  5 AG/GG 0.00322 -1.8 0.69724 0.68765 0.65 0.97779 0.95558 
53 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 0.11 0.81626 NA -1.01 0.67218 NA 
53 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.19 0.66177 NA 0.03 0.988 NA 
53 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 1.35 0.2357 NA 5.83 0.30785 NA 
54 APOC2p623C4p3927/rs5167 C4-exon3  5 GG/TG/TT 0.35955 0.11 0.81626 0.21163 -1.01 0.67218 0.31879 
54 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.19 0.66177 NA 0.03 0.988 NA 
54 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 1.35 0.2357 NA 5.83 0.30785 NA 
54 APOC2p2870 intron 1 4 GG/GT 0.00403 6.33 0.05291 NA -36.2 0.02793 NA 
55 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/CG/GG 0.49678 0.19 0.66177 0.17473 0.03 0.988 0.11939 
55 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 1.35 0.2357 NA 5.83 0.30785 NA 
55 APOC2p2870 intron 1 4 GG/GT 0.00403 6.33 0.05291 NA -36.2 0.02793 NA 
55 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -1.24 0.3101 NA 6.94 0.2529 NA 
56 APOC2p1851/rs12709886 intron 1 6 GA/GG 0.03722 1.35 0.2357 0.18265 5.83 0.30785 0.12229 
56 APOC2p2870 intron 1 4 GG/GT 0.00403 6.33 0.05291 NA -36.2 0.02793 NA 
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56 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -1.24 0.3101 NA 6.94 0.2529 NA 
56 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.14 0.74796 NA 0.29 0.89544 NA 
57 APOC2p2870 intron 1 4 GG/GT 0.00403 6.33 0.05291 0.54107 -36.2 0.02793 0.09748 
57 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -1.24 0.3101 NA 6.94 0.2529 NA 
57 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.14 0.74796 NA 0.29 0.89544 NA 
57 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 0.21 0.6757 NA -2.81 0.2692 NA 
58 APOC2p3348/rs10420434 intron 1 no data GA/GG 0.0371 -1.24 0.3101 0.78242 6.94 0.2529 0.53289 
58 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.14 0.74796 NA 0.29 0.89544 NA 
58 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 0.21 0.6757 NA -2.81 0.2692 NA 
58 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.26 0.63942 NA 1.64 0.56044 NA 
59 APOC2p3778/rs5120 intron 1 4 AA/AT/TT 0.49756 0.14 0.74796 0.88628 0.29 0.89544 0.21504 
59 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 0.21 0.6757 NA -2.81 0.2692 NA 
59 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.26 0.63942 NA 1.64 0.56044 NA 
59 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 0.36 0.41406 NA -1.16 0.6041 NA 
60 APOC2p4853/rs199828513 3' flanking no data DD/WD/WW 0.27832 0.21 0.6757 0.9147 -2.81 0.2692 0.38319 
60 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.26 0.63942 NA 1.64 0.56044 NA 
60 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 0.36 0.41406 NA -1.16 0.6041 NA 
60 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 0.06 0.91243 NA -3.11 0.23298 NA 
61 APOC2p5004/rs10421404 3' flanking no data CC/CT/TT 0.18233 0.26 0.63942 0.77002 1.64 0.56044 0.71778 
61 APOC2p5310/rs7258345 3' flanking no data GG/TG/TT 0.46487 0.36 0.41406 NA -1.16 0.6041 NA 
61 APOC2p5398/rs12709889 3' flanking 6 AA/GA/GG 0.27603 0.06 0.91243 NA -3.11 0.23298 NA 
61 APOC2p5644 3' flanking 6 AG/GG 0.00923 1.74 0.42698 NA 7.67 0.4929 NA 
wind: 4-SNPs haplotype window; w.snps: SNPs that were included in each window; p-value: single-locus p-value; hap-P: haplotype global p-
value. 





Table 33.  Haplotype-based association summary of significant windows with LDL-C in NHWs 
LDL-C 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.3 1 A T C C 0.2591 -6.76 3.01 -2.25 0.02486 
Geno.4 1 A T C T 0.0211 -1.35 7.63 -0.18 0.85966 
Geno.5 1 A T G C 0.1182 3.48 3.70 0.94 0.34709 
Geno.7 1 T G G C 0.0814 -18.23 4.88 -3.74 0.00020 
Geno.8 1 T T C C 0.0783 0.97 4.57 0.21 0.83201 
Geno.rare 1 * * * * 0.0027 -18.70 0.03 -615.99 <10E-06 
haplo.base 1 A G G C 0.4391 NA NA NA NA 
Geno.2 3 C C G G 0.3374 -4.93 2.65 -1.86 0.06304 
Geno.31 3 C T G G 0.0211 -1.67 7.67 -0.22 0.82803 
Geno.52 3 G C A G 0.1150 2.98 3.79 0.79 0.43109 
Geno.72 3 G C G G 0.1221 -13.46 3.69 -3.65 0.00029 
Geno.rare2 3 * * * * 0.0019 -10.87 0.09 -124.49 <10E-06 
haplo.base2 3 G C G A 0.4026 NA NA NA NA 
Geno.32 4 C A G T 0.1150 10.18 3.78 2.69 0.00724 
Geno.53 4 C G A T 0.4019 7.14 2.48 2.87 0.00419 
Geno.9 4 T G G T 0.0210 5.04 7.73 0.65 0.51461 
Geno.rare3 4 * * * * 0.0112 3.41 10.84 0.31 0.75341 
haplo.base3 4 C G G T 0.4508 NA NA NA NA 
Geno.33 5 A G T G 0.1147 9.92 3.76 2.64 0.00850 
Geno.61 5 G A T G 0.4002 6.75 2.44 2.76 0.00586 
Geno.rare4 5 * * * * 0.0129 6.44 0.24 26.92 <10E-06 
haplo.base4 5 G G T G 0.4722 NA NA NA NA 
Geno.62 7 T G T C 0.1489 8.17 3.18 2.57 0.01049522 
Geno.rare6 7 * * * * 0.0137 6.30 0.11 55.65 <10E-06 
haplo.base6 7 T G T T 0.8375 NA NA NA NA 
Geno.35 8 G T C C 0.1490 5.03 3.20 1.57 0.11629 
Geno.63 8 G T T T 0.0781 -22.79 4.35 -5.24 2.26E-07 
Geno.rare7 8 * * * * 0.0048 40.70 0.05 853.88 <10E-06 
haplo.base7 8 G T T C 0.7680 NA NA NA NA 
Geno.36 9 T C C T 0.1514 5.97 3.12 1.92 0.05594 
Geno.73 9 T T T T 0.0805 -20.88 4.13 -5.06 5.62E-07 
Geno.rare8 9 * * * * 0.0048 -26.44 0.06 -427.62 <10E-06 
haplo.base8 9 T T C T 0.7632 NA NA NA NA 
Geno.21 10 C C T C 0.1522 6.01 3.11 1.93 0.05361 
Geno.74 10 T T T C 0.0805 -20.91 4.12 -5.07 5.27E-07 
Geno.rare9 10 * * * * 0.0048 -31.49 0.06 -507.97 <10E-06 
haplo.base9 10 T C T C 0.7624 NA NA NA NA 
Geno.54 11 T T C C 0.0805 -21.80 4.12 -5.29 1.68E-07 
Geno.rare10 11 * * * * 0.0129 -6.08 10.20 -0.60 0.55144 
haplo.base10 11 C T C C 0.9066 NA NA NA NA 
Geno.22 14 C C C G 0.0810 0.41 4.31 0.09 0.92476 
Geno.43 14 C T C A 0.1101 -15.73 3.90 -4.03 6.17E-05 
Geno.64 14 C T T G 0.3559 -5.13 2.56 -2.01 0.04537 
Geno.rare13 14 * * * * 0.0095 8.41 0.33 25.81 <10E-06 
haplo.base13 14 C T C G 0.4435 NA NA NA NA 
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Geno.23 15 C C G C 0.0838 0.06 4.25 0.01 0.98920 
Geno.44 15 T C A C 0.1101 -16.16 3.91 -4.13 4.10E-05 
Geno.81 15 T T G C 0.3579 -5.12 2.54 -2.01 0.04453 
Geno.rare14 15 * * * * 0.0055 -14.66 0.16 -90.88 <10E-06 
haplo.base14 15 T C G C 0.4428 NA NA NA NA 
Geno.11 16 C A C C 0.1094 -16.12 3.86 -4.17 3.45E-05 
Geno.65 16 T G C C 0.3602 -5.19 2.44 -2.13 0.03336 
Geno.rare15 16 * * * * 0.0048 -14.78 0.09 -172.37 <10E-06 
haplo.base15 16 C G C C 0.5255 NA NA NA NA 
Geno.12 17 A C C I 0.1086 -13.12 3.66 -3.58 0.00037 
Geno.66 17 G C C I 0.1210 4.10 3.46 1.18 0.23656 
Geno.rare16 17 * * * * 0.0058 -12.94 0.08 -161.31 <10E-06 
haplo.base16 17 G C C W 0.7646 NA NA NA NA 
Geno.46 29 G C A T 0.1483 8.80 3.25 2.71 0.00700 
Geno.56 29 G C G G 0.0354 18.27 6.44 2.84 0.00471 
Geno.rare28 29 * * * * 0.0074 -4.63 0.36 -12.75 <10E-06 
haplo.base28 29 G C G T 0.8088 NA NA NA NA 
Geno.26 30 C A T G 0.1522 7.41 3.17 2.34 0.01968 
Geno.311 30 C G G G 0.0388 12.99 5.81 2.24 0.02557 
Geno.rare29 30 * * * * 0.0024 48.33 0.03 1478.96 <10E-06 
haplo.base29 30 C G T G 0.8066 NA NA NA NA 
Geno.27 31 A T G A 0.1519 9.03 3.17 2.85 0.00457 
Geno.47 31 G G G G 0.0363 17.96 6.13 2.93 0.00351 
Geno.68 31 G T G A 0.0349 6.75 6.29 1.07 0.28422 
Geno.rare30 31 * * * * 0.0033 -44.40 0.24 -184.85 <10E-06 
haplo.base30 31 G T G G 0.7737 NA NA NA NA 
Geno.28 32 G G G A 0.0376 12.34 6.17 2.00 0.04586 
Geno.48 32 T G A G 0.1883 7.13 2.93 2.43 0.01529 
Geno.rare31 32 * * * * 0.0037 36.13 0.31 116.64 <10E-06 
haplo.base31 32 T G G A 0.7704 NA NA NA NA 
Geno.312 33 G A G C 0.1850 11.78 3.20 3.68 0.00025 
Geno.69 33 G G A G 0.3723 9.14 2.61 3.50 0.00050 
Geno.rare32 33 * * * * 0.0070 13.80 0.03 487.26 <10E-06 
haplo.base32 33 G G A C 0.4358 NA NA NA NA 
Geno.13 34 A G C C 0.1851 11.71 3.20 3.66 0.00028 
Geno.610 34 G A G C 0.3480 9.11 2.68 3.40 0.00072 
Geno.75 34 G A G G 0.0246 8.66 7.15 1.21 0.22644 
Geno.rare33 34 * * * * 0.0061 16.42 0.05 303.71 <10E-06 
haplo.base33 34 G A C C 0.4363 NA NA NA NA 
Geno.49 35 A G C C 0.3457 8.75 2.66 3.29 0.00107 
Geno.611 35 A G G C 0.0239 7.87 7.26 1.08 0.27866 
Geno.76 35 G C C C 0.1550 10.92 3.39 3.22 0.00134 
Geno.rare34 35 * * * * 0.0081 9.03 0.16 55.45 <10E-06 
haplo.base34 35 A C C C 0.4674 NA NA NA NA 
Geno.314 40 A T G C 0.4225 8.26 2.54 3.25 0.00120 
Geno.412 40 A T G G 0.1152 -6.88 3.71 -1.85 0.06432 
Geno.rare39 40 * * * * 0.0038 -8.13 0.07 -114.06 <10E-06 
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haplo.base39 40 A T C C 0.4584 NA NA NA NA 
Geno.315 41 T C C C 0.3218 -5.88 3.17 -1.86 0.06353 
Geno.413 41 T C C G 0.1359 -11.56 3.80 -3.04 0.00249 
Geno.83 41 T G C G 0.0645 3.46 5.80 0.60 0.55073 
Geno.91 41 T G G C 0.0894 -14.42 4.54 -3.17 0.00158 
Geno.10 41 T G G G 0.0259 -15.84 8.35 -1.90 0.05835 
Geno.rare40 41 * * * * 0.0037 -15.60 0.17 -93.81 <10E-06 
haplo.base40 41 T G C C 0.3587 NA NA NA NA 
Geno.15 42 C C C C 0.3241 -6.11 3.16 -1.93 0.05371 
Geno.316 42 C C G C 0.1304 -12.23 3.91 -3.13 0.00184 
Geno.77 42 G C G C 0.0661 3.75 5.75 0.65 0.51499 
Geno.84 42 G G C C 0.0912 -14.70 4.51 -3.26 0.00118 
Geno.92 42 G G G C 0.0256 -16.28 8.48 -1.92 0.05521 
Geno.rare41 42 * * * * 0.0055 1.95 0.28 7.05 4.95E-12 
haplo.base41 42 G C C C 0.3572 NA NA NA NA 
Geno.29 43 C C C T 0.0130 17.22 11.08 1.55 0.12054 
Geno.414 43 C G C C 0.1930 -2.97 3.02 -0.98 0.32675 
Geno.613 43 G C C C 0.0886 -10.16 4.43 -2.29 0.02213 
Geno.85 43 G G C C 0.0249 -10.90 8.38 -1.30 0.19376 
Geno.rare42 43 * * * * 0.0137 -13.67 10.84 -1.26 0.20771 
haplo.base42 43 C C C C 0.6668 NA NA NA NA 
Geno.317 46 C C G A 0.0362 -1.31 6.13 -0.21 0.83047 
Geno.59 46 T C A A 0.0226 3.78 7.79 0.49 0.62766 
Geno.rare45 46 * * * * 0.0025 67.19 0.04 1511.14 <10E-06 
haplo.base45 46 C C A A 0.9387 NA NA NA NA 
Geno.417 47 C G A G 0.0362 -1.43 6.12 -0.23 0.81513 
Geno.rare46 47 * * * * 0.0041 47.71 0.05 901.97 <10E-06 
haplo.base46 47 C A A G 0.9597 NA NA NA NA 
Geno.16 54 A G C G 0.0224 -20.88 7.53 -2.77 0.00576 
Geno.620 54 G G T G 0.4791 -3.14 2.28 -1.38 0.16831 
Geno.rare53 54 * * * * 0.0113 -0.45 0.51 -0.87 0.38446 
haplo.base53 54 G G C G 0.4872 NA NA NA NA 
Geno.422 60 G G A G 0.0371 -0.47 6.16 -0.08 0.93870 
Geno.517 60 G G G G 0.4548 0.45 2.29 0.20 0.84486 
Geno.rare58 60 * * * * 0.0048 53.51 0.16 343.07 <10E-06 
haplo.base59 60 C G G G 0.5033 NA NA NA NA 
Geno.320 61 G A G G 0.0372 -1.28 6.06 -0.21 0.83302 
Geno.423 61 G G G A 0.0363 -7.79 6.12 -1.27 0.20308 
Geno.rare59 61 * * * * 0.0048 52.71 0.09 598.53 <10E-06 
haplo.base60 61 G G G G 0.9217 NA NA NA NA 
Geno.18 62 A G G A 0.0372 -0.52 6.16 -0.08 0.93272 
Geno.212 62 G G A A 0.0372 -5.86 6.15 -0.95 0.34095 
Geno.321 62 G G G A 0.4196 1.50 2.33 0.65 0.51914 
Geno.rare60 62 * * * * 0.0040 53.39 0.19 286.58 <10E-06 
haplo.base61 62 G G G T 0.5020 NA NA NA NA 
Geno.19 63 G A A D 0.0374 -5.71 6.12 -0.93 0.35098 
Geno.213 63 G G A D 0.1823 -1.76 2.98 -0.59 0.55596 
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Geno.322 63 G G A W 0.2760 3.62 2.72 1.33 0.18266 
Geno.rare61 63 * * * * 0.0061 40.97 0.20 209.25 <10E-06 
haplo.base62 63 G G T D 0.4983 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
 
Table 34. Haplotype-based association summary of significant windows with TC in NHWs 
TC 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.3 1 A T C C 0.2563 -10.78 2.98 -3.61 0.00033 
Geno.4 1 A T C T 0.0211 -0.04 7.67 -0.01 0.99575 
Geno.5 1 A T G C 0.1195 4.03 3.70 1.09 0.27585 
Geno.7 1 T G G C 0.0804 -22.45 4.80 -4.67 3.62E-06 
Geno.8 1 T T C C 0.0796 1.47 4.54 0.32 0.74659 
Geno.rare 1 * * * * 0.0046 95.77 0.16 604.97 <10E-06 
haplo.base 1 A G G C 0.4386 NA NA NA NA 
Geno.2 3 C C G G 0.3374 -7.44 2.75 -2.71 0.00695 
Geno.31 3 C T G G 0.0211 -1.58 7.96 -0.20 0.84270 
Geno.52 3 G C A G 0.1149 2.78 3.93 0.71 0.48050 
Geno.72 3 G C G G 0.1220 -16.61 3.83 -4.34 1.67E-05 
Geno.rare2 3 * * * * 0.0019 -8.91 0.09 -99.94 <10E-06 
haplo.base2 3 G C G A 0.4027 NA NA NA NA 
Geno.32 4 C A G T 0.1149 12.74 3.92 3.25 0.00123 
Geno.53 4 C G A T 0.4021 9.73 2.58 3.77 0.00018 
Geno.9 4 T G G T 0.0211 7.66 8.03 0.95 0.34050 
Geno.rare3 4 * * * * 0.0112 2.13 11.30 0.19 0.85094 
haplo.base3 4 C G G T 0.4507 NA NA NA NA 
Geno.33 5 A G T G 0.1147 12.36 3.91 3.17 0.00163 
Geno.61 5 G A T G 0.4004 9.20 2.54 3.62 0.00032 
Geno.rare4 5 * * * * 0.0129 6.05 0.25 24.40 <10E-06 
haplo.base4 5 G G T G 0.4721 NA NA NA NA 
Geno.34 6 A T G T 0.4000 6.75 2.45 2.76 0.0059 
Geno.41 6 G G G T 0.0112 0.80 0.15 5.51 5.31E-08 
Geno.rare5 6 * * * * 0.0024 30.16 0.00 8221.07 <10E-06 
haplo.base5 6 G T G T 0.5864 NA NA NA NA 
Geno.35 8 G T C C 0.1493 3.84 3.29 1.16 0.24448 
Geno.63 8 G T T T 0.0776 -22.06 4.46 -4.95 9.68E-07 
Geno.rare7 8 * * * * 0.0054 59.95 0.08 705.34 <10E-06 
haplo.base7 8 G T T C 0.7677 NA NA NA NA 
Geno.36 9 T C C T 0.1515 4.56 3.31 1.38 0.16872 
Geno.73 9 T T T T 0.0806 -18.87 4.33 -4.36 1.54E-05 
Geno.rare8 9 * * * * 0.0048 -37.56 0.07 -576.22 <10E-06 
haplo.base8 9 T T C T 0.7631 NA NA NA NA 
Geno.21 10 C C T C 0.1523 4.68 3.30 1.42 0.15737 
Geno.74 10 T T T C 0.0806 -18.81 4.33 -4.34 1.66E-05 
Geno.rare9 10 * * * * 0.0048 -35.00 0.07 -534.40 <10E-06 
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haplo.base9 10 T C T C 0.7622 NA NA NA NA 
Geno.54 11 T T C C 0.0806 -19.27 4.33 -4.46 9.95E-06 
Geno.rare10 11 * * * * 0.0129 -1.15 10.71 -0.11 0.91464 
haplo.base10 11 C T C C 0.9065 NA NA NA NA 
Geno.22 14 C C C G 0.0811 0.23 4.49 0.05 0.95933 
Geno.43 14 C T C A 0.1094 -16.60 4.01 -4.14 3.94E-05 
Geno.64 14 C T T G 0.3556 -6.51 2.67 -2.44 0.01504 
Geno.rare13 14 * * * * 0.0095 15.17 0.33 46.30 <10E-06 
haplo.base13 14 C T C G 0.4444 NA NA NA NA 
Geno.23 15 C C G C 0.0838 0.14 4.41 0.03 0.97417 
Geno.44 15 T C A C 0.1094 -17.19 4.02 -4.28 2.18E-05 
Geno.81 15 T T G C 0.3579 -6.35 2.64 -2.41 0.01636 
Geno.rare14 15 * * * * 0.0055 -24.20 0.17 -142.40 <10E-06 
haplo.base14 15 T C G C 0.4435 NA NA NA NA 
Geno.11 16 C A C C 0.1087 -17.52 3.97 -4.42 1.17E-05 
Geno.65 16 T G C C 0.3602 -6.48 2.53 -2.57 0.01054 
Geno.rare15 16 * * * * 0.0049 -16.38 0.09 -192.48 <10E-06 
haplo.base15 16 C G C C 0.5263 NA NA NA NA 
Geno.12 17 A C C I 0.1081 -14.22 3.83 -3.71 0.00022 
Geno.66 17 G C C I 0.1216 3.33 3.61 0.92 0.35675 
Geno.rare16 17 * * * * 0.0058 -11.10 0.08 -132.40 <10E-06 
haplo.base16 17 G C C W 0.7646 NA NA NA NA 
Geno.46 29 G C A T 0.1515 6.46 3.32 1.95 0.05198 
Geno.56 29 G C G G 0.0387 14.61 6.10 2.40 0.01690 
Geno.rare28 29 * * * * 0.0042 24.64 0.07 345.55 <10E-06 
haplo.base28 29 G C G T 0.8057 NA NA NA NA 
Geno.26 30 C A T G 0.1521 6.68 3.28 2.03 0.04235 
Geno.311 30 C G G G 0.0388 14.82 6.03 2.46 0.01430 
Geno.rare29 30 * * * * 0.0024 84.10 0.03 2478.60 <10E-06 
haplo.base29 30 C G T G 0.8067 NA NA NA NA 
Geno.27 31 A T G A 0.1541 6.77 3.31 2.05 0.04109 
Geno.47 31 G G G G 0.0379 13.68 6.19 2.21 0.02751 
Geno.68 31 G T G A 0.0342 8.14 6.70 1.21 0.22501 
Geno.rare30 31 * * * * 0.0017 49.83 NA NA NA 
haplo.base30 31 G T G G 0.7722 NA NA NA NA 
Geno.28 32 G G G A 0.0387 14.69 6.05 2.43 0.01550 
Geno.48 32 T G A G 0.1893 6.50 3.01 2.16 0.03130 
Geno.rare31 32 * * * * 0.0026 65.08 0.03 2546.45 <10E-06 
haplo.base31 32 T G G A 0.7694 NA NA NA NA 
Geno.312 33 G A G C 0.1849 10.70 3.34 3.20 0.00144 
Geno.69 33 G G A G 0.3729 9.46 2.73 3.47 0.00056 
Geno.rare32 33 * * * * 0.0071 37.39 0.02 2008.39 <10E-06 
haplo.base32 33 G G A C 0.4352 NA NA NA NA 
Geno.13 34 A G C C 0.1850 10.72 3.35 3.20 0.00142 
Geno.610 34 G A G C 0.3486 9.72 2.80 3.47 0.00056 
Geno.75 34 G A G G 0.0246 6.62 7.45 0.89 0.37435 
Geno.rare33 34 * * * * 0.0061 35.54 0.06 593.93 <10E-06 
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haplo.base33 34 G A C C 0.4357 NA NA NA NA 
Geno.49 35 A G C C 0.3462 9.18 2.79 3.29 0.00106 
Geno.611 35 A G G C 0.0239 5.59 7.57 0.74 0.46084 
Geno.76 35 G C C C 0.1546 9.84 3.53 2.79 0.00547 
Geno.rare34 35 * * * * 0.0082 20.91 0.14 146.67 <10E-06 
haplo.base34 35 A C C C 0.4672 NA NA NA NA 
Geno.314 40 A T G C 0.4232 8.18 2.66 3.08 0.00220 
Geno.412 40 A T G G 0.1148 -5.83 3.87 -1.51 0.13185 
Geno.rare39 40 * * * * 0.0038 -20.96 0.08 -274.35 <10E-06 
haplo.base39 40 A T C C 0.4583 NA NA NA NA 
Geno.315 41 T C C C 0.3211 -7.56 3.33 -2.27 0.02337 
Geno.413 41 T C C G 0.1366 -9.68 3.97 -2.44 0.01497 
Geno.83 41 T G C G 0.0638 -0.58 6.34 -0.09 0.92727 
Geno.91 41 T G G C 0.0890 -14.54 4.79 -3.03 0.00252 
Geno.10 41 T G G G 0.0259 -12.67 8.86 -1.43 0.15319 
Geno.rare40 41 * * * * 0.0036 -28.99 0.19 -154.32 <10E-06 
haplo.base40 41 T G C C 0.3600 NA NA NA NA 
Geno.15 42 C C C C 0.3232 -7.85 3.33 -2.36 0.01861 
Geno.316 42 C C G C 0.1312 -9.75 4.07 -2.39 0.01697 
Geno.77 42 G C G C 0.0652 -0.50 6.31 -0.08 0.93707 
Geno.84 42 G G C C 0.0907 -14.86 4.77 -3.12 0.00190 
Geno.92 42 G G G C 0.0256 -13.00 8.96 -1.45 0.14753 
Geno.rare41 42 * * * * 0.0054 -8.58 0.30 -28.83 <10E-06 
haplo.base41 42 G C C C 0.3587 NA NA NA NA 
Geno.317 46 C C G A 0.0362 -4.71 6.37 -0.74 0.45918 
Geno.59 46 T C A A 0.0226 8.36 8.12 1.03 0.30381 
Geno.rare45 46 * * * * 0.0025 89.59 0.05 1945.73 <10E-06 
haplo.base45 46 C C A A 0.9387 NA NA NA NA 
Geno.417 47 C G A G 0.0362 -5.06 6.37 -0.79 0.42772 
Geno.rare46 47 * * * * 0.0041 60.52 0.05 1100.73 <10E-06 
haplo.base46 47 C A A G 0.9597 NA NA NA NA 
Geno.510 48 G A G C 0.0362 -5.27 6.41 -0.82 0.41096 
Geno.rare47 48 * * * * 0.0041 36.56 0.06 661.46 <10E-06 
haplo.base47 48 A A G C 0.9597 NA NA NA NA 
Geno.422 60 G G A G 0.0371 -4.22 6.42 -0.66 0.51117 
Geno.517 60 G G G G 0.4548 -0.81 2.39 -0.34 0.73305 
Geno.rare58 60 * * * * 0.0048 58.46 0.16 359.65 <10E-06 
haplo.base59 60 C G G G 0.5032 NA NA NA NA 
Geno.320 61 G A G G 0.0372 -4.16 6.32 -0.66 0.51082 
Geno.423 61 G G G A 0.0363 -3.62 6.40 -0.57 0.57191 
Geno.rare59 61 * * * * 0.0048 58.74 0.09 635.36 <10E-06 
haplo.base60 61 G G G G 0.9217 NA NA NA NA 
Geno.18 62 A G G A 0.0372 -4.77 6.42 -0.74 0.45765 
Geno.212 62 G G A A 0.0372 -2.98 6.43 -0.46 0.64363 
Geno.321 62 G G G A 0.4195 -1.47 2.43 -0.60 0.54721 
Geno.rare60 62 * * * * 0.0040 56.97 0.19 292.45 <10E-06 
haplo.base61 62 G G G T 0.5020 NA NA NA NA 
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Geno.19 63 G A A D 0.0374 -2.79 6.41 -0.43 0.66380 
Geno.213 63 G G A D 0.1823 -5.23 3.12 -1.68 0.09413 
Geno.322 63 G G A W 0.2759 0.92 2.84 0.32 0.74682 
Geno.rare61 63 * * * * 0.0061 45.74 0.21 223.11 <10E-06 
haplo.base62 63 G G T D 0.4983 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
Table 35. Haplotype-based association summary of significant windows with ApoB in NHWs 
ApoB 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.2 1 A T C C 0.2534 0.24 0.58 0.41 0.67873 
Geno.3 1 A T C T 0.0221 0.92 1.41 0.65 0.51564 
Geno.4 1 A T G C 0.1313 2.00 0.69 2.91 0.00382 
Geno.6 1 T G G C 0.0748 -2.62 0.95 -2.75 0.00616 
Geno.7 1 T T C C 0.0781 1.36 0.86 1.58 0.11430 
Geno.rare 1 * * * * 0.0012 -20.89 6.37 -3.28 0.00113 
haplo.base 1 A G G C 0.4390 NA NA NA NA 
Geno.5 2 T C C G 0.3288 1.04 0.49 2.13 0.03342 
Geno.61 2 T C T G 0.0214 1.56 1.45 1.07 0.28307 
Geno.71 2 T G C A 0.1258 2.47 0.70 3.55 0.00042 
Geno.rare1 2 * * * * 0.0104 -4.18 2.26 -1.85 0.06480 
haplo.base1 2 G G C G 0.5136 NA NA NA NA 
Geno.21 3 C C G G 0.3301 0.18 0.51 0.36 0.72077 
Geno.31 3 C T G G 0.0222 0.46 1.42 0.32 0.74598 
Geno.51 3 G C A G 0.1270 1.65 0.70 2.34 0.01960 
Geno.72 3 G C G G 0.1212 -3.20 0.70 -4.53 7.49E-06 
Geno.rare2 3 * * * * 0.0025 -6.15 4.42 -1.39 0.16502 
haplo.base2 3 G C G A 0.3970 NA NA NA NA 
Geno.32 4 C A G T 0.1274 2.36 0.73 3.26 0.00122 
Geno.52 4 C G A T 0.3962 0.71 0.49 1.46 0.14637 
Geno.10 4 T G G T 0.0221 1.39 1.45 0.96 0.33866 
Geno.rare3 4 * * * * 0.0104 0.06 2.23 0.03 0.97919 
haplo.base3 4 C G G T 0.4438 NA NA NA NA 
Geno.33 5 A G T G 0.1269 2.26 0.72 3.13 0.00185 
Geno.62 5 G A T G 0.3951 0.59 0.49 1.22 0.22353 
Geno.rare4 5 * * * * 0.0115 1.49 2.10 0.71 0.47789 
haplo.base4 5 G G T G 0.4666 NA NA NA NA 
Geno.34 6 A T G T 0.3949 0.12 0.46 0.25 0.80387 
Geno.41 6 G G G T 0.0104 -0.11 2.19 -0.05 0.95879 
Geno.rare5 6 * * * * 0.0023 11.46 4.57 2.51 0.01251 
haplo.base5 6 G T G T 0.5924 NA NA NA NA 
Geno.63 7 T G T C 0.1582 2.04 0.61 3.31 0.00101 
Geno.rare6 7 * * * * 0.0127 2.37 1.97 1.20 0.22976 
haplo.base6 7 T G T T 0.8291 NA NA NA NA 
Geno.35 8 G T C C 0.1606 1.52 0.58 2.63 0.00888 
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Geno.64 8 G T T T 0.0810 -5.37 0.76 -7.03 8.41E-12 
Geno.rare7 8 * * * * 0.0032 10.05 4.26 2.36 0.01883 
haplo.base7 8 G T T C 0.7552 NA NA NA NA 
Geno.36 9 T C C T 0.1586 1.37 0.60 2.28 0.02327 
Geno.73 9 T T T T 0.0797 -5.53 0.81 -6.79 3.76E-11 
Geno.rare8 9 * * * * 0.0056 3.67 3.38 1.09 0.27814 
haplo.base8 9 T T C T 0.7560 NA NA NA NA 
Geno.22 10 C C T C 0.1606 1.50 0.61 2.46 0.01427 
Geno.74 10 T T T C 0.0804 -5.41 0.84 -6.47 2.67E-10 
Geno.rare9 10 * * * * 0.0118 1.31 2.18 0.60 0.54871 
haplo.base9 10 T C T C 0.7471 NA NA NA NA 
Geno.37 11 C T C C 0.0702 -0.15 0.81 -0.18 0.85709 
Geno.8 11 T T C T 0.0813 -5.59 0.76 -7.32 1.21E-12 
Geno.rare10 11 * * * * 0.0110 0.37 2.07 0.18 0.85654 
haplo.base10 11 C T C T 0.8375 NA NA NA NA 
Geno.1 13 C C C G 0.0717 -0.59 0.85 -0.70 0.48383 
Geno.23 13 C T C A 0.1109 -4.07 0.73 -5.57 4.54E-08 
Geno.42 13 C T T G 0.3568 -0.49 0.48 -1.03 0.30417 
Geno.rare12 13 * * * * 0.0081 0.58 2.52 0.23 0.81910 
haplo.base12 13 C T C G 0.4526 NA NA NA NA 
Geno.24 14 C C G C 0.0749 -0.45 0.83 -0.54 0.59038 
Geno.38 14 T C A C 0.1109 -4.09 0.73 -5.61 3.67E-08 
Geno.75 14 T T G C 0.3572 -0.49 0.48 -1.02 0.30781 
Geno.rare13 14 * * * * 0.0023 -3.82 4.44 -0.86 0.38954 
haplo.base13 14 T C G C 0.4547 NA NA NA NA 
Geno.11 15 C A C C 0.1098 -4.05 0.72 -5.59 4.00E-08 
Geno.65 15 T G C C 0.3585 -0.45 0.46 -0.98 0.32812 
Geno.rare14 15 * * * * 0.0035 -3.19 3.64 -0.88 0.38004 
haplo.base14 15 C G C C 0.5283 NA NA NA NA 
Geno.12 16 A C C I 0.1084 -3.63 0.69 -5.24 2.49E-07 
Geno.66 16 G C C I 0.1325 1.42 0.64 2.22 0.02712 
Geno.rare15 16 * * * * 0.0048 -2.00 3.16 -0.63 0.52723 
haplo.base15 16 G C C W 0.7543 NA NA NA NA 
Geno.26 19 I G A G 0.2402 -0.77 0.52 -1.48 0.13858 
Geno.rare18 19 * * * * 0.0047 7.68 3.24 2.37 0.01838 
haplo.base18 19 W G A G 0.7551 NA NA NA NA 
Geno.rare19 20 * * * * 0.0058 6.84 3.24 2.11 0.03538 
haplo.base19 20 G A G G 0.9942 NA NA NA NA 
Geno.311 27 C G C A 0.1626 1.61 0.61 2.66 0.00813 
Geno.rare26 27 * * * * 0.0082 -2.29 2.80 -0.82 0.41387 
haplo.base26 27 C G C G 0.8291 NA NA NA NA 
Geno.44 28 G C A T 0.1629 1.67 0.61 2.75 0.00623 
Geno.55 28 G C G G 0.0349 2.17 1.18 1.85 0.06524 
Geno.rare27 28 * * * * 0.0047 -0.72 3.76 -0.19 0.84788 
haplo.base27 28 G C G T 0.7975 NA NA NA NA 
Geno.27 29 C A T A 0.1626 1.71 0.61 2.81 0.00519 
Geno.45 29 C G G G 0.0311 1.80 1.32 1.36 0.17327 
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Geno.56 29 C G T A 0.0339 1.74 1.28 1.36 0.17368 
Geno.rare28 29 * * * * 0.0050 6.58 4.47 1.47 0.14222 
haplo.base28 29 C G T G 0.7674 NA NA NA NA 
Geno.46 30 A T A G 0.1638 1.63 0.61 2.67 0.00791 
Geno.68 30 G G G A 0.0311 1.97 1.35 1.46 0.14504 
Geno.82 30 G T A G 0.0340 1.83 1.29 1.42 0.15664 
Geno.rare29 30 * * * * 0.0063 4.40 3.90 1.13 0.26068 
haplo.base29 30 G T G A 0.7648 NA NA NA NA 
Geno.28 31 G G A C 0.0348 2.94 1.19 2.47 0.01378 
Geno.312 31 T A G C 0.1978 2.67 0.62 4.31 2.06E-05 
Geno.69 31 T G A G 0.3566 1.64 0.52 3.18 0.00155 
Geno.rare30 31 * * * * 0.0063 0.48 3.06 0.16 0.87473 
haplo.base30 31 T G A C 0.4045 NA NA NA NA 
Geno.29 32 A G C C 0.1976 2.53 0.62 4.07 5.68E-05 
Geno.76 32 G A G C 0.3343 1.43 0.53 2.72 0.00672 
Geno.83 32 G A G G 0.0224 1.43 1.43 1.00 0.31820 
Geno.rare31 32 * * * * 0.0065 0.27 3.08 0.09 0.93039 
haplo.base31 32 G A C C 0.4393 NA NA NA NA 
Geno.47 33 A G C C 0.3325 1.25 0.53 2.35 0.01942 
Geno.57 33 A G G C 0.0224 1.20 1.44 0.83 0.40541 
Geno.77 33 G C C C 0.1696 2.08 0.65 3.19 0.00154 
Geno.rare32 33 * * * * 0.0071 1.35 3.06 0.44 0.66038 
haplo.base32 33 A C C C 0.4684 NA NA NA NA 
Geno.415 47 C C C G 0.3667 0.31 0.47 0.65 0.51801 
Geno.515 47 C C T A 0.0193 -5.00 1.52 -3.28 0.00114 
Geno.612 47 C C T G 0.1148 1.44 0.71 2.02 0.04446 
Geno.rare46 47 * * * * 0.0038 -3.04 3.69 -0.82 0.41088 
haplo.base46 47 C T C G 0.4954 NA NA NA NA 
Geno.212 48 C C G G 0.3678 0.29 0.47 0.61 0.54354 
Geno.416 48 C T A G 0.0185 -5.01 1.55 -3.23 0.00135 
Geno.613 48 C T G G 0.1148 1.45 0.71 2.02 0.04349 
Geno.rare47 48 * * * * 0.0119 -1.28 2.12 -0.60 0.54826 
haplo.base47 48 T C G G 0.4869 NA NA NA NA 
Geno.213 49 C G G C 0.3798 0.09 0.48 0.18 0.85784 
Geno.614 49 T A G C 0.0185 -5.09 1.55 -3.27 0.00115 
Geno.93 49 T G G C 0.1148 1.37 0.72 1.90 0.05776 
Geno.rare48 49 * * * * 0.0119 -1.31 2.12 -0.62 0.53790 
haplo.base48 49 C G G T 0.4750 NA NA NA NA 
Geno.14 50 A G C G 0.0214 -5.20 1.47 -3.54 0.00045 
Geno.615 50 G G T G 0.4740 -0.41 0.45 -0.92 0.35904 
Geno.rare49 50 * * * * 0.0116 -1.74 2.16 -0.81 0.41994 
haplo.base49 50 G G C G 0.4930 NA NA NA NA 




Table 36. Haplotype-based association summary of significant windows with TG in NHWs 
TG 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.3 1 A T C C 0.2597 -0.093 0.030 -3.063 0.00229 
Geno.4 1 A T C T 0.0212 -0.125 0.077 -1.614 0.10696 
Geno.5 1 A T G C 0.1191 -0.021 0.037 -0.563 0.57379 
Geno.7 1 T G G C 0.0815 -0.047 0.048 -0.979 0.32783 
Geno.8 1 T T C C 0.0767 -0.074 0.046 -1.602 0.10978 
Geno.rare 1 * * * * 0.0018 0.680 0.387 1.755 0.07969 
haplo.base 1 A G G C 0.4400 NA NA NA NA 
Geno.51 2 T C C G 0.3351 -0.079 0.025 -3.107 0.00198 
Geno.6 2 T C T G 0.0208 -0.119 0.078 -1.523 0.12829 
Geno.71 2 T G C A 0.1134 -0.008 0.038 -0.201 0.84085 
Geno.rare1 2 * * * * 0.0106 -0.091 0.115 -0.796 0.42648 
haplo.base1 2 G G C G 0.5201 NA NA NA NA 
Geno.2 3 C C G G 0.3364 -0.083 0.027 -3.082 0.00215 
Geno.31 3 C T G G 0.0212 -0.130 0.078 -1.667 0.09597 
Geno.52 3 G C A G 0.1148 -0.019 0.038 -0.486 0.62712 
Geno.72 3 G C G G 0.1220 -0.047 0.038 -1.261 0.20779 
Geno.rare2 3 * * * * 0.0019 -0.439 0.275 -1.598 0.11047 
haplo.base2 3 G C G A 0.4037 NA NA NA NA 
Geno.33 5 A G T G 0.1146 0.048 0.038 1.257 0.20924 
Geno.61 5 G A T G 0.4015 0.072 0.025 2.902 0.00384 
Geno.rare4 5 * * * * 0.0129 -0.003 0.102 -0.026 0.97936 
haplo.base4 5 G G T G 0.4710 NA NA NA NA 
Geno.67 23 G G G A 0.3371 -0.075 0.024 -3.124 0.00187 
Geno.rare22 23 * * * * 0.0091 -0.165 0.122 -1.354 0.17626 
haplo.base22 23 G G G G 0.6538 NA NA NA NA 
Geno.55 24 G G A G 0.3362 -0.075 0.024 -3.117 0.00191 
Geno.rare23 24 * * * * 0.0082 -0.175 0.135 -1.303 0.19293 
haplo.base23 24 G G G G 0.6555 NA NA NA NA 
Geno.45 25 G A G C 0.3382 -0.078 0.024 -3.222 0.00134 
Geno.rare24 25 * * * * 0.0100 -0.058 0.122 -0.474 0.63557 
haplo.base24 25 G G G C 0.6518 NA NA NA NA 
Geno.39 26 A G C G 0.3397 -0.078 0.024 -3.231 0.00130 
Geno.rare25 26 * * * * 0.0066 -0.012 0.161 -0.071 0.94310 
haplo.base25 26 G G C G 0.6537 NA NA NA NA 
Geno.312 33 G A G C 0.1855 0.027 0.033 0.836 0.40320 
Geno.69 33 G G A G 0.3737 0.047 0.026 1.775 0.07645 
Geno.rare32 33 * * * * 0.0069 0.390 0.217 1.796 0.07293 
haplo.base32 33 G G A C 0.4339 NA NA NA NA 
Geno.417 47 C G A G 0.0365 0.020 0.062 0.321 0.74844 
Geno.rare46 47 * * * * 0.0041 0.573 0.199 2.878 0.00414 
haplo.base46 47 C A A G 0.9594 NA NA NA NA 
Geno.510 48 G A G C 0.0365 0.019 0.062 0.302 0.76284 
Geno.rare47 48 * * * * 0.0041 0.452 0.200 2.260 0.02417 
haplo.base47 48 A A G C 0.9594 NA NA NA NA 
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Geno.511 49 A G C T 0.4935 0.019 0.023 0.825 0.40944 
Geno.rare48 49 * * * * 0.0041 0.465 0.201 2.320 0.02069 
haplo.base48 49 A G C C 0.5024 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
Table 37. Haplotype-based association summary of significant windows with HDL-C in NHWs 
HDL-C 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.37 12 T C C C 0.0814 0.034 0.019 1.765 0.07798 
Geno.rare11 12 * * * * 0.0130 0.096 0.050 1.934 0.05354 
haplo.base11 12 T C C T 0.9057 NA NA NA NA 
Geno.1 13 C C C C 0.0800 0.035 0.020 1.743 0.08184 
Geno.42 13 C C T T 0.3545 0.008 0.011 0.755 0.45065 
Geno.rare12 13 * * * * 0.0108 0.133 0.056 2.379 0.01768 
haplo.base12 13 C C T C 0.5547 NA NA NA NA 
Geno.24 19 I G A G 0.2290 -0.021 0.013 -1.668 0.09583 
Geno.rare18 19 * * * * 0.0032 0.318 0.130 2.440 0.01497 
haplo.base18 19 W G A G 0.7677 NA NA NA NA 
Geno.rare19 20 * * * * 0.0049 0.278 0.092 3.014 0.00268 
haplo.base19 20 G A G G 0.9951 NA NA NA NA 
Geno.416 43 C C T C 0.0175 0.010 0.043 0.233 0.81592 
Geno.612 43 G C C C 0.2173 0.033 0.013 2.591 0.00980 
Geno.rare42 43 * * * * 0.0101 -0.106 0.062 -1.702 0.08927 
haplo.base42 43 C C C C 0.7551 NA NA NA NA 
Geno.513 49 G C C C 0.3625 0.001 0.012 0.045 0.96388 
Geno.614 49 G C C T 0.1390 0.020 0.016 1.280 0.20088 
Geno.rare48 49 * * * * 0.0024 -0.317 0.131 -2.424 0.01563 
haplo.base48 49 G C T C 0.4961 NA NA NA NA 
Geno.318 57 T G C G 0.0212 0.073 0.041 1.811 0.07062 
Geno.517 57 T G G G 0.3370 0.001 0.012 0.105 0.91679 
Geno.79 57 T T G G 0.1597 0.024 0.015 1.532 0.12595 
Geno.rare56 57 * * * * 0.0024 -0.342 0.131 -2.616 0.00910 
haplo.base56 57 T T C G 0.4796 NA NA NA NA 






Table 38. Haplotype-based association summary of significant windows with ApoA1 in NHWs 
ApoA1 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.25 18 C I G A 0.2396 -0.79 2.62 -0.30 0.76340 
Geno.rare17 18 * * * * 0.0035 49.06 0.04 1119.99 <10E-06 
haplo.base17 18 C W G A 0.7569 NA NA NA NA 
Geno.26 19 I G A G 0.2408 -0.02 2.62 -0.01 0.99278 
Geno.rare18 19 * * * * 0.0046 44.78 0.06 761.17 <10E-06 
haplo.base18 19 W G A G 0.7546 NA NA NA NA 
Geno.rare19 20 * * * * 0.0058 30.69 0.01 2087.61 <10E-06 
haplo.base19 20 G A G G 0.9942 NA NA NA NA 
Geno.321 52 C G G C 0.0207 -11.21 7.92 -1.42 0.15749 
Geno.418 52 C G G G 0.3413 -0.77 2.52 -0.31 0.76016 
Geno.617 52 C G T G 0.1506 -1.13 3.27 -0.34 0.73060 
Geno.rare51 52 * * * * 0.0061 41.27 0.22 184.54 <10E-06 
haplo.base51 52 T G T C 0.4813 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
 
 
3.6.3.2  African Blacks 
Tables 39-46 summarized the haplotype-based association analysis in Blacks and Figure 24 
represents the plots of haplotype 4-SNP windows p-value with lipid traits. Multiple windows 
showed significant global p-values with LDL-C and TC as it has been seen in NHWs, but the 
effect on apoB was much smaller in Blacks as compared to NHWs. The top significant 
associated windows with LDL-C and TC were mapped to the APOE2/E4 alleles. The significant 
signals with LDL-C and TC were derived from common/uncommon variants (MAF>1%) with 
significant single effect except one region mapped to windows 95, 96, and 97 where none of the 
variants included in those windows had significant effect in the single locus analysis. Most of the 
significant haplotype windows with HDL-C, TG, and apoA1 contained SNPs that also yielded 
significant association in the single-locus association analysis. However, three windows, 41, 42, 
and 43, that showed significant haplotype global p-values with HDL-C and apoA1, did not 
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contain any SNP that was significant in the single-locus analysis. Two of the variants included in 
these three windows, rs7259004 and HCR2p188/rs35136575, were associated with HDL-C and 

























 f) ApoA1 
 
Figure 24. Haplotype p-value plots with lipid traits in Blacks 
The X-axis has the genotyped markers that included in each window and the Y-axis has the –log (global p-value), 
the red line represent the significance threshold of the global haplotype p-value, each line is corresponding to 
one window, all line underneath the red line means non significant global p-value and vice versa. 
 175 
Table 39.  Haplotype-based association results with LDL-C, TC, and ApoB in Blacks  
HAPLOTYPE WINDOWS LDL-Ca TCa ApoBa 
wind w.snp Function RegulomeDB score Genotype MAF Beta Single-p hap_P Beta single-p hap_P Beta single-p hap_P 
1 APOE73/rs1081101 5'flanking 4 CC/CT/TT 0.0611 -0.62 0.11098 0.02165 -0.2 0.32826 0.14422 0.65 0.54877 0.27317 
1 APOE173 5'flanking 3a AA/GA 0.002 -1.14 0.59789 NA 0.41 0.71509 NA 3.2 0.59226 NA 
1 APOE308/rs769445 5'flanking 4 CC/TC 0.0072 -0.37 0.75764 NA -0.06 0.92177 NA 1.87 0.55135 NA 
1 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.3663 0.58 0.00307 NA 0.25 0.01773 NA 0.92 0.09509 NA 
2 APOE173 5'flanking 3a AA/GA 0.002 -1.14 0.59789 0.00975 0.41 0.71509 0.04834 3.2 0.59226 0.21585 
2 APOE308/rs769445 5'flanking 4 CC/TC 0.0072 -0.37 0.75764 NA -0.06 0.92177 NA 1.87 0.55135 NA 
2 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.3663 0.58 0.00307 NA 0.25 0.01773 NA 0.92 0.09509 NA 
2 APOE618 5'flanking 4 GC/GG 0.0006 -2.85 0.44324 NA -3.62 0.0634 NA 4.15 0.68762 NA 
3 APOE308/rs769445 5'flanking 4 CC/TC 0.0072 -0.37 0.75764 0.00658 -0.06 0.92177 0.03895 1.87 0.55135 0.32323 
3 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.3663 0.58 0.00307 NA 0.25 0.01773 NA 0.92 0.09509 NA 
3 APOE618 5'flanking 4 GC/GG 0.0006 -2.85 0.44324 NA -3.62 0.0634 NA 4.15 0.68762 NA 
3 APOE624/rs769446 5'flanking 3a TC/TT 0.0077 -2.86 0.02138 NA -1.25 0.04403 NA -4.19 0.20373 NA 
4 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.3663 0.58 0.00307 0.00341 0.25 0.01773 0.01752 0.92 0.09509 0.26109 
4 APOE618 5'flanking 4 GC/GG 0.0006 -2.85 0.44324 NA -3.62 0.0634 NA 4.15 0.68762 NA 
4 APOE624/rs769446 5'flanking 3a TC/TT 0.0077 -2.86 0.02138 NA -1.25 0.04403 NA -4.19 0.20373 NA 
4 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.2561 0.6 0.00436 NA 0.22 0.05286 NA 0.66 0.26113 NA 
5 APOE618 5'flanking 4 GC/GG 0.0006 -2.85 0.44324 0.00338 -3.62 0.0634 0.01618 4.15 0.68762 0.26816 
5 APOE624/rs769446 5'flanking 3a TC/TT 0.0077 -2.86 0.02138 NA -1.25 0.04403 NA -4.19 0.20373 NA 
5 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.2561 0.6 0.00436 NA 0.22 0.05286 NA 0.66 0.26113 NA 
5 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.05 0.91835 NA 0.12 0.63205 NA 1.38 0.27683 NA 
6 APOE624/rs769446 5'flanking 3a TC/TT 0.0077 -2.86 0.02138 0.01244 -1.25 0.04403 0.05618 -4.19 0.20373 0.18559 
6 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.2561 0.6 0.00436 NA 0.22 0.05286 NA 0.66 0.26113 NA 
6 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.05 0.91835 NA 0.12 0.63205 NA 1.38 0.27683 NA 
6 APOE1163/rs440446 intron1 4 CC/CG/GG 0.1004 0.44 0.17914 NA 0.12 0.47483 NA 2.3 0.01093 NA 
7 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.2561 0.6 0.00436 0.08954 0.22 0.05286 0.25817 0.66 0.26113 0.13222 
7 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.05 0.91835 NA 0.12 0.63205 NA 1.38 0.27683 NA 
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7 APOE1163/rs440446 intron1 4 CC/CG/GG 0.1004 0.44 0.17914 NA 0.12 0.47483 NA 2.3 0.01093 NA 
7 APOE1231 intron1 2b GA/GG 0.0125 -0.71 0.41393 NA -0.46 0.3315 NA -1.71 0.47484 NA 
8 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.05 0.91835 0.0781 0.12 0.63205 0.79076 1.38 0.27683 0.0897 
8 APOE1163/rs440446 intron1 4 CC/CG/GG 0.1004 0.44 0.17914 NA 0.12 0.47483 NA 2.3 0.01093 NA 
8 APOE1231 intron1 2b GA/GG 0.0125 -0.71 0.41393 NA -0.46 0.3315 NA -1.71 0.47484 NA 
8 APOE1279/rs877973 intron1 4 AA/CA/CC 0.0597 -0.15 0.72081 NA 0.04 0.85443 NA -0.45 0.68467 NA 
9 APOE1163/rs440446 intron1 4 CC/CG/GG 0.1004 0.44 0.17914 0.48376 0.12 0.47483 0.77016 2.3 0.01093 0.1435 
9 APOE1231 intron1 2b GA/GG 0.0125 -0.71 0.41393 NA -0.46 0.3315 NA -1.71 0.47484 NA 
9 APOE1279/rs877973 intron1 4 AA/CA/CC 0.0597 -0.15 0.72081 NA 0.04 0.85443 NA -0.45 0.68467 NA 
9 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.0086 -1.03 0.28621 NA -0.33 0.51724 NA 0.23 0.93296 NA 
10 APOE1231 intron1 2b GA/GG 0.0125 -0.71 0.41393 0.53353 -0.46 0.3315 0.57901 -1.71 0.47484 0.85223 
10 APOE1279/rs877973 intron1 4 AA/CA/CC 0.0597 -0.15 0.72081 NA 0.04 0.85443 NA -0.45 0.68467 NA 
10 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.0086 -1.03 0.28621 NA -0.33 0.51724 NA 0.23 0.93296 NA 
10 APOE2072/rs189660912 intron 2 4 GA/GG 0.0079 -0.5 0.64333 NA -0.4 0.47964 NA 0.7 0.81486 NA 
11 APOE1279/rs877973 intron1 4 AA/CA/CC 0.0597 -0.15 0.72081 0.0365 0.04 0.85443 0.25311 -0.45 0.68467 0.75077 
11 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.0086 -1.03 0.28621 NA -0.33 0.51724 NA 0.23 0.93296 NA 
11 APOE2072/rs189660912 intron 2 4 GA/GG 0.0079 -0.5 0.64333 NA -0.4 0.47964 NA 0.7 0.81486 NA 
11 APOE2269/rs6135770 intron 2 5 GA/GG 0.0169 -2.05 0.00643 NA -0.69 0.07713 NA -2.56 0.22005 NA 
12 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.0086 -1.03 0.28621 0.02941 -0.33 0.51724 0.20075 0.23 0.93296 0.41949 
12 APOE2072/rs189660912 intron 2 4 GA/GG 0.0079 -0.5 0.64333 NA -0.4 0.47964 NA 0.7 0.81486 NA 
12 APOE2269/rs6135770 intron 2 5 GA/GG 0.0169 -2.05 0.00643 NA -0.69 0.07713 NA -2.56 0.22005 NA 
12 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.387 0.2 0.34094 NA 0.11 0.30813 NA -0.5 0.37248 NA 
13 APOE2072/rs189660912 intron 2 4 GA/GG 0.0079 -0.5 0.64333 0.04441 -0.4 0.47964 0.25754 0.7 0.81486 0.3972 
13 APOE2269/rs6135770 intron 2 5 GA/GG 0.0169 -2.05 0.00643 NA -0.69 0.07713 NA -2.56 0.22005 NA 
13 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.387 0.2 0.34094 NA 0.11 0.30813 NA -0.5 0.37248 NA 
13 APOE3673/rs769453 intron 3 5 CC/GC 0.0066 -0.37 0.76494 NA -0.07 0.90541 NA 2.02 0.5386 NA 
14 APOE2269/rs6135770 intron 2 5 GA/GG 0.0169 -2.05 0.00643 0.00475 -0.69 0.07713 0.09962 -2.56 0.22005 0.62589 
14 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.387 0.2 0.34094 NA 0.11 0.30813 NA -0.5 0.37248 NA 
14 APOE3673/rs769453 intron 3 5 CC/GC 0.0066 -0.37 0.76494 NA -0.07 0.90541 NA 2.02 0.5386 NA 
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14 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.2656 0.46 0.03172 NA 0.17 0.13228 NA 0.05 0.9371 NA 
15 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.387 0.2 0.34094 0.00141 0.11 0.30813 0.03556 -0.5 0.37248 0.34287 
15 APOE3673/rs769453 intron 3 5 CC/GC 0.0066 -0.37 0.76494 NA -0.07 0.90541 NA 2.02 0.5386 NA 
15 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.2656 0.46 0.03172 NA 0.17 0.13228 NA 0.05 0.9371 NA 
15 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -2.23 0.00095 NA -0.87 0.01293 NA -3.45 0.06644 NA 
16 APOE3673/rs769453 intron 3 5 CC/GC 0.0066 -0.37 0.76494 3.41E-08 -0.07 0.90541 0.00012 2.02 0.5386 0.06604 
16 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.2656 0.46 0.03172 NA 0.17 0.13228 NA 0.05 0.9371 NA 
16 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -2.23 0.00095 NA -0.87 0.01293 NA -3.45 0.06644 NA 
16 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.0605 -2.05 5.35E-07 NA -0.82 0.00012 NA -2.35 0.03564 NA 
17 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.2656 0.46 0.03172 9.58E-09 0.17 0.13228 0.00004 0.05 0.9371 0.03501 
17 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -2.23 0.00095 NA -0.87 0.01293 NA -3.45 0.06644 NA 
17 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.0605 -2.05 5.35E-07 NA -0.82 0.00012 NA -2.35 0.03564 NA 
17 APOE4569 3'UTR 5 GG/GT 0.0007 8.87 0.01732 NA 5.12 0.00895 NA 14.25 0.1684 NA 
18 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -2.23 0.00095 8.86E-09 -0.87 0.01293 0.00004 -3.45 0.06644 0.03755 
18 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.0605 -2.05 5.35E-07 NA -0.82 0.00012 NA -2.35 0.03564 NA 
18 APOE4569 3'UTR 5 GG/GT 0.0007 8.87 0.01732 NA 5.12 0.00895 NA 14.25 0.1684 NA 
18 APOE5223 3'flanking 2b CC/CG 0.0051 -2.25 0.08744 NA -0.94 0.1738 NA -2.54 0.51655 NA 
19 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.0605 -2.05 5.35E-07 8.23E-06 -0.82 0.00012 0.0017 -2.35 0.03564 0.19616 
19 APOE4569 3'UTR 5 GG/GT 0.0007 8.87 0.01732 NA 5.12 0.00895 NA 14.25 0.1684 NA 
19 APOE5223 3'flanking 2b CC/CG 0.0051 -2.25 0.08744 NA -0.94 0.1738 NA -2.54 0.51655 NA 
19 APOE5231 3'flanking 2b GG/GT/TT 0.027 -0.1 0.85869 NA -0.03 0.92075 NA -0.82 0.60359 NA 
20 APOE4569 3'UTR 5 GG/GT 0.0007 8.87 0.01732 0.43401 5.12 0.00895 0.92313 14.25 0.1684 0.33533 
20 APOE5223 3'flanking 2b CC/CG 0.0051 -2.25 0.08744 NA -0.94 0.1738 NA -2.54 0.51655 NA 
20 APOE5231 3'flanking 2b GG/GT/TT 0.027 -0.1 0.85869 NA -0.03 0.92075 NA -0.82 0.60359 NA 
20 rs439401 intragenic  1b CC/CT/TT 0.1092 0.39 0.19327 NA 0.07 0.66212 NA 1.42 0.0862 NA 
21 APOE5223 3'flanking 2b CC/CG 0.0051 -2.25 0.08744 0.27982 -0.94 0.1738 0.67578 -2.54 0.51655 0.4156 
21 APOE5231 3'flanking 2b GG/GT/TT 0.027 -0.1 0.85869 NA -0.03 0.92075 NA -0.82 0.60359 NA 
21 rs439401 intragenic  1b CC/CT/TT 0.1092 0.39 0.19327 NA 0.07 0.66212 NA 1.42 0.0862 NA 
21 rs445925 intragenic  No Data AA/GA/GG 0.299 -0.01 0.95085 NA -0.01 0.89831 NA -0.31 0.59161 NA 
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22 APOE5231 3'flanking 2b GG/GT/TT 0.027 -0.1 0.85869 0.12356 -0.03 0.92075 0.60182 -0.82 0.60359 0.19909 
22 rs439401 intragenic  1b CC/CT/TT 0.1092 0.39 0.19327 NA 0.07 0.66212 NA 1.42 0.0862 NA 
22 rs445925 intragenic  No Data AA/GA/GG 0.299 -0.01 0.95085 NA -0.01 0.89831 NA -0.31 0.59161 NA 
22 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 -0.57 0.00839 NA -0.2 0.07407 NA -1.1 0.06438 NA 
23 rs439401 intragenic  1b CC/CT/TT 0.1092 0.39 0.19327 0.09082 0.07 0.66212 0.48628 1.42 0.0862 0.12299 
23 rs445925 intragenic  No Data AA/GA/GG 0.299 -0.01 0.95085 NA -0.01 0.89831 NA -0.31 0.59161 NA 
23 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 -0.57 0.00839 NA -0.2 0.07407 NA -1.1 0.06438 NA 
23 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.002 3.7 0.08521 NA 1.71 0.13168 NA 8.19 0.17048 NA 
24 rs445925 intragenic  No Data AA/GA/GG 0.299 -0.01 0.95085 0.03672 -0.01 0.89831 0.27701 -0.31 0.59161 0.22067 
24 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 -0.57 0.00839 NA -0.2 0.07407 NA -1.1 0.06438 NA 
24 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.002 3.7 0.08521 NA 1.71 0.13168 NA 8.19 0.17048 NA 
24 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.0308 0.49 0.3678 NA 0.31 0.27827 NA 0.98 0.51091 NA 
25 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 -0.57 0.00839 0.04284 -0.2 0.07407 0.16734 -1.1 0.06438 0.22334 
25 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.002 3.7 0.08521 NA 1.71 0.13168 NA 8.19 0.17048 NA 
25 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.0308 0.49 0.3678 NA 0.31 0.27827 NA 0.98 0.51091 NA 
25 APOC1p1331/rs10408994 intron2 4 AG/GG 0.0666 0.62 0.12376 NA 0.34 0.1116 NA -0.83 0.46727 NA 
26 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.002 3.7 0.08521 0.21391 1.71 0.13168 0.17969 8.19 0.17048 0.56497 
26 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.0308 0.49 0.3678 NA 0.31 0.27827 NA 0.98 0.51091 NA 
26 APOC1p1331/rs10408994 intron2 4 AG/GG 0.0666 0.62 0.12376 NA 0.34 0.1116 NA -0.83 0.46727 NA 
26 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.0579 -0.05 0.90533 NA 0.12 0.58756 NA -0.22 0.84865 NA 
27 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.0308 0.49 0.3678 0.30552 0.31 0.27827 0.179 0.98 0.51091 0.77431 
27 APOC1p1331/rs10408994 intron2 4 AG/GG 0.0666 0.62 0.12376 NA 0.34 0.1116 NA -0.83 0.46727 NA 
27 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.0579 -0.05 0.90533 NA 0.12 0.58756 NA -0.22 0.84865 NA 
27 APOC1p1642 intron2 4 CC/CT 0.0103 -1.05 0.26484 NA -0.64 0.21318 NA -1.86 0.47702 NA 
28 APOC1p1331/rs10408994 intron2 4 AG/GG 0.0666 0.62 0.12376 0.14874 0.34 0.1116 0.14809 -0.83 0.46727 0.14402 
28 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.0579 -0.05 0.90533 NA 0.12 0.58756 NA -0.22 0.84865 NA 
28 APOC1p1642 intron2 4 CC/CT 0.0103 -1.05 0.26484 NA -0.64 0.21318 NA -1.86 0.47702 NA 
28 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.0973 -0.51 0.11788 NA -0.16 0.36396 NA -1.48 0.09465 NA 
29 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.0579 -0.05 0.90533 0.304 0.12 0.58756 0.26146 -0.22 0.84865 0.19431 
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29 APOC1p1642 intron2 4 CC/CT 0.0103 -1.05 0.26484 NA -0.64 0.21318 NA -1.86 0.47702 NA 
29 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.0973 -0.51 0.11788 NA -0.16 0.36396 NA -1.48 0.09465 NA 
29 APOC1p3358 intron3 No Data AA/GA 0.0021 -0.25 0.9068 NA 0.34 0.76322 NA -3.96 0.50955 NA 
30 APOC1p1642 intron2 4 CC/CT 0.0103 -1.05 0.26484 0.51472 -0.64 0.21318 0.57007 -1.86 0.47702 0.46237 
30 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.0973 -0.51 0.11788 NA -0.16 0.36396 NA -1.48 0.09465 NA 
30 APOC1p3358 intron3 No Data AA/GA 0.0021 -0.25 0.9068 NA 0.34 0.76322 NA -3.96 0.50955 NA 
30 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.331 0.19 0.35557 NA 0.12 0.29576 NA -0.04 0.94719 NA 
31 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.0973 -0.51 0.11788 0.49945 -0.16 0.36396 0.79551 -1.48 0.09465 0.31902 
31 APOC1p3358 intron3 No Data AA/GA 0.0021 -0.25 0.9068 NA 0.34 0.76322 NA -3.96 0.50955 NA 
31 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.331 0.19 0.35557 NA 0.12 0.29576 NA -0.04 0.94719 NA 
31 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 -0.02 0.93742 NA 0.07 0.63708 NA -0.71 0.36467 NA 
32 APOC1p3358 intron3 No Data AA/GA 0.0021 -0.25 0.9068 0.64592 0.34 0.76322 0.85041 -3.96 0.50955 0.43518 
32 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.331 0.19 0.35557 NA 0.12 0.29576 NA -0.04 0.94719 NA 
32 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 -0.02 0.93742 NA 0.07 0.63708 NA -0.71 0.36467 NA 
32 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 -0.38 0.28869 NA -0.1 0.60525 NA -1.22 0.2099 NA 
33 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.331 0.19 0.35557 0.33982 0.12 0.29576 0.56257 -0.04 0.94719 0.54287 
33 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 -0.02 0.93742 NA 0.07 0.63708 NA -0.71 0.36467 NA 
33 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 -0.38 0.28869 NA -0.1 0.60525 NA -1.22 0.2099 NA 
33 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 0.3 0.19047 NA 0.13 0.27278 NA 0.66 0.29256 NA 
34 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 -0.02 0.93742 0.12074 0.07 0.63708 0.43673 -0.71 0.36467 0.58189 
34 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 -0.38 0.28869 NA -0.1 0.60525 NA -1.22 0.2099 NA 
34 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 0.3 0.19047 NA 0.13 0.27278 NA 0.66 0.29256 NA 
34 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.1446 -0.77 0.00631 NA -0.3 0.04743 NA -1.01 0.18808 NA 
35 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 -0.38 0.28869 0.02523 -0.1 0.60525 0.12946 -1.22 0.2099 0.61316 
35 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 0.3 0.19047 NA 0.13 0.27278 NA 0.66 0.29256 NA 
35 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.1446 -0.77 0.00631 NA -0.3 0.04743 NA -1.01 0.18808 NA 
35 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.1745 -0.22 0.39246 NA -0.05 0.72955 NA -0.7 0.33774 NA 
36 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 0.3 0.19047 0.02869 0.13 0.27278 0.13147 0.66 0.29256 0.51852 
36 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.1446 -0.77 0.00631 NA -0.3 0.04743 NA -1.01 0.18808 NA 
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36 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.1745 -0.22 0.39246 NA -0.05 0.72955 NA -0.7 0.33774 NA 
36 rs4803770 HCR-1 5 CC/GC/GG 0.2695 0.38 0.08103 NA 0.18 0.11016 NA 0.9 0.13554 NA 
37 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.1446 -0.77 0.00631 0.02105 -0.3 0.04743 0.08779 -1.01 0.18808 0.42696 
37 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.1745 -0.22 0.39246 NA -0.05 0.72955 NA -0.7 0.33774 NA 
37 rs4803770 HCR-1 5 CC/GC/GG 0.2695 0.38 0.08103 NA 0.18 0.11016 NA 0.9 0.13554 NA 
37 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.0073 -0.58 0.6076 NA 0.12 0.83438 NA 2.07 0.5106 NA 
38 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.1745 -0.22 0.39246 0.4397 -0.05 0.72955 0.5191 -0.7 0.33774 0.56102 
38 rs4803770 HCR-1 5 CC/GC/GG 0.2695 0.38 0.08103 NA 0.18 0.11016 NA 0.9 0.13554 NA 
38 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.0073 -0.58 0.6076 NA 0.12 0.83438 NA 2.07 0.5106 NA 
38 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.3595 0.17 0.40674 NA 0.08 0.46903 NA 0.27 0.64249 NA 
39 rs4803770 HCR-1 5 CC/GC/GG 0.2695 0.38 0.08103 0.55556 0.18 0.11016 0.33791 0.9 0.13554 0.40008 
39 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.0073 -0.58 0.6076 NA 0.12 0.83438 NA 2.07 0.5106 NA 
39 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.3595 0.17 0.40674 NA 0.08 0.46903 NA 0.27 0.64249 NA 
39 rs5112 APC1P1 4 CC/GC/GG 0.4797 0.1 0.60734 NA 0.16 0.10913 NA 0.54 0.31703 NA 
40 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.0073 -0.58 0.6076 0.86661 0.12 0.83438 0.70627 2.07 0.5106 0.75338 
40 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.3595 0.17 0.40674 NA 0.08 0.46903 NA 0.27 0.64249 NA 
40 rs5112 APC1P1 4 CC/GC/GG 0.4797 0.1 0.60734 NA 0.16 0.10913 NA 0.54 0.31703 NA 
40 rs7259004 APC1P1 6 CC/CG/GG 0.302 -0.02 0.90614 NA 0.09 0.39758 NA 0.37 0.51449 NA 
41 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.3595 0.17 0.40674 0.91652 0.08 0.46903 0.72208 0.27 0.64249 0.6815 
41 rs5112 APC1P1 4 CC/GC/GG 0.4797 0.1 0.60734 NA 0.16 0.10913 NA 0.54 0.31703 NA 
41 rs7259004 APC1P1 6 CC/CG/GG 0.302 -0.02 0.90614 NA 0.09 0.39758 NA 0.37 0.51449 NA 
41 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.1546 -0.16 0.53272 NA 0.01 0.9184 NA -0.61 0.4015 NA 
42 rs5112 APC1P1 4 CC/GC/GG 0.4797 0.1 0.60734 0.59044 0.16 0.10913 0.42978 0.54 0.31703 0.60429 
42 rs7259004 APC1P1 6 CC/CG/GG 0.302 -0.02 0.90614 NA 0.09 0.39758 NA 0.37 0.51449 NA 
42 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.1546 -0.16 0.53272 NA 0.01 0.9184 NA -0.61 0.4015 NA 
42 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 0.79 0.07851 NA 0.31 0.18468 NA 1.37 0.27692 NA 
43 rs7259004 APC1P1 6 CC/CG/GG 0.302 -0.02 0.90614 0.32356 0.09 0.39758 0.37754 0.37 0.51449 0.42678 
43 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.1546 -0.16 0.53272 NA 0.01 0.9184 NA -0.61 0.4015 NA 
43 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 0.79 0.07851 NA 0.31 0.18468 NA 1.37 0.27692 NA 
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43 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.0026 2.74 0.14181 NA 1.17 0.23621 NA 6.71 0.19588 NA 
44 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.1546 -0.16 0.53272 0.1954 0.01 0.9184 0.40593 -0.61 0.4015 0.51614 
44 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 0.79 0.07851 NA 0.31 0.18468 NA 1.37 0.27692 NA 
44 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.0026 2.74 0.14181 NA 1.17 0.23621 NA 6.71 0.19588 NA 
44 APOC4p368 5’ flanking  6 TC/TT 0.0019 1.04 0.6283 NA 0.71 0.52903 NA -1.39 0.81479 NA 
45 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 0.79 0.07851 0.12917 0.31 0.18468 0.24482 1.37 0.27692 0.34524 
45 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.0026 2.74 0.14181 NA 1.17 0.23621 NA 6.71 0.19588 NA 
45 APOC4p368 5’ flanking  6 TC/TT 0.0019 1.04 0.6283 NA 0.71 0.52903 NA -1.39 0.81479 NA 
45 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.0452 -0.23 0.61266 NA -0.13 0.58316 NA 1.34 0.29549 NA 
46 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.0026 2.74 0.14181 0.50368 1.17 0.23621 0.53391 6.71 0.19588 0.55865 
46 APOC4p368 5’ flanking  6 TC/TT 0.0019 1.04 0.6283 NA 0.71 0.52903 NA -1.39 0.81479 NA 
46 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.0452 -0.23 0.61266 NA -0.13 0.58316 NA 1.34 0.29549 NA 
46 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.0376 0.14 0.77797 NA 0.13 0.61917 NA 0.45 0.7436 NA 
47 APOC4p368 5’ flanking  6 TC/TT 0.0019 1.04 0.6283 0.95138 0.71 0.52903 0.92464 -1.39 0.81479 0.70523 
47 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.0452 -0.23 0.61266 NA -0.13 0.58316 NA 1.34 0.29549 NA 
47 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.0376 0.14 0.77797 NA 0.13 0.61917 NA 0.45 0.7436 NA 
47 APOC4p1088 intron1 2b GT/TT 0.0013 -2.69 0.30478 NA -1.51 0.27674 NA -2.07 0.7775 NA 
48 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.0452 -0.23 0.61266 0.73798 -0.13 0.58316 0.8653 1.34 0.29549 0.36088 
48 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.0376 0.14 0.77797 NA 0.13 0.61917 NA 0.45 0.7436 NA 
48 APOC4p1088 intron1 2b GT/TT 0.0013 -2.69 0.30478 NA -1.51 0.27674 NA -2.07 0.7775 NA 
48 APOC4p1130 intron1 5 CT/TT 0.0007 -0.71 0.84908 NA 1.5 0.44346 NA -21.03 0.04207 NA 
49 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.0376 0.14 0.77797 0.68677 0.13 0.61917 0.83976 0.45 0.7436 0.33508 
49 APOC4p1088 intron1 2b GT/TT 0.0013 -2.69 0.30478 NA -1.51 0.27674 NA -2.07 0.7775 NA 
49 APOC4p1130 intron1 5 CT/TT 0.0007 -0.71 0.84908 NA 1.5 0.44346 NA -21.03 0.04207 NA 
49 APOC4p1192/rs113745034 intron1 4 GA/GG 0.0124 -0.63 0.48231 NA -0.31 0.50557 NA 2.83 0.26681 NA 
50 APOC4p1088 intron1 2b GT/TT 0.0013 -2.69 0.30478 0.3418 -1.51 0.27674 0.65242 -2.07 0.7775 0.12845 
50 APOC4p1130 intron1 5 CT/TT 0.0007 -0.71 0.84908 NA 1.5 0.44346 NA -21.03 0.04207 NA 
50 APOC4p1192/rs113745034 intron1 4 GA/GG 0.0124 -0.63 0.48231 NA -0.31 0.50557 NA 2.83 0.26681 NA 
50 APOC4p1325del3 intron1 4 WD/WW 0.0245 0.7 0.2711 NA 0.28 0.40992 NA 1.71 0.33255 NA 
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51 APOC4p1130 intron1 5 CT/TT 0.0007 -0.71 0.84908 0.63734 1.5 0.44346 0.65455 -21.03 0.04207 0.08634 
51 APOC4p1192/rs113745034 intron1 4 GA/GG 0.0124 -0.63 0.48231 NA -0.31 0.50557 NA 2.83 0.26681 NA 
51 APOC4p1325del3 intron1 4 WD/WW 0.0245 0.7 0.2711 NA 0.28 0.40992 NA 1.71 0.33255 NA 
51 APOC4p1430ins intron1 5 II/WI/WW 0.0341 0.32 0.5609 NA 0.35 0.22899 NA 1.43 0.35841 NA 
52 APOC4p1192/rs113745034 intron1 4 GA/GG 0.0124 -0.63 0.48231 0.60585 -0.31 0.50557 0.60688 2.83 0.26681 0.25455 
52 APOC4p1325del3 intron1 4 WD/WW 0.0245 0.7 0.2711 NA 0.28 0.40992 NA 1.71 0.33255 NA 
52 APOC4p1430ins intron1 5 II/WI/WW 0.0341 0.32 0.5609 NA 0.35 0.22899 NA 1.43 0.35841 NA 
52 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.0141 -0.83 0.30264 NA -0.42 0.33673 NA 1.19 0.59549 NA 
53 APOC4p1325del3 intron1 4 WD/WW 0.0245 0.7 0.2711 0.5103 0.28 0.40992 0.48905 1.71 0.33255 0.52124 
53 APOC4p1430ins intron1 5 II/WI/WW 0.0341 0.32 0.5609 NA 0.35 0.22899 NA 1.43 0.35841 NA 
53 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.0141 -0.83 0.30264 NA -0.42 0.33673 NA 1.19 0.59549 NA 
53 APOC4p2467/rs115225947 intron1 5 GA/GG 0.0141 0.68 0.40563 NA 0.3 0.49226 NA -0.42 0.85407 NA 
54 APOC4p1430ins intron1 5 II/WI/WW 0.0341 0.32 0.5609 0.61806 0.35 0.22899 0.40631 1.43 0.35841 0.69268 
54 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.0141 -0.83 0.30264 NA -0.42 0.33673 NA 1.19 0.59549 NA 
54 APOC4p2467/rs115225947 intron1 5 GA/GG 0.0141 0.68 0.40563 NA 0.3 0.49226 NA -0.42 0.85407 NA 
54 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.0986 -0.27 0.40279 NA -0.22 0.20901 NA -0.98 0.27438 NA 
55 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.0141 -0.83 0.30264 0.59808 -0.42 0.33673 0.37761 1.19 0.59549 0.51034 
55 APOC4p2467/rs115225947 intron1 5 GA/GG 0.0141 0.68 0.40563 NA 0.3 0.49226 NA -0.42 0.85407 NA 
55 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.0986 -0.27 0.40279 NA -0.22 0.20901 NA -0.98 0.27438 NA 
55 APOC4p2607/rs5156 intron1 4 AG/GG 0.0129 -1.04 0.23497 NA -0.49 0.2981 NA 1.6 0.50775 NA 
56 APOC4p2467/rs115225947 intron1 5 GA/GG 0.0141 0.68 0.40563 0.40521 0.3 0.49226 0.40068 -0.42 0.85407 0.37254 
56 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.0986 -0.27 0.40279 NA -0.22 0.20901 NA -0.98 0.27438 NA 
56 APOC4p2607/rs5156 intron1 4 AG/GG 0.0129 -1.04 0.23497 NA -0.49 0.2981 NA 1.6 0.50775 NA 
56 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.1723 0.28 0.27026 NA 0.13 0.32874 NA 1.43 0.04428 NA 
57 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.0986 -0.27 0.40279 0.42585 -0.22 0.20901 0.4764 -0.98 0.27438 0.30408 
57 APOC4p2607/rs5156 intron1 4 AG/GG 0.0129 -1.04 0.23497 NA -0.49 0.2981 NA 1.6 0.50775 NA 
57 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.1723 0.28 0.27026 NA 0.13 0.32874 NA 1.43 0.04428 NA 
57 APOC4p2640/rs5158 intron1 2b CC/CT 0.0213 0.55 0.41401 NA 0.01 0.97117 NA 1.44 0.44596 NA 
58 APOC4p2607/rs5156 intron1 4 AG/GG 0.0129 -1.04 0.23497 0.36303 -0.49 0.2981 0.56782 1.6 0.50775 0.20187 
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58 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.1723 0.28 0.27026 NA 0.13 0.32874 NA 1.43 0.04428 NA 
58 APOC4p2640/rs5158 intron1 2b CC/CT 0.0213 0.55 0.41401 NA 0.01 0.97117 NA 1.44 0.44596 NA 
58 APOC4p2678/rs148564866 intron1 2b GC/GG 0.0086 -0.61 0.55495 NA -0.31 0.58397 NA 0.87 0.76308 NA 
59 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.1723 0.28 0.27026 0.66648 0.13 0.32874 0.84546 1.43 0.04428 0.07085 
59 APOC4p2640/rs5158 intron1 2b CC/CT 0.0213 0.55 0.41401 NA 0.01 0.97117 NA 1.44 0.44596 NA 
59 APOC4p2678/rs148564866 intron1 2b GC/GG 0.0086 -0.61 0.55495 NA -0.31 0.58397 NA 0.87 0.76308 NA 
59 APOC4p2767/rs127721107 intron1 4 GG/GT 0.0254 0.35 0.57878 NA 0.16 0.62791 NA 3.15 0.07284 NA 
60 APOC4p2640/rs5158 intron1 2b CC/CT 0.0213 0.55 0.41401 0.69787 0.01 0.97117 0.94946 1.44 0.44596 0.28586 
60 APOC4p2678/rs148564866 intron1 2b GC/GG 0.0086 -0.61 0.55495 NA -0.31 0.58397 NA 0.87 0.76308 NA 
60 APOC4p2767/rs127721107 intron1 4 GG/GT 0.0254 0.35 0.57878 NA 0.16 0.62791 NA 3.15 0.07284 NA 
60 APOC4p3348 intron1 5 AG/GG 0.0007 -2.86 0.44034 NA 0.74 0.70666 NA -9.98 0.33555 NA 
61 APOC4p2678/rs148564866 intron1 2b GC/GG 0.0086 -0.61 0.55495 0.827 -0.31 0.58397 0.93681 0.87 0.76308 0.35963 
61 APOC4p2767/rs127721107 intron1 4 GG/GT 0.0254 0.35 0.57878 NA 0.16 0.62791 NA 3.15 0.07284 NA 
61 APOC4p3348 intron1 5 AG/GG 0.0007 -2.86 0.44034 NA 0.74 0.70666 NA -9.98 0.33555 NA 
61 APOC2p75APOC4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.1368 0.02 0.93583 NA -0.01 0.92441 NA -0.07 0.92847 NA 
62 APOC4p2767/rs127721107 intron1 4 GG/GT 0.0254 0.35 0.57878 0.72016 0.16 0.62791 0.76596 3.15 0.07284 0.10037 
62 APOC4p3348 intron1 5 AG/GG 0.0007 -2.86 0.44034 NA 0.74 0.70666 NA -9.98 0.33555 NA 
62 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.1368 0.02 0.93583 NA -0.01 0.92441 NA -0.07 0.92847 NA 
62 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.2368 0.21 0.36149 NA 0.11 0.35464 NA 0.95 0.13191 NA 
63 APOC4p3348 intron1 5 AG/GG 0.0007 -2.86 0.44034 0.66798 0.74 0.70666 0.77939 -9.98 0.33555 0.45032 
63 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.1368 0.02 0.93583 NA -0.01 0.92441 NA -0.07 0.92847 NA 
63 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.2368 0.21 0.36149 NA 0.11 0.35464 NA 0.95 0.13191 NA 
63 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.0066 -0.78 0.51255 NA -0.43 0.49532 NA 2.49 0.4501 NA 
64 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.1368 0.02 0.93583 0.86909 -0.01 0.92441 0.86658 -0.07 0.92847 0.31477 
64 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.2368 0.21 0.36149 NA 0.11 0.35464 NA 0.95 0.13191 NA 
64 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.0066 -0.78 0.51255 NA -0.43 0.49532 NA 2.49 0.4501 NA 
64 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.0272 -0.02 0.97528 NA 0.02 0.94191 NA 1.96 0.24561 NA 
65 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.2368 0.21 0.36149 0.63255 0.11 0.35464 0.67514 0.95 0.13191 0.22814 
65 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.0066 -0.78 0.51255 NA -0.43 0.49532 NA 2.49 0.4501 NA 
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65 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.0272 -0.02 0.97528 NA 0.02 0.94191 NA 1.96 0.24561 NA 
65 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.0007 -4.47 0.23235 NA -1.4 0.48018 NA -9.04 0.38386 NA 
66 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.0066 -0.78 0.51255 0.79407 -0.43 0.49532 0.84915 2.49 0.4501 0.59814 
66 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.0272 -0.02 0.97528 NA 0.02 0.94191 NA 1.96 0.24561 NA 
66 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.0007 -4.47 0.23235 NA -1.4 0.48018 NA -9.04 0.38386 NA 
66 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.0146 0.13 0.87346 NA -0.07 0.86634 NA -0.83 0.71058 NA 
67 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.0272 -0.02 0.97528 0.3186 0.02 0.94191 0.51413 1.96 0.24561 0.25723 
67 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.0007 -4.47 0.23235 NA -1.4 0.48018 NA -9.04 0.38386 NA 
67 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.0146 0.13 0.87346 NA -0.07 0.86634 NA -0.83 0.71058 NA 
67 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.4594 -0.37 0.05268 NA -0.16 0.10575 NA -0.54 0.31017 NA 
68 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.0007 -4.47 0.23235 0.29963 -1.4 0.48018 0.44481 -9.04 0.38386 0.41284 
68 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.0146 0.13 0.87346 NA -0.07 0.86634 NA -0.83 0.71058 NA 
68 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.4594 -0.37 0.05268 NA -0.16 0.10575 NA -0.54 0.31017 NA 
68 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 0.18 0.86495 NA -0.004 0.99377 NA 4.09 0.15807 NA 
69 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.0146 0.13 0.87346 0.28969 -0.07 0.86634 0.44485 -0.83 0.71058 0.25662 
69 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.4594 -0.37 0.05268 NA -0.16 0.10575 NA -0.54 0.31017 NA 
69 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 0.18 0.86495 NA -0.004 0.99377 NA 4.09 0.15807 NA 
69 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.0007 -1.33 0.72116 NA -1.34 0.49361 NA 6.46 0.53306 NA 
70 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.4594 -0.37 0.05268 0.29355 -0.16 0.10575 0.46468 -0.54 0.31017 0.27985 
70 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 0.18 0.86495 NA -0.004 0.99377 NA 4.09 0.15807 NA 
70 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.0007 -1.33 0.72116 NA -1.34 0.49361 NA 6.46 0.53306 NA 
70 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11 -0.2 0.53149 NA -0.06 0.70512 NA -0.53 0.5399 NA 
71 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 0.18 0.86495 0.38779 -0.004 0.99377 0.52916 4.09 0.15807 0.05501 
71 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.0007 -1.33 0.72116 NA -1.34 0.49361 NA 6.46 0.53306 NA 
71 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11 -0.2 0.53149 NA -0.06 0.70512 NA -0.53 0.5399 NA 
71 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.0178 -1.25 0.08548 NA -0.55 0.15479 NA -4.39 0.02431 NA 
72 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.0007 -1.33 0.72116 0.41917 -1.34 0.49361 0.54987 6.46 0.53306 0.12738 
72 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11 -0.2 0.53149 NA -0.06 0.70512 NA -0.53 0.5399 NA 
72 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.0178 -1.25 0.08548 NA -0.55 0.15479 NA -4.39 0.02431 NA 
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72 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.0178 0.21 0.77726 NA 0.17 0.67391 NA 3.17 0.13276 NA 
73 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11 -0.2 0.53149 0.44704 -0.06 0.70512 0.51182 -0.53 0.5399 0.15897 
73 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.0178 -1.25 0.08548 NA -0.55 0.15479 NA -4.39 0.02431 NA 
73 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.0178 0.21 0.77726 NA 0.17 0.67391 NA 3.17 0.13276 NA 
73 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.014 -0.17 0.83981 NA 0.04 0.93279 NA 2.78 0.23927 NA 
74 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.0178 -1.25 0.08548 0.07529 -0.55 0.15479 0.1048 -4.39 0.02431 0.15071 
74 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.0178 0.21 0.77726 NA 0.17 0.67391 NA 3.17 0.13276 NA 
74 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.014 -0.17 0.83981 NA 0.04 0.93279 NA 2.78 0.23927 NA 
74 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.0352 -0.95 0.07519 NA -0.48 0.09537 NA -0.23 0.87888 NA 
75 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.0178 0.21 0.77726 0.01391 0.17 0.67391 0.01114 3.17 0.13276 0.10023 
75 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.014 -0.17 0.83981 NA 0.04 0.93279 NA 2.78 0.23927 NA 
75 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.0352 -0.95 0.07519 NA -0.48 0.09537 NA -0.23 0.87888 NA 
75 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.2581 0.51 0.02019 NA 0.28 0.01532 NA 1.37 0.02344 NA 
76 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.014 -0.17 0.83981 0.03127 0.04 0.93279 0.03556 2.78 0.23927 0.23594 
76 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.0352 -0.95 0.07519 NA -0.48 0.09537 NA -0.23 0.87888 NA 
76 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.2581 0.51 0.02019 NA 0.28 0.01532 NA 1.37 0.02344 NA 
76 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.8 0.01138 NA 0.42 0.01106 NA 1.08 0.21814 NA 
77 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.0352 -0.95 0.07519 0.05978 -0.48 0.09537 0.10413 -0.23 0.87888 0.61764 
77 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.2581 0.51 0.02019 NA 0.28 0.01532 NA 1.37 0.02344 NA 
77 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.8 0.01138 NA 0.42 0.01106 NA 1.08 0.21814 NA 
77 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.3655 -0.54 0.00842 NA -0.2 0.07368 NA -0.21 0.7176 NA 
78 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.2581 0.51 0.02019 0.02612 0.28 0.01532 0.11574 1.37 0.02344 0.43439 
78 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.8 0.01138 NA 0.42 0.01106 NA 1.08 0.21814 NA 
78 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.3655 -0.54 0.00842 NA -0.2 0.07368 NA -0.21 0.7176 NA 
78 APOC2p2935/rs11879392 intron1 2b CC/GC 0.0135 0.87 0.31703 NA 0.27 0.53988 NA 0.44 0.85516 NA 
79 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.8 0.01138 0.04403 0.42 0.01106 0.18207 1.08 0.21814 0.85396 
79 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.3655 -0.54 0.00842 NA -0.2 0.07368 NA -0.21 0.7176 NA 
79 APOC2p2935/rs11879392 intron1 2b CC/GC 0.0135 0.87 0.31703 NA 0.27 0.53988 NA 0.44 0.85516 NA 
79 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.1253 0.03 0.92147 NA -0.05 0.74391 NA -0.91 0.2581 NA 
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80 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.3655 -0.54 0.00842 0.0249 -0.2 0.07368 0.28434 -0.21 0.7176 0.48475 
80 APOC2p2935/rs11879392 intron1 2b CC/GC 0.0135 0.87 0.31703 NA 0.27 0.53988 NA 0.44 0.85516 NA 
80 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.1253 0.03 0.92147 NA -0.05 0.74391 NA -0.91 0.2581 NA 
80 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.0172 -0.19 0.8123 NA -0.04 0.92973 NA 2.28 0.31473 NA 
81 APOC2p2935/rs11879392 intron1 2b CC/GC 0.0135 0.87 0.31703 0.05641 0.27 0.53988 0.13454 0.44 0.85516 0.26005 
81 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.1253 0.03 0.92147 NA -0.05 0.74391 NA -0.91 0.2581 NA 
81 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.0172 -0.19 0.8123 NA -0.04 0.92973 NA 2.28 0.31473 NA 
81 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.1845 0.6 0.01577 NA 0.33 0.01287 NA 1.11 0.10763 NA 
82 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.1253 0.03 0.92147 0.06512 -0.05 0.74391 0.10754 -0.91 0.2581 0.31029 
82 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.0172 -0.19 0.8123 NA -0.04 0.92973 NA 2.28 0.31473 NA 
82 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.1845 0.6 0.01577 NA 0.33 0.01287 NA 1.11 0.10763 NA 
82 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.1649 0.35 0.18831 NA 0.13 0.35514 NA 0.72 0.33716 NA 
83 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.0172 -0.19 0.8123 0.06095 -0.04 0.92973 0.09301 2.28 0.31473 0.22803 
83 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.1845 0.6 0.01577 NA 0.33 0.01287 NA 1.11 0.10763 NA 
83 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.1649 0.35 0.18831 NA 0.13 0.35514 NA 0.72 0.33716 NA 
83 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.3008 -0.3 0.1716 NA -0.08 0.47136 NA -0.1 0.87424 NA 
84 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.1845 0.6 0.01577 0.04904 0.33 0.01287 0.07184 1.11 0.10763 0.34215 
84 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.1649 0.35 0.18831 NA 0.13 0.35514 NA 0.72 0.33716 NA 
84 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.3008 -0.3 0.1716 NA -0.08 0.47136 NA -0.1 0.87424 NA 
84 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.0358 -0.21 0.69569 NA -0.11 0.69795 NA -0.03 0.98356 NA 
85 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.1649 0.35 0.18831 0.43254 0.13 0.35514 0.7624 0.72 0.33716 0.28002 
85 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.3008 -0.3 0.1716 NA -0.08 0.47136 NA -0.1 0.87424 NA 
85 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.0358 -0.21 0.69569 NA -0.11 0.69795 NA -0.03 0.98356 NA 
85 APOC2p4086/rs114780592 intron2 4 GA/GG 0.0278 -0.04 0.95091 NA -0.02 0.95061 NA 3.05 0.0669 NA 
86 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.3008 -0.3 0.1716 0.48676 -0.08 0.47136 0.81254 -0.1 0.87424 0.27317 
86 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.0358 -0.21 0.69569 NA -0.11 0.69795 NA -0.03 0.98356 NA 
86 APOC2p4086/rs114780592 intron2 4 GA/GG 0.0278 -0.04 0.95091 NA -0.02 0.95061 NA 3.05 0.0669 NA 
86 APOC2p4118/rs201709243 exon3 4 GA/GG 0.0007 -6.14 0.10156 NA 0.52 0.79263 NA -2.87 0.7826 NA 
87 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.0358 -0.21 0.69569 0.57578 -0.11 0.69795 0.88586 -0.03 0.98356 0.37786 
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87 APOC2p4086/rs114780592 intron2 4 GA/GG 0.0278 -0.04 0.95091 NA -0.02 0.95061 NA 3.05 0.0669 NA 
87 APOC2p4118/rs201709243 exon3 4 GA/GG 0.0007 -6.14 0.10156 NA 0.52 0.79263 NA -2.87 0.7826 NA 
87 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.0592 0.19 0.62684 NA 0.15 0.47956 NA -0.25 0.82293 NA 
88 APOC2p4086/rs114780592 intron2 4 GA/GG 0.0278 -0.04 0.95091 0.88184 -0.02 0.95061 0.73983 3.05 0.0669 0.19049 
88 APOC2p4118/rs201709243 exon3 4 GA/GG 0.0007 -6.14 0.10156 NA 0.52 0.79263 NA -2.87 0.7826 NA 
88 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.0592 0.19 0.62684 NA 0.15 0.47956 NA -0.25 0.82293 NA 
88 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.0135 0.46 0.57155 NA 0.34 0.438 NA 2.64 0.26202 NA 
89 APOC2p4118/rs201709243 exon3 4 GA/GG 0.0007 -6.14 0.10156 0.26909 0.52 0.79263 0.68884 -2.87 0.7826 0.43281 
89 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.0592 0.19 0.62684 NA 0.15 0.47956 NA -0.25 0.82293 NA 
89 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.0135 0.46 0.57155 NA 0.34 0.438 NA 2.64 0.26202 NA 
89 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.0499 -0.14 0.75702 NA -0.07 0.77098 NA 1.71 0.18011 NA 
90 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.0592 0.19 0.62684 0.70993 0.15 0.47956 0.63651 -0.25 0.82293 0.67584 
90 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.0135 0.46 0.57155 NA 0.34 0.438 NA 2.64 0.26202 NA 
90 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.0499 -0.14 0.75702 NA -0.07 0.77098 NA 1.71 0.18011 NA 
90 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.0606 0.26 0.50883 NA 0.25 0.22124 NA 0.19 0.85817 NA 
91 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.0135 0.46 0.57155 0.86975 0.34 0.438 0.6579 2.64 0.26202 0.60027 
91 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.0499 -0.14 0.75702 NA -0.07 0.77098 NA 1.71 0.18011 NA 
91 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.0606 0.26 0.50883 NA 0.25 0.22124 NA 0.19 0.85817 NA 
91 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.2736 0.1 0.65443 NA -0.02 0.84447 NA -0.05 0.93724 NA 
92 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.0499 -0.14 0.75702 0.6262 -0.07 0.77098 0.47478 1.71 0.18011 0.61816 
92 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.0606 0.26 0.50883 NA 0.25 0.22124 NA 0.19 0.85817 NA 
92 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.2736 0.1 0.65443 NA -0.02 0.84447 NA -0.05 0.93724 NA 
92 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.0082 -1.49 0.17137 NA -0.79 0.16638 NA 3.46 0.24889 NA 
93 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.0606 0.26 0.50883 0.44971 0.25 0.22124 0.46142 0.19 0.85817 0.95026 
93 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.2736 0.1 0.65443 NA -0.02 0.84447 NA -0.05 0.93724 NA 
93 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.0082 -1.49 0.17137 NA -0.79 0.16638 NA 3.46 0.24889 NA 
93 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 -0.34 0.11492 NA -0.11 0.33714 NA -0.04 0.94186 NA 
94 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.2736 0.1 0.65443 0.09847 -0.02 0.84447 0.30622 -0.05 0.93724 0.77226 
94 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.0082 -1.49 0.17137 NA -0.79 0.16638 NA 3.46 0.24889 NA 
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94 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 -0.34 0.11492 NA -0.11 0.33714 NA -0.04 0.94186 NA 
94 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.0352 0.77 0.1368 NA 0.3 0.27612 NA 1.27 0.37773 NA 
95 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.0082 -1.49 0.17137 0.04372 -0.79 0.16638 0.13522 3.46 0.24889 0.69567 
95 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 -0.34 0.11492 NA -0.11 0.33714 NA -0.04 0.94186 NA 
95 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.0352 0.77 0.1368 NA 0.3 0.27612 NA 1.27 0.37773 NA 
95 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.3067 0.37 0.10176 NA 0.17 0.14969 NA 0.29 0.63627 NA 
96 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 -0.34 0.11492 0.03596 -0.11 0.33714 0.19789 -0.04 0.94186 0.84515 
96 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.0352 0.77 0.1368 NA 0.3 0.27612 NA 1.27 0.37773 NA 
96 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.3067 0.37 0.10176 NA 0.17 0.14969 NA 0.29 0.63627 NA 
96 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.2587 0.19 0.38929 NA 0.02 0.84406 NA 0.16 0.79862 NA 
97 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.0352 0.77 0.1368 0.02314 0.3 0.27612 0.17091 1.27 0.37773 0.64727 
97 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.3067 0.37 0.10176 NA 0.17 0.14969 NA 0.29 0.63627 NA 
97 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.2587 0.19 0.38929 NA 0.02 0.84406 NA 0.16 0.79862 NA 
97 APOC2p5491 3'flanking  6 CC/TC 0.0007 7.19 0.05297 NA 4.21 0.03146 NA -8.06 0.43745 NA 
98 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.3067 0.37 0.10176 0.11359 0.17 0.14969 0.294 0.29 0.63627 0.69666 
98 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.2587 0.19 0.38929 NA 0.02 0.84406 NA 0.16 0.79862 NA 
98 APOC2p5491 3'flanking  6 CC/TC 0.0007 7.19 0.05297 NA 4.21 0.03146 NA -8.06 0.43745 NA 
98 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.0083 -1.02 0.3246 NA -0.1 0.86343 NA -2.23 0.43911 NA 
99 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.2587 0.19 0.38929 0.81337 0.02 0.84406 0.92059 0.16 0.79862 0.75514 
99 APOC2p5491 3'flanking  6 CC/TC 0.0007 7.19 0.05297 NA 4.21 0.03146 NA -8.06 0.43745 NA 
99 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.0083 -1.02 0.3246 NA -0.1 0.86343 NA -2.23 0.43911 NA 
99 APOC2p5562 3'flanking  No Data CG/GG 0.0175 -0.41 0.60115 NA -0.21 0.59488 NA -0.92 0.67145 NA 
100 APOC2p5491 3'flanking  6 CC/TC 0.0007 7.19 0.05297 0.28478 4.21 0.03146 0.48016 -8.06 0.43745 0.727 
100 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.0083 -1.02 0.3246 NA -0.1 0.86343 NA -2.23 0.43911 NA 
100 APOC2p5562 3'flanking  No Data CG/GG 0.0175 -0.41 0.60115 NA -0.21 0.59488 NA -0.92 0.67145 NA 
100 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.1001 -0.58 0.07133 NA -0.23 0.17781 NA 0.13 0.88663 NA 
101 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.0083 -1.02 0.3246 0.15191 -0.1 0.86343 0.44452 -2.23 0.43911 0.89229 
101 APOC2p5562 3'flanking  No Data CG/GG 0.0175 -0.41 0.60115 NA -0.21 0.59488 NA -0.92 0.67145 NA 
101 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.1001 -0.58 0.07133 NA -0.23 0.17781 NA 0.13 0.88663 NA 
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101 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.3164 0.42 0.04737 NA 0.18 0.11697 NA 0.34 0.55855 NA 
102 APOC2p5562 3'flanking  No Data CG/GG 0.0175 -0.41 0.60115 0.00536 -0.21 0.59488 0.02416 -0.92 0.67145 0.59526 
102 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.1001 -0.58 0.07133 NA -0.23 0.17781 NA 0.13 0.88663 NA 
102 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.3164 0.42 0.04737 NA 0.18 0.11697 NA 0.34 0.55855 NA 
102 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.0784 0.98 0.00786 NA 0.48 0.01291 NA 1.47 0.14838 NA 
103 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.1001 -0.58 0.07133 0.00228 -0.23 0.17781 0.00959 0.13 0.88663 0.28549 
103 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.3164 0.42 0.04737 NA 0.18 0.11697 NA 0.34 0.55855 NA 
103 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.0784 0.98 0.00786 NA 0.48 0.01291 NA 1.47 0.14838 NA 
103 APOC2p5965 3'flanking  5 GA/GG 0.0013 2.76 0.29503 NA 1.58 0.25416 NA -10.45 0.15456 NA 
104 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.3164 0.42 0.04737 0.00016 0.18 0.11697 0.0006 0.34 0.55855 0.30334 
104 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.0784 0.98 0.00786 NA 0.48 0.01291 NA 1.47 0.14838 NA 
104 APOC2p5965 3'flanking  5 GA/GG 0.0013 2.76 0.29503 NA 1.58 0.25416 NA -10.45 0.15456 NA 
104 APOC2p6334 3'flanking  No Data GA/GG 0.0096 1.76 0.06779 NA 0.94 0.06281 NA 3.15 0.2415 NA 
wind: 4-SNPs haplotype window; w.snps: SNPs that were included in each window; p-value: single-locus p-value; hap-P: haplotype global p-
value; a Cox-Box transformed data. 
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 Table 40.  Haplotype-based association results with HDL-C, TG, and ApoA1 in Blacks 
WINDOWS HDL-Ca TGa ApoA1a 
wind w.snp Function RegulomeDB score Genotype MAF Beta single-p hap_P Beta single-p hap_P Beta single-p hap_P 
1 APOE73/rs1081101 5'flanking 4 CC/CT/TT 0.0611 0.3 0.42732 0.54158 0.04 0.00927 0.03529 -0.003 0.99719 0.45239 
1 APOE173 5'flanking 3a AA/GA 0.00197 -2.1 0.32058 NA 0.04 0.70282 NA 6.86 0.19127 NA 
1 APOE308/rs769445 5'flanking 4 CC/TC 0.00721 -1.06 0.34278 NA 0.06 0.20649 NA 3.21 0.2461 NA 
1 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.36627 -0.18 0.35635 NA -0.001 0.84824 NA -0.49 0.31886 NA 
2 APOE173 5'flanking 3a AA/GA 0.00197 -2.1 0.32058 0.10899 0.04 0.70282 0.44666 6.86 0.19127 0.50993 
2 APOE308/rs769445 5'flanking 4 CC/TC 0.00721 -1.06 0.34278 NA 0.06 0.20649 NA 3.21 0.2461 NA 
2 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.36627 -0.18 0.35635 NA -0.001 0.84824 NA -0.49 0.31886 NA 
2 APOE618 5'flanking 4 GC/GG 0.00064 -12.25 0.00079 NA 0.02 0.85598 NA -18.42 0.04342 NA 
3 APOE308/rs769445 5'flanking 4 CC/TC 0.00721 -1.06 0.34278 0.54334 0.06 0.20649 0.69378 3.21 0.2461 0.26279 
3 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.36627 -0.18 0.35635 NA -0.001 0.84824 NA -0.49 0.31886 NA 
3 APOE618 5'flanking 4 GC/GG 0.00064 -12.25 0.00079 NA 0.02 0.85598 NA -18.42 0.04342 NA 
3 APOE624/rs769446 5'flanking 3a TC/TT 0.00766 0.65 0.56874 NA 0.004 0.90959 NA 3.55 0.20204 NA 
4 APOE560/rs449647 5'flanking 5 AA/AT/TT 0.36627 -0.18 0.35635 0.05152 -0.001 0.84824 0.83955 -0.49 0.31886 0.57085 
4 APOE618 5'flanking 4 GC/GG 0.00064 -12.25 0.00079 NA 0.02 0.85598 NA -18.42 0.04342 NA 
4 APOE624/rs769446 5'flanking 3a TC/TT 0.00766 0.65 0.56874 NA 0.004 0.90959 NA 3.55 0.20204 NA 
4 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.25611 -0.19 0.36119 NA 0.002 0.74568 NA -0.67 0.19928 NA 
5 APOE618 5'flanking 4 GC/GG 0.00064 -12.25 0.00079 0.27407 0.02 0.85598 0.55355 -18.42 0.04342 0.5495 
5 APOE624/rs769446 5'flanking 3a TC/TT 0.00766 0.65 0.56874 NA 0.004 0.90959 NA 3.55 0.20204 NA 
5 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.25611 -0.19 0.36119 NA 0.002 0.74568 NA -0.67 0.19928 NA 
5 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.61 0.17876 NA 0.02 0.18141 NA 0.24 0.83418 NA 
6 APOE624/rs769446 5'flanking 3a TC/TT 0.00766 0.65 0.56874 0.43137 0.004 0.90959 0.16448 3.55 0.20204 0.58623 
6 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.25611 -0.19 0.36119 NA 0.002 0.74568 NA -0.67 0.19928 NA 
6 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.61 0.17876 NA 0.02 0.18141 NA 0.24 0.83418 NA 
6 APOE1163/rs440446 intron1 4 CC/CG/GG 0.10042 -0.54 0.09464 NA 0.02 0.05369 NA -0.44 0.58046 NA 
7 APOE832/rs405509 5'flanking 1f GG/GT/TT 0.25611 -0.19 0.36119 0.33192 0.002 0.74568 0.17516 -0.67 0.19928 0.78005 
7 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.61 0.17876 NA 0.02 0.18141 NA 0.24 0.83418 NA 
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7 APOE1163/rs440446 intron1 4 CC/CG/GG 0.10042 -0.54 0.09464 NA 0.02 0.05369 NA -0.44 0.58046 NA 
7 APOE1231 intron1 2b GA/GG 0.01247 -0.27 0.755 NA -0.03 0.34414 NA -1.12 0.59594 NA 
8 APOE1109/rs9282609 Splice site 4 CC/TC/TT 0.0415 0.61 0.17876 0.20634 0.02 0.18141 0.05866 0.24 0.83418 0.5871 
8 APOE1163/rs440446 intron1 4 CC/CG/GG 0.10042 -0.54 0.09464 NA 0.02 0.05369 NA -0.44 0.58046 NA 
8 APOE1231 intron1 2b GA/GG 0.01247 -0.27 0.755 NA -0.03 0.34414 NA -1.12 0.59594 NA 
8 APOE1279/rs877973 intron1 4 AA/CA/CC 0.05971 0.51 0.19812 NA -0.03 0.05132 NA 1.06 0.27597 NA 
9 APOE1163/rs440446 intron1 4 CC/CG/GG 0.10042 -0.54 0.09464 0.1736 0.02 0.05369 0.08886 -0.44 0.58046 0.28818 
9 APOE1231 intron1 2b GA/GG 0.01247 -0.27 0.755 NA -0.03 0.34414 NA -1.12 0.59594 NA 
9 APOE1279/rs877973 intron1 4 AA/CA/CC 0.05971 0.51 0.19812 NA -0.03 0.05132 NA 1.06 0.27597 NA 
9 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.00856 1.35 0.15682 NA 0.002 0.95463 NA 4.24 0.0738 NA 
10 APOE1231 intron1 2b GA/GG 0.01247 -0.27 0.755 0.5938 -0.03 0.34414 0.17822 -1.12 0.59594 0.5068 
10 APOE1279/rs877973 intron1 4 AA/CA/CC 0.05971 0.51 0.19812 NA -0.03 0.05132 NA 1.06 0.27597 NA 
10 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.00856 1.35 0.15682 NA 0.002 0.95463 NA 4.24 0.0738 NA 
10 APOE2072/rs189660912 intron 2 4 GA/GG 0.00789 -0.4 0.70658 NA 0.01 0.82286 NA -1.35 0.61188 NA 
11 APOE1279/rs877973 intron1 4 AA/CA/CC 0.05971 0.51 0.19812 0.43466 -0.03 0.05132 0.11116 1.06 0.27597 0.46006 
11 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.00856 1.35 0.15682 NA 0.002 0.95463 NA 4.24 0.0738 NA 
11 APOE2072/rs189660912 intron 2 4 GA/GG 0.00789 -0.4 0.70658 NA 0.01 0.82286 NA -1.35 0.61188 NA 
11 APOE2269/rs6135770 intron 2 5 GA/GG 0.01691 0.77 0.29121 NA 0.04 0.1489 NA 1.09 0.55027 NA 
12 APOE1539/rs184686013 intron1 4 AA/AG/GG 0.00856 1.35 0.15682 0.66542 0.002 0.95463 0.5628 4.24 0.0738 0.73887 
12 APOE2072/rs189660912 intron 2 4 GA/GG 0.00789 -0.4 0.70658 NA 0.01 0.82286 NA -1.35 0.61188 NA 
12 APOE2269/rs6135770 intron 2 5 GA/GG 0.01691 0.77 0.29121 NA 0.04 0.1489 NA 1.09 0.55027 NA 
12 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.38696 -0.02 0.93935 NA 0.002 0.7396 NA -0.17 0.73856 NA 
13 APOE2072/rs189660912 intron 2 4 GA/GG 0.00789 -0.4 0.70658 0.57996 0.01 0.82286 0.46495 -1.35 0.61188 0.87705 
13 APOE2269/rs6135770 intron 2 5 GA/GG 0.01691 0.77 0.29121 NA 0.04 0.1489 NA 1.09 0.55027 NA 
13 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.38696 -0.02 0.93935 NA 0.002 0.7396 NA -0.17 0.73856 NA 
13 APOE3673/rs769453 intron 3 5 CC/GC 0.00657 -1.1 0.34567 NA 0.04 0.42419 NA 3.93 0.17574 NA 
14 APOE2269/rs6135770 intron 2 5 GA/GG 0.01691 0.77 0.29121 0.72016 0.04 0.1489 0.3086 1.09 0.55027 0.07438 
14 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.38696 -0.02 0.93935 NA 0.002 0.7396 NA -0.17 0.73856 NA 
14 APOE3673/rs769453 intron 3 5 CC/GC 0.00657 -1.1 0.34567 NA 0.04 0.42419 NA 3.93 0.17574 NA 
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14 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.26558 -0.14 0.50743 NA -0.01 0.30755 NA -1 0.05924 NA 
15 APOE2440/rs769450 intron 2 5 AA/AG/GG 0.38696 -0.02 0.93935 0.74715 0.002 0.7396 0.15443 -0.17 0.73856 0.06787 
15 APOE3673/rs769453 intron 3 5 CC/GC 0.00657 -1.1 0.34567 NA 0.04 0.42419 NA 3.93 0.17574 NA 
15 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.26558 -0.14 0.50743 NA -0.01 0.30755 NA -1 0.05924 NA 
15 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -0.46 0.48274 NA 0.06 0.03718 NA -0.71 0.66412 NA 
16 APOE3673/rs769453 intron 3 5 CC/GC 0.00657 -1.1 0.34567 0.29748 0.04 0.42419 0.12966 3.93 0.17574 0.0007 
16 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.26558 -0.14 0.50743 NA -0.01 0.30755 NA -1 0.05924 NA 
16 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -0.46 0.48274 NA 0.06 0.03718 NA -0.71 0.66412 NA 
16 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.06049 0.75 0.06615 NA -0.02 0.23759 NA 3.85 0.00008 NA 
17 APOE3937/rs429358 exon 4 5 CC/CT/TT 0.26558 -0.14 0.50743 0.28056 -0.01 0.30755 0.08336 -1 0.05924 0.0005 
17 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -0.46 0.48274 NA 0.06 0.03718 NA -0.71 0.66412 NA 
17 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.06049 0.75 0.06615 NA -0.02 0.23759 NA 3.85 0.00008 NA 
17 APOE4569 3'UTR 5 GG/GT 0.00066 5.29 0.14968 NA 0.07 0.59764 NA 15.53 0.08835 NA 
18 APOE4036/rs769455 exon 4 5 CC/TC/TT 0.02 -0.46 0.48274 0.24697 0.06 0.03718 0.13785 -0.71 0.66412 0.00074 
18 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.06049 0.75 0.06615 NA -0.02 0.23759 NA 3.85 0.00008 NA 
18 APOE4569 3'UTR 5 GG/GT 0.00066 5.29 0.14968 NA 0.07 0.59764 NA 15.53 0.08835 NA 
18 APOE5223 3'flanking 2b CC/CG 0.00508 0.39 0.763 NA 0.01 0.90777 NA 1.29 0.70886 NA 
19 APOE4075/rs7412 exon 4 5 AA/GA/GG 0.06049 0.75 0.06615 0.28508 -0.02 0.23759 0.39788 3.85 0.00008 0.00076 
19 APOE4569 3'UTR 5 GG/GT 0.00066 5.29 0.14968 NA 0.07 0.59764 NA 15.53 0.08835 NA 
19 APOE5223 3'flanking 2b CC/CG 0.00508 0.39 0.763 NA 0.01 0.90777 NA 1.29 0.70886 NA 
19 APOE5231 3'flanking 2b GG/GT/TT 0.02697 -0.18 0.76449 NA -0.02 0.28357 NA -0.03 0.98493 NA 
20 APOE4569 3'UTR 5 GG/GT 0.00066 5.29 0.14968 0.18127 0.07 0.59764 0.54136 15.53 0.08835 0.688 
20 APOE5223 3'flanking 2b CC/CG 0.00508 0.39 0.763 NA 0.01 0.90777 NA 1.29 0.70886 NA 
20 APOE5231 3'flanking 2b GG/GT/TT 0.02697 -0.18 0.76449 NA -0.02 0.28357 NA -0.03 0.98493 NA 
20 rs439401 intragenic  1b CC/CT/TT 0.10925 -0.6 0.04448 NA 0.01 0.3401 NA -0.5 0.50161 NA 
21 APOE5223 3'flanking 2b CC/CG 0.00508 0.39 0.763 0.33128 0.01 0.90777 0.58925 1.29 0.70886 0.90501 
21 APOE5231 3'flanking 2b GG/GT/TT 0.02697 -0.18 0.76449 NA -0.02 0.28357 NA -0.03 0.98493 NA 
21 rs439401 intragenic  1b CC/CT/TT 0.10925 -0.6 0.04448 NA 0.01 0.3401 NA -0.5 0.50161 NA 
21 rs445925 intragenic  No Data AA/GA/GG 0.29896 0.1 0.64004 NA -0.01 0.37485 NA 0.36 0.48026 NA 
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22 APOE5231 3'flanking 2b GG/GT/TT 0.02697 -0.18 0.76449 0.50534 -0.02 0.28357 0.06604 -0.03 0.98493 0.51882 
22 rs439401 intragenic  1b CC/CT/TT 0.10925 -0.6 0.04448 NA 0.01 0.3401 NA -0.5 0.50161 NA 
22 rs445925 intragenic  No Data AA/GA/GG 0.29896 0.1 0.64004 NA -0.01 0.37485 NA 0.36 0.48026 NA 
22 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 0.27 0.20872 NA -0.01 0.11371 NA 1.03 0.04836 NA 
23 rs439401 intragenic  1b CC/CT/TT 0.10925 -0.6 0.04448 0.39897 0.01 0.3401 0.059 -0.5 0.50161 0.46512 
23 rs445925 intragenic  No Data AA/GA/GG 0.29896 0.1 0.64004 NA -0.01 0.37485 NA 0.36 0.48026 NA 
23 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 0.27 0.20872 NA -0.01 0.11371 NA 1.03 0.04836 NA 
23 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.00198 0.74 0.72955 NA 0.02 0.79072 NA 0.4 0.93927 NA 
24 APOC1rs445925 intragenic  No Data AA/GA/GG 0.29896 0.1 0.64004 0.76357 -0.01 0.37485 0.05661 0.36 0.48026 0.42518 
24 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 0.27 0.20872 NA -0.01 0.11371 NA 1.03 0.04836 NA 
24 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.00198 0.74 0.72955 NA 0.02 0.79072 NA 0.4 0.93927 NA 
24 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.03077 -0.61 0.25404 NA 0.03 0.16303 NA -1.09 0.40589 NA 
25 APOC1p720ins4/rs71962921 5'flanking  4 II/WI/WW 0.2737 0.27 0.20872 0.40482 -0.01 0.11371 0.23671 1.03 0.04836 0.31929 
25 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.00198 0.74 0.72955 NA 0.02 0.79072 NA 0.4 0.93927 NA 
25 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.03077 -0.61 0.25404 NA 0.03 0.16303 NA -1.09 0.40589 NA 
25 APOC1p1331/rs10408994 intron2 4 AG/GG 0.06658 0.35 0.38621 NA 0.02 0.28616 NA -0.66 0.50656 NA 
26 APOC1p894/rs190454394 5'flanking  4 CC/CT 0.00198 0.74 0.72955 0.36566 0.02 0.79072 0.23032 0.4 0.93927 0.54481 
26 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.03077 -0.61 0.25404 NA 0.03 0.16303 NA -1.09 0.40589 NA 
26 APOC1p1331/rs10408994 intron2 4 AG/GG 0.06658 0.35 0.38621 NA 0.02 0.28616 NA -0.66 0.50656 NA 
26 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.05792 0.55 0.1745 NA -0.02 0.11175 NA 1.38 0.165 NA 
27 APOC1p1166/rs72654452 intron1 2b CC/CT/TT 0.03077 -0.61 0.25404 0.37708 0.03 0.16303 0.26295 -1.09 0.40589 0.48858 
27 APOC1p1331/rs10408994 intron2 4 AG/GG 0.06658 0.35 0.38621 NA 0.02 0.28616 NA -0.66 0.50656 NA 
27 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.05792 0.55 0.1745 NA -0.02 0.11175 NA 1.38 0.165 NA 
27 APOC1p1642 intron2 4 CC/CT 0.01027 -0.59 0.53986 NA -0.02 0.58314 NA -1.9 0.4104 NA 
28 APOC1p1331/rs10408994 intron2 4 AG/GG 0.06658 0.35 0.38621 0.40668 0.02 0.28616 0.42419 -0.66 0.50656 0.60006 
28 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.05792 0.55 0.1745 NA -0.02 0.11175 NA 1.38 0.165 NA 
28 APOC1p1642 intron2 4 CC/CT 0.01027 -0.59 0.53986 NA -0.02 0.58314 NA -1.9 0.4104 NA 
28 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.09729 0.4 0.20729 NA -0.02 0.15409 NA 0.73 0.34454 NA 
29 APOC1p1526/rs5114 intron2 4 CC/CT/TT 0.05792 0.55 0.1745 0.27406 -0.02 0.11175 0.54353 1.38 0.165 0.63514 
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29 APOC1p1642 intron2 4 CC/CT 0.01027 -0.59 0.53986 NA -0.02 0.58314 NA -1.9 0.4104 NA 
29 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.09729 0.4 0.20729 NA -0.02 0.15409 NA 0.73 0.34454 NA 
29 APOC1p3358 intron3 No Data AA/GA 0.00208 3.44 0.10895 NA 0.002 0.97274 NA -2.34 0.6601 NA 
30 APOC1p1642 intron2 4 CC/CT 0.01027 -0.59 0.53986 0.12516 -0.02 0.58314 0.6562 -1.9 0.4104 0.6398 
30 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.09729 0.4 0.20729 NA -0.02 0.15409 NA 0.73 0.34454 NA 
30 APOC1p3358 intron3 No Data AA/GA 0.00208 3.44 0.10895 NA 0.002 0.97274 NA -2.34 0.6601 NA 
30 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.33104 0.24 0.26136 NA -0.001 0.81164 NA -0.36 0.48713 NA 
31 APOC1p1684/rs12709881 intron2 4 AA/GA/GG 0.09729 0.4 0.20729 0.08271 -0.02 0.15409 0.62061 0.73 0.34454 0.6907 
31 APOC1p3358 intron3 No Data AA/GA 0.00208 3.44 0.10895 NA 0.002 0.97274 NA -2.34 0.6601 NA 
31 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.33104 0.24 0.26136 NA -0.001 0.81164 NA -0.36 0.48713 NA 
31 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 0.55 0.0455 NA 0.001 0.90959 NA 0.4 0.55931 NA 
32 APOC1p3358 intron3 No Data AA/GA 0.00208 3.44 0.10895 0.13261 0.002 0.97274 0.63103 -2.34 0.6601 0.74383 
32 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.33104 0.24 0.26136 NA -0.001 0.81164 NA -0.36 0.48713 NA 
32 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 0.55 0.0455 NA 0.001 0.90959 NA 0.4 0.55931 NA 
32 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 0.32 0.3879 NA -0.02 0.17321 NA 0.67 0.44123 NA 
33 APOC1p3423/rs389261 intron3 No Data AA/GA/GG 0.33104 0.24 0.26136 0.31249 -0.001 0.81164 0.20941 -0.36 0.48713 0.78355 
33 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 0.55 0.0455 NA 0.001 0.90959 NA 0.4 0.55931 NA 
33 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 0.32 0.3879 NA -0.02 0.17321 NA 0.67 0.44123 NA 
33 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 -0.31 0.16174 NA 0.003 0.65241 NA -0.42 0.4506 NA 
34 APOC1p3573/rs10424339 intron3 No Data AA/GA/GG 0.1396 0.55 0.0455 0.09833 0.001 0.90959 0.05564 0.4 0.55931 0.58076 
34 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 0.32 0.3879 NA -0.02 0.17321 NA 0.67 0.44123 NA 
34 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 -0.31 0.16174 NA 0.003 0.65241 NA -0.42 0.4506 NA 
34 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.14459 0.23 0.42209 NA -0.03 0.00699 NA 1.01 0.14096 NA 
35 APOC1p5006/rs112528434 intron3 No Data GG/GT/TT 0.085 0.32 0.3879 0.66834 -0.02 0.17321 0.07071 0.67 0.44123 0.63652 
35 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 -0.31 0.16174 NA 0.003 0.65241 NA -0.42 0.4506 NA 
35 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.14459 0.23 0.42209 NA -0.03 0.00699 NA 1.01 0.14096 NA 
35 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.17453 0.31 0.22541 NA -0.02 0.04423 NA 0.87 0.17334 NA 
36 APOC1p5053/rs12721052 intron3 No Data DD/WD/WW 0.22 -0.31 0.16174 0.59414 0.003 0.65241 0.11658 -0.42 0.4506 0.4423 
36 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.14459 0.23 0.42209 NA -0.03 0.00699 NA 1.01 0.14096 NA 
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36 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.17453 0.31 0.22541 NA -0.02 0.04423 NA 0.87 0.17334 NA 
36 rs4803770 HCR-1 5 CC/GC/GG 0.26954 -0.27 0.21475 NA 0.005 0.5732 NA -0.53 0.32036 NA 
37 APOC1p5667/rs12721054 3'UTR 6 AA/GA/GG 0.14459 0.23 0.42209 0.33569 -0.03 0.00699 0.10784 1.01 0.14096 0.26008 
37 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.17453 0.31 0.22541 NA -0.02 0.04423 NA 0.87 0.17334 NA 
37 rs4803770 HCR-1 5 CC/GC/GG 0.26954 -0.27 0.21475 NA 0.005 0.5732 NA -0.53 0.32036 NA 
37 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.00726 2.06 0.06453 NA 0.02 0.55251 NA 5.74 0.04801 NA 
38 APOC1p5926/rs56131196 3'flanking  No Data AA/AG/GG 0.17453 0.31 0.22541 0.18352 -0.02 0.04423 0.32895 0.87 0.17334 0.20305 
38 rs4803770 HCR-1 5 CC/GC/GG 0.26954 -0.27 0.21475 NA 0.005 0.5732 NA -0.53 0.32036 NA 
38 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.00726 2.06 0.06453 NA 0.02 0.55251 NA 5.74 0.04801 NA 
38 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.35949 0.19 0.36879 NA -0.004 0.61322 NA -0.63 0.22016 NA 
39 rs4803770 HCR-1 5 CC/GC/GG 0.26954 -0.27 0.21475 0.19821 0.005 0.5732 0.71998 -0.53 0.32036 0.06248 
39 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.00726 2.06 0.06453 NA 0.02 0.55251 NA 5.74 0.04801 NA 
39 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.35949 0.19 0.36879 NA -0.004 0.61322 NA -0.63 0.22016 NA 
39 rs5112 APC1P1 4 CC/GC/GG 0.47975 0.25 0.18503 NA 0.01 0.18177 NA 0.8 0.0924 NA 
40 HCR1p424/rs117664574 HCR-1 4 AG/GG 0.00726 2.06 0.06453 0.33872 0.02 0.55251 0.90041 5.74 0.04801 0.25936 
40 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.35949 0.19 0.36879 NA -0.004 0.61322 NA -0.63 0.22016 NA 
40 rs5112 APC1P1 4 CC/GC/GG 0.47975 0.25 0.18503 NA 0.01 0.18177 NA 0.8 0.0924 NA 
40 rs7259004 APC1P1 6 CC/CG/GG 0.30201 0.29 0.15235 NA 0.01 0.43279 NA 0.83 0.10102 NA 
41 HCR1p575/rs157599 HCR-1 3a AA/AG/GG 0.35949 0.19 0.36879 0.00037 -0.004 0.61322 0.32698 -0.63 0.22016 0.04554 
41 rs5112 APC1P1 4 CC/GC/GG 0.47975 0.25 0.18503 NA 0.01 0.18177 NA 0.8 0.0924 NA 
41 rs7259004 APC1P1 6 CC/CG/GG 0.30201 0.29 0.15235 NA 0.01 0.43279 NA 0.83 0.10102 NA 
41 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.15462 0.3 0.23716 NA 0 0.604 NA 0.85 0.18117 NA 
42 rs5112 APC1P1 4 CC/GC/GG 0.47975 0.25 0.18503 0.00098 0.01 0.18177 0.47329 0.8 0.0924 0.05761 
42 rs7259004 APC1P1 6 CC/CG/GG 0.30201 0.29 0.15235 NA 0.01 0.43279 NA 0.83 0.10102 NA 
42 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.15462 0.3 0.23716 NA 0.005 0.604 NA 0.85 0.18117 NA 
42 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 -0.7 0.11626 NA 0.03 0.1292 NA -0.59 0.59403 NA 
43 rs7259004 APC1P1 6 CC/CG/GG 0.30201 0.29 0.15235 0.00122 0.01 0.43279 0.23994 0.83 0.10102 0.02426 
43 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.15462 0.3 0.23716 NA 0.005 0.604 NA 0.85 0.18117 NA 
43 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 -0.7 0.11626 NA 0.03 0.1292 NA -0.59 0.59403 NA 
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43 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.00263 0.02 0.99167 NA 0.03 0.62894 NA -0.21 0.96328 NA 
44 HCR2p188/rs35136575 HCR-2 2a CC/GC/GG 0.15462 0.3 0.23716 0.53105 0.005 0.604 0.40465 0.85 0.18117 0.56339 
44 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 -0.7 0.11626 NA 0.03 0.1292 NA -0.59 0.59403 NA 
44 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.00263 0.02 0.99167 NA 0.03 0.62894 NA -0.21 0.96328 NA 
44 APOC4p368 5’ flanking  6 TC/TT 0.00194 0.33 0.87548 NA 0.09 0.26413 NA -0.69 0.8967 NA 
45 HCR2p286 HCR-2 2a AA/AG/GG 0.0457 -0.7 0.11626 0.61331 0.03 0.1292 0.29318 -0.59 0.59403 0.9891 
45 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.00263 0.02 0.99167 NA 0.03 0.62894 NA -0.21 0.96328 NA 
45 APOC4p368 5’ flanking  6 TC/TT 0.00194 0.33 0.87548 NA 0.09 0.26413 NA -0.69 0.8967 NA 
45 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.04516 0.1 0.82864 NA -0.01 0.4457 NA 0.14 0.90262 NA 
46 HCR2p523/rs118004808 HCR-2 2b CC/TC 0.00263 0.02 0.99167 0.99283 0.03 0.62894 0.00438 -0.21 0.96328 0.67928 
46 APOC4p368 5’ flanking  6 TC/TT 0.00194 0.33 0.87548 NA 0.09 0.26413 NA -0.69 0.8967 NA 
46 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.04516 0.1 0.82864 NA -0.01 0.4457 NA 0.14 0.90262 NA 
46 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.03763 -0.19 0.69377 NA 0.06 0.00052 NA -1.4 0.23935 NA 
47 APOC4p368 5’ flanking  6 TC/TT 0.00194 0.33 0.87548 0.82562 0.09 0.26413 0.00098 -0.69 0.8967 0.60638 
47 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.04516 0.1 0.82864 NA -0.01 0.4457 NA 0.14 0.90262 NA 
47 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.03763 -0.19 0.69377 NA 0.06 0.00052 NA -1.4 0.23935 NA 
47 APOC4p1088 intron1 2b GT/TT 0.00133 -4.26 0.10128 NA 0.18 0.06327 NA -4.8 0.45794 NA 
48 APOC4p637/rs113814026 5’ flanking  No Data GG/GT/TT 0.04516 0.1 0.82864 0.99009 -0.01 0.4457 0.00086 0.14 0.90262 0.69116 
48 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.03763 -0.19 0.69377 NA 0.06 0.00052 NA -1.4 0.23935 NA 
48 APOC4p1088 intron1 2b GT/TT 0.00133 -4.26 0.10128 NA 0.18 0.06327 NA -4.8 0.45794 NA 
48 APOC4p1130 intron1 5 CT/TT 0.00066 9.46 0.00979 NA 0.1 0.48004 NA 14.38 0.11483 NA 
49 APOC4p757/rs12721105 5’ flanking  5 GG/GT/TT 0.03763 -0.19 0.69377 0.96485 0.06 0.00052 0.00099 -1.4 0.23935 0.29465 
49 APOC4p1088 intron1 2b GT/TT 0.00133 -4.26 0.10128 NA 0.18 0.06327 NA -4.8 0.45794 NA 
49 APOC4p1130 intron1 5 CT/TT 0.00066 9.46 0.00979 NA 0.1 0.48004 NA 14.38 0.11483 NA 
49 APOC4p1192/rs113745034 intron1 4 GA/GG 0.01238 0.35 0.69302 NA -0.01 0.8015 NA 3.44 0.12841 NA 
50 APOC4p1088 intron1 2b GT/TT 0.00133 -4.26 0.10128 0.90718 0.18 0.06327 0.09132 -4.8 0.45794 0.46302 
50 APOC4p1130 intron1 5 CT/TT 0.00066 9.46 0.00979 NA 0.1 0.48004 NA 14.38 0.11483 NA 
50 APOC4p1192/rs113745034 intron1 4 GA/GG 0.01238 0.35 0.69302 NA -0.01 0.8015 NA 3.44 0.12841 NA 
50 APOC4p1325del3 intron1 4 WD/WW 0.02447 0.3 0.63292 NA -0.04 0.09089 NA -0.31 0.84012 NA 
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51 APOC4p1130 intron1 5 CT/TT 0.00066 9.46 0.00979 0.08027 0.1 0.48004 0.43671 14.38 0.11483 0.07629 
51 APOC4p1192/rs113745034 intron1 4 GA/GG 0.01238 0.35 0.69302 NA -0.01 0.8015 NA 3.44 0.12841 NA 
51 APOC4p1325del3 intron1 4 WD/WW 0.02447 0.3 0.63292 NA -0.04 0.09089 NA -0.31 0.84012 NA 
51 APOC4p1430ins intron1 5 II/WI/WW 0.03411 0.69 0.22691 NA -0.01 0.64588 NA 2.68 0.05543 NA 
52 APOC4p1192/rs113745034 intron1 4 GA/GG 0.01238 0.35 0.69302 0.77257 -0.01 0.8015 0.32748 3.44 0.12841 0.13951 
52 APOC4p1325del3 intron1 4 WD/WW 0.02447 0.3 0.63292 NA -0.04 0.09089 NA -0.31 0.84012 NA 
52 APOC4p1430ins intron1 5 II/WI/WW 0.03411 0.69 0.22691 NA -0.01 0.64588 NA 2.68 0.05543 NA 
52 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.01414 0.35 0.6678 NA -0.03 0.27451 NA 3.04 0.13403 NA 
53 APOC4p1325del3 intron1 4 WD/WW 0.02447 0.3 0.63292 0.76353 -0.04 0.09089 0.22013 -0.31 0.84012 0.0836 
53 APOC4p1430ins intron1 5 II/WI/WW 0.03411 0.69 0.22691 NA -0.01 0.64588 NA 2.68 0.05543 NA 
53 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.01414 0.35 0.6678 NA -0.03 0.27451 NA 3.04 0.13403 NA 
53 APOC4p2467/rs115225947 intron1 5 GA/GG 0.01414 0.03 0.96646 NA -0.03 0.37943 NA -2.52 0.2125 NA 
54 APOC4p1430ins intron1 5 II/WI/WW 0.03411 0.69 0.22691 0.70625 -0.01 0.64588 0.54162 2.68 0.05543 0.03425 
54 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.01414 0.35 0.6678 NA -0.03 0.27451 NA 3.04 0.13403 NA 
54 APOC4p2467/rs115225947 intron1 5 GA/GG 0.01414 0.03 0.96646 NA -0.03 0.37943 NA -2.52 0.2125 NA 
54 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.09858 -0.2 0.53148 NA -0.01 0.49082 NA -1.47 0.06609 NA 
55 APOC4p2099/rs111339708 intron1 No Data GG/GT 0.01414 0.35 0.6678 0.7705 -0.03 0.27451 0.46951 3.04 0.13403 0.06868 
55 APOC4p2467/rs115225947 intron1 5 GA/GG 0.01414 0.03 0.96646 NA -0.03 0.37943 NA -2.52 0.2125 NA 
55 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.09858 -0.2 0.53148 NA -0.01 0.49082 NA -1.47 0.06609 NA 
55 APOC4p2607/rs5156 intron1 4 AG/GG 0.01293 0.43 0.62963 NA -0.03 0.37912 NA 3.6 0.10172 NA 
56 APOC4p2467/rs115225947 intron1 5 GA/GG 0.01414 0.03 0.96646 0.90903 -0.03 0.37943 0.65639 -2.52 0.2125 0.15584 
56 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.09858 -0.2 0.53148 NA -0.01 0.49082 NA -1.47 0.06609 NA 
56 APOC4p2607/rs5156 intron1 4 AG/GG 0.01293 0.43 0.62963 NA -0.03 0.37912 NA 3.6 0.10172 NA 
56 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.17232 -0.14 0.59553 NA 0.0006 0.94809 NA 0.78 0.21466 NA 
57 APOC4p2559/rs5155 intron1 4 CC/CT/TT 0.09858 -0.2 0.53148 0.91285 -0.01 0.49082 0.16019 -1.47 0.06609 0.20674 
57 APOC4p2607/rs5156 intron1 4 AG/GG 0.01293 0.43 0.62963 NA -0.03 0.37912 NA 3.6 0.10172 NA 
57 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.17232 -0.14 0.59553 NA 0.0006 0.94809 NA 0.78 0.21466 NA 
57 APOC4p2640/rs5158 intron1 2b CC/CT 0.02129 -0.29 0.66191 NA -0.05 0.03532 NA -1.12 0.4997 NA 
58 APOC4p2607/rs5156 intron1 4 AG/GG 0.01293 0.43 0.62963 0.93012 -0.03 0.37912 0.16394 3.6 0.10172 0.10981 
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58 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.17232 -0.14 0.59553 NA 0.0006 0.94809 NA 0.78 0.21466 NA 
58 APOC4p2640/rs5158 intron1 2b CC/CT 0.02129 -0.29 0.66191 NA -0.05 0.03532 NA -1.12 0.4997 NA 
58 APOC4p2678/rs148564866 intron1 2b GC/GG 0.00863 0.07 0.94518 NA 0.04 0.28796 NA 2.67 0.29564 NA 
59 APOC4p2623/rs5157 intron1 4 CC/CT/TT 0.17232 -0.14 0.59553 0.88648 0.0006 0.94809 0.1914 0.78 0.21466 0.21469 
59 APOC4p2640/rs5158 intron1 2b CC/CT 0.02129 -0.29 0.66191 NA -0.05 0.03532 NA -1.12 0.4997 NA 
59 APOC4p2678/rs148564866 intron1 2b GC/GG 0.00863 0.07 0.94518 NA 0.04 0.28796 NA 2.67 0.29564 NA 
59 APOC4p2767/rs127721107 intron1 4 GG/GT 0.02537 0.56 0.37292 NA -0.01 0.75986 NA 2.17 0.1601 NA 
60 APOC4p2640/rs5158 intron1 2b CC/CT 0.02129 -0.29 0.66191 0.61063 -0.05 0.03532 0.18293 -1.12 0.4997 0.21732 
60 APOC4p2678/rs148564866 intron1 2b GC/GG 0.00863 0.07 0.94518 NA 0.04 0.28796 NA 2.67 0.29564 NA 
60 APOC4p2767/rs127721107 intron1 4 GG/GT 0.02537 0.56 0.37292 NA -0.01 0.75986 NA 2.17 0.1601 NA 
60 APOC4p3348 intron1 5 AG/GG 0.00066 11.56 0.00153 NA -0.23 0.09471 NA 14.52 0.11008 NA 
61 APOC4p2678/rs148564866 intron1 2b GC/GG 0.00863 0.07 0.94518 0.58303 0.04 0.28796 0.43139 2.67 0.29564 0.06222 
61 APOC4p2767/rs127721107 intron1 4 GG/GT 0.02537 0.56 0.37292 NA -0.01 0.75986 NA 2.17 0.1601 NA 
61 APOC4p3348 intron1 5 AG/GG 0.00066 11.56 0.00153 NA -0.23 0.09471 NA 14.52 0.11008 NA 
61 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.13684 -0.11 0.69346 NA 0.01 0.16334 NA -1.25 0.06839 NA 
62 APOC4p2767/rs127721107 intron1 4 GG/GT 0.02537 0.56 0.37292 0.67057 -0.01 0.75986 0.48353 2.17 0.1601 0.07338 
62 APOC4p3348 intron1 5 AG/GG 0.00066 11.56 0.00153 NA -0.23 0.09471 NA 14.52 0.11008 NA 
62 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.13684 -0.11 0.69346 NA 0.01 0.16334 NA -1.25 0.06839 NA 
62 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.23681 -0.14 0.53341 NA -0.001 0.87833 NA 0.88 0.11098 NA 
63 APOC4p3348 intron1 5 AG/GG 0.00066 11.56 0.00153 0.78469 -0.23 0.09471 0.41289 14.52 0.11008 0.0498 
63 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.13684 -0.11 0.69346 NA 0.01 0.16334 NA -1.25 0.06839 NA 
63 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.23681 -0.14 0.53341 NA -0.001 0.87833 NA 0.88 0.11098 NA 
63 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.00663 -0.72 0.54187 NA 0.04 0.41379 NA 3.31 0.25501 NA 
64 APOC2p75C4p3380/rs12721104 C4-intron1 5 AA/GA/GG 0.13684 -0.11 0.69346 0.69081 0.01 0.16334 0.5277 -1.25 0.06839 0.10008 
64 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.23681 -0.14 0.53341 NA -0.001 0.87833 NA 0.88 0.11098 NA 
64 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.00663 -0.72 0.54187 NA 0.04 0.41379 NA 3.31 0.25501 NA 
64 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.02722 0.75 0.21469 NA -0.01 0.72615 NA 2 0.17721 NA 
65 APOC2p194C4p3498/rs1132899 C4-exon2  5 CC/CT/TT 0.23681 -0.14 0.53341 0.6609 -0.001 0.87833 0.90956 0.88 0.11098 0.07457 
65 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.00663 -0.72 0.54187 NA 0.04 0.41379 NA 3.31 0.25501 NA 
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65 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.02722 0.75 0.21469 NA -0.01 0.72615 NA 2 0.17721 NA 
65 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.00068 5.9 0.11176 NA -0.14 0.31613 NA 11.51 0.21156 NA 
66 APOC2p228/rs5164 C4-exon2  5 AG/GA/GG 0.00663 -0.72 0.54187 0.76619 0.04 0.41379 0.89102 3.31 0.25501 0.24679 
66 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.02722 0.75 0.21469 NA -0.01 0.72615 NA 2 0.17721 NA 
66 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.00068 5.9 0.11176 NA -0.14 0.31613 NA 11.51 0.21156 NA 
66 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.01465 -0.04 0.96019 NA -0.02 0.40589 NA -1.54 0.43321 NA 
67 APOC2p288C4p3592/rs12691090 C4-exon2  5 CC/CT 0.02722 0.75 0.21469 0.44559 -0.01 0.72615 0.57369 2 0.17721 0.45181 
67 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.00068 5.9 0.11176 NA -0.14 0.31613 NA 11.51 0.21156 NA 
67 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.01465 -0.04 0.96019 NA -0.02 0.40589 NA -1.54 0.43321 NA 
67 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.45935 0.05 0.77107 NA 0.01 0.34212 NA 0.19 0.6794 NA 
68 APOC2p396C4p3700 C4-intron2 5 GA/GG 0.00068 5.9 0.11176 0.98309 -0.14 0.31613 0.67109 11.51 0.21156 0.80964 
68 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.01465 -0.04 0.96019 NA -0.02 0.40589 NA -1.54 0.43321 NA 
68 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.45935 0.05 0.77107 NA 0.01 0.34212 NA 0.19 0.6794 NA 
68 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 -0.06 0.94985 NA 0.02 0.66857 NA -2.07 0.41707 NA 
69 APOC2p488C4p3792/rs5165 C4-intron2 5 GA/GG 0.01465 -0.04 0.96019 0.9349 -0.02 0.40589 0.50575 -1.54 0.43321 0.5806 
69 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.45935 0.05 0.77107 NA 0.01 0.34212 NA 0.19 0.6794 NA 
69 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 -0.06 0.94985 NA 0.02 0.66857 NA -2.07 0.41707 NA 
69 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.00066 -7.15 0.05187 NA 0.29 0.0381 NA -9.42 0.30174 NA 
70 APOC2p623C4p3927/rs5167 C4-exon3 5 GG/GT/TT 0.45935 0.05 0.77107 0.80536 0.01 0.34212 0.50769 0.19 0.6794 0.35483 
70 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 -0.06 0.94985 NA 0.02 0.66857 NA -2.07 0.41707 NA 
70 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.00066 -7.15 0.05187 NA 0.29 0.0381 NA -9.42 0.30174 NA 
70 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11003 0.24 0.43314 NA -0.004 0.75183 NA 1.17 0.12757 NA 
71 APOC2p665C4p3969/rs138548797 C4-exon3 No Data AA/CA 0.0086 -0.06 0.94985 0.48905 0.02 0.66857 0.43709 -2.07 0.41707 0.00654 
71 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.00066 -7.15 0.05187 NA 0.29 0.0381 NA -9.42 0.30174 NA 
71 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11003 0.24 0.43314 NA -0.004 0.75183 NA 1.17 0.12757 NA 
71 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.01781 1.1 0.13505 NA -0.04 0.18665 NA 5.95 0.00071 NA 
72 APOC2p708C4p4012 C4-exon3 6 GA/GG 0.00066 -7.15 0.05187 0.64651 0.29 0.0381 0.27827 -9.42 0.30174 0.00761 
72 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11003 0.24 0.43314 NA -0.004 0.75183 NA 1.17 0.12757 NA 
72 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.01781 1.1 0.13505 NA -0.04 0.18665 NA 5.95 0.00071 NA 
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72 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.01781 0.58 0.44007 NA -0.01 0.63757 NA 3.23 0.08379 NA 
73 APOC2p853C4p4157/rs10425530 C4-3' UTR 6 AA/GA/GG 0.11003 0.24 0.43314 0.36562 -0.004 0.75183 0.63914 1.17 0.12757 0.00311 
73 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.01781 1.1 0.13505 NA -0.04 0.18665 NA 5.95 0.00071 NA 
73 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.01781 0.58 0.44007 NA -0.01 0.63757 NA 3.23 0.08379 NA 
73 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.01402 0.83 0.31821 NA -0.01 0.81539 NA 3.2 0.12314 NA 
74 APOC2p1042C4p4346/rs12709885 C4-3'FR/C2-5'FR 5 AA/TA/TT 0.01781 1.1 0.13505 0.26994 -0.04 0.18665 0.69332 5.95 0.00071 0.00273 
74 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.01781 0.58 0.44007 NA -0.01 0.63757 NA 3.23 0.08379 NA 
74 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.01402 0.83 0.31821 NA -0.01 0.81539 NA 3.2 0.12314 NA 
74 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.03519 -0.18 0.7323 NA 0.01 0.74933 NA 0.35 0.79182 NA 
75 APOC2p1187C4p4491/rs111782345 C4-3'FR/C2-5'FR 5 AG/GG 0.01781 0.58 0.44007 0.51163 -0.01 0.63757 0.71138 3.23 0.08379 0.1427 
75 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.01402 0.83 0.31821 NA -0.01 0.81539 NA 3.2 0.12314 NA 
75 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.03519 -0.18 0.7323 NA 0.01 0.74933 NA 0.35 0.79182 NA 
75 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.25813 0.05 0.80869 NA -0.01 0.36144 NA 0.8 0.13323 NA 
76 APOC2p1229C4p4533/rs112698600 C4-3'FR/C2-5'FR 2b CC/CT 0.01402 0.83 0.31821 0.79706 -0.01 0.81539 0.48636 3.2 0.12314 0.26557 
76 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.03519 -0.18 0.7323 NA 0.01 0.74933 NA 0.35 0.79182 NA 
76 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.25813 0.05 0.80869 NA -0.01 0.36144 NA 0.8 0.13323 NA 
76 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.09 0.77127 NA -0.01 0.50004 NA 0.48 0.5384 NA 
77 APOC2p1275C4p4579/rs111356234 C4-3'FR/C2-5'FR 4 GA/GG 0.03519 -0.18 0.7323 0.97717 0.01 0.74933 0.52662 0.35 0.79182 0.3722 
77 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.25813 0.05 0.80869 NA -0.01 0.36144 NA 0.8 0.13323 NA 
77 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.09 0.77127 NA -0.01 0.50004 NA 0.48 0.5384 NA 
77 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.36554 0.09 0.65299 NA 0.01 0.14059 NA 0.75 0.13555 NA 
78 APOC2p1357C4p4661/rs2288912 C4-3'FR/C2-5'FR 1a CC/GC/GG 0.25813 0.05 0.80869 0.95561 -0.01 0.36144 0.10511 0.8 0.13323 0.35521 
78 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.09 0.77127 NA -0.01 0.50004 NA 0.48 0.5384 NA 
78 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.36554 0.09 0.65299 NA 0.01 0.14059 NA 0.75 0.13555 NA 
78 APOC2p2935/rs11879392 intron1 2b CC/GC 0.01351 0.57 0.49871 NA -0.07 0.02851 NA 0.18 0.93035 NA 
79 APOC2p1540C4p4844/rs75463753 C2-intron1 4 AA/GA/GG 0.1079 0.09 0.77127 0.62972 -0.01 0.50004 0.01057 0.48 0.5384 0.32093 
79 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.36554 0.09 0.65299 NA 0.01 0.14059 NA 0.75 0.13555 NA 
79 APOC2p2935/rs11879392 intron1 2b CC/GC 0.01351 0.57 0.49871 NA -0.07 0.02851 NA 0.18 0.93035 NA 
79 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.12535 0.15 0.62186 NA -0.02 0.12716 NA -1.32 0.06568 NA 
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80 APOC2p2486/rs9304645 intron1 4 AA/GA/GG 0.36554 0.09 0.65299 0.71956 0.01 0.14059 0.00893 0.75 0.13555 0.31915 
80 APOC2p2935/rs11879392 intron1 2b CC/GC 0.01351 0.57 0.49871 NA -0.07 0.02851 NA 0.18 0.93035 NA 
80 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.12535 0.15 0.62186 NA -0.02 0.12716 NA -1.32 0.06568 NA 
80 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.01719 0.76 0.3536 NA -0.01 0.62291 NA 3.01 0.14108 NA 
81 APOC2p2935/rs11879392 intron1 2b CC/GC 0.01351 0.57 0.49871 0.8007 -0.07 0.02851 0.12282 0.18 0.93035 0.21883 
81 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.12535 0.15 0.62186 NA -0.02 0.12716 NA -1.32 0.06568 NA 
81 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.01719 0.76 0.3536 NA -0.01 0.62291 NA 3.01 0.14108 NA 
81 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.18452 0.08 0.74123 NA -7.31E-05 0.99372 NA 0.79 0.19964 NA 
82 APOC2p3010/rs10419086 intron1 6 AA/AG/GG 0.12535 0.15 0.62186 0.8782 -0.02 0.12716 0.56244 -1.32 0.06568 0.16569 
82 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.01719 0.76 0.3536 NA -0.01 0.62291 NA 3.01 0.14108 NA 
82 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.18452 0.08 0.74123 NA -7.31E-05 0.99372 NA 0.79 0.19964 NA 
82 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.16489 -0.16 0.53621 NA -0.003 0.7465 NA -0.55 0.40568 NA 
83 APOC2p3692/rs12721060 intron1 No Data GT/TT 0.01719 0.76 0.3536 0.64388 -0.01 0.62291 0.55285 3.01 0.14108 0.08769 
83 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.18452 0.08 0.74123 NA -7.31E-05 0.99372 NA 0.79 0.19964 NA 
83 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.16489 -0.16 0.53621 NA -0.003 0.7465 NA -0.55 0.40568 NA 
83 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.30081 0.25 0.23836 NA 0.01 0.14544 NA 0.97 0.06515 NA 
84 APOC2p3778/rs5120 intron1 4 AA/AT/TT 0.18452 0.08 0.74123 0.78035 -7.31E-05 0.99372 0.67164 0.79 0.19964 0.13092 
84 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.16489 -0.16 0.53621 NA -0.003 0.7465 NA -0.55 0.40568 NA 
84 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.30081 0.25 0.23836 NA 0.01 0.14544 NA 0.97 0.06515 NA 
84 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.03581 -0.03 0.95269 NA 0.004 0.8416 NA 0.2 0.87741 NA 
85 APOC2p3805/rs7257095 intron1 2a CC/CG/GG 0.16489 -0.16 0.53621 0.7583 -0.003 0.7465 0.65222 -0.55 0.40568 0.40381 
85 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.30081 0.25 0.23836 NA 0.01 0.14544 NA 0.97 0.06515 NA 
85 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.03581 -0.03 0.95269 NA 0.004 0.8416 NA 0.2 0.87741 NA 
85 APOC2p4086/rs114780592 intron2 4 GA/GG 0.02778 0.49 0.40801 NA -0.004 0.84856 NA 1.53 0.29745 NA 
86 APOC2p3814/rs10422603 intron1 2b GG/GT/TT 0.30081 0.25 0.23836 0.76741 0.01 0.14544 0.61933 0.97 0.06515 0.35166 
86 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.03581 -0.03 0.95269 NA 0.004 0.8416 NA 0.2 0.87741 NA 
86 APOC2p4086/rs114780592 intron2 4 GA/GG 0.02778 0.49 0.40801 NA -0.004 0.84856 NA 1.53 0.29745 NA 
86 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.05922 -0.14 0.71873 NA -0.01 0.60254 NA 0.49 0.61561 NA 
87 APOC2p3892/rs5121 exon2 5 CC/TC/TT 0.03581 -0.03 0.95269 0.79364 0.004 0.8416 0.9505 0.2 0.87741 0.33968 
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87 APOC2p4086/rs114780592 intron2 4 GA/GG 0.02778 0.49 0.40801 NA -0.004 0.84856 NA 1.53 0.29745 NA 
87 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.05922 -0.14 0.71873 NA -0.01 0.60254 NA 0.49 0.61561 NA 
87 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.01348 0.82 0.32552 NA -0.02 0.50114 NA 3.47 0.09379 NA 
88 APOC2p4086/rs114780592 intron2 4 GA/GG 0.02778 0.49 0.40801 0.1506 -0.004 0.84856 0.61636 1.53 0.29745 0.40068 
88 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.05922 -0.14 0.71873 NA -0.01 0.60254 NA 0.49 0.61561 NA 
88 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.01348 0.82 0.32552 NA -0.02 0.50114 NA 3.47 0.09379 NA 
88 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.04993 0.12 0.80049 NA -0.01 0.51928 NA 0.68 0.54818 NA 
89 APOC2p4319/rs5123 intron3 No Data AA/GA/GG 0.05922 -0.14 0.71873 0.18546 -0.01 0.60254 0.81011 0.49 0.61561 0.12586 
89 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.01348 0.82 0.32552 NA -0.02 0.50114 NA 3.47 0.09379 NA 
89 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.04993 0.12 0.80049 NA -0.01 0.51928 NA 0.68 0.54818 NA 
89 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.06057 -0.01 0.9801 NA -0.004 0.78701 NA 1.17 0.22087 NA 
90 APOC2p4513/rs180809422 intron3 5 AA/AC/CC 0.01348 0.82 0.32552 0.64317 -0.02 0.50114 0.86408 3.47 0.09379 0.17425 
90 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.04993 0.12 0.80049 NA -0.01 0.51928 NA 0.68 0.54818 NA 
90 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.06057 -0.01 0.9801 NA -0.004 0.78701 NA 1.17 0.22087 NA 
90 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.27365 -0.18 0.40916 NA 0.001 0.90826 NA -0.86 0.10718 NA 
91 APOC2p4587/rs5126 exon4 5 AA/CA/CC 0.04993 0.12 0.80049 0.86082 -0.01 0.51928 0.95412 0.68 0.54818 0.42444 
91 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.06057 -0.01 0.9801 NA -0.004 0.78701 NA 1.17 0.22087 NA 
91 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.27365 -0.18 0.40916 NA 0.001 0.90826 NA -0.86 0.10718 NA 
91 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.00816 -0.6 0.58323 NA 0.01 0.8053 NA 0.16 0.95293 NA 
92 APOC2p4754/rs7253690 exon4 5 AA/GA/GG 0.06057 -0.01 0.9801 0.76271 -0.004 0.78701 0.65349 1.17 0.22087 0.37166 
92 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.27365 -0.18 0.40916 NA 0.001 0.90826 NA -0.86 0.10718 NA 
92 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.00816 -0.6 0.58323 NA 0.01 0.8053 NA 0.16 0.95293 NA 
92 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 0.16 0.46461 NA 0.01 0.15992 NA 0.61 0.24821 NA 
93 APOC2p4853/rs150448996 3'flamking  No Data DD/WD/WW 0.27365 -0.18 0.40916 0.78688 0.001 0.90826 0.231 -0.86 0.10718 0.6192 
93 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.00816 -0.6 0.58323 NA 0.01 0.8053 NA 0.16 0.95293 NA 
93 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 0.16 0.46461 NA 0.01 0.15992 NA 0.61 0.24821 NA 
93 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.03521 0 0.9939 NA -0.02 0.21115 NA 0.36 0.77793 NA 
94 APOC2p4973/rs199828513 3'flamking  No Data WI/WW 0.00816 -0.6 0.58323 0.73997 0.01 0.8053 0.19479 0.16 0.95293 0.86684 
94 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 0.16 0.46461 NA 0.01 0.15992 NA 0.61 0.24821 NA 
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94 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.03521 0 0.9939 NA -0.02 0.21115 NA 0.36 0.77793 NA 
94 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.30672 0.11 0.61363 NA -0.01 0.21601 NA -0.42 0.44209 NA 
95 APOC2p5004/rs10421404 3'flanking  No Data CC/CT/TT 0.2908 0.16 0.46461 0.85485 0.01 0.15992 0.12002 0.61 0.24821 0.83539 
95 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.03521 0 0.9939 NA -0.02 0.21115 NA 0.36 0.77793 NA 
95 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.30672 0.11 0.61363 NA -0.01 0.21601 NA -0.42 0.44209 NA 
95 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.25869 -0.12 0.59063 NA -0.001 0.92941 NA -0.63 0.24337 NA 
96 APOC2p5018/rs78403558 3'flanking  5 DD/WD/WW 0.03521 0 0.9939 0.94641 -0.02 0.21115 0.23866 0.36 0.77793 0.40777 
96 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.30672 0.11 0.61363 NA -0-0.00101 0.21601 NA -0.42 0.44209 NA 
96 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.25869 -0.12 0.59063 NA 0 0.92941 NA -0.63 0.24337 NA 
96 APOC2p5491 3'flanking  6 CC/TC 0.00066 6.53 0.0762 NA -0.04 0.77499 NA -5.71 0.53224 NA 
97 APOC2p5310/rs7258345 3'flanking  No Data GG/GT/TT 0.30672 0.11 0.61363 0.8772 -0.01 0.21601 0.14049 -0.42 0.44209 0.40161 
97 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.25869 -0.12 0.59063 NA -0.001 0.92941 NA -0.63 0.24337 NA 
97 APOC2p5491 3'flanking  6 CC/TC 0.00066 6.53 0.0762 NA -0.04 0.77499 NA -5.71 0.53224 NA 
97 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.00826 0.05 0.96332 NA 0.09 0.02969 NA 0.1 0.96886 NA 
98 APOC2p5398/rs12709889 3'flanking  6 AA/GA/GG 0.25869 -0.12 0.59063 0.65752 -0.001 0.92941 0.23309 -0.63 0.24337 0.71321 
98 APOC2p5491 3'flanking  6 CC/TC 0.00066 6.53 0.0762 NA -0.04 0.77499 NA -5.71 0.53224 NA 
98 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.00826 0.05 0.96332 NA 0.09 0.02969 NA 0.1 0.96886 NA 
98 APOC2p5562 3'flanking  No Data CG/GG 0.01754 -0.67 0.37221 NA -0.01 0.61087 NA 0.65 0.73492 NA 
99 APOC2p5491 3'flanking  6 CC/TC 0.00066 6.53 0.0762 0.37011 -0.04 0.77499 0.19328 -5.71 0.53224 0.61336 
99 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.00826 0.05 0.96332 NA 0.09 0.02969 NA 0.1 0.96886 NA 
99 APOC2p5562 3'flanking  No Data CG/GG 0.01754 -0.67 0.37221 NA -0.01 0.61087 NA 0.65 0.73492 NA 
99 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.10014 0.47 0.13813 NA -0.01 0.48499 NA 1 0.20571 NA 
100 APOC2p5512/rs12721064 3'flanking  6 CC/CT 0.00826 0.05 0.96332 0.49943 0.09 0.02969 0.18213 0.1 0.96886 0.54365 
100 APOC2p5562 3'flanking  No Data CG/GG 0.01754 -0.67 0.37221 NA -0.01 0.61087 NA 0.65 0.73492 NA 
100 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.10014 0.47 0.13813 NA -0.01 0.48499 NA 1 0.20571 NA 
100 APOC2p5771 3'flanking 6 WD/WW 0.0047 -0.58 0.67563 NA 0.03 0.55408 NA -1.1 0.74972 NA 
101 APOC2p5562 3'flanking  No Data CG/GG 0.01754 -0.67 0.37221 0.62837 -0.01 0.61087 0.54062 0.65 0.73492 0.69283 
101 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.10014 0.47 0.13813 NA -0.01 0.48499 NA 1 0.20571 NA 
101 APOC2p5771 3'flanking 6 WD/WW 0.0047 -0.58 0.67563 NA 0.03 0.55408 NA -1.1 0.74972 NA 
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101 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.31642 0.03 0.8759 NA -0.01 0.20297 NA -0.43 0.41044 NA 
102 APOC2p5586/rs73558127 3'flanking  No Data GG/GT/TT 0.10014 0.47 0.13813 0.64497 -0.01 0.48499 0.49479 1 0.20571 0.70402 
102 APOC2p5771 3'flanking 6 WD/WW 0.0047 -0.58 0.67563 NA 0.03 0.55408 NA -1.1 0.74972 NA 
102 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.31642 0.03 0.8759 NA -0.01 0.20297 NA -0.43 0.41044 NA 
102 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.07843 -0.01 0.98595 NA 0.02 0.25815 NA 0.05 0.95405 NA 
103 APOC2p5771 3'flanking 6 WD/WW 0.0047 -0.58 0.67563 0.98058 0.03 0.55408 0.45755 -1.1 0.74972 0.80829 
103 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.31642 0.03 0.8759 NA -0.01 0.20297 NA -0.43 0.41044 NA 
103 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.07843 -0.01 0.98595 NA 0.02 0.25815 NA 0.05 0.95405 NA 
103 APOC2p5965 3'flanking  5 GA/GG 0.00132 2.75 0.29064 NA -0.01 0.95121 NA -2.79 0.66578 NA 
104 APOC2p5815/rs10423208 3'flanking  5 AA/GA/GG 0.31642 0.03 0.8759 0.77402 -0.01 0.20297 0.46584 -0.43 0.41044 0.57874 
104 APOC2p5922/rs10422888 3'flanking  5 AA/AG/GG 0.07843 -0.01 0.98595 NA 0.02 0.25815 NA 0.05 0.95405 NA 
104 APOC2p5965 3'flanking  5 GA/GG 0.00132 2.75 0.29064 NA -0.01 0.95121 NA -2.79 0.66578 NA 
104 APOC2p6334 3'flanking  No Data GA/GG 0.00959 0.6 0.52729 NA 0.01 0.68863 NA -2.3 0.33277 NA 
wind: 4-SNPs haplotype window; w.snps: SNPs that were included in each window; p-value: single-locus p-value; hap-P: haplotype global p-












Table 41. Haplotype-based association summary of significant windows with LDL-C in African Blacks 
LDL-C 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.2 1 C A C T 0.36494 0.53 0.20 2.65 0.00815 
Geno.6 1 T A C A 0.06140 -0.36 0.40 -0.91 0.36339 
Geno.rare 1 * * * * 0.00666 -0.25 1.29 -0.20 0.84412 
haplo.base 1 C A C A 0.56700 NA NA NA NA 
Geno.4 2 A C T G 0.36464 0.59 0.19 3.01 0.00266 
Geno.rare1 2 * * * * 0.00731 -0.40 1.33 -0.30 0.76355 
haplo.base1 2 A C A G 0.62805 NA NA NA NA 
Geno.61 3 C T G T 0.36310 0.54 0.20 2.79 0.00547 
Geno.rare2 3 * * * * 0.01303 -1.01 0.92 -1.10 0.27269 
haplo.base2 3 C A G T 0.62387 NA NA NA NA 
Geno.3 4 A G T T 0.04221 0.50 0.50 1.01 0.31120 
Geno.62 4 T G T G 0.15663 0.43 0.28 1.54 0.12379 
Geno.7 4 T G T T 0.21424 0.67 0.23 2.88 0.00406 
Geno.rare3 4 * * * * 0.00716 -2.53 1.26 -2.01 0.04529 
haplo.base3 4 A G T G 0.57976 NA NA NA NA 
Geno.5 5 G T G T 0.04142 0.24 0.46 0.53 0.59901 
Geno.63 5 G T T C 0.25707 0.58 0.21 2.76 0.00592 
Geno.rare4 5 * * * * 0.00715 -2.71 1.27 -2.13 0.03354 
haplo.base4 5 G T G C 0.69436 NA NA NA NA 
Geno.51 6 T G T G 0.04209 0.19 0.46 0.41 0.67890 
Geno.64 6 T T C C 0.09836 0.65 0.32 2.00 0.04579 
Geno.71 6 T T C G 0.15818 0.53 0.26 2.01 0.04437 
Geno.rare5 6 * * * * 0.01387 -1.83 0.89 -2.05 0.04074 
haplo.base5 6 T G C G 0.68751 NA NA NA NA 
Geno.25 11 A A G G 0.05634 -0.19 0.41 -0.47 0.64066 
Geno.54 11 C A G A 0.01593 -2.06 0.79 -2.59 0.00971 
Geno.rare10 11 * * * * 0.01631 -0.93 0.77 -1.21 0.22486 
haplo.base10 11 C A G G 0.91142 NA NA NA NA 
Geno.32 12 A G A G 0.01681 -2.00 0.75 -2.69 0.00738 
Geno.43 12 A G G A 0.38633 0.09 0.20 0.42 0.67194 
Geno.rare11 12 * * * * 0.01549 -0.81 0.74 -1.09 0.27669 
haplo.base11 12 A G G G 0.58137 NA NA NA NA 
Geno.33 13 G A G C 0.01681 -1.98 0.75 -2.66 0.00802 
Geno.44 13 G G A C 0.38655 0.10 0.20 0.49 0.62637 
Geno.rare12 13 * * * * 0.01405 -0.44 0.82 -0.54 0.59146 
haplo.base12 13 G G G C 0.58259 NA NA NA NA 
Geno.26 14 A G C T 0.01682 -2.12 0.74 -2.84 0.00462 
Geno.55 14 G G C C 0.26690 0.23 0.23 0.98 0.32691 
Geno.66 14 G G C T 0.32732 -0.43 0.23 -1.85 0.06475 
Geno.rare13 14 * * * * 0.00712 -0.43 1.17 -0.37 0.71146 
haplo.base13 14 G A C T 0.38185 NA NA NA NA 
Geno.34 15 G C C C 0.26692 0.22 0.23 0.94 0.34618 
Geno.56 15 G C T C 0.32485 -0.41 0.23 -1.78 0.07500 
Geno.67 15 G C T T 0.01952 -2.28 0.68 -3.37 0.00080 
Geno.rare14 15 * * * * 0.00712 -0.45 1.17 -0.38 0.70263 
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haplo.base14 15 A C T C 0.38160 NA NA NA NA 
Geno.11 16 C C C G 0.26743 0.22 0.21 1.04 0.29819 
Geno.35 16 C T C A 0.05813 -2.05 0.40 -5.08 4.65E-07 
Geno.57 16 C T T G 0.01984 -2.47 0.67 -3.69 0.00024 
Geno.rare1. 5 16 * * * * 0.00601 -0.43 1.24 -0.35 0.72988 
haplo.base15 16 C T C G 0.64859 NA NA NA NA 
Geno.12 17 C C G G 0.26686 0.19 0.21 0.92 0.35766 
Geno.45 17 T C A G 0.05813 -2.06 0.40 -5.11 4.14E-07 
Geno.68 17 T T G G 0.01983 -2.47 0.67 -3.69 0.00024 
haplo.base16 17 T C G G 0.65451 NA NA NA NA 
Geno.13 18 C A G C 0.05810 -2.14 0.40 -5.39 9.62E-08 
Geno.69 18 T G G C 0.01979 -2.51 0.67 -3.78 0.00017 
Geno.rare16 18 * * * * 0.00589 -1.35 1.28 -1.06 0.28994 
haplo.base17 18 C G2 G C 0.91623 NA NA NA NA 
Geno.27 19 A G C T 0.05817 -2.04 0.40 -5.09 4.44E-07 
Geno.36 19 G G C G 0.02629 -0.16 0.56 -0.28 0.77761 
Geno.rare17 19 * * * * 0.00589 -1.25 1.37 -0.91 0.36338 
haplo.base18 19 G G C T 0.90966 NA NA NA NA 
Geno.16 24 A I C C 0.13261 -0.32 0.30 -1.08 0.28098 
Geno.38 24 A W C C 0.16401 0.27 0.31 0.90 0.36953 
Geno.59 24 G I C C 0.13751 -0.61 0.32 -1.89 0.05977 
Geno.82 24 G W C T 0.02495 1.66 0.70 2.39 0.01713 
Geno.rare22 24 * * * * 0.00746 -2.54 1.33 -1.91 0.05649 
haplo.base23 24 G W C C 0.53345 NA NA NA NA 
Geno.17 25 I C C G 0.27035 -0.49 0.22 -2.27 0.02351 
Geno.39 25 W C C A 0.06631 0.40 0.41 0.99 0.32384 
Geno.611 25 W C T G 0.02898 0.34 0.57 0.60 0.54773 
Geno.rare23 25 * * * * 0.00335 2.08 1.98 1.05 0.29342 
haplo.base24 25 W C C G 0.63100 NA NA NA NA 
Geno.113 35 G D A G 0.21977 0.27 0.23 1.14 0.25378 
Geno.315 35 G W A A 0.06231 0.78 0.41 1.88 0.06102 
Geno.514 35 G W G A 0.03311 -1.36 0.60 -2.28 0.02300 
Geno.615 35 G W G G 0.02413 -0.23 0.68 -0.34 0.73547 
Geno.78 35 T W G A 0.08798 -0.44 0.34 -1.30 0.19301 
haplo.base34 35 G W A G 0.57271 NA NA NA NA 
Geno.215 36 D A G G 0.21908 0.29 0.23 1.23 0.21764 
Geno.414 36 W A A C 0.06120 0.85 0.42 2.01 0.04461 
Geno.616 36 W A G G 0.05080 0.30 0.42 0.69 0.48774 
Geno.79 36 W G A C 0.12309 -0.69 0.31 -2.24 0.02534 
Geno.9 36 W G G C 0.02412 -0.13 0.71 -0.18 0.85506 
haplo.base35 36 W A G C 0.52097 NA NA NA NA 
Geno.114 37 A A C G 0.06082 0.86 0.42 2.03 0.04284 
Geno.515 37 A G G G 0.26924 0.34 0.22 1.54 0.12471 
Geno.710 37 G A C G 0.12049 -0.69 0.31 -2.23 0.02617 
Geno.91 37 G G C G 0.02338 -0.03 0.71 -0.04 0.96558 
Geno.rare31 37 * * * * 0.00738 -0.48 1.17 -0.41 0.68376 
haplo.base36 37 A G C G 0.51869 NA NA NA NA 
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Geno.96 75 G C A G 0.02667 -1.52 0.64 -2.35 0.01879 
Geno.105 75 G C G C 0.24608 0.40 0.23 1.79 0.07334 
Geno.rare67 75 * * * * 0.02585 0.31 0.67 0.45 0.64964 
haplo.base74 75 G C G G 0.70140 NA NA NA NA 
Geno.428 76 C A G G 0.02498 -1.46 0.67 -2.18 0.02972 
Geno.534 76 C G C A 0.09245 0.67 0.35 1.93 0.05382 
Geno.633 76 C G C G 0.15584 0.22 0.28 0.80 0.42320 
Geno.124 76 T G G G 0.01110 -0.39 0.98 -0.40 0.69145 
Geno.rare68 76 * * * * 0.01745 0.98 0.87 1.13 0.25729 
haplo.base75 76 C G G G 0.69817 NA NA NA NA 
Geno.120 78 C A G C 0.10388 0.56 0.34 1.67 0.09628 
Geno.229 78 C G A C 0.05838 -0.17 0.49 -0.35 0.72687 
Geno.430 78 C G G C 0.09877 0.30 0.41 0.75 0.45603 
Geno.720 78 G G A C 0.28994 -0.47 0.26 -1.84 0.06630 
Geno.818 78 G G A G 0.01323 0.91 0.85 1.07 0.28551 
Geno.rare70 78 * * * * 0.00422 1.74 1.62 1.07 0.28505 
haplo.base77 78 G G G C 0.43159 NA NA NA NA 
Geno.330 79 A G C A 0.10305 0.57 0.35 1.64 0.10223 
Geno.634 79 G A C A 0.33439 -0.47 0.24 -1.99 0.04692 
Geno.721 79 G A C G 0.01326 -0.83 1.00 -0.83 0.40439 
Geno.819 79 G A G A 0.01314 0.85 0.85 1.00 0.31762 
Geno.106 79 G G C G 0.11232 0.01 0.35 0.04 0.96931 
Geno.rare71 79 * * * * 0.00495 0.83 1.78 0.47 0.64025 
haplo.base78 79 G G C A 0.41889 NA NA NA NA 
Geno.126 80 A C A G 0.01486 0.26 0.86 0.31 0.75976 
Geno.230 80 A C A T 0.31966 -0.62 0.22 -2.76 0.00593 
Geno.331 80 A C G T 0.01588 -0.92 0.91 -1.01 0.31257 
Geno.535 80 A G A T 0.01202 1.12 0.90 1.24 0.21690 
Geno.98 80 G C G T 0.10905 0.02 0.34 0.07 0.94184 
Geno.rare72 80 * * * * 0.00261 -4.64 2.06 -2.25 0.02474 
haplo.base79 80 G C A T 0.52593 NA NA NA NA 
Geno.130 84 A C G C 0.30079 -0.07 0.23 -0.28 0.78159 
Geno.537 84 A G T C 0.13216 0.52 0.31 1.69 0.09062 
Geno.638 84 A G T T 0.03586 -0.01 0.52 -0.02 0.98253 
Geno.820 84 T C T C 0.18380 0.65 0.27 2.41 0.01630 
haplo.base83 84 A C T C 0.34740 NA NA NA NA 
Geno.436 95 W C W T 0.30785 0.31 0.24 1.27 0.20455 
Geno.543 95 W T D G 0.03499 0.77 0.52 1.48 0.13834 
Geno.640 95 W T W G 0.24705 -0.30 0.25 -1.18 0.23870 
Geno.rare80 95 * * * * 0.00896 -1.53 1.02 -1.50 0.13373 
haplo.base94 95 W C W G 0.40115 NA NA NA NA 
Geno.234 96 C W G A 0.25779 -0.22 0.26 -0.86 0.39099 
Geno.334 96 C W G G 0.13634 -0.73 0.33 -2.24 0.02561 
Geno.641 96 T D G G 0.03499 0.38 0.53 0.72 0.47241 
Geno.823 96 T W G G 0.25475 -0.70 0.26 -2.69 0.00733 
Geno.rare81 96 * * * * 0.00332 -0.67 1.63 -0.41 0.68042 
haplo.base95 96 C W T G 0.31282 NA NA NA NA 
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Geno.139 97 D G G C 0.03491 1.05 0.52 2.01 0.04463 
Geno.335 97 W G A C 0.25752 0.46 0.24 1.88 0.06011 
Geno.824 97 W T G C 0.30988 0.62 0.24 2.57 0.01042 
haplo.base96 97 W G G C 0.39702 NA NA NA NA 
Geno.143 102 C T A A 0.01626 -0.21 0.78 -0.27 0.78644 
Geno.338 102 G G A A 0.10007 -0.30 0.33 -0.91 0.36180 
Geno.545 102 G T A G 0.07827 1.11 0.38 2.95 0.00323 
Geno.643 102 G T G A 0.31767 0.49 0.22 2.23 0.02630 
haplo.base101 102 G T A A 0.48750 NA NA NA NA 
Geno.144 103 G A A G 0.10014 -0.27 0.33 -0.84 0.40117 
Geno.728 103 T A G G 0.07769 1.15 0.37 3.08 0.00218 
Geno.826 103 T G A G 0.31685 0.52 0.22 2.41 0.01626 
Geno.rare86 103 * * * * 0.00134 3.22 0.00 3.0E+16 <10E-06 
haplo.base102 103 T A A G 0.50398 NA NA NA NA 
Geno.644 104 A G G G 0.07743 1.23 0.37 3.33 0.00090 
Geno.827 104 G A G G 0.31638 0.60 0.21 2.86 0.00430 
Geno.rare87 104 * * * * 0.01120 2.19 0.95 2.30 0.02184 
haplo.base103 104 A A G G 0.59500 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
 
Table 42. Haplotype-based association summary of significant windows with TC in African Blacks 
TC 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.4 2 A C T G 0.3624 0.245 0.103 2.378 0.01764 
Geno.rare1 2 * * * * 0.0080 -0.262 0.588 -0.445 0.65610 
haplo.base1 2 A C A G 0.6295 NA NA NA NA 
Geno.41 3 C T G T 0.3619 0.230 0.103 2.231 0.02597 
Geno.rare2 3 * * * * 0.0139 -0.423 0.447 -0.946 0.34462 
haplo.base2 3 C A G T 0.6242 NA NA NA NA 
Geno.3 4 A G T T 0.0424 0.005 0.258 0.021 0.98317 
Geno.61 4 T G T G 0.1554 0.168 0.146 1.148 0.25134 
Geno.7 4 T G T T 0.2141 0.284 0.123 2.304 0.02149 
Geno.rare3 4 * * * * 0.0079 -1.334 0.614 -2.174 0.03002 
haplo.base3 4 A G T G 0.5802 NA NA NA NA 
Geno.5 5 G T G T 0.0412 0.219 0.243 0.900 0.36837 
Geno.62 5 G T T C 0.2571 0.216 0.112 1.937 0.05312 
Geno.rare4 5 * * * * 0.0079 -1.387 0.618 -2.245 0.02508 
haplo.base4 5 G T G C 0.6938 NA NA NA NA 
Geno.34 15 G C C C 0.2678 0.061 0.124 0.491 0.62327 
Geno.46 15 G C T C 0.3236 -0.190 0.122 -1.555 0.12041 
Geno.55 15 G C T T 0.0205 -0.907 0.351 -2.584 0.00995 
Geno.rare13 15 * * * * 0.0079 -0.096 0.589 -0.164 0.87005 
haplo.base14 15 A C T C 0.3802 NA NA NA NA 
Geno.11 16 C C C G 0.2674 0.072 0.112 0.637 0.52426 
Geno.35 16 C T C A 0.0586 -0.825 0.212 -3.888 0.00011 
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Geno.56 16 C T T G 0.0207 -0.960 0.347 -2.771 0.00573 
Geno.rare14 16 * * * * 0.0068 -0.131 0.617 -0.212 0.83225 
haplo.base15 16 C T C G 0.6466 NA NA NA NA 
Geno.12 17 C C G G 0.2677 0.059 0.112 0.525 0.59942 
Geno.47 17 T C A G 0.0588 -0.828 0.212 -3.908 0.00010 
Geno.66 17 T T G G 0.0207 -0.962 0.346 -2.777 0.00562 
haplo.base16 17 T C G G 0.6521 NA NA NA NA 
Geno.13 18 C A G C 0.0588 -0.851 0.209 -4.080 0.00005 
Geno.67 18 T G G C 0.0206 -0.967 0.345 -2.806 0.00515 
Geno.rare15 18 * * * * 0.0060 -0.404 0.679 -0.594 0.55242 
haplo.base17 18 C G G C 0.9147 NA NA NA NA 
Geno.27 19 A G C T 0.0588 -0.812 0.209 -3.880 0.00011 
Geno.36 19 G G C G 0.0252 -0.049 0.313 -0.157 0.87518 
Geno.rare16 19 * * * * 0.0060 -0.360 0.724 -0.498 0.61882 
haplo.base18 19 G G C T 0.9100 NA NA NA NA 
Geno.95 75 G C A G 0.0258 -0.776 0.337 -2.303 0.02153 
Geno.105 75 G C G C 0.2451 0.231 0.119 1.935 0.05331 
Geno.rare65 75 * * * * 0.0251 0.251 0.360 0.697 0.48596 
haplo.base74 75 G C G G 0.7040 NA NA NA NA 
Geno.431 76 C A G G 0.0241 -0.725 0.350 -2.070 0.03884 
Geno.534 76 C G C A 0.0938 0.365 0.182 2.007 0.04514 
Geno.629 76 C G C G 0.1538 0.136 0.147 0.921 0.35750 
Geno.125 76 T G G G 0.0101 -0.048 0.561 -0.086 0.93140 
Geno.rare66 76 * * * * 0.0177 0.500 0.468 1.068 0.28583 
haplo.base75 76 C G G G 0.7005 NA NA NA NA 
Geno.145 102 C T A A 0.0180 -0.118 0.390 -0.303 0.76200 
Geno.337 102 G G A A 0.1005 -0.099 0.174 -0.572 0.56761 
Geno.545 102 G T A G 0.0805 0.540 0.196 2.751 0.00608 
Geno.639 102 G T G A 0.3143 0.218 0.117 1.872 0.06166 
haplo.base101 102 G T A A 0.4867 NA NA NA NA 
Geno.146 103 G A A G 0.1005 -0.080 0.173 -0.466 0.64169 
Geno.731 103 T A G G 0.0797 0.571 0.197 2.902 0.00382 
Geno.825 103 T G A G 0.3135 0.240 0.115 2.080 0.03791 
Geno.rare85 103 * * * * 0.0014 1.801 NA NA NA 
haplo.base102 103 T A A G 0.5050 NA NA NA NA 
Geno.640 104 A G G G 0.0793 0.596 0.192 3.103 0.00199 
Geno.826 104 G A G G 0.3130 0.266 0.111 2.410 0.01617 
Geno.rare86 104 * * * * 0.0113 1.160 0.502 2.310 0.02114 
haplo.base103 104 A A G G 0.5963 NA NA NA NA 






 Table 43. Haplotype-based association summary of significant windows with ApoB in African Blacks 
ApoB 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.12 17 C C G G 0.2652 -0.30 0.60 -0.50 0.61601 
Geno.47 17 T C A G 0.0593 -2.59 1.13 -2.29 0.02206 
Geno.67 17 T T G G 0.0198 -3.83 1.90 -2.01 0.04480 
haplo.base16 17 T C G G 0.6551 NA NA NA NA 
Geno.13 18 C A G C 0.0592 -2.51 1.11 -2.25 0.02478 
Geno.56 18 T G G C 0.0198 -3.80 1.91 -1.99 0.04669 
Geno.rare16 18 * * * * 0.0052 -0.89 3.90 -0.23 0.81963 
haplo.base17 18 C G G C 0.9158 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
 
Table 44. Haplotype-based association summary of significant windows with TG in African Blacks 
TG 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.2 1 C A C T 0.36137 0.003 0.008 0.424 0.67171 
Geno.6 1 T A C A 0.06186 0.039 0.015 2.641 0.00843 
Geno.rare 1 * * * * 0.00668 0.060 0.045 1.313 0.18941 
haplo.base 1 C A C A 0.57009 NA NA NA NA 
Geno.419 46 C T G T 0.03746 0.061 0.018 3.375 0.00078 
Geno.516 46 C T T G 0.04651 -0.009 0.017 -0.556 0.57807 
Geno.rare40 46 * * * * 0.00470 0.060 0.056 1.084 0.27891 
haplo.base45 46 C T G G 0.91133 NA NA NA NA 
Geno.517 47 T G T T 0.03746 0.061 0.018 3.388 0.00074 
Geno.622 47 T T G T 0.04651 -0.009 0.017 -0.537 0.59118 
Geno.rare41 47 * * * * 0.00337 0.131 0.068 1.933 0.05362 
haplo.base46 47 T G G T 0.91266 NA NA NA NA 
Geno.420 48 G T T T 0.03808 0.063 0.018 3.506 0.00048 
Geno.518 48 T G T T 0.04650 -0.009 0.017 -0.543 0.58745 
Geno.rare42 48 * * * * 0.00205 0.159 0.096 1.653 0.09882 
haplo.base47 48 G G T T 0.91336 NA NA NA NA 
Geno.317 49 G T T A 0.01264 -0.003 0.032 -0.104 0.91684 
Geno.519 49 T T T G 0.03809 0.063 0.018 3.527 0.00044 
Geno.rare43 49 * * * * 0.00205 0.160 0.096 1.662 0.09696 
haplo.base48 49 G T T G 0.94723 NA NA NA NA 
Geno.332 79 A G C A 0.10358 -0.009 0.013 -0.683 0.49486 
Geno.632 79 G A C A 0.33332 0.006 0.009 0.621 0.53458 
Geno.721 79 G A C G 0.01407 0.079 0.037 2.124 0.03400 
Geno.818 79 G A G A 0.01382 -0.071 0.031 -2.310 0.02116 
Geno.106 79 G G C G 0.11102 -0.034 0.013 -2.540 0.01129 
Geno.rare69 79 * * * * 0.00482 0.031 0.077 0.404 0.68667 
haplo.base78 79 G G C A 0.41936 NA NA NA NA 
Geno.125 80 A C A G 0.01492 -0.004 0.032 -0.140 0.88873 
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Geno.228 80 A C A T 0.31847 0.007 0.009 0.804 0.42170 
Geno.333 80 A C G T 0.01670 0.078 0.035 2.234 0.02579 
Geno.535 80 A G A T 0.01293 -0.073 0.032 -2.308 0.02126 
Geno.98 80 G C G T 0.10829 -0.033 0.013 -2.493 0.01287 
Geno.rare70 80 * * * * 0.00188 -0.082 0.127 -0.647 0.51751 
haplo.base79 80 G C A T 0.52681 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
Table 45. Haplotype-based association summary of significant windows with HDL-C in African Blacks 
HDL-C 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.87 40 G A G C 0.2123 0.770 0.328 2.349 0.0191 
Geno.94 40 G A G G 0.1305 0.258 0.383 0.674 0.5005 
Geno.114 40 G G C G 0.2259 0.592 0.326 1.815 0.0699 
Geno.121 40 G G G C 0.0751 0.330 0.522 0.633 0.5269 
Geno.131 40 G G G G 0.0602 0.414 0.581 0.712 0.4770 
Geno.rare33 40 * * * * 0.0188 0.176 0.801 0.220 0.8263 
haplo.base39 40 G A C G 0.2772 NA NA NA NA 
Geno.419 41 A C G G 0.0261 1.084 0.801 1.353 0.1766 
Geno.514 41 A G C C 0.1872 1.067 0.318 3.350 0.0008 
Geno.616 41 A G C G 0.0245 -1.566 0.849 -1.844 0.0655 
Geno.714 41 A G G C 0.0937 -0.049 0.401 -0.123 0.9023 
Geno.88 41 A G G G 0.0374 2.071 0.594 3.488 0.0005 
Geno.102 41 G C G C 0.1867 0.501 0.343 1.461 0.1444 
Geno.115 41 G C G G 0.0382 1.672 0.682 2.450 0.0145 
Geno.122 41 G G C C 0.0565 0.759 0.552 1.374 0.1699 
Geno.132 41 G G C G 0.0184 0.842 1.129 0.746 0.4562 
Geno.141 41 G G G C 0.0506 0.645 0.527 1.223 0.2215 
Geno.151 41 G G G G 0.0103 -3.702 1.653 -2.239 0.0254 
Geno.rare34 41 * * * * 0.0118 -1.657 0.978 -1.694 0.0906 
haplo.base40 41 A C G C 0.2583 NA NA NA NA 
Geno.116 42 C C C G 0.0109 -2.013 1.026 -1.963 0.0501 
Geno.315 42 C G C A 0.0197 -1.155 0.813 -1.421 0.1557 
Geno.617 42 C G G G 0.0576 1.377 0.525 2.622 0.0089 
Geno.715 42 G C C A 0.0111 1.192 1.246 0.957 0.3390 
Geno.89 42 G C C G 0.2355 0.764 0.246 3.109 0.0020 
Geno.103 42 G C G G 0.0411 -1.408 0.571 -2.467 0.0139 
Geno.123 42 G G C G 0.1371 -0.131 0.319 -0.412 0.6802 
Geno.142 42 G G G G 0.0460 1.089 0.591 1.843 0.0658 
Geno.rare35 42 * * * * 0.0164 -0.707 1.091 -0.648 0.5170 
haplo.base41 42 C G C G 0.4248 NA NA NA NA 
Geno.117 43 C C A C 0.0123 1.011 1.122 0.901 0.3677 
Geno.218 43 C C G C 0.2435 0.671 0.225 2.978 0.0030 
Geno.515 43 C G G C 0.0404 -1.407 0.573 -2.455 0.0143 
Geno.618 43 G C A C 0.0250 -1.129 0.642 -1.759 0.0789 
Geno.104 43 G G G C 0.1041 1.252 0.340 3.678 0.0003 
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Geno.rare36 43 * * * * 0.0126 -0.046 1.002 -0.046 0.9637 
haplo.base42 43 G C G C 0.5620 NA NA NA NA 
hap.freq: haplotype frequency; coef: coefficient; se: standard errors; t.stat: test statistic; p-val: haplotyep p-value. 
Table 46. Haplotype-based association summary of significant windows with ApoA1 in African Blacks 
ApoA1 
 Window loc.1 loc.2 loc.3 loc.4 hap.freq coef se t.stat pval 
Geno.11 16 C C C G 0.2641 -0.69 0.53 -1.30 0.19546 
Geno.35 16 C T C A 0.0601 3.63 0.98 3.69 0.00024 
Geno.56 16 C T T G 0.0205 -0.56 1.65 -0.34 0.73524 
Geno.rare15 16 * * * * 0.0067 3.80 2.88 1.32 0.18695 
haplo.base15 16 C T C G 0.6486 NA NA NA NA 
Geno.12 17 C C G G 0.2645 -0.75 0.53 -1.41 0.16024 
Geno.47 17 T C A G 0.0600 3.60 0.98 3.66 0.00027 
Geno.66 17 T T G G 0.0205 -0.63 1.65 -0.38 0.70465 
haplo.base16 17 T C G G 0.6543 NA NA NA NA 
Geno.13 18 C A G C 0.0600 3.87 0.97 3.98 0.00008 
Geno.57 18 T G G C 0.0205 -0.29 1.65 -0.18 0.85797 
Geno.rare16 18 * * * * 0.0052 3.55 3.42 1.04 0.29928 
haplo.base17 18 C G G C 0.9143 NA NA NA NA 
Geno.27 19 A G C T 0.0600 3.89 0.97 4.01 0.00007 
Geno.36 19 G G C G 0.0270 0.20 1.39 0.14 0.88674 
Geno.rare17 19 * * * * 0.0052 3.57 3.64 0.98 0.32651 
haplo.base18 19 G G C T 0.9078 NA NA NA NA 
Geno.418 41 A C G G 0.0289 3.56 2.18 1.64 0.10196 
Geno.516 41 A G C C 0.1977 2.48 0.78 3.17 0.00160 
Geno.616 41 A G C G 0.0226 -1.02 2.11 -0.48 0.62939 
Geno.712 41 A G G C 0.0964 -0.07 1.08 -0.06 0.94838 
Geno.89 41 A G G G 0.0351 2.90 1.70 1.71 0.08848 
Geno.102 41 G C G C 0.1882 0.34 0.92 0.37 0.71262 
Geno.116 41 G C G G 0.0350 1.79 1.85 0.97 0.33243 
Geno.122 41 G G C C 0.0562 -1.20 1.32 -0.91 0.36309 
Geno.132 41 G G C G 0.0203 1.27 2.58 0.49 0.62174 
Geno.141 41 G G G C 0.0483 2.02 1.46 1.38 0.16697 
Geno.151 41 G G G G 0.0105 -4.83 4.01 -1.20 0.22894 
Geno.rare35 41 * * * * 0.0111 -3.08 2.43 -1.27 0.20511 
haplo.base40 41 A C G C 0.2496 NA NA NA NA 
Geno.118 43 C C A C 0.0119 5.27 2.82 1.87 0.06164 
Geno.217 43 C C G C 0.2512 1.08 0.56 1.92 0.05535 
Geno.517 43 C G G C 0.0410 -0.97 1.42 -0.68 0.49511 
Geno.618 43 G C A C 0.0244 -3.38 1.61 -2.10 0.03593 
Geno.104 43 G G G C 0.1001 1.85 0.89 2.08 0.03812 
Geno.rare37 43 * * * * 0.0131 2.12 2.64 0.80 0.42278 
haplo.base42 43 G C G C 0.5583 NA NA NA NA 
Geno.119 54 I G G C 0.0337 2.50 1.36 1.84 0.06673 
 213 
 Cont. Table 46 
Geno.319 54 W G A C 0.0138 -2.46 2.00 -1.23 0.21953 
Geno.526 54 W G G T 0.0964 -1.33 0.80 -1.66 0.09749 
Geno.623 54 W T G C 0.0138 2.85 2.01 1.42 0.15609 
haplo.base53 54 W G G C 0.8423 NA NA NA NA 
Geno.321 63 G A C G 0.1338 -1.15 0.71 -1.62 0.10520 
Geno.717 63 G G T G 0.2364 0.73 0.57 1.28 0.20162 
Geno.rare53 63 * * * * 0.0075 4.40 3.12 1.41 0.15918 
haplo.base62 63 G G C G 0.6223 NA NA NA NA 
Geno.225 71 A G A A 0.0916 0.18 0.83 0.22 0.82698 
Geno.326 71 A G A T 0.0174 5.81 1.74 3.34 0.00088 
Geno.rare61 71 * * * * 0.0095 -2.37 2.69 -0.88 0.37862 
haplo.base70 71 A G G A 0.8815 NA NA NA NA 
Geno.226 72 G A A A 0.0142 2.53 2.03 1.25 0.21301 
Geno.327 72 G A A G 0.0777 -0.21 0.88 -0.24 0.81144 
Geno.430 72 G A T G 0.0174 5.91 1.74 3.40 0.00071 
Geno.rare62 72 * * * * 0.0037 3.97 4.41 0.90 0.36868 
haplo.base71 72 G G A G 0.8869 NA NA NA NA 
Geno.227 73 A A A T 0.0133 3.16 2.05 1.54 0.12390 
Geno.328 73 A A G C 0.0775 -0.33 0.88 -0.38 0.70749 
Geno.533 73 A T G C 0.0174 5.93 1.74 3.41 0.00068 
Geno.rare63 73 * * * * 0.0042 5.37 4.50 1.19 0.23390 
haplo.base72 73 G A G C 0.8876 NA NA NA NA 
Geno.431 74 A A T G 0.0130 2.87 2.11 1.36 0.17354 
Geno.534 74 A G C A 0.0337 0.18 1.34 0.14 0.89176 
Geno.816 74 T G C G 0.0175 5.98 1.73 3.45 0.00060 
Geno.rare64 74 * * * * 0.0047 6.17 4.42 1.39 0.16367 
haplo.base73 74 A G C G 0.9312 NA NA NA NA 




3.6.4 Rare variants association analysis 
3.6.4.1  NHWs 
Rare variants association analyses showed significant associations with total cholesterol in 
NHWs and the association signal is more likely derived from rare variants with MAF<1% 
(Table 47). 
Table 47.  Rare variants association results with lipid traits in NHWs 
LDL-C  MAF ≤0.01 MAF ≤0.02 MAF <0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.1508 32 0.2309 41 0.1461 
HDL-C  MAF ≤0.01 MAF ≤0.02 MAF <0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.1222 32 0.1792 41 0.1206 
TC 
 MAF ≤0.01 MAF ≤0.02 MAF <0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.0088 32 0.0165 41 0.0498 
TG 
 MAF ≤0.01 MAF ≤0.02 MAF <0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.2975 32 0.3971 41 0.2951 
ApoB 
 MAF ≤0.01 MAF ≤0.02 MAF <0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.4424 32 0.5605 41 0.0574 
ApoA1 
 MAF ≤0.01 MAF ≤0.02 MAF ≤0.05 
Test N.RV P N.RV P N.RV P SKATO 31 0.1951 32 0.2628 41 0.3951 




3.6.4.2  African Blacks 
Rare variants with MAF<1% were associated with TG while less common variants with MAF 
(1-5%) were associated with apoA1 in Blacks (Table 48). 
Table 48.  Rare variants association results with lipid traits in Blacks 
SKAT-O (optimal sequencing Kernel association test), N.RV (number of rare variants), P (p-value). 
LDL-C  MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.2981 45 0.0826 61 0.2337 
HDL-C 
 MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.6361 45 0.4110 61 0.3466 
TC 
 MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.5931 45 0.3806 61 0.7164 
TG 
 MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.0302 45 0.6291 61 0.2645 
ApoB 
 MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.4289 45 0.5518 61 0.2123 
ApoA1 
 MAF (0.01) MAF (0.02) MAF (0.05) 
Test N.RV P N.RV P N.RV P SKATO 29 0.0756 45 0.0248 61 0.0213 
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4.0  DISCUSSION 
Dyslipidemia is a major risk factor for CVD, which is the leading cause of death worldwide and 
apolipoproteins are considered major determinants of plasma lipoprotein–lipid variation. 
Therefore, genetic variation in genes coding for apolipoproteins could have significant impact on 
lipid metabolism and consequently may affect the CVD risk. The opposite effects of HDL-C and 
LDL-C on CVD risk have been well established where higher levels of HDL-C are considered 
antiatherogenic and higher levels of LDL-C are proatherogenic. Since a substantial portion of 
plasma lipid levels is under genetic control (Beekman et al., 2003; Lusis et al., 2004) and genetic 
variation in apolipoprotein genes impacts variation in plasma lipids, it is important to 
comprehensively examine the role of this genetic variation in relation to plasma lipid levels in 
the general population.   
The APOE-C1-C4-C2 gene cluster, encompassing 45 kb, is located on chromosome 
19q13.32. The members of this gene cluster have arisen from the same ancestral gene family 
sharing high sequencing similarities and functional properties (Allan et al., 1995; Lauer et al., 
1988; Li et al., 1988) and they play an important role in lipid metabolism. Multiple genome-wide 
association studies (GWAS) have confirmed the contribution of this gene cluster to plasma lipid 
variation and CVD risk. Although the established contribution of the APOE gene cluster is on 
LDL-related traits, recent GWAS meta-analysis reported multiple SNPs in this gene cluster to be 
associated with TG and HDL-C (Teslovich et al., 2010). However, all identified common 
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variants together explain small portion of lipid traits heritability, implying that there could be 
additional rare variants with larger effect sizes that contribute to the remaining unexplained 
heritability (Teslovich et al., 2010; Kathiresan et al., 2009; Weisglass-Volkov and Pajukanta, 
2010). Therefore, sequencing candidate genes in selected subjects with extreme lipid traits 
increases the possibility of discovering potential functional rare variants. In this study, we have 
examined the role of both common and rare variants in relation to plasma lipoprotein-lipid 
levels.   
 We resequenced the APOE-C1-C4-C2 gene cluster along with its hepatic control regions 
(HCR-1 and HCR-2) in selected subjects with extreme HDL-C/TG distribution in order to 
examine the role of common and rare variants with plasma lipid levels in two epidemiologically 
well-characterized samples of U.S non-Hispanic Whites (NHWs) and African Blacks. In the un-
sequenced intergenic regions, we used HapMap tagSNPs to cover the entire cluster. Since recent 
GWAS data indicate that this gene cluster affect both LDL and non-LDL traits, we examined the 
association of SNPs in this gene cluster with both LDL-related (LDL-C, TC and apoB) and non-
LDL (HDL-C, TG and apoA1) traits for genotype-phenotype association analysis.  
4.1 COMPARISON OF OUR SEQUENCING RESULTS WITH PUBLICLY 
AVAILABLE DATABASES 
We compared our sequencing data to publicly available databases (SeattleSNPs and NCBI db 
SNPs databases). SeattleSNPs database sequenced these four genes (APOE = 5,491 bp, APOC1 
= 4,941 bp, APOC4 = 4,510 bp, and APOC2 = 6,438 bp) in 48 African Americans and 48 
individuals with European descent. By comparison, we sequenced these four genes (APOE = 
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5,491 bp, APOC1 = 6,687 bp, APOC4 = 5,086 bp, and APOC2 = 6,438 bp) along with their two 
hepatic control regions (HCR-1 = 820 bp, and HCR-2 = 849 bp) in 190 subjects with extreme 
HDL-C/TG levels in NHWs and African blacks.  
Sequencing the four genes and their two hepatic control regions in 190 subjects with 
extreme lipid traits revealed a total of 230 variants (215 substitutions, 15 indels), of which 63 
variants were common in both racial groups, 52 were NHW-specific and 115 were Black-
specific. While 70% (160/230) of the identified variants in the sequencing subsets have been 
reported previously in public databases (NCBI build 138), the remaining 30% (70/230) are 
novel.    
  We observed all SeattleSNPs reported variants of APOE in our study, except two 
variants at nucleotides 545/rs1081103 (MAF=0.02) and 1522/rs769447 (MAF=0.04). In APOC1, 
we observed all the reported variants in SeattleSNPs database, except two common variants 
(4180/rs3925681 [MAF=0.28] and 4824/rs12721056 [MAF=0.27]) and 3 rare variants 
(1249/rs127210471 [MAF=0.02], 4298/rs12721044 [MAF=0.02] and 5338/rs12721050 
[MAF=0.02]). In APOC4, we observed all the reported variants in SeattleSNPs database, except 
two variants (2753/rs12721106 [MAF=0.02] and 2886/rs12709883 [MAF=0.02]). In APOC2, we 
observed all the reported variants in SeattleSNPs database, except three variants 
(3289/rs12721058 [MAF=0.014), 3459/rs12721062 [MAF=0.02] and 3820/rs12709888 
[MAF=0.28]).  
We also compared our sequencing data to Chip bioinformatics database (hg19, build 131) 
and NCBI db SNPs (build 138). We observed all the reported variants in YRI (Yoruba in Ibadan, 
Nigeria) and CEU (Utah residents with Northern and Western European ancestry from the CEPH 
collection) populations, except APOC2-4852/rs5127 [MAF=0.3 in CEU and 0.17 in YRI] in 
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APOC2, which might be overlooked due to the nearby common deletion 
APOC2p4853/rs199828513. 
We observed more variation in our study as compared to the publicly available databases 
(SeattleSNPs, Chip Bioinformatics, and NCBI db SNPs), which are more likely due to: 1) our 
sequencing sample size was larger, 2) we selected individuals based on their extreme low or high 
HDL-C/TG levels, and 3) we sequenced larger genomic regions of APOC1 and APOC4 as well 
as we sequenced the two hepatic control regions. Furthermore, we used African sample 
compared to African Americans used in SeattleSNPs that have considerable white admixture and 
could explain why we did not observe rare variants in our sample that were reported in African 
Americans. The lack of observation of some reported variants in our sample could also be due to 
the use of different software tools and algorithms applied in variant analyses and/or difficulties in 
annotation of particular sequencing regions.   
4.2 ASSOCIATION WITH LIPID TRAITS  
Association of Common Variants: To our knowledge, this is the first study that has considered 
both common and rare variants for genotype-phenotype association analysis in this gene cluster. 
A total of 70 variants (65 sequencing-identified, 5 HapMap intergenic tagSNPs) in NHWs and 
108 variants (103 sequencing-identified, and 5 HapMap intergenic tagSNPs) in Blacks were 
successfully genotyped in the entire datasets of 623 NHWs and 788 African Blacks and were 
considered for the association analysis. The established association of APOE*2 (rs7412) and 
APOE*4 (rs426538) with lipid traits (Medina-Urrutia et al., 2004; Sanna et al., 2011; Lucatelli et 
al., 2011) was confirmed in our study in which APOE*2 (rs7412) allele was associated with 
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lower LDL-C, TC, and apoB in NHWs (P=1.84E-07, P=9.50E-06, and P=9.70E-13, respectively) 
and Blacks (P=5.35E-07, P=0.0001, and P=0.035, respectively). On the other hand, APOE*4 
(rs426538) allele was associated with higher LDL-C, TC, and apoB in NHWs (P=0.0103, 
P=0.038, and P=0.0005, respectively) and with higher LDL-C in Blacks (P=0.0317). Although 
APOE*4 did not show significant association with TC and apoB in Blacks, we observed similar 
trend of association as seen in NHWs.  
Gene-based association analysis of all 63 variants in NHWs and 106 variants in Blacks 
with complete phenotype data revealed significant association with LDL-C in both racial groups 
(P=0.0004 in NHWs, P=0.0011 in Blacks) and TC (P=0.0002 in NHWs, P=0.036 in Blacks).  On 
the other hand, gene-based analysis showed race-specific association for apoB (P=3.6E-05 in 
NHWs, P=0.23 in Blacks) and apoA1 (P=0.607 in NHWs, P=0.028 in Blacks).  
Single-locus association analysis of 39 common/less common variants (MAF>1%) in 
NHWs and 79 common/less common variants (MAF>1%) in African Blacks revealed nominal 
significant association (P < 0.05) with at least one lipid trait for 20 variants in NHWs and 24 
variants in Blacks. We observed 21 variants that showed association with LDL-related traits 
(LDL-C, TC, and apoB) independent of the effects of APOE*2/E*4 alleles, and two of them 
(APOE560/rs449647 and APOE832/rs405509) were present in both racial groups. The first 
variant exerts opposite effect on LDL-C and TC in the two racial groups where it was associated 
with lowering effect in NHWs and elevating effect in Blacks. The second variant was observed 
to be associated with higher apoB in NHWs and higher LDL-C in Blacks. Six significant LDL-
related traits variants showed association in NHWs only (APOE2440/rs769450, 
APOC1p5641/rs1064725, APOC4p2683/rs12721109, rs4803770, rs5112, and rs7259004) and 13 
variants showed association in Blacks only  (APOE1163/rs440446, APOC1p720/rs72654451, 
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APOC4p2623/rs5157, APOC4p4661/rs2288912, APOC2p2486/rs9304645, 
APOC2p3778/rs5120, APOC2p5815/rs10423208, APOC2p5922/rs10422888, 
APOE2269/rs6135770, APOE4036/rs769455, APOC1p5667/rs12721054, 
APOC4p4346/rs12709885, and APOC2p1540/rs75463753). Of the above-mentioned 21 LDL-
traits associated variants, only 9 variants have been examined before in relation to lipid traits, 
including APOE560/rs449647, APOE832/rs405509, APOE1163/rs440446, rs4803770, 
rs7259004, APOC1p720/rs71962921, APOC4p2683/rs12721109, APOC1p5667/rs12721054 and 
APOE4036/rs769455. Previously APOE560/rs449647 was found to be associated with lowering 
effect on LDL-C in US-whites but increasing effect on LDL-C in African Americans  (Ozturk et 
al., 2010). Interestingly, we have observed the identical opposite trend in our study on LDL-C 
and TC in the two racial groups. This variant is located in the promoter region and it could be 
functional by itself although it is unlikely to exert opposite effect in Whites and Blacks. 
Alternatively, this SNP could be in LD with a yet to be characterized functional SNP that has 
different LD pattern in Whites and Blacks.    
APOE832/rs405509 was previously found to be associated with LDL-related traits  
(LDL-C, TC, and apoB) (Klos et al., 2006; Ken-Dror et al., 2010; Chasman et al., 2009), and in 
agreement, we observed this variant to be associated with apoB in NHWs and LDL-C in Blacks. 
APOE1163/rs440446 was earlier reported to be associated with CHD risk (Silander et al., 2008) 
and our current finding of its association with apoB indirectly supports the reported association 
as elevated apoB level is a risk indicator for CHD. Recently, Ken-Dror et al. (2010) have 
reported the association of rs4803770 with LDL-C and apoB. Likewise, we found this variant to 
be associated with LDL-C and TC in NHWs. Although its association with apoB did not achieve 
the significance level, we observed similar trend of association in NHWs (β=0.56; P=0.219). One 
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additional intergenic variant, rs7259004, was previously found to be associated with LDL-C, and 
apoB in US-whites (Ken-Dror et al., 2010). In our study, this variant also showed similar 
association with LDL-C and TC and a trend of association with apoB in NHWs. Previous studies 
have shown the association of APOC1p720/rs71962921 with elevating APOC1 gene expression, 
dysbetalipoproteinemia, and higher risk of CVD and Alzheimer’s disease (Gao et al., 2002; Shi 
et al., 2004; Retz et al., 2001). Moreover, this variant was found to be associated with lower TG 
and apoB and higher HDL-C among APOE*3 carriers (Xu et al., 1999). In our study, 
APOC1p720/rs71962921 was associated with lower LDL-C and higher apoA1 in Blacks and 
with a similar trend of associations in NHWs. Although we did not observe significant 
association with apoB and HDL-C, we observed association with their corresponding lipoprotein 
and apolipoprotein, respectively. We have confirmed the previously reported association of a 
NHW-specific variant, APOC4p2683/rs12721109, with LDL-C (Jeemon et al., 2011), and apoB 
(Talmud et al., 2009) of observing significant association with LDL-C and apoB.  
In our study, a Black-specific non-synonymous variant [APOE4036/rs769455 
(Arg163Cys)] was associated with higher TG and lower LDL-C and TC. Previously the same 
variant was found to be associated with type III hyperlipoproteinemia in five Latin-American 
family members (Havel et al., 1983; Rall et al., 1989). Although APOC1p5667/rs12721054 was 
previously found to be associated with TG (Coram et al., 2013), we found its association with 
TG as well as with LDL-related traits.  
The remaining 12 LDL-traits associated variants found in this study  
(APOE2440/rs769450, APOC2p1357C4p4661/rs2288912, rs5112, APOC2p3778/rs5120, 
APOC4p2623/rs5157, APOE2269/rs6135770, APOC1p5641/rs1064725, 
APOC2p1042C4p4346/rs12709885, APOC2p1540C4p4844/rs75463753, 
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APOC2p2486/rs9304645, APOC2p5815/rs10423208, and APOC2p5922/rs10422888) have not 
been examined before in relation to lipid traits and thus our observations should be considered 
provisional until replicated in independent samples. APOE2440/rs769450 was observed to be 
associated with TG and LDL-C only in NHWs without significant effect on any other lipid traits 
in Blacks, which is more likely due to its correlation with other functional variants in this racial 
group. Its RegulomeDB score of 5 is only suggestive of affecting regulatory function. Similarly, 
APOC2p1357C4p4661/rs2288912 was found to be associated with LDL-C, TC, and apoB in 
Blacks without any effect on lipid traits in NHWs. This variant seems to be functional because of 
its location in the flanking region between APOC4 and APOC2 genes and its RegulomeDB score 
of 1a, indicating its involvement in gene regulation and gene expression. However, this seems 
counterintuitive that apparently a functional variant shows significant effect on lipid trait in one 
racial group but not in the other. Alternatively, this variant may directly be associated with CHD, 
although we do not have this data to confirm our hypothesis. Although this intergenic variant, 
rs5112, was observed in both population groups, it was associated with TC in NHWs only, which 
could be due to its different LD with a functional variant(s) in the two populations. However, this 
variant was not in LD with any variants in this gene cluster that showed association with TC.  
Similarly, APOC2p3778/rs5120 and APOC4p2623/rs5157 variants were present in both 
population groups and they showed significant association with LDL-related traits in Blacks only 
but not in the other racial group. While both of these variants were in moderate LD (r2=0.30) in 
Blacks where they showed significant associations, they were in strong LD (r2=0.93) in NHWs 
implying that the strong correlation between them lessens their significant effect in NHWs 
suggesting that their effect on LDL-related traits in Blacks is independent of each other. Another 
variant, APOE2269/rs6135770, is in complete LD with a functional variant, 
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APOE4036/rs769455, and thus its association with LDL-C and TC is not independent. 
APOC1p5641/rs1064725 located in the 3’ flanking region of APOC1 and it is not in LD with any 
other variant in this gene cluster and thus it could be functional by itself. Alternatively, its 
significant association with LDL-C, and TC in NHWs could be mediated by tagging another 
functional variant present outside of the examined genomic region in this racial group, although 
we do not have direct evidence to support this hypothesis. 
 For the remaining five Black-specific variants, APOC2p1042C4p4346/rs12709885 was 
observed to be associated with apoB, APOC2p1540C4p4844/rs75463753 with LDL-C and TC, 
and APOC2p2486/rs9304645, APOC2p5815/rs10423208, and APOC2p5922/rs10422888 with 
LDL-C. Their genomic locations in introns or flanking regions along with their RegulomeDB 
scores of 4-5 suggest their potential involvement in gene regulation process. Since they were not 
in LD with each other, their association with LDL-related traits could be independent of each 
other. 
  Although the major contribution of SNPs in the APOE gene cluster was with LDL-
related traits, we also observed multiple associations with non-LDL traits (HDL-C, apoA1, and 
TG). Two variants in NHWs (APOE1575/rs769448, and HCR2p188/rs35136575), and two 
variants in Blacks (rs439401, and APOC1p3573/rs10424339) showed significant association 
with HDL-C. Moreover, four variants showed significant association with apoA1, including two 
in NHWs (HCR2p188/rs35136575, and rs7259004), and two in Blacks 
(APOC1p720/rs71962921, and APOC4p4346/rs12709885). Six variants showed significant 
association with TG in NHWs (APOE832/rs405509, APOE1163/rs440446, 
APOE2440/rs769450, APOC1p2041/rs3826688, APOC4p2683/rs12721109, and rs439401). 
While the first three TG-associated variants (APOE832/rs405509, APOE1163/rs440446, and 
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APOE2440/rs769450) were in modest LD with each other (0.60 < r2 < 0.61), these two variants 
(APOC1p2041/rs3826688 and rs439401) were in strong LD (r2=0.94). In Blacks, seven variants 
showed significant association with TG (APOE73/rs1081101, APOE4036/rs769455, 
APOC1p5667/rs12721054, APOC1p5926/rs56131196, APOC4p757/rs12721105, 
APOC4p2640/rs5158, and APOC2p2935/rs11879392). While two of them 
(APOC1p5667/rs12721054 and APOC1p5926/rs56131196) were in modest LD (r2=0.47), 
APOC4p2640/rs5158, and APOC2p2935/rs11879392 were in strong LD (r2=0.84). The 
RegulomeDB score of the strongly correlated variants is 2b, which is highly suggestive of their 
regulatory function. Eight of the 13 TG-associated variants have been previously reported to be 
associated with TG, including APOE832/rs405509 (Chasman et al., 2009), APOE1163/rs440446 
(Silander et al., 2008), APOE4036/rs769455 (Havel et al., 1983; Rall et al., 1989), rs439401 
(Jeemon et al., 2011; Chasman et al., 2009), APOC1p5667/rs12721054 (Coram et al., 2013), 
APOC4p2683/rs12721109 (Jeemon et al., 2011), rs7259004 (Ken-Dror et al., 2010), and 
APOC1p720/rs71962921 (Xu et al., 1999). One of these variants (rs439401) has shown genome-
wide significant association with TG (Chasman et al., 2009; Teslovich et al., 2010; Jeemon et al., 
2011), which we replicated in NHWs; the same variant also showed association with HDL-C in 
Blacks. We found significant association of HCR2p188/rs35136575 with HDL-C, and apoA1 in 
NHWs, which is consistent with its reported association with these traits in Whites (Klos et al., 
2008). In concordance with previous findings showing association of rs7259004 with apoA1 
(Ken-Dror et al., 2010), and association of APOC1p720/rs71962921 with HDL-C (Xu et al., 
1999), we observed the same associations in NHWs. The associations of remaining ten variants   
with non-LDL related traits should be considered provisional until they are validated in 
independent studies  
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Association of Rare Variants: Our observations confirm the significant contribution of 
rare variants to plasma lipid traits variation as it has been shown previously for some lipid genes, 
including ABCA1, LIPG, PCSK9, ANGPTL3, ANGPTL4, APOA5, GCKR, LPL, and APOB 
where rare variants were associated with dyslipidemia and were accumulated in patients with 
extreme lipid traits (Evans et al., 2011; Johansen et al., 2010; Johansen and Hegele, 2012; Cohen 
et al., 2004; Cohen et al., 2005; Kotowski et al., 2006; Romeo et al., 2007; Pollin et al., 2008). In 
addition to the significant association of common variants with lipid traits, rare and uncommon 
variants showed significant association with TC in NHWs (P=0.008) and with TG (P=0.030) and 
apoA1 (P=0.021) in Blacks in SKAT-O analysis of rare variants. The significant signal with TC 
in NHWs is more likely derived from 4 rare variants with MAF<1% that showed nominal 
association with TC in the single-locus association analysis: APOC1p3494 located in intron 3 
(P=0.00044), APOC4p1150/rs148247675 located in intron 1 (P=0.00043, RegulomeDB score = 
5), APOE4310/rs199768005 [Val254Glu] (P=0.01279, Regulome DB score = 5), and 
APOC2p2870 located in intron 1 (P=0.00179, Regulome DB score = 4). As expected, all these 
four rare variants that showed significant single-locus association with TC also were associated 
with LDL-C in NHWs. Of the 3 intronic variants mentioned above, two are predicted to affect 
gene regulation process based on their Regulome DB scores of 4 and 5. The non-synonymous 
variant has been reported previously to be associated with type III hyperlipoproteinemia (van den 
Maagdenberg et al., 1993). In Blacks, the association signal with TG is more likely derived 
either from a synonymous variant, APOC2p708C4p4012 [APOC4-exon 3, Lys124Lys] 
(P=0.038, Regulome DB score = 6), or APOC2p5512/rs12721064 located in 3’flanking region 
(P=0.0297, Regulome DB score = 6) with MAF<1% that were significant in single-locus 
analysis. The association signal with apoA1 is seemed to be derived from either 
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HCR1p424/rs117664574 (P=0.048, Regulome DB score=4) located in the first hepatic control 
region, or APOC2p1042C4p4346/rs12709885, located in the flanking region between APOC4 
and APOC2 genes (P=0.00071, Regulome DB score=5) with MAF<2%.  Since their Regulome 
DB score is only suggestive of their involvement in the gene regulatory process, further studies 
are warranted to elucidate their role in affecting plasma TG and apoA1 levels.  
Haplotype Association:  Haplotype-based association analysis is more powerful than the 
single-locus analysis to detect the cumulative effect for set of markers (Liu et al., 2008) because 
the power of single-marker analysis in detection the significance signal depends primarily on the 
LD structure between the tested marker and the disease-causing marker. In this study, haplotype-
based association analysis confirmed the single-locus association results and was more powerful 
in detecting functionally relevant regions that did not have significant single-locus effect. For 
example, window 52 that mapped to APOC4 variation showed significant global p-value with 
apoA1 in NHWs (P=0.042), but none of the variants included in this window had significant 
effect in single-locus analysis. The significant haplotype association in NHWs with apoA1 in 
window 52 seems to be mediated by a non-synonymous variant rs5167/Leu96Arg in APOC4 
(P=0.672 in single-locus analysis), a previously reported variant to be associated with HDL-C 
and apoA1 (Ken-Dror et al., 2010). This non-synonymous variant is mapped to APOC4-exon3 
that results in amino acid change and could affect the protein function. Single-locus analysis 
could not detect its weak effect on apoA1 but haplotype-based association analysis was more 
powerful in detecting its joint effect on apoA1. Similarly, we observed three windows to be 
associated with HDL-C (window 41, 42, and 43) and apoA1 (window 41, and 43) in Blacks 
where none of the variants included in these windows showed significant association in single-
locus analysis. However, two of the variants mapped to this region (rs7259004, and 
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HCR2p188/rs35136575) showed significant association with HDL-C/apoA1 in the single-locus 
association analysis. The first variant: rs7259004 was associated with apoA1 (P=0.046) and the 
second one: HCR2p188/rs35136575 was associated with HDL-C (P=0.033) and apoA1 
(P=0.049) in NHWs and they could contribute to the significant signal in haplotype association 
analysis that was found in Blacks.  
4.3 CONCLUSIONS AND FURTHER DIRECTIONS 
 
Coronary heart disease continues to be a leading cause of premature mortality and co-morbidity 
in western countries and dyslipidemia with elevated level of LDL-C and decreased level of 
HDL-C is a major risk factor for CHD. As compared to APOE polymorphisms, little attention 
has been paid to the role of APOE-C1-C4-C2 genetic variants in relations to plasma lipid levels. 
To our knowledge, this is the first comprehensive association study targeting the four genes in 
the APOE gene cluster on chromosome 19q13.32 to characterize both common and rare variants 
and to evaluate their associations with major lipid traits in two distinct racial groups.   
 In addition to the established association of APOE variation with LDL-C and apoB, we 
observed multiple variants to be associated with the other lipid traits, including TG, HDL-C, and 
apoA1. Moreover, in addition to the significant contribution of common variants, we observed 
rare and less common variants to be associated with lipid traits, confirming the significant 
contribution of rare variation in modulating complex lipid phenotype. Our findings confirm the 
complicated genetic architecture of complex lipid traits and future evaluation of the complex 
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interaction with other genetic and environmental factors would provide better insight of the 
genetic basis of complex traits. 
Strengths of our study include the use of two extreme lipid groups for resequencing from 
two racial groups and then genotyping the entire sample sets for genotype-phenotype association 
analyses. Limitations of our study include the use of relatively small sample sizes in two extreme 
lipid groups and not adjusting p-values for multiple comparisons. Many of our significant 
findings with rare variants should be considered provisional until replicated in independent and 
larger data sets.  
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